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The transcription factors Oct4, Nanog and Sox2 are key regulatory players in 
embryonic stem (ES) cell biology. Dissecting their transcriptional networks will 
provide inroads to the molecular mechanisms that direct ES cell pluripotency and 
early differentiation. I describe a role for a zinc finger transcription factor, Zic3, in 
the maintenance of ES cell pluripotency. Zic3 is expressed in ES cells and this 
expression is repressed upon differentiation. The binding of transcription factors 
Oct4, Nanog and Sox2 have been mapped to the gene regulatory region of Zic3 
in ES cells. Here I demonstrate that Zic3 is activated downstream of these key 
pluripotency genes. In addition, gene expression microarray experiments have 
uncovered significant overlaps between the Oct4, Nanog, Sox2 and Zic3 
pathways in ES cells. 
 
Targeted repression of Zic3 in human and mouse ES cells was performed to 
investigate the functional role of Zic3 in ES cells, and the results indicate that loss 
of Zic3 expression induces the expression of several markers of the endodermal 
lineage. This suggests that Zic3 plays an important role in the maintenance of 
pluripotency by preventing differentiation of ES cells into endoderm. This project 
therefore establishes a foundation for further investigation into the mechanisms 
involved in the maintenance of ES cell pluripotency.  
 
Little is known about the regulatory networks that Zic3 employs to maintain 
pluripotency or to determine lineage specificity during embryonic development. I 
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have established the global regulatory targets of Zic3 in ES cells and investigated 
its interactions with other ES cell-associated proteins. Here I define a Zic3 
consensus DNA binding motif and present evidence for the cooperative action of 
Zic3 with a key ES cell transcription factor, Sox2. These results include: (1) 
physical interaction between Zic3 and Sox2 proteins, (2) evidence for common 
regulatory pathways, and (3) a significant overlap between their target genes. 
These results indicate that Zic3 binds both in close proximity with Sox2 in ES 
cells and comes in direct contact with DNA.  
 
In addition, I report that Zic3 occupies promoters of ES cell-related genes as well 
as genes involved in early embryonic patterning, and mesoderm and ectoderm 
formation. Although Zic3-bound developmental regulators are transcriptionally 
silent in ES cells, functional analysis indicates that Zic3 has capacity to activate 
these genes outside the pluripotent state. This suggests that Zic3 may confer 
ectoderm and mesoderm specificity during differentiation of ES cells. In support of 
this, I demonstrate that transient drug-induced overexpression of Zic3 in ES cells 
enhances the rate of neurogenesis under conditions that promote neural 
differentiation. 
 
The zinc finger transcription factor, Zic3, is critical for the maintenance of ES cell 
pluripotency and, additionally, is a positive regulator of embryonic 
morphogenesis, and cardiac, skeletal and neural differentiation during embryonic 
development. To date, little is known about the transcriptional network that Zic3 
regulates to confer ES cell pluripotency or to define lineage specificity during 
development. To this end, the results of my work provide key molecular insight 
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into the Zic3-regulated pathways that influence ES cell pluripotency and the 
critical lineage decisions made during differentiation. This thesis therefore 
extends our knowledge of ES cell transcriptional circuitry and contributes to a 
greater understanding of the role of Zic3 in development. 
  x
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CHAPTER 1:    
INTRODUCTION 
  2
1.1 Derivation of embryonic stem cells 
The inner cell mass (ICM) of an embryonic blastocyst is a source of pluripotent 
cells that ultimately give rise to the embryo proper. Following implantation into the 
uterine wall, pluripotent ICM cells develop into both extra-embryonic endoderm as 
well as the three key embryonic germ layers comprising ectoderm, endoderm and 
mesoderm tissue1 (Figure 1A). The unique cells of the ICM therefore represent an 
opportunity for the study of fundamental processes behind embryonic 
development and cell fate determination.  
 
In 1981, Evans & Kaufman at the University of Cambridge made a significant 
breakthrough in their establishment of pluripotent ICM cells in laboratory 
cultures2. They had successfully delayed embryonic implantation to achieve 
enlarged blastocysts from which ICM cells could be isolated and expanded in 
vitro. Using a separate approach, developmental biologist Gail Martin 
independently extracted ICM cells from non-enlarged blastocysts, and aided their 
expansion with teratocarinoma-conditioned media, which she hypothesized 
contained growth factors that stimulated cell growth and prevented 
differentiation3. These ICM cells, henceforth termed “embryonic stem cells”, were 
shown to be pluripotent and could self-renew indefinitely in culture2,3 (Figure 1B). 
 
These two developments represented a significant breakthrough in the study of 
pluripotent cell types, and provided the basis of isolation techniques for ES cells 
from other species4-6. In 1998, knowledge gained from prior studies culminated in 





Figure 1. Contribution of the blastocyst inner cell mass to 
embryonic development and embryonic stem cells. (A) The 
ICM gives rise to extra-embryonic endoderm and the three germ 
layers of the embryo proper. (B) ES cells are derived from the inner 
cell mass of the embryonic blastocyst and can be propagated 
indefinitely in culture.
A.  Embryonic Development
B.  ES cells
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blastocysts of discarded in-vitro fertilization (IVF) embryos7. These cell lines 
demonstrated stable karyotype after several months of continuous passage, and 
had the ability to form extra-embryonic trophoblast and the three germ layers of 
the embryo proper7. Thomson et al. thus speculated that directed differentiation of 
human ES cells would one day be harnessed to treat clinical disease7. 
 
Today ES cells are recognized for their vast potential in a host of applications. In 
addition to being harnessed as a model for early embryonic development, and a 
vector for introduction of targeted mutations into the mouse germ-line8,9, ES cells 
are viewed as an important potential tool for clinical therapy and drug discovery10.  
 
1.2 Regulation of embryonic stem cells 
1.2.1 The key properties of ES cells 
Embryonic stem cells have the capacity to self-renew indefinitely when cultured 
under conditions that prevent differentiation11, and undergo rapid proliferation by 
symmetric division every 12 hours12. ES cells display an unusual cell cycle with a 
shortened Gap 1 (G1) phase lasting an average of 1.5 hours13. At the G1 phase, 
mammalian cells typically face a choice between entering the quiescent Gap 0 
(G0) state associated with post-mitotic differentiation, or to continue through the 
DNA Synthesis (S) phase in preparation for mitosis (Figure 2). The G1/S 
transition is therefore a critical point beyond which cells are committed to 
dividing14. In ES cells, the G1 control pathways commonly found in other cell 
types are reduced or absent13, resulting in prolonged maintenance of the self-
renewal state.  
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Figure 2. Components of the cell cycle. Gap 1 phase (G1) – The 
cell undergoes metabolic changes in preparation for division. This 
phase is marked by the synthesis of enzymes required for DNA 
replication in the S phase. Beyond the restriction point (R), the cell is 
committed to division and moves into the S phase. Synthesis phase 
(S) - DNA synthesis replicates the genetic material in preparation for 
mitosis, and each chromosome now consists of two sister chromatids.
Gap 2 phase (G2) – A period of intense protein synthesis where 
cytoplasmic material mainly consisting of microtubules are produced 
and organized for mitosis and cytokinesis. Mitosis (M) – This is a 
relatively brief phase comprising a nuclear division (karyokinesis) 
followed by a cell division (cytokinesis) to produce two identical 
daughter cells. Interphase (I) - The period between mitotic divisions, 
G1, S and G2, are collectively known as the interphase. Figure adapted 
from Clinical tools, Inc.
R
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Pluripotency is maintained during ES cell self-renewal through the prevention of 
differentiation and the promotion of proliferation15. Pluripotency is broadly defined 
as the potential to give rise to all the cells and tissues within an embryo proper, 
while lacking the self-organizing ability conferred by extra-embryonic tissue to 
generate a whole organism15,16. Pluripotent ES cells are characterized by the 
presence of ES cell surface markers (e.g. Stage-specific embryonic antigens), 
and specific patterns of gene expression, DNA methylation, and telomerase 
activity. In addition, pluripotent cells have ability to form teratomas when 
introduced into a host organism, generate chimeras upon injection into 8-cell 
embryos or blastocysts17, and show germline transmission18. 
 
Studies over the past few years have revealed that transcription factor 
networks19,20, epigenetic processes21-23, and extrinsic signalling pathways24-27 play 
important roles in the maintenance of ES cell pluripotency. These processes are 
described in greater detail in the following sections. 
 
1.2.2 Extrinsic signalling pathways maintaining ES cell pluripotency 
Embryonic stem cells are maintained by a network of extrinsic and intrinsic 
signals that collectively regulate the properties of pluripotency and self-renewal. A 
unique trademark of ES cells is their ability to propagate indefinitely without 
showing signs of senescence and cell death. However, the maintenance of the 
undifferentiated stem cell phenotype is not a cell autonomous process (Figure 3). 
ES cells are dependent upon exogenous factors that are supplied either by co-
culture with fibroblast feeder cells, or through the use of conditioned media28. One 




Figure 3. Signalling pathways contributing to the pluripotency of 
ES cells. Cell-surface receptors initiate signals that are conveyed (thin 
black lines) to the nucleus and affect key pluripotency transcription 
factors such as Oct4, Nanog, Sox2, and self-renewal transcription 
factors such as Stat3. These signals comprise: (A) The LIF-gp130 
pathway that triggers the JAK-kinase pathway activation of Stat3, (B) 
the Bmp4 signalling pathway, and (C) the Wnt-Frizzled activated 
pathway that signals Sox2 and Oct4 activity via mediators such as β-
catenin and the Smad proteins. (Adapted from Boiani & Schöler, 2004)
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sustains mouse ES cell self-renewal in the absence of the feeders24 (Figure 3A). 
The withdrawal of LIF from ES cell cultures results in a decrease in cell 
proliferation and induction of differentiation in mouse ES cells25. The expression 
of LIF in mouse embryonic feeder cells is stimulated by the presence of ES cells, 
and LIF is secreted into the media of ES cell co-cultures for the maintenance of 
pluripotency29. The importance of LIF is underscored by studies showing that 
feeder cells lacking a functional Lif gene do not effectively support ES cell 
propagation30. 
 
LIF binds to the gp130 heterodimer receptor on the cell membrane and activates 
downstream signaling pathways, beginning with JAK kinase-mediated recruitment 
of the transcription factor, Stat3 (Figure 3A). Stat3 undergoes phosphorylation 
and dimerization before being translocated to the nucleus, where it activates 
important transcriptional programs to maintain self-renewal in ES cells25. 
Significantly, studies have shown that activation of this transcription factor is 
sufficient to support ES cell self-renewal in medium lacking LIF31, thus confirming 
that Stat3 is the downstream effector of the LIF pathway.   
 
The LIF-Stat pathway alone is insufficient to maintain the pluripotent state in 
feeder-free ES cultures; additional signalling by Bmp4 is required for normal ES 
cell maintenance under serum-free conditions27. In the presence of LIF, Bmp4 
contributes to the LIF pathway by the activation of Smad4, which in turn activates 
members of the Id (inhibitor of differentiation) gene family to prevent neuronal 
specification in mouse ES cells27 (Figure 3B). The Bmp proteins also share their 
targets with the Wnt-activated ligand pathway26 (Figure 3C). The Wnt proteins are 
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secreted glycoproteins that have widespread roles in tissue differentiation and 
organogenesis32, and the canonical Wnt pathway is activated when a Wnt protein 
binds to the Frizzled receptor on the cell membrane. This leads to inhibition of 
Gsk3 (glycogen-synthase kinase-3) and subsequent translocation of β-catenin to 
the nucleus to regulate expression of downstream target genes (Figure 3C). 
Inhibition of the Gsk3 pathway results in the maintenance of undifferentiated 
mouse and human ES cells, with sustained expression of key pluripotent 
transcription factors Oct4, and Nanog even in the absence of LIF33. 
 
However Ying et al. (2008) have recently demonstrated that these extrinsic 
stimuli, previously thought to be critical for ES cell self-renewal, may in fact be 
dispensible. Small molecule-induced inhibition of the Gsk3 and phospho-ERK 
pathways that lie upstream of extrinsic signalling pathways resulted in replication 
of the pluripotent state34, and complete bypass of cytokine signalling was 
demonstrated using Stat3-deficient cells. This suggests that the BMP/Smad/Id and 
LIF/STAT3 pathways are not instructive for self-renewal but instead shield the 
pluripotent state from induced phospho-ERK. These new findings indicate that ES 
cells may have innate self-renewal capacity and are not dependent on external 
signalling factors for propagation of the pluripotent state. 
 
1.3   Transcriptional networks in ES cells 
The extrinsic signalling pathways eventually reach the ES cell nucleus to activate 
or repress transcriptional programs responsible for the pluripotent state of the ES 
cells (Figure 4). Here the nuclear transcription factors Oct4, Nanog and Sox2 
feature prominently in directing self-renewal and maintaining pluripotency. In early 
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studies of ES cells, these transcription factors were identified as potential 
regulators of pluripotency due to their unique expression pattern and critical roles 
in early development35-39 and their function as essential regulators of cell-fate 
specification in many organisms37,40. The activity of these transcription factors also 
depends on the accessibility of their target genes, which are made more or less 
accessible by the modification of their DNA, histones, or chromatin structure22,23,41. In 
recent years, it has emerged that Oct4, Nanog and Sox2 contribute to the 
hallmark characteristics of ES cells by: 1) activation of target genes that encode 
pluripotency and self-renewal mechanisms and 2) repression of signalling 
pathways that promote differentiation42 (Figure 4). These key transcription factors 
will be reviewed in the following section. 
 
1.3.1 Regulation of transcription networks 
Proper regulation of gene transcription is critical for activation of tissue-specific 
programs, and is foundational to the establishment of unique tissue properties. 
The biological properties of an organism are characterized by gene expression 
patterns that result from a dynamic interplay between transcription factors and 
their target genes. Delineation of transcriptional networks is therefore required to 
understand the molecular basis of cell fate.  
 
Transcription factors comprise several domains that are essential for its function43 
(Figure 5). DNA-binding domains (DBD) associate with DNA in non-coding 
regions, and confer specificity by recognition of specific DNA sequences within 
the promoter of each gene. Secondly, several transcription factors also contain a 
signal sensing domain (SSD) which senses and transmits external signals to the 
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Figure 4. Role of Oct4, Nanog and Sox2 in ES cell pluripotency. Oct4, 
Nanog and Sox2 activate target genes in ES cells that signal the
expression of pluripotency and self-renewal factors. These core ES cell 
transcriptional factors concurrently repress the expression of genes 
encoding pathways that promote ES cell differentiation. Source: Orkin, 
S.H., 2005
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rest of the transcription complex to regulate gene expression (Figure 5). Finally, 
the trans-activating domains (TAD) of transcription factors contain binding sites 
for coactivator proteins (Figure 6) which signal the basal transcription proteins to 
initiate RNA-polymerase mediated transcription of the target gene. The 
transcription initiation complex in Figure 6 illustrates the core units required for 
activation of gene transcription, and demonstrates how signals from the 
transcriptional activators and repressors are transmitted via coactivator proteins 
to regulate the activity of RNA polymerase. 
 
Transcription networks are built upon a series of interconnected pathways that 
collectively regulate the gene expression program of an organism. At the most  
basic level, transcription networks are organized into 6 simple motifs with specific 
patterns of regulation between transcription factors and their target genes44. 
These transcriptional motifs are illustrated in Figure 7. The single-input motif is a 
connection between a target gene and its sole transcriptional regulator, while the 
multiple-input motif is simultaneously regulated by a group of factors45. The target 
genes belonging to these two motifs are usually co-expressed at levels 
proportional to the number of transcription factors involved46.  
 
A feed-forward loop is established when a TF regulates the expression of a 
second TF, and both factors together regulate the expression of a common set of 
target genes44-46. Integrated networks characterized by these multiple feed-
forward loops tend to show stable regulatory patterns47. Other common motifs 
identified in yeast include the autoregulatory and regulatory chain motifs48. The 
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Figure 5. Functional domains of a transcription factor. The 
amino acid sequence of a prototypical transcription factor is 
illustrated, containing a DNA-binding domain (DBD), a signal 
sensing domain (SSD), and a transactivation domain (TAD). The 
number and order of domains may differ in various types of 
transcription factors. Adapted from Latchman, DS. (1997)
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DBD
TAD
Figure 6. Assembly of a transcription initiation complex. Transcription 
factors (red) bind to promoter or enhancer regions to determine the genes 
that will be transcriptionally activated. The interaction of DNA binding domain 
(DBD) with DNA and trans-activating domain (TAD) with coactivators are 
represented here. Repressor proteins (grey) bind to DNA at sites known as 
silencers and interfere with the function of activators to decrease the rate of 
transcription. Co-activators (Green) are adaptor molecules that integrate 
activator and repressor signals and relay the results to the basal factors (blue) 
which position RNA polymerase at the start of the protein-coding region of a 
gene, and initiate the transcriptional activity of the enzyme. Adapted from 
“Transcription of Eukaryotic DNA”, Roanoke College, Biology 201 Chapter 
11b.
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predominating motif is often determined by the type of transcriptional response 
required, such that an “all-or-none” response is usually characterized by single-
input motifs, whereas more subtle and gradated response usually results from a 
combination of multiple-input motifs47. Together, these individual network motifs 
form the entire assembly of regulatory interactions known as the ‘transcriptional 
regulatory network’, which specifies the blueprint for gene expression patterns 
within an organism44. 
 
 
1.3.2 Oct4, Nanog and Sox2 are key regulators of transcription in ES cells 
In ES cells Oct4, Nanog, and Sox2 co-occupy promoters of hundreds of genes 
that are both expressed and repressed in the pluripotent state19,20,49 (Figure 8).  
 
This suggests complex regulatory circuitry in which Oct4, Nanog, and Sox2 
collectively and uniquely regulate downstream genes to control ES cell 
differentiation. Recent advances in genomic technologies have enabled the 
construction of transcriptional regulatory networks of Oct4, Nanog, and Sox2 in 
ES cells. Two groups have harnessed the chromatin-immunoprecipitation (ChIP) 
technique followed by genomic analysis of the target material to identify DNA 
bound by the three factors in human and mouse genomes19,20,49. Oct4, Nanog, 
and Sox2 were found to co-occupy a substantial portion of their target genes, 
suggesting that the three factors interact to regulate a large subset of common 
targets. Nanog shares 44.5% (345) of Oct4-bound genes in mouse ES cells20, 
while 353 genes are co-bound by Oct4, Nanog, and Sox2 in human ES cells19.  
However, a comparison of the Oct4- and Nanog-bound regions revealed small  
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Figure 7. The transcriptional circuit is built on basic network motifs. 
The motifs in this figure represent the most common units found in 
transcription networks, comprising single and multiple input motifs, and 
autoregulatory, feed-forward, multi-component and regulator chain loops. 
Source: Blais & Dynlacht, 2005
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Figure 8. The core transcriptional regulatory network in ES 
cells. Genomics studies have enabled the elucidation of Oct4, 
Sox2 and Nanog networks, which reveal an integrated circuitry 
comprising genes that are involved in pluripotency and those that 
specify the development of both extra-embryonic and embryonic 
lineages. Boxes and circles indicate genes and proteins, 
respectively. Arrows represent interactions only, and not positive 
or negative effects. Adapted from Boyer. et al., Cell, Vol. 122, 
947–956, September 23, 2005
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overlaps between their target genes in mouse and human ES cells20,50 (Figure 
9A). The lack of similarities between their genomic targets have been attributed to 
the differing genomic platforms employed in the two studies, and possible 
genuine differences between the regulatory networks of human and mouse ES 
cells. 
 
A closer examination of the Oct4, Nanog and Sox2 targets revealed that these 
key transcription factors occupy the promoters of both transcriptionally active and 
inactive genes in ES cells19,20,49. Among the active targets are genes encoding ES 
cell self-renewal genes including Stat3 and components of the Wnt and TGF-β 
pathways. Amongst the inactive targets are a large number of transcriptionally 
silent lineage-specification genes. It was therefore concluded that Oct4, Nanog 
and Sox2 regulate a wide spectrum of cellular processes, and collectively function  
to maintain pluripotency by promoting the expression of other self-renewal genes 
while simultaneously preventing expression of differentiation-promoting genes 
involved in mesoderm, endoderm and ectoderm specification during development 
(Figure 8). 
 
The assays for Oct4, Nanog and Sox2 targets revealed two regulatory motifs in 
the ES cell transcriptional circuitry19. Figure 9B represents the feed-forward loop 
in which Oct4 and Sox2 interact to co-activate Nanog expression, which 
subsequently acts in concert with these two factors to control downstream target 
genes. Oct4, Nanog and Sox2 also occupy the promoters of their own genes to 
form the interconnected auto-regulatory loops shown in Figure 9C. Collectively, 
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Figure 9. Transcriptional regulatory motifs between Oct4, Nanog 
and Sox2 and their common targets in ES Cells. (A) Oct4 and Nanog 
share a small subset of target genes between mouse and human ES 
cells. (B) Feedforward transcriptional regulatory circuitry in human ES 
cells. Regulators are represented by blue circles; gene promoters are 
represented by red rectangles. Binding of a regulator to a promoter is 
indicated by a solid arrow. Genes encoding regulators are linked to their 
respective regulators by dashed arrows. (C) The interconnected 
autoregulatory loop formed by Oct4, Nanog and Sox2. Adapted from: 





these feedforward and auto-regulatory loops provide the advantage of reduced 
response time to environmental stimuli and increased stability of gene expression 
in ES cells.  
 
In addition to transcription factor binding targets, a recent study was conducted to 
determine protein interaction patterns of key pluripotency genes51. The results 
indicate that a large subset of pluripotency-associated proteins such as Oct4, 
Esrrb, Rif1, and Sall4 are highly enriched within Nanog-associated complexes. 
Significantly, a substantial portion of the Nanog interactome members are also 
transcription targets of Oct4, Sox2 or Nanog in ES cells19,20. Moreover, a recent 
chromatin-immunoprecipitation assay combined with ultra-high-throughput 
sequencing (ChIP-sequencing) of 13 ES cell transcription factor binding sites 
revealed their dense occupancy patterns throughout the genome. The sites with 
dense TF occupancy were termed “multiple transcription-binding loci” (MTLs) of 
which 43.4% reflected Oct4, Nanog and Sox2 co-occupancy and were frequently 
associated with Smad1 and Stat3 binding49. This suggests that Smad1 and Stat3 
share many common target sites with Nanog, Oct4, and Sox2, and reflects a 
point of convergence between the Smad1 and Stat3 signaling pathways with the 
core ES cell circuitry comprising Nanog, Oct4, and Sox219,20.   
 
Interestingly, while the withdrawal of LIF and Bmp4 led to a significant reduction 
in binding of Stat3 and Smad1 proteins respectively, the extent of Oct4 
occupancy remained unaffected. These results strongly indicate that Oct4 is 
central to the stability of the nucleoprotein complex49. The Oct4/Nanog/Sox2 
MTLs also exhibit significant characteristics of enhanceosome complexes52, such 
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as dense TF occupancy and an ability to enhance transcription from a distance. 
In addition, a second highly occurring MTL cluster comprising c-Myc, n-Myc, Zfx, 
and E2f1 co-occupancy was identified in ES cells. Together with the 
Oct4/Sox2/Nanog loci, the collective targets of these two clusters comprise 60% 
of genes upregulated in ES cells49.  
 
The recent data have therefore identified functionally-important genomic 
“hotspots” within the ES cell genome. These sites are extensively co-occupied by 
transcription factors and reflect in particular the presence of Oct4, Nanog, and 
Sox2 feedforward loops in ES cell transcriptional networks (Figure 9). In the 
following sections, I will review the properties of these three key ES cell 
transcriptional regulators that establish the genomic state necessary for the ES 




The transcription factor Oct4 is a POU-domain protein encoded by Pou5f1. The 
POU-domain family is named after three mammalian transcription factors, Pit-l, 
Oct-l, Oct-2, and a C. elegans protein Unc-86, which share a region of homology 
known as the POU domain53-57. The POU domain is a bipartite DNA-binding 
domain comprising two highly conserved regions tethered by a variable linker. 
The 75-amino acid N-terminal region is known as the POU-specific domain, while 
the C-terminal 60-amino acid region, the POU homeodomain. High-affinity site-
specific DNA-binding by POU domain transcription factors requires both the POU-
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specific domain and the POU homeodomain. The two subdomains can 
cooperatively bind DNA even when they are not joined by the linker53,57-60. 
 
Certain transcription factors containing the POU-homeodomain are important 
regulators of early mammalian development36,57,61-63. Oct4 is expressed in the 
unfertilized egg and within the early embryo during the cleavage stages prior to 
the separation of the ICM from the trophectoderm64. The expression of Oct4 is 
then maintained in the epiblast of pre- and post-implantation embryos before 
becoming restricted to the migratory primordial germ cells65,66. In addition, Oct4 
expression is downregulated in the trophectoderm, primitive endoderm and the 
extraembryonic and somatic lineages66. Interestingly, Oct4-deficient embryos 
develop to the blastocyst stage but comprise only trophectoderm cells without the 
ICM38. These Oct4-null embryos also specifically give rise to trophectodermal 
cells when dissociated and maintained in vitro38. Moreover, RNAi-mediated 
depletion of Oct4 causes human ES cells to differentiate towards the 
trophectodermal lineage67. These results indicate that Oct4 plays a central role in 
preventing trophectodermal differentiation while maintaining the pluripotent state 
of the ICM during embryonic development (Figure 10).  
 
Consistent with its role as a repressor of trophectoderm commitment, Oct4 is a 
negative regulator of Cdx2, a factor essential for the self-renewal of trophoblast 
stem cells and specification of the trophoblast lineage in vivo68. Moreover, 
overexpression of Oct4 in mouse ES cells results in endodermal and mesodermal 
lineage specification69 (Figure 10). These results collectively indicate that Oct4 
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has a key role in regulating ES cell pluripotency, and that precise levels of Oct4 
protein are required to maintain its function in ES cells69.  
 
1.3.2.2 Sox2 
Sox2 is a member of the Sox (SRY-related HMG box) gene family that encodes 
transcription factors with a high mobility group (HMG) DNA-binding domain70. 
Based on homology within and outside the HMG box, Sox2 belongs to the SoxB1 
subgroup that encompasses the Sox1 and Sox3 proteins. Several lines of 
evidence suggest that Sox2 functions to maintain developmental potential in their 
target cells. Firstly, Sox2 expression is found in growing and mature oocytes37. 
Secondly, it is present in blastomeres and then later in the ICM of blastocysts and 
epiblasts cells71. Sox2-deficient embryos give rise to defective ICMs from which 
pluripotent ES cells cannot be derived (Figure 10), and subsequently, to abnormal 
development of the epiblast37, and these Sox2 null embryos also demonstrate 
lethality around the peri-natal stages. Third, Sox2 expression is associated with 
embryonic stem cells19,20 and uncommitted precursor cells within the developing  
central nervous system72 (Figure 10). Thus the expression pattern of Sox2 is 
similar to that of Oct4 within embryonic stem cells, and the embryonic ICM, 
epiblast and germ cells. However, unlike Oct4, Sox2 is also found within the 
multipotent cells of the extraembryonic endoderm, suggesting that Sox2 may be 
involved in establishment of primitive and extra-embryonic ectoderm, and that its 




Oct4LOF – differentiation of ES and ICM cells 
into trophectoderm 1
GOF – differentiation into 
primitive mesdoderm & 
endoderm 2
Nanog GOF – promotes self-
renewal via the LIF-
STAT3 pathway 7
LOF – spontaneous 
differentiation into 
primitive endoderm 5,6
Oct4 interacts with Sox2 3
* Sox2 expression is also 
found in early neural 
lineages4
LOF – differentiation 
of ES cells; specific 
phenotype unknown
GOF - unknown
Figure 10. Gain- and Loss-of-function phenotypes of Oct4, Nanog 
and Sox2 in ES Cells. Loss-of-function phenotypes are described in the 
left column, and grain-of-function phenotypes are described in the right 
column.
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The expression of Sox2 in ES cells is known to be mediated by two 
promoter/enhancer regions on the Sox2 gene, known as SRR1 and SRR273. Oct4 
has recently been shown to bind and regulate an octamer recognition sequence 
within the SRR1 region74, and SRR2 contains a composite sox-oct binding 
element 1.2 kb downstream of the Sox2 transcription start site73. Binding of Oct4 
or Sox2 to SRR2 is mediated by the presence of Oct4, and mutations to the 
SRR2 region that resulted in ablation of Oct4 binding disrupted the formation of a 
DNA/protein complex, and subsequent loss of SRR2 activity73. These results 
indicate that Oct4/Sox2 heterodimer occupancy of the SRR2 region is essential 
for the expression of Sox2. The above results are supported by structural 
validation of the ability of the POU and HMG domains to mediate specific protein-
protein and DNA-protein interactions75,76, and the observation that regulatory 
regions of a set of important Oct4/Sox2 co-regulated genes in ES cells contain an 
sox-oct element on which Oct4/Sox2 heterodimers bind and interact 
synergistically37,77 to regulate expression of their downstream targets. 
 
1.3.2.3  Nanog 
Nanog was identified as an important ES cell transcription factor through gain-of-
function studies demonstrating its ability to maintain mouse ES cells in the 
absence of LIF and feeder cultures39,78 (Figure 10). The Nanog protein comprises 
a 96 amino acid N-terminal domain and a 150 amino acid C-terminal domain. 
Both the N- and C-terminal domains of mouse Nanog have the ability to trans-
activate Nanog target genes, with the C-terminal domain being 7 times as active 
as the N-terminal one79. This unique arrangement of dual trans-activators may be 
responsible for the flexibility and specificity of Nanog to regulate downstream 
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targets critical for both ES cell pluripotency and differentiation. The Nanog protein 
also contains a homeobox domain which confers binding specificity by recognition 
of DNA motifs, and Nanog consensus sequences have been defined in the 
promoter/enhancer regions of Rex1 and Gata6 genes80,81.  
 
Nanog expression is first observed in the embryonic morula, and high levels of 
Nanog RNA persist in the early blastocyst and declines just prior to 
implantation39,78. Nanog expression is subsequently restricted to a subset of 
epiblast cells and is down-regulated during primitive streak formation39,78. The in 
vivo depletion of Nanog disrupts inner cell mass proliferation and prevents 
formation of epiblast39,78. Nanog-null embryos do not give rise to primitive 
ectoderm at E5.539, and hence subsequently do not form the three primary germ 
layers of the embryo. In addition, Nanog is expressed in pluripotent germ cells of 
the nascent gonad during embryonic development, and within in germ cell 
tumours and teratoma-derived cell lines35. These results collectively indicate that 
Nanog signalling is important in pluripotency and early embryonic development. 
 
Recent studies have shown that Oct4 and Sox2 co-occupy the promoter of Nanog 
and positively regulate its expression in ES cells (Figure 9B)19,82,83. Nanog is 
known to be essential for propagation of ES cells in an undifferentiated state, and 
loss of Nanog results in spontaneous differentiation into primitive endoderm 
(Figure 10). This is similar to the cell type formed upon ectopic expression of 
Gata4 and Gata6 in ES cells84, and it is thought that Nanog maintains 
pluripotency through repression of Gata4 and Gata6 pathways to prevent 
primitive endoderm differentiation in ES cells.  
  27
1.3.3 Identifying genes that contribute to stem cell pluripotency 
The transcriptional networks governing the unique properties of ES cell 
pluripotency and self-renewal have been the focus of many genome- and 
proteome-wide studies to date. These approaches include high-throughput gene 
expression profiling to determine transcripts upregulated in the pluripotent 
state85,86, chromatin-immunoprecipitation to identify targets of Oct4, Nanog and 
Sox2 in mouse and human ES cells19,20,49,87, RNAi-mediated depletion of key 
regulators in ES cell pluripotency accompanied by global analysis of gene 
expression to determine affected pathways87, and affinity purification of Nanog-
associated proteins followed by mass spectrometry to establish a protein 
interaction network in ES cells51.  
 
Many transcription factors apart from Oct4, Nanog and Sox2 have recently been 
identified that are essential for the undifferentiated state of ES cells. An RNAi-
mediated knockdown approach has demonstrated that 8 genes (Nanog, Oct4, 
Sox2, Tbx3, Esrrb, Tcl1, Dppa4 and Mm.343880) are important for maintaining 
the morphology and proliferation of ES cells87. In addition, a genome-wide study 
has identified and characterized Rif1 and Esrrb as important downstream 
effectors of Oct4 and Nanog of mouse ES cells20. Another study that combined a 
list of Oct4 binding targets with gene expression profile changes resulting from 
perturbations of endogenous Oct4 levels has identified Tcl1 as a critical regulator 
of cell proliferation88. Furthermore, two separate studies have also shown that a 
member of the spalt-like protein family, Sall4, physically interacts with Nanog and 
positively regulates transcription of Oct4 in ES cells89,90. Two recent studies have 
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also demonstrated that Tcf3, a downstream effector of the Wnt pathway, is a 
regulator of ES cell pluripotency and self-renewal91,92.  
 
A series of breakthrough experiments initiated by Takahashi and Yamanaka have 
demonstrated the ability of four transcription factors Oct4, Sox2, Klf4 and c-Myc 
to re-establish a pluripotent state when ectopically expressed in mouse and 
human embryonic fibroblasts93,94. Importantly, these reprogrammed cells were 
were able to form viable chimaeras that demonstrated germline transmission95,96. 
However, the tumorigenicity resulting from the reactivation of retroviral-
transduced c-Myc render these induced pluripotent cells (iPS) unsuitable for 
transplantation96. To this end, another study has shown that Nanog and Lin28 
may be used in place of Klf4 and c-Myc to successfully generate human iPS 
cells97.  
 
The above findings demonstrate that the ES cell pluripotent state is maintained by 
a large number of transcription factors apart from Oct4, Nanog and Sox2 in auto- 
and co-regulatory feedback loops. In addition, pluripotency may be re-established 
in differentiated cells by ectopic expression of ES cell transcription factors by 
various combinations of Oct4, Nanog, Sox2, Klf4, c-Myc and Lin28. These results 
indicate that ES cell pluripotency is a complex network encompassing a large 
host of transcription factors. There is therefore a critical need to dissect the ES 
cell transcriptional pathways to achieve a greater understanding of ES cell 
properties, in order to gain insight into embryonic development and important 
knowledge to harness these cells for effective therapy. 
 
  29
1.4 Properties of zinc finger transcription factor Zic3 
The zinc finger transcription factor Zic3 was initially identified as a potential 
regulator of ES cell pluripotency due to its expression profile. Zic3 is highly 
expressed in mouse and human ES cells85,86, and its expression is rapidly 
downregulated as the cells begin to differentiate. I have investigated the role of 
Zic3 in the regulation of ES cell transcriptional networks in this thesis, and the 
following sections therefore contain a review of the properties of Zic3 and a 
description of its roles in embryonic development. 
 
1.4.1 The Zic gene family 
The Zic proteins (Zinc finger protein of the cerebellum) belong to the GLI 
superfamily of transcription factors and are vertebrate homologues of the 
Drosophila zinc finger pair-rule protein, odd-paired (opa), essential for the 
parasegmental division of the Drosophila embryo  98. The five known mammalian 
Zic genes (Zic1 – 5) encode five tandem C2H2 zinc finger domains that are highly 
conserved across species98-104 (Table 1, Figure 11A). The zinc finger (ZF) domain 
of Zic family genes is characterized by an unusually long intervening sequence 
between the two cysteine residues of the first ZF motif. In addition, the N-terminal 
region contains a ZOC domain conserved between vertebrate Zic and the 
Drosophila Odd-paired (Opa) proteins98 (Figure 11A), to which transcriptional 
activity has been mapped105.  


















































Figure 11. Structure and relationship between the Zic family 
proteins. (A) Structure of Zic protein family members with zinc 
finger (ZF) and ZOC domains indicated. (B) Phylogenic tree 
showing relations within the Zic family proteins, derived from a 
comparison of Zic family DNA sequences. The Zic1 – 3 subgroup 
is indicated by the red box. Adapted from: Aruga, J. Mol Cell 




The Zic genes are thought to share a common ancestral gene, and phylogenic 
analysis has revealed that Zic1, Zic2 and Zic3 are most closely related and form a 
subgroup among Zic family genes (Figure 11B). Zic3 shares overall 64% and 
59% homology with Zic1 and Zic2 respectively, and this homology increases to 
91% within the zinc finger domain106 (Figure 12). Thus members of Zic family are 
strong candidates for redundancy in molecular signalling owing to the high degree 
of homology and overlapping expression observed among the members of this 
family. In addition, the genomic locations of gene pairs Zic1 and Zic4, and Zic2 
and Zic5 demonstrate a head-to-head arrangement in 30-kb genomic regions, 
implying chromosomal duplication of an ancestral gene complex that contributes 
to the high complexity of Zic genes and the evolution of body plans during 
development106. 
 
Zic family proteins share high homology with the Gli and NKL (Gli-Kruppel zinc-
finger protein) families in their zinc finger domains, where the last three C2H2 
motifs in particular are well conserved. Gli family proteins function as 
transcriptional mediators of the hedgehog (Hh) signaling cascade107,108 and are 
known to play critical roles in dorsoventral neural patterning109-111. Furthermore, 
characterization of the NKL/Gli protein family has shown that NKL promotes 
neuronal differentiation in the formation of primary neurons and other neuronal 
precursors112-114. The Zic proteins are also hypothesized to regulate genes 
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Figure 12. DNA sequence of the Zinc finger domain. The amino 
acid sequence alignment of zinc finger domains of the Zic, Zic2, Zic3, 
and Opa proteins. Bold letters indicate the conserved or similar 
residues among all four proteins, and the asterisks above the Zic1 line 
indicate the cysteine and histidine residues of a typical C2H2 motif. 
Adapted from: Nakata et al., Mech Dev. 1998 Jul;75(1-2):43-51.
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involved in the hedgehog and neural development pathways, and may derive 
their function from these conserved zinc finger domains between the Gli and NKL 
families. 
 
1.4.2 Discovery of Zic3 and its general expression domains during 
development 
In the adult, the Zic genes are expressed almost exclusively in the 
cerebellum98,101. The first mammalian Zic family member, Zic1, was identified 
through an adult mouse cerebellum cDNA library screen101 and Zic3 was 
subsequently discovered through its shared homology of the zinc finger domain 
(Figure 12) by low-stringency genomic screens and cDNA cloning98. Although the 
Zic genes are expressed together in the adult mouse cerebellum, expression 
profiling revealed that they are found in partially overlapping and sometimes 
distinct domains during development115,116. The expression of Zic3 has been 
identified in the mouse ectoderm and mesoderm during gastrulation, the dorsal 
neural tube during neurulation, and the developing brain and limb buds during 
organogenesis (Table 2). Zic1 and Zic2 expression has also been detected in 
these regions, and it is thought that the overlapping domains and high structural 
homology between Zic1, Zic2, and Zic3 may allow these proteins to function in 
compensatory mechanisms during development. 
 
1.4.3 Biochemical pathways involving Zic3 
The Zic and Gli family proteins physically interact through their zinc finger 
domains to regulate neural and skeletal patterning117,118, and the Zic proteins are 
known to bind a DNA sequence highly similar to the Gli binding site, recognizing a 
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Table 2. Expression of Zic genes during early mouse and 
xenopus development
Adapted from: Herman & El-Hodiri, Cytogenet Genome Res. 2002;99(1-
4):229-35. 
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core motif comprising 5’-TGGGTGGTC-3’105. Zic/Gli interactions also facilitate the  
nuclear translocation of these proteins to function as transcriptional activators and 
repressors103,119,120, which forms the basis of their antagonistic and synergistic 
features in development. As the Gli family members are well-characterized 
regulators of the hedgehog (HH) signaling pathway110,121,122, it has been 
speculated based on interactive capacity that the Zic proteins are potential 
modulators of the hedgehog-mediated signaling pathway120. At the molecular 
level, Zic3 appears to function primarily as a transcriptional cofactor with the Gli 
proteins, with interactions occurring at the zinc-finger domain105,120. A Zic3 DNA-
binding sequence has been identified, although its binding affinity is significantly 
lower than that of Gli proteins105. 
 
The specific pattern of Zic3 expression during gastrulation suggests an important 
role in development of embryonic ectoderm and mesoderm tissue. This is 
supported by molecular pathways in which Zic3 has been implicated. For 
example the mesoderm-associated gene Brachyury induces Zic3 expression in 
Xenopus123, and the embryonic patterning gene Nodal is regulated by Zic3 during 
gastrulation through interaction with an upstream enhancer region in both mouse 
and Xenopus embryos124. A recent study demonstrated that Zic3 activates a 
2.7kb enhancer region of Nodal at the node of the murine embryos124. This 
enhancer region, located 7.5 kb upstream of the Nodal translational start site, has 
been shown to be responsible for node -specific expression of Nodal in murine 
embryos125. In ectodermal development, Zic3 is a potent inducer of Xenopus 
proneural and neural crest genes126, and is induced directly downstream of 
transcription factors Pbx1b and Meis1 in the Xenopus ectoderm127,128. 
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1.5  Role of Zic3 in early embryonic development 
1.5.1 The embryonic midline 
The earliest reported phenotypic abnormality in Zic3-null mutants is a defect in 
establishment of the Left-Right axis129, resulting in a congenital defect known as 
X-linked heterotaxy124,130,131.  A key process in early embryonic development is 
the formation of positional axes. Along with the anteroposterior and dorsoventral 
axes, the presence of the evolutionarily conserved left-right axis is crucial for the 
proper morphogenesis of internal organs. Disturbances in left-right asymmetry 
can result in severe developmental aberrations such as (1) situs inversus, a 
complete inversion of organs relative to the L-R axis; (2) heterotaxia or situs 
ambiguous, the randomization of organ placement within the embryo; or (3) 
isomerism, where mirror image duplications of paired organs are observed132. 
 
During development, the establishment of the Left-Right (LR) axis can be 
described in three consecutive stages: (1) initial disruption of embryonic 
symmetry; (2) establishment of asymmetric gene expression; and (3) 
transmission of positional information to the developing organs133. These phases 
are reflected in Figure 13 and are described in greater detail in the following 
paragraphs.  
 
1.5.1.1   Breaking bilateral symmetry  
Left-right asymmetry is initiated in mouse embryos early in the gastrulation 
phase134 (Figure 13). A series of experiments at this stage have identified an 
organizer, or node, as an early inducer of laterality135,136. The nodal-flow model 
describes a role for the monocilia at this region. Firstly, monocilia create a critical 
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Figure 13. Determination of Left-Right asymmetry in the developing 
embryo. (1) Left-right asymmetry begins with an initial process that orients 
direction in the embryo. (2) The asymmetric pattern is propagated and 
amplified by cascades of gene expression that culminate in production of a 
Nodal protein on the left side of the embryo. (3) Nodal action is modulated 
by lefty proteins, in particular by constraining its action at the dorsal 
midline. At this stage of embryogenesis, nodal proteins regulate expression 
of Pitx2c and other factors that influence morphogenesis in asymmetrically 
developing organs (3). Source: Mercola 2003. J Cell Sci. 2003 Aug 
15;116(Pt 16):3251-7 
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unidirectional flow of signalling molecules and morphogens consistently to the 
embryo’s left137. The importance of this process is underscored by studies 
demonstrating that when cilia are rendered immotile by deletion of the left-right 
dynein gene (lrd)138,139, or absent through mouse knockouts of the kif3 
genes137,140, randomized laterality is observed in the resulting mutant embryos. 
Restoring the leftward flow in dynein (lrd) mutants rescued the mutant 
phenotype137. Furthermore, when an artificial rightward nodal flow was created in 
wildtype embryos, an inversion of laterality was observed141. Thus directional flow 
appears to be an important factor in correct handedness determination. 
 
Based on fluid dynamics, Cartwright et al suggested that the cilia are able to 
direct leftward flow by capitalizing on a posterior tilt of the embryo, which impedes 
rightward fluid movement as the cilia stroke close to the cell surface142. This 
model has been experimentally validated, firstly through video microscopy of E8.0 
mouse embryos, and secondly, through a mechanical model in which leftward 
velocity is shown to be proportional to the angle of tilt143. Further evidence from 
rabbit and medakafish embryos support the posterior tilt model for leftward flow 
that results in left-right axis development144. Thus recent evidence has shed some 
light on the role of cilia in generating unidirectional nodal flow, and demonstrates 
their importance in the establishment of the left-right axis during early gastrulation 
through facilitating the asymmetric transport of morphogens. 
 
1.5.1.2  Asymmetric Gene Expression: Reinforcement of Left-Right Polarity 
Following the break in bilateral symmetry, asymmetric gene distribution is induced 
in the embryo (Figure 13). At this stage, retinoic acid (RA) is a demonstrated 
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inducer of left side genes such as Nodal, Lefty, and Pitx2. Ectopic administration 
of RA resulted in misexpression of Nodal, Lefty, and Pitx2 and caused abnormal 
situs in the developing embryo145,146. Conversely, the presence of RA-inhibitors 
caused a downregulation in the expression of Nodal, Lefty, and Pitx2145,146. 
Furthermore, studies have shown that the cis-regulatory region of Nodal contains 
retinoic acid response elements, and that Lefty expression is induced by RA in 
the P19 embryocarinoma cell line125,147. 
Nodal is a key morphogen that regulates specification of the left-right axis148 
(Figure 13). It has been shown to have critical functions during early murine 
embryogenesis and to be expressed in different tissues of the early embryo. The 
epiblast expression of Nodal is crucial for the establishment of the primitive 
streak149,150, and the primitive endoderm expression of Nodal is important for 
patterning of the anterior aspects of the A-P axis149. Two distinct cis-acting 
regulatory elements control Nodal expression at different tissue sites: an 
upstream enhancer region directs node-specific expression, while an intronic 
enhancer controls expression in the epiblast and the visceral endoderm125. 
 
The importance of Nodal signalling in L-R axis formation is underscored by 
studies of the lefty genes which act as inhibitors of Nodal signalling during 
gastrulation151,152, possibly through inhibition of putative Nodal receptors such as 
the Activin receptor, ActRIIB152. Lefty expression is found in the embryonic 
midline and overlaps with that of nodal expression (Figure 13)151, and Lefty2 has 
the ability to function as a feedback inhibitor to block both Nodal and Lefty2 
expression on the left153. Significantly, Lefty expression has been shown to be 
  41
affected in mutant mouse backgrounds that affect organ situs154,155. In addition, 
mutations in mouse Lefty1 lead to defects in left-right specification, including 
altered symmetric expression of Lefty2 in the lateral plate mesoderm and left 
pulmonary isomerism155. The above results collectively indicate that the lefty 
genes are key regulators of left-right axis development. 
 
The asymmetric expression patterns described above are dependent on an intact 
midline (Figure 13) consisting of two tissues - the axial mesoderm and the 
overlying neuroectoderm. The midline is partly derived from the node and 
distinguishes the left and right sides of the embryo. An intact midline is crucial for 
the development of L-R asymmetry, and mouse mutants with parts of the axial 
mesoderm disrupted, such as the notochord in No turning and SIL mice156,157, 
show randomized heart looping and symmetric expression of nodal. These results 
demonstrate the importance of the midline in the maintenance of embryonic 
asymmetry by preventing the right lateral plate from acquiring left-sided identity.  
 
 
1.5.2 Zic3 in the development of the embryonic midline 
Zic3 loss-of-function mutants display both situs ambiguous, a partial reversal of 
asymmetric structures, and situs inversus, a complete mirror image reversal of 
midline organs124,130,131. These results imply that Zic3 is involved in early left-right 
axis formation, such as the establishment of the midline node and notochord. In 
accordance with this, a recent study has demonstrated that Zic3 is expressed in 
the node at late headfold and early somite stages of development115. Other 
groups have also shown that Zic3 acts early in gastrulation but have 
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hypothesised that Zic3 affects the L-R axis following the formation of the midline 
by binding to and activating the Nodal promoter in the left lateral plate 
mesoderm124,158. 
 
Based on recent findings, Zic3 expression initiates prior to gastrulation with 
transcript detected throughout the extra-embryonic ectoderm and within the 
proximal epiblast of 5.0 dpc embryos115. As gastrulation proceeds with the 
formation of the primitive streak, expression of Zic3 is found in the primitive 
streak, in the wings of mesoderm of the embryonic region and in the ectoderm 
adjacent to the expressing mesoderm115.  
 
 
1.5.3 The Zic3-null mouse model 
Zic3-null mice exhibit a wide spectrum of phenotypes associated with defects in 
left-right patterning. Fifty percent of null mice succumb to embryonic lethality over 
different gestational stages, and thirty percent to peri-natal lethality as a result of 
congenital heart defects, pulmonary isomerism and defects in the central nervous 
system129. The earliest and most profound Zic3-null defects have been attributed 
to failure in establishment of the anterior-posterior axis by the anterior visceral 
endoderm (AVE) prior to gastrulation158. In less severely affected embryos, 
abnormalities are observed at gastrulation in the distribution and accumulation of 
excess mesoderm tissue. Taken together, the defects in embryonic lethal mice 
demonstrate a key role for Zic3 in early embryonic patterning that encompasses 
anterior visceral endoderm formation, initiation of gastrulation, and primitive 
streak morphogenesis158.  
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Laterality defects were detected in 6 out of 55 heterozygous Zic3 female mice 
examined129, indicating that both complete and partial deficiency of the X-linked 
Zic3 gene result in disruption of laterality. Interestingly, a higher proportion of Zic3 
null males died in utero whereas Zic3 null females died within the perinatal 
period, suggesting a sex-limited effect. The majority of perinatal deaths were 
attributable to congenital heart defects (CHD), suggesting that Zic3 null females 
may be more susceptible to this defect129. These results indicate a role for 
environmental factors, potentially in combination with genetic modifying loci 
encompassing modifier genes and gene threshold effects, in contributing to the 
laterality phenotype observed in Zic3 mutants. 
 
The varying degrees of severity in failure to complete gastrulation displayed by 
Zic3-null mice may be attributed to compensatory mechanisms in developing 
embryos, as indicated by the overlapping domains of expression between Zic 
family, as indicated by the partially overlapping expression patterns exhibited by 
members of the Zic gene family115,116 (Table 2). Similar to Zic3-null mice, previous 
studies in Zic1-deficient mice and Zic2 knockdown mice have reported skeletal 
and CNS anomalies99,159. Zic3 shares overall 64 and 59% homology with Zic1 and 
Zic2, respectively, and this homology increases to 91% within the zinc finger 
domain. Thus members of Zic family are strong candidates for redundancy in 
molecular signaling during development.  
 
By characterizing the early embryonic lethality of Zic3-null mouse embryos, a 
recent study has revealed a new function for Zic3 during gastrulation at a stage 
earlier than left-right patterning158. An examination of the most severely affected 
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Zic3-deficient embryos revealed that these mutants either fail to initiate 
gastrulation or undergo an initial specification of the mesodermal cell population 
with failure to progress158. It was found that Zic3-null embryos showed 
abnormalities in anterior visceral endoderm (AVE). This abnormality was reflected 
in the inappropriate distal localization of AVE markers such as Cer-1 and in the 
absence of Hex expression at day 6.5 to day 7.0 when a global anterior-ward 
rotation of the visceral endoderm should have occurred prior to streak 
formation158,160. This rotation is critical for the conversion of the proximal-distal (P-
D) polarity to the anterior-posterior (A-P) axis of the murine embryo.  
 
It has been suggested that while the extraembryonic ectoderm seems to signal to 
the proximal epiblast to induce expression of proximal-posterior genes, the AVE 
counters this activity by repressing expression of these genes in the underlying 
epiblast so as to prime it for anterior patterning160. Thus, this failure to undergo a 
P-D to A-P rotation appears to be the main cause for the Zic3-null embryos to 




1.5.4 Zic3 mutations result in X-linked heterotaxy 
A large number of congenital disorders arise from defects in embryonic midline 
development129,161-164, indicating that the midline tissue of the vertebrate embryo 
plays a critical role in its development. In humans, Zic3 mutations are associated 
with X-linked heterotaxy, a disorder characterized by disruptions in embryonic 
laterality and midline developmental field defect103. In addition, clinical 
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abnormalities resulting from X-linked heterotaxy manifest in organs such as the 
spleen (asplenia or polysplenia) and lungs (bilateral trilobed or bilobed lungs), 
and in complex cardiovascular malformations with cardiac looping 
abnormalities124,165. 
 
Zic3-associated X-linked heterotaxy is a recessive disorder of variable clinical 
expression that predominantly affects males. More rarely, heterozygous females 
with isolated congenital heart defect are reported119,166. In females, functional 
nullisomy of the Zic3 protein can occur as a result of constitutional X-autosome 
translocations with one breakpoint in the Zic3 region, leading to gene disruptions 
or defects arising from its ectopic position, as well as preferential inactivation of 
the normal X-chromosome166.  
 
The locus for Zic3 in humans was initially mapped to Xq26.2 by linkage analysis 
in a single family and by detection of a deletion in an unrelated situs ambiguus 
male167,168. From this chromosomal region, Zic3 was positionally cloned103. The 
Zic3 mutations that gave rise to situs ambiguus included one frameshift, two 
missense and two nonsense mutations. A recent study has further established 
that X-linked heterotaxy in humans results from several Zic3 mutations that 
render the protein unstable and absent in cells, or incapable of nuclear 




1.6  Role of Zic3 in neural development 
Zic3 is involved in a spectrum of processes related to neural development, from 
the establishment of the neuroectoderm, to the patterning of the dorsal neural 
tube, and finally, the development of mature dorsal neurons. These phases are 
summarized in Figure 14 and are described in detail in the following paragraphs. 
 
At the beginning of gastrulation when the neuroectoderm is being established, 
Zic3 expression is upregulated near the dorsal lip of the blastopore, where the 
dosalizing center secretes a neural inducer. As gastrulation proceeds, Zic3 
expression is extended anteriorly and is subsequently found at the border of the 
neural plate, where it is involved in generating dorsal neural tissue and neural 
crest tissue126,169. The expression of Zic3 at this stage is negatively regulated by 
Bmp, as indicated by an increase in Zic3 expression domain when a Bmp 
antagonist, noggin, or a dominant-negative Bmp receptor is overexpressed126. In 
accordance with this, it has been observed during neuroectodermal differentiation 
that Zic3 is expressed by ectoderm cells only when Bmp signals are blocked by a 
secreted Bmp-antagonizing neural inducer170. Furthermore, it has been shown 
that the anti-neural protein, Msx1, represses Zic3 expression through dominant 
negative Bmp receptors171. Conversely, a dominant-negative form of Msx1 was 
able to trigger the expression of Zic3172, indicating that the inhibition of Zic3 
expression by Bmp is mediated in part by Msx1. These results collectively 
indicate that signalling of Bmp is essential for the proper establishment of Zic3 
expression in the ectoderm (Figure 14; early phase). 
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Figure 14. The role of Zic genes in neural development. The 
dorsoventral axis in neural tissue is reflected on the y-axis, and the  
developmental stages are shown in the x-axis. The green area indicates the 
region expressing Zic. Blue letters indicate major roles of Zic genes in neural 
development. Source: Aruga, J. Mol Cell Neurosci. 2004 Jun;26(2):205-21 
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The expression of Zic3 is found in the dorsal ectoderm at the late blastula stage 
just prior to neuroectodermal differentiation126. Thus Zic3 expression is detected 
earlier than most proneural genes. A study has shown that overexpression of Zic3 
at this stage resulted in an expansion of the resulting neuroectoderm126. In 
addition, ectopic expression of Zic3 in animal cap explants induced neural crest 
and proneural markers. Taken together, the above data indicate that Zic3 is a 
primary regulator both of neural and neural crest development, and is an inducer 
of pro-neural transcription factors that activate the neural differentiation program. 
 
An alternative model for the function of Zic3 in neuroectodermal fate 
determination has been proposed in the context of calcium signalling. Localized 
calcium-expressing domains are found exclusively in the anterior dorsal part of 
the ectoderm, and these domains have been shown to mediate the choice 
between epidermal and neural tissue fates173. When ectodermal cell explants 
were treated with a voltage-sensitive calcium channel inhibitor or by a calcium-
chelating reagent, Zic3 expression was significantly reduced174,175, indicating that 
Zic3 is upregulated by the presence of calcium. Further investigation revealed an 
early calcium sensitive target gene, expressed in neural territories, known as 
arginine methyltransferase, was shown to specifically induce the expression of 
Zic3175,176. Arginine methyltransferase is thought to play an instructive role in the 
embryonic choice of determination between epidermal and neural fate173, and its 
ability to regulate the expression of Zic3 may represent another pathway by which 




Zic3 is also known to be an important regulator of neurulation (Figure 14; 
intermediate phase). Neural tube defects are commonly observed in the hindbrain 
region of Zic3 mutant mice, in domains where Zic3 expression is normally found 
in wildtype mice106,129,178. In addition, Zic3-deficient mice show hypoplastic 
changes in the cerebellar anterior lobe, indicating that Zic3 is involved in 
cerebellar patterning106. 
 
Zic3 is also known to regulate the process of axon targeting within the retina in 
the developing visual system179 (Figure 14; late phase). During this phase, 
radially-positioned ganglion cell axons begin to project toward the optic disc, a 
small opening in the center of the retina. An expression assay determined that 
Zic3 is found in a periphery-high, center-low gradient in the developing retina. 
During retinal cell differentiation and axonogenesis, Zic3 expression 
correspondingly recedes toward the periphery of the retina179. Interestingly, 
disruption of the Zic3 expression gradient during this process resulted in axons 
being misrouted to the sub-retinal space on the photoreceptor side of the retina. 
In contrast, misexpression of Zic3 did not affect retinal neurogenesis or 
lamination, and it was shown instead that the axonal mis-projection phenotype 
was the result of an inhibitory factor regulated by Zic3. These results suggest that 
Zic3 may regulate a currently unknown pathway influencing intra-retinal axon 
pathfinding179. In summary, Zic3 has been shown to regulate extensive processes 
in the establishment and patterning of neural tissue, and is therefore a critical 
factor in embryonic ectoderm development and neurogenesis. 
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1.7 Experimental approach and study rationale 
Zic3 is preferentially expressed in the pluripotent state and has recently been 
identified as a target of Oct4, Nanog, and Sox2 in ES cells19,20,179 85,86. However, 
the detailed molecular networks regulated by Zic3 to confer its properties on ES 
cells remain unknown. Therefore I set out to address the following questions in 
this thesis:  
1. How do Oct4, Nanog, and Sox2 regulate the expression of Zic3, and what 
results from this interaction?  
2. What phenotype results from a Zic3 loss-of-function, and what can be 
inferred about the role of Zic3 in the ES cells? 
3. Does Zic3 interact with ES cell-related proteins to regulate pluripotency?  
4. What are the targets regulated by Zic3 in ES cells, and do these genes 
reveal the networks that Zic3 controls to maintain pluripotency? 
5. Does Zic3 repress lineage-specific genes in ES cells, and are these genes 
related to the established functions of Zic3 in development? 
 
To understand the dynamics of Zic3-governed transcriptional networks in ES 
cells, I used a combination of gene expression analysis, Zic3 gain- and loss-of-
function experiments, co-immunoprecipitation for interacting partners of Zic3, 
chromatin-immunoprecipitation to identify Zic3-regulated targets, and functional 
annotation of these targets to gain deeper insight into Zic3-regulated processes 
and to establish the Zic3 regulatory network in ES cells (Figure 15). The results of 
these analyses are presented and discussed in Chapters 3 to 6. 
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A detailed knowledge of ES cell transcriptional circuitry may contribute to a more 
comprehensive understanding of embryonic development, and is critical for the 
realization of ES cell therapeutic potential. The critical need to dissect their 
transcriptional networks is underscored by their potential to yield critical insights 
into genetic mechanisms at the earliest stages of embryo development and to 
provide significant inroads into the properties ES cell unlimited growth and 
differentiation potential that will render them therapeutically useful. 
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Figure 15. Experimental approach for establishing the transcriptional 
network of Zic3 in ES cells. Zic3 gene expression profiling, depletion of Zic3 
gene expression, co-immunoprecipitation of protein complexes, chromatin-
immunoprecipitation, functional annotation of Zic3 gene targets, and Zic3 gain-







CHAPTER 2:    
Methods & Materials 
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2.1 Molecular biology techniques 
2.1.1 Cloning 
The sub-cloning of DNA fragments into vectors was achieved by restriction 
enzyme digestion, gel purification of digested DNA, and T4 ligase treatment to 
yield the final construct. Restriction digests were preformed overnight at 37°C 
according to manufacturers’ instructions (New England Biolabs). The following 
day, digested DNA was resolved on 1% - 1.5% agarose gels in TAE buffer, and 
the desired fragments were visualized under UV lighting and excised from the gel. 
The DNA fragments were released from agarose matrix using the Qiagen gel 
extraction kit according to manufacturer’s instructions. The concentration of the 
recovered DNA was quantified by UV absorbance using the nanodrop instrument, 
and ligations were performed at 5:1 (insert:vector) molar ratio in 20 μl reactions 
containing1U of T4 DNA ligase in 1 x  T4 ligase buffer (Roche) at 16°C overnight. 
2.1.2 Transformation of chemically competent cells  
For transformation of ligated plasmids, a 50µl aliquot of One-Shot Top10 
chemically competent E.coli cells (Invitrogen) was thawed on ice. Approximately 
10ng of ligation reaction was added to the thawed cells and gently mixed followed 
by incubation on ice for 30 minutes. Transformation was induced by heat-shock 
treatment at 42ºC for 1 minute. The cells were cooled on ice for 2 minutes, and 
200μl of nutrient-rich LB-SOC was then added to the tube for incubation at 37ºC 
for 1 hour in a bacterial shaker. Following incubation, 50 to 300ul of the culture 
was plated on LB-agar plates containing the appropriate antibiotic selection, and 
the plates were placed in an incubator at 37ºC overnight to allow growth of 
bacterial colonies.  
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2.1.3 PCR analysis of transformants 
Bacterial colonies were screened for positive ligation events as follows: 20 μl 
sterile PBS for inoculated with a single colony to serve as a PCR template. PCR 
reactions were carried out in 25 μl volumes comprising 1 x PCR buffer w/o MgCl2 
(ProMega), 2 mM MgCl2, 0.2mM dNTPs, 0.5 μM of each forward and reverse 
primer, 1 U Taq Polymerase in Buffer B (ProMega), and 5 μl PBS containing 
template DNA. The PCR conditions were as follows: 95°C for 3 minutes, followed 
by 32 cycles of 95°C for 30s, 52°C for 30s, 72°C for 1 min 30s, and finally, a 
single cycle of 72°C for 7 minutes before holding at 4°C. PCR products were 
resolved on 1% agarose gels for 40 minutes at 100V to check for correct insert 
size. 
2.1.4 Isolation of plasmid DNA from bacteria  
Bacterial colonies containing positive ligation events were expanded as follows: 5 
ml LB medium with appropriate antibiotic selection was inoculated for overnight 
culture at 37ºC. The overnight cell suspensions were centrifuged at max speed 
for 15 minutes to pellet bacteria. The bacterial cells were then lysed and plasmid 
DNA purified using the Qiagen miniprep kit according to manufacturer’s 
instructions. The DNA was eluted in 30 – 50 μl dH2O and quantified by nanodrop 
to ensure a final concentration in the range of 200 – 1000 µg/ul.  
2.1.5 Preparation of bacterial stocks 
Bacterial stocks of successful transformation events were prepared in 33.3% 
sterile glycerol. The LB-glycerol suspension was vortexed to ensure thorough 
mixing, cooled on ice for 1 hour, and then placed at -80°C for long term storage. 
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2.1.6 Isolation of genomic DNA from cell lines 
Confluent cell cultures were rinsed thrice with PBS and then gently scraped for 
release from adherent culture dishes. The cells were pelleted for 5 minutes at 500 
rpm and then lysed in 3 ml DNA buffer (10 mM Tris-HCl at pH 8.0, 0.1 M EDTA, 
0.5% SDS, and 100 μg/ml proteinase K) and incubated overnight at 45°C with 
gentle agitation. The following day, the cell lysate was treated thrice with 
Chloroform/ Isoamyl alcohol (24:1) as follows: An equal volume of Chloroform/ 
Isoamyl alcohol was added to the lysate, mixed thoroughly and centrifuged at 4°C 
for 10 minutes at maximum speed. The resulting supernatant was transferred to a 
fresh eppendorf tube and the above procedure was repeated. Following the third 
extraction, the supernatant was transferred into a fresh 50 ml falcon tube 
containing 1/10 volume 3 M sodium acetate (pH 5.2) and 3 volumes 100% 
isopropanol. The tube was gently inverted to allow precipitation of DNA which 
was then transferred into a fresh 50 ml falcon tube containing 30 ml of 70% 
ethanol. The DNA was rinsed in ethanol for 2 hours, then centrifuged at 4°C for 
20 min at maximum speed. The DNA pellet was dried in a SpeedVac for 5 
minutes and then resuspended in 1 ml sterile dH20 for 1 hour at 37°C. The 
resulting genomic DNA was quantified to ensure concentrations above 1000 
ng/ul, and then resolved on 1% agarose gels to check for DNA quality. 
 
2.2 Cell culture 
2.2.1 Mouse ES cell culture 
Feeder-free E14 mouse ES cells were maintained on 0.1% gelatin coated dishes 
in E14 proliferative medium containing DMEM/15% ES FBS (Gibco), 0.1 mM 
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MEM non-essential amino acids (Gibco), 2 mM L-glutamine (Gibco), 0.1 mM β-
mercaptoethanol (Gibco), and CHO-LIF (1,000 U/ml). The cells were passaged 
every 2 days with the following procedure: Each dish was rinsed twice with 1x 
PBS solution (Gibco) and then incubated in 3 ml 0.05% Trypsin (Gibco) for 3 
minutes at 37°C to allow detachment of cells from the culture surface. The 
trypsin-treated cells were diluted with 7 ml E14 culture media, pelleted in a 
centrifuge for 5 min/500rpm, and then re-suspended in 5 ml fresh E14 culture 
media. The cells were then triturated to achieve a single cell suspension, and 
seeded in gelatin-coated plates at a density of 4.0 x 106 cells per 10 cm2 dish. 
 
Mouse ES cells cultured on mouse embryonic fibroblast (MEF) feeder layers were 
maintained in the proliferative medium described above, with the exception of 
CHO-LIF. The mouse ES cells were passaged every 2 days as described above 
and seeded at a density of 3.0 x 106 cells per 10 cm2 dish. One day prior to 
passaging, 2.5 x 106 inactivated Balb/c MEFs (ref. section 2.2.3) were seeded on 
gelatin-coated plates and allowed to adhere to the plate surface overnight at 
37°C. All cultures were maintained in an incubator at 37°C with 5% CO2. 
 
2.2.2 Human ES cell culture 
Feeder-free undifferentiated HuES9 human ES cells  were maintained on 
matrigel-coated dishes in conditioned medium containing Knockout DMEM/10% 
serum replacement (Gibco), 0.1 mM MEM non-essential amino acids (Gibco), 1 
mM L-glutamine (Gibco), 0.1 mM β-mercaptoethanol (Gibco), 8% plasmanate 
(NUH pharmacy), 12 ng/ml LIF, and 10 ng/ml human recombinant Basic 
Fibroblast Growth Factor (bFGF; Gibco). Conditioned media was obtained by 
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culturing mouse embryonic fibroblast (MEF) cells with HuES9 media. The media 
was collected at 24 hour intervals, filter sterilized and further supplemented with 8 
ng/ml bFGF for HuES9 cell culture. 
 
2.2.3 Isolation, expansion, and mitotic inactivation of MEF cells 
Pregnant female Balb/C mice were sacrificed at day 13 post-coitum by cervical 
dislocation. The mouse abdomens were swabbed once with 70% Ethanol and 
peritoneal walls were dissected to expose the uterine horns, which were removed 
and placed in a 10 cm2 dish. The uterine horns were rinsed thrice with 10 ml PBS 
(Gibco #14190-169) without bivalent cations. The embryos were then released 
from the embryonic sac and subsequently separated from the placenta and 
associated membranes. Dark red visceral tissue was removed and each embryo 
was rinsed 3 x 10 ml PBS in a fresh Petri dish. 
 
The embryos were transferred into a new Petri dish containing a minimal amount 
of PBS, and were finely minced with two pairs of forceps. The fragmented tissue 
was placed in 2 ml Trypsin-EDTA (Gibco) per embryo, then further minced and 
subsequently incubated at 37°C for 15 min with gentle agitation. The Trypsin-
EDTA was neutralized in a fresh 50ml conical tube containing 20 ml MEF culture 
medium, prepared as follows: DMEM supplemented with 10% FBS, 1% L-
glutamine (v/v) and 1% Pen-step (v/v). The larger pieces of tissue were briefly 
allowed to settle, and the supernatant containing MEF cells was then pelleted at 
500 rpm for 5 mins at room temperature. The MEF cells were then resuspended 
in fresh culture media warmed to 37°C, and plated at a density of 1 embryo per 
10 cm2 dish (Passage 0). 
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The MEF primary cultures were typically confluent within 2 days. Confluent dishes 
were trypsinized according to the procedure described for HEK293T cells, and re-
seeded at a density of 1:5. The cells were expanded to Passage 5 and then 
mitotically inactivated by treatment with Mitomycin-C at 10 μg/ml for 2 hours at 
37°C. The inactivated cells were then rinsed twice with PBS, trypsinzed as 
described above, and then resuspended in freezing media (ref. section 2.2.5) at a 
density of 2.5 x 106 cells per cryotube.  
 
2.2.4 Maintenance of HEK293T cells 
HEK 293T cells were cultured in DMEM supplemented with 10% fetal bovine 
serum (Gibco-Invitrogen) and 2 mM L-glutamine (Gibco-Invitrogen), and 
maintained in an incubator at 37°C with 5% CO2. The cells were passaged every 
4 days with the following procedure: Each dish was rinsed twice with 1x PBS 
solution (Gibco) and incubated in 3 ml 0.25% Trypsin (Gibco) for 3 minutes at 
37°C. The cells were then diluted with 7 ml 293T culture media, pelleted in a 
centrifuge for 5 min/500rpm, and re-suspended in 5 ml fresh 293T culture media. 
The cells were triturated to achieve a single cell suspension, and seeded in 10 
cm2 dishes at a density of 1.0 x 106 cells. 
 
2.2.5 Cryopreservation of cell lines 
Confluent cell cultures were trypsinised as described above and centrifuged for 5 
minutes at 500rpm. The cells were resuspended in freezing media (70% DMEM 
supplemented with 20% FCS and 10% dimethyl sulphoxide) and then transferred 
into Nunc cryotubes at 1 ml per vial. The cryotubes were placed at -80°C 
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overnight in Mr Frosty containers buffered with isopropyl alcohol and then 
transferred to a liquid nitrogen tank the following day for long-term storage. 
 
2.2.6 Thawing of cell lines 
Frozen cryotubes were retrieved from liquid nitrogen tanks and placed 
immediately into a 37°C waterbath. The cells were rapidly thawed and then 
transferred into 10 ml of pre-warmed culture media. The cell suspension was 
pelleted for 5 minutes at 500 rpm, then gently resuspended in culture media and 
plated in 10 cm2 tissue culture dishes to allow for overnight adhesion of cells to 
the vessel surface.  
 
2.3 ES Cell-based assays 
2.3.1 RNA interference (siRNA) 
RNA interference (RNAi) experiments were performed with Dharmacon 
siGENOME SMARTpool reagents against human or mouse Zic3. The Dharmacon 
siCONTROL nontargeting siRNA pool was used as a negative control. Mouse ES 
cells were transfected according to manufacturer’s instructions in 12-well plates at 
a density of 2 x 105 cells per well. Re-transfections were performed on pre-
adherent cells at 48-hour intervals, and RNA expression analysis was performed 
on Day 5 samples. Human ES cells were transfected in 12-well plates with 2 x 105 
cells per well in suspension. Subsequent re-transfections were performed on 
adherent cells at 24-hour intervals and RNA was harvested for analysis at Day 5.  
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2.3.2 RNA interference (shRNA) 
The Oct4, Nanog, Sox2 and Zic3 shRNA sequences were designed according to 
criteria by Ui-tei et al. 180. and Reynolds et al. 181, and cloned into the 
pSUPER.puro or pSUPER.neo-GFP shRNA vectors (Oligoengine) as per 
manufacturer’s instructions. Details of the shRNA sequences are listed in Table 3. 
For shRNA experiments, E14 cells were seeded at a density of 4 x 105 cells per 
well in 6-well plates 1 day prior to transfection. The following day, the cells were 
transfected with 2.0 μg of shRNA construct each. Puromycin or neomycin 
selection was introduced 1 day post-transfection at 1.0 µg/ml, and maintained for 
3 days prior to RNA isolation. The ES cells were maintained in mouse ES cell 
culture medium at all times.  
 
2.3.3 Rescue of RNAi knockdown 
The Zic3 open reading frame (ORF; NM_009575) was cloned from reverse-
transcribed cDNA from mouse embryonic stem cells, using the primers indicated 
in Table 4A. The PCR product was subsequently cloned into an overexpression 
construct downstream of a cytomegarovirus/chicken β-actin (CAG) promoter, 
which is known to drive efficient episomal expression in ES cells69. The RNAi-
immune Zic3 ORF R3M was generated from this construct using the QuikChange 
site-directed mutagenesis kit (Strategene) as per manufacturer’s protocol with the 
primers shown in Table 4A. To perform the rescue experiments, 4 x 105 mouse 
ES cells were seeded per well in 6-well plates, and transfected according to the 
scheme in Table 4B. Hygromycin (1.0µg/ml) was introduced 1 day post-
transfection for selection of transfected cells, and ES cell culture media containing 
hygromycin was refreshed daily until the cells were harvested for analysis.  
  62
 
Table 3. shRNA sequences for pSUPER vector
 
1 Forward 5’-AACACCagatctATGACGATGCTCCTGGACGGAGGCC-3’ Zic3 ORF R3M 
3 Forward, 5’ - AACACCagatctATGACGATGCTCCTGGACGGAGGCC-3’  
Reverse, 5’- TTTTGGacgcgtTCAGACGTACCATTCGTTAAAATTG-3’ 
Reverse, 5’- TTTTGGacgcgtTCAGACGTACCATTCGTTAAAATTG-3’ 
Forward, 5’ -AATGTGAATTTGAGGGATGCGATCGACGGTTTGCCAACAG-3’ 
Reverse, 5’-CTGTTGGCAAACCGTCGATCGCATCCCTCAAATTCACATT-3’ 









~ Zic3 ORF 
Set Description 











RNAi construct / 1.0 μg Experiment 










Zic3-SENSE  GATCCCCGTGCGCAGTTCCCTAACTATTCAAGAGATAGTTAGGGAACTGCGCACTTTTTA 
Zic3-ANTI-SENSE  AGCTTAAAAAGTGCGCAGTTCCCTAACTATCTCTTGAATAGTTAGGGAACTGCGCACGGG 
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2.3.4 Secondary ES-colony replating assay 
ES cells were transfected with Zic3- or empty pSUPER shRNA constructs and 
selected 24 hours later with puromycin at 1.0 μg/ml over four days. At the end of 
four days few cells remained in the untransfected control wells indicating that 
selection was effective. The surviving cells were trypsinized as described in 
Section 2.2.1 and resuspended in E14 medium without LIF. Ten- or twenty-
thousand cells were plated onto mouse feeder layers in six-well plates for 
secondary ES cell-colony formation. After seven days, emerging colonies were 
stained with the Wright-Giemsa stain (Sigma) according to manufacturer’s 
instructions. Three biological replicates were performed for each experiment. The 
extent of differentiated colonies was defined as the percentage of unstained 
colonies out of the total number of colonies in the well.  
 
2.3.5 Reprogramming assays 
2.3.5.1  Viral packaging of reprogramming factors 
One day prior to transfection, 8 x 106 Plat-E viral packing cells182 were seeded per 
10cm2 dish, and the cells were allowed to adhere overnight at 37○C. The following 
day, each plate of 10cm2 Plat-E cells was transfected with 9µg of pMXs plasmids 
containing Oct4, Sox2, Klf4, c-Myc or Zic3, using the Fugene 6 system (Roche) 
according to manufacturer’s specifications. Briefly, 27µl of Fugene 6 was 
incubated with DMEM for 5 minutes at room temperature. pMXs DNA was then 
added dropwise, and gently mixed and further incubated for 15 minutes at room 
temperature. Following incubation, the DNA/Fugene 6 complex was added 
dropwise to the Plat-E cells and allowed to transfect overnight at 37°C. The 
transfection mix was aspirated the following day and replaced by Plat-E culture 
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media containing DMEM supplemented with 10% FBS, 50 units per 50 μg/ml 
pen/strep, 1 μg/ml puromycin (Sigma), and 100 μg/ml of blasticidin S (Funakoshi). 
Twenty-four hours later, the retrovirus-containing media was harvested, filter-
sterilized, and supplemented with polybrene (4 mg/ml) to increase efficiency of 
retroviral infection. 
 
2.3.5.2  Viral infection of fibroblast cells 
Mouse embryonic fibroblast (MEF) cells were isolated from mouse embryos, 
expanded to Passage 6, and inactivated as described in Section 2.2.3. These 
inactivated MEF cells were plated as a feeder layer for the reprogramming 
experiment, at a density of 2.5 x 106 per gelatin-coated 10 cm2 dish. The following 
day, Passage 3 balb/c fibroblasts were seeded on the inactivated feeder layer at 
a density of 8 x 105 per dish, and allowed to adhere overnight. Twenty-four hours 
later, fresh retroviral-containing media (ref section 2.3.5.2) for each 
reprogramming factor was mixed in equal parts to a total volume of 10 ml, and 
then added to the fibroblast cultures for overnight infection at 37°C. The cells 
were supplied daily with fresh Plat-E media (Section 2.3.5.1), and allowed to grow 
for 2 to 3 weeks. ES-like colonies arising from the infections were treated with the 
Wright-Giemsa stain (Sigma) according to manufacturer’s instructions, and 




2.4 Establishment of clonal cell lines 
2.4.1 Clonal Zic3 knockdown lines 
Clonal Zic3 knockdown lines were established by transfection of shRNA 
constructs as described in Section 2.3.2. The Zic3 knockdown and vector control 
colonies were picked after 7 days of puromycin selection (1.0 µg/ml). Colonies 
were dissociated into single cell suspensions by treatment with 0.05% Trypsin 
(Gibco) and plated on puromycin-resistant mitomycin-inactivated DR4 MEFs 
(ATCC). In total, 15 Zic3 clonal knockdown and 7 vector control lines were 
established and maintained under constant puromycin selection. The lines 
analyzed in this thesis were maintained feeder-free in ES cell proliferative media 
on 0.1% gelatin-coated dishes over a period of 8 passages. 
 
2.4.2 Clonal Zic3-inducible ES cells  
The Ainv18 cell line (gift of George Daley, Harvard Medical School, Boston, MA) 
is an E14 mouse ES line modified for targeted gene insertion downstream of a 
doxycycline-responsive promoter 183. The Zic3 transgene was PCR-amplified from 
a mouse cDNA library and subcloned into the KpnI/XbaI sites of the pLox-N-tag-
HA vector (George Daley, Harvard Medical School, Boston, MA) with the 
following primers, restriction sites indicated in uppercase: Forward 5’-tat-tat-GGT-
ACC-tac-gat-gct-cct-gga-cgg-ag-3’ and Reverse 5’-tcg-gca-TCT-AGA-tca-gac-
gta-cca-ttc-gtt-aaa-att-g-3’. An additional nucleotide was inserted in the forward 
primer to allow in-frame processing of the Zic3 insert with the N-terminal HA tags. 
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For targeted insertion at the HPRT locus, 20 μg each of pLox-N-tag-HA-Zic3 and 
pSALK-Cre were transfected with Lipofectamine 2000 (Invitrogen, Carlsbad, CA) 
into 6x105 AINV18 cells seeded in 10cm2 dishes. For derivation of Ainv18-Zic3 
clonal lines, mouse ESC medium was supplemented with 350 μg/ml G418 
solution (Invitrogen) 24 hours after transfection and maintained for 14 days. 
Colonies arising from G418 selection were individually picked and expanded on 
neomycin-resistant MEFs. Site-specific integration was confirmed by PCR 
analysis with the following primers: LoxinF 5'-cta-gat-ctc-gaa-gga-tct-gga-g-3' and 
LoxinR 5'–ata-ctt-tct-cgg-cag-gag-ca-3'. 
 
To induce overexpression, AINV18-Zic3 cells were treated with 1.0 µg/mL 
doxycycline in mouse ESC medium. Protein was harvested to test and confirm 
the efficacy of regulation by doxycycline.  
 
2.5 ES cell differentiation protocols 
2.5.1 Retinoic acid differentiation 
Mouse ES cells were cultured in LIF-deficient ES cell medium with all-trans 
retinoic acid (RA) at 100 nM. Retinoic acid stock powder was dissolved in DMSO 
to give a concentration of 0.1 M and stored at -80°C. For each differentiation 
experiment, an aliquot of 0.1 M RA solution was thawed and diluted 1:1000 in 
100% EtOH to yield a 0.1 mM solution, which was further diluted 1:1000 in ES 
cell media excluding LIF for a final working concentration of 100 μM. RA-treated 
cells were seeded on gelatin-coated tissue culture dishes at a density of 4 x 106 
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cells per 10 cm2 dish. The cells were passaged every 2 days according to the 
protocol in Section 2.2.1.  
 
2.5.2 DMSO and HMBA differentiation 
For differentiation, ES cells were seeded in 6-well plates at a density of 3 x 105 
cells per well. The cells were cultured in ES cell media (detailed in Section 2.2.1) 
excluding LIF with 1% DMSO or 5mM HMBA. The cells were passaged and 
harvested for RNA extraction every 2 days according to the protocol in Section 
2.2.1. 
 
2.5.3 Neural differentiation of ES cells 
To achieve neural differentiation, AINV18-Zic3 cells were exposed to doxycycline 
for 48 hours in ES culture medium and then treated with N2B27 medium as 
previously described184. Briefly, ES cells were dissociated and plated onto 0.1% 
gelatin-coated culture dishes at a density of 0.5−1.5 x 104/cm2, in N2B27 medium 
comprising a 1:1 mixture of Neurobasal medium (Gibco) supplemented with B27 
(Gibco), and DMEM/F12 (Gibco) supplemented with modified N2 (25 g/ml insulin, 
100 g/ml apo-transferrin, 6 ng/ml progesterone, 16 g/ml putrescine, 30 nM sodium 
selenite and 50  g/ml bovine serum albumin fraction V (Gibco). N2B27 medium 
was refreshed every 2 days and the cells were observed daily under the 
microscope for changes in morphology.  
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2.6 Gene expression analysis 
2.6.1 RNA extraction 
RNA was extracted from mammalian cells with TriZol reagent (Invitrogen) and 
then further purified with the RNeasy minikit (Qiagen) according to manufacturer’s 
instructions. RNA samples were treated with DNase for removal of genomic DNA 
contamination. This was performed in 100 μl reactions containing 5 μg RNA, 0.2 
U/μl RNAse inhibitor, and 0.15 U/μl RNase-free DNase (ProMega). Samples were 
incubated at 37°C for 30 minutes, followed by heat-inactivation of enzymes at 
65°C for 15 minutes. The RNA samples were then purified using two phenol 
extractions and one chloroform extraction, and back extractions were performed 
with each step using equal volumes of sterile dH20 to minimize loss of RNA. Total 
RNA was precipitated, washed with 70% ethanol and finally resuspended in 30 μl 
of sterile nuclease-free dH20. 
 
2.6.2 cDNA synthesis 
cDNA was synthesized with 1.0 μg total RNA using the High Capacity cDNA 
Archive kit (Applied Biosystems) as per manufacturer’s instructions. Briefly, cDNA 
synthesis was performed in 100 μl reactions consisting of 1.0 μg RNA diluted in 
50 μl nuclease-free dH20, and cDNA Archive kit components: 1 x Reverse 
Transcriptase buffer, 5.5mM MgCl2, 500 μM dNTP mix, 2.5 μM random primers, 
and 0.25 U/μl MultiScribe Reverse Transcriptase. Synthesis reactions were 
incubated in a PCR thermocycler at 25°C for 10 minutes followed by 37°C for 2 
hours. The cDNA samples were stored at -20°C following synthesis. 
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2.6.3 Quantitative real-time PCR 
Quantitative PCR assays were performed as follows: Reversed transcribed cDNA 
samples were diluted 10x in nuclease-free water, and added to 5.0 ul TaqMan® 
Universal PCR Master Mix reagent (Applied Biosystems) containing 0.5 μl of a 
single TaqMan probe (20x TaqMan® Gene Expression Assay reagents; Applied 
Biosystems). The list of TaqMan probes are provided in Table 5. Reactions were 
conducted in triplicate within 384-well reaction plates (ABI) at a final volume of 10 
μl on the ABI Prism 7900 machine.  
 
2.7 Protein expression analysis 
2.7.1 Cell lysis and protein quantitation 
Confluent cell cultures were harvested by scraping and washing with 1 x PBS 
solution. The cells were centrifuged for 5 minutes at 500 rpm, and then re-
suspended in cell lysis buffer comprising 50 mM Tris pH 7.4, 150 mM NaCl, 2mM 
EDTA, 1% NP-40, 0.1% SDS, and 1 x EDTA-free Protease inhibitor (Roche). The 
cell lysate was incubated with rotation for 10 minutes at 4°C and was cleared by 
centrifugation at 12,000 rpm for 30 minutes at 4°C. The supernatant was 
transferred to a fresh tube and protein was quantitated using the Bradford assay 
(Bio-Rad Laboratories). Six bovine serum albumin (BSA) protein standards were 
used at 0μg, 50μg, 100μg, 200μg, 300μg and 400μg for the Bradford assay. 
Protein samples and standards were diluted in 0.15M NaCl prior to triplicate 
loadings onto a 96-well ELISA plate. Absorbance values were measured on a 




Trophectoderm Bone morphogenetic protein 4 BMP4 
Ectoderm Fibroblast growth factor 5 FGF5 
Ectoderm REST Co-repressor 1 CoREST 
Ectoderm RE1-silencing transcription factor  REST 
Ectoderm SRY-box containing gene 1 Sox1 
Ectoderm Teratocarcinoma-derived growth factor  / Cripto TDGF1 
Ectoderm Paired box gene 6  Pax6 
Ectoderm Glial fibrillary acidic protein  GFAP 
Wnt pathway Dickkopf homolog 3  DKK3 
Trophectoderm Caudal type homeobox 2  CDX2 
Ectoderm Nestin Nestin 
Wnt pathway Glycogen synthase kinase 3 beta  Gsk3beta 
Mesoderm NK2 transcription factor related, locus 5  Nkx2.5 
Mesoderm GATA binding protein 2 Gata2 
Mesendoderm Mix1 homeobox-like 1  MixL1 
Endoderm Forkhead box A2 Foxa2 
Mesoderm Heart and neural crest derivatives expressed 1 Hand1 
Mesendoderm Nodal Nodal 
Mesendoderm Goosecoid GSC 
Endoderm GATA binding protein 6 Gata6 
Endoderm GATA binding protein 4 Gata4 
Endoderm Platelet-derived growth factor receptor, alpha 
l tid
PDGFRA 
Endoderm SRY-box containing gene 17  Sox17 
Lineage Description Gene Symbol 
Table 5. List of marker genes used to assess lineage development  in ES cells. 
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2.7.2 SDS-PAGE 
Denaturing polyacrylamide gel electrophoresis was conducted to resolve proteins 
by size. Thirty micrograms of protein was added to 6x SDS loading buffer (250 
mM Tris/HCl pH6.8, 30% glycerol, 10% SDS, 5% β-mercaptoethanol, and 0.02% 
bromophenol blue), followed by incubation at 55°C for 5 minutes. Protein samples 
were loaded onto a 10% or 12% acrylamide gel for electrophoresis at 100V for 
1.5 hours. The resolved protein samples were then electroblotted onto Hybond C 
extra nitrocellulose membrane (Amersham) for 1 hour in Western Transfer Buffer 
(20% Ethanol, 70% dH20, and 1x Western Transfer Buffer stock containing 14.5g 
Glycine and 3.0g Tris base).  
 
Consistency of protein loading and quality of Western blot transfer was assessed 
by Ponceau S staining (0.5% Ponceau S, 1% glacial acetic acid). In this protocol, 
the electroblotted membrane was rinsed once in Tris-buffered saline containing 
Tween-20 (TBS-T; 10mM Tris/HCl pH 8.0, 150mM NaCl, 0.5% Tween-20; pH 8.). 
Ponceau S was then applied for 30 seconds to enable visualization of proteins on 
the membrane, following which the membrane was rinsed twice in dH20 and then 
thrice in TBS-T. The nitrocellulose membranes were immediately probed for 
protein (Section 2.7.3) or stored at 4°C in air-tight boxes containing TBS-T. 
 
2.7.3 Protein detection and chemiluminescence detection 
Immunodetection of proteins was carried out as follows: Nitrocellulose 
membranes were blocked for 1 hour at room temperature in 5% (w/v) skimmed-
milk powder and 1% BSA. Protein detection was performed with goat-anti-Zic3 
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antibody (1:800; C-12, Santa Cruz Biotechnology) or rabbit-anti-HA (1:1000, sc-
805, Santa Cruz Biotechnology), followed by HRP-conjugated donkey-anti-mouse 
or donkey-anti-rabbit secondary antibodies (Santa Cruz Biotechnology) at a 
dilution of 1:5000. 
 
Loading consistency was determined with mouse-anti-βactin (1:3000; Invitrogen) 
and goat-anti-mouse HRP secondary antibodies (1:5000; Santa Cruz 
Biotechnology). The primary antibodies were incubated overnight at 4°C and the 
secondary antibodies were subsequently incubated for 1 hour at room 
temperature, with 3 x TBS-T rinses for 15 minutes performed in between 
incubations. Chemiluminescence detection was carried out using the Enhanced-
Chemiluminescence (ECL) Western blotting kit (Amersham) according to 




For imaging of Zic3 clonal knockdown lines, cells were seeded at a density of 1.0 
x 105 cells per well on fibronectin-coated chamber slides, fixed in 4% 
paraformaldehyde and permeabilized with 0.3% Triton X-100. Blocking was 
performed with 5% FBS and 1% BSA in PBS solution for 30 minutes. Cells were 
stained with the following primary antibodies (1:100): goat- or mouse-anti-Oct4 
(Santa Cruz Biotechnology, N-19 and C-10 respectively), rabbit-anti-Nanog 
(Chemicon), goat-anti-FoxA2 (M-20, Santa Cruz Biotechnology), goat-anti-Gata6 
(C-20, Santa Cruz Biotechnology), or mouse-anti-CD140a (PDGFRA; 
eBioscience #16-1401). This was followed by the appropriate secondary 
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antibodies detecting mouse or goat IgG Alexa Fluor 488 (1:500; Molecular 
Probes) for Oct4 staining, rabbit IgG Alexa Fluor 594 (1:500; Molecular Probes) 
for Nanog staining, or Qdot® 655 anti-goat or anti-mouse antibodies (Molecular 
Probes) for FoxA2, Gata6 and PDGFRA staining (1:150) according to 
manufacturer’s protocol. Images were captured with the Zeiss LSM 5 Duo 
inverted confocal microscope (Zeiss, Thornwood, NJ). 
 
N2B27-differentiated cells were fixed at room temperature in 4% 
paraformaldehyde and permeabilized with 0.3% Triton X-100 in 24-well plates. 
Blocking was performed for 30 minutes in buffer comprising 5% FBS and 1% BSA 
in PBS solution. Cells were stained with the following primary antibodies: mouse-
anti-Nestin (Chemicon, MAB353), rabbit-anti-TuJ1 (Covance, MRB-435P) and 
anti-MAP2 (Sigma-Aldrich) for 1 hour at room temperature. The cells were rinsed 
3 times with blocking buffer and incubated with Alexa Fluor 488 secondary 
antibodies (#A11070, #A11017, #A11055; Molecular Probes) for 30 minutes. 
DAPI staining was performed at 1 μg/ml for 5 minutes at room temperature 
(D9542, Sigma) and images were captured on a Carl Zeiss Observer.D1 with 
AxioVision v 4.6.3 software (Carl Zeiss Inc, Thornwood, NY). 
 
2.8 Custom production of Zic3 antibodies 
A region was selected on the Zic3 protein that is not conserved among the other 
Zic family members (Figure 16; Clustal W protein sequence alignment). For a 
further test of specificity, this region was subjected to a protein BLAST search 
(NCBI). The peptide sequence and antibody properties are listed in Table 6. 
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Peptide synthesis and antibody production were performed according to the 
custom polyclonal antibody protocol by Biogenes GmBH (Berlin, Germany). The 
rabbits were immunized and boosted every 28 days for 3 months. Subsequent 
monthly production bleeds were affinity-purified for total IgG (tris-glycine buffer pH 
7.5, 250mM NaCl, 0.02% thimerosal) and their specificity was tested by western 
blots. Antibodies from the 3rd production bleed were the most sensitive and 
produced the lowest background. These antibodies were used in our 
experiments. 
 
2.9 Chromatin Immunoprecipitation (ChIP) 
2.9.1 ChIP protocol 
E14 cells were cultured to a density of 1 x 108 cells for each IP. Two biological 
ChIP replicates were performed per experiment. Cells were cross-linked for 10 
minutes at room temperature with 1% (w/v) formaldehyde and the reaction was 
subsequently quenched with 125mM glycine. Nuclear fractions were isolated and 
the DNA was sheared to lengths of 200 to 500 bp. Antibodies against Zic3, Sox2 
(sc-17320, Santa Cruz Biotechnology) and GST (sc-459 & sc-34073; Santa Cruz 
Biotechnology) were used for immunoprecipitation. Ten micrograms of each ChIP 
antibody was incubated with pre-blocked Protein G sepharose beads for 2 hours 
at 4°C. Following incubation, the antibody-sepharose bead complexes were 
rinsed, gently pelleted at 500 rpm for 1 minute at 4°C, and then resuspended in 
the pre-cleared (2 hour incubation at 4°C with pre-blocked protein G sepharose 
beads) cross-linked nuclear protein fractions for overnight incubation at 4°C. The 
following day, the protein-antibody-bead complexes were rinsed and pelleted by 
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Zic family CLUSTAL W (1.83) multiple sequence alignment (Page 1 of 2) 
 
Zic1            -------------------------------------------------MLLDAGPQYPA 11 
Zic2            -------------------------------------------------MLLDAGPQFPA 11 
Zic3            -----------------------------------------------MTMLLDGGPQFPG 13 
Zic4            ------------------------------------------------------------ 
Zic5            MMEPPLSKRNPPALRLADLATAQAQQLQNMTGFPVLVGPPAHSQRRAVAMHLHPRDLGTD 60 
                                                                             
 
Zic1            IGVTTFGASRHHSAG-------DVAERDVGLG-------INPFADGMGAFKLNPS-SHEL 56 
Zic2            IGVGSFARHHHHSAAAAAAAAAEMQDRELSLAAA-QNGFVDSAAAHMGAFKLNPG-AHEL 69 
Zic3            LGVGSFGAPRHHEMP-------NREPAGMGLNPFGDSTHAAAAAAAAAAFKLSPATAHDL 66 
Zic4            ------------------------------------------------------------ 
Zic5            PGVASTALGPEHMAQASGQGPCPPSQGLPGLSQVPAPAARSVASGTHPGARTHPDGGGSS 120 
                                                                             
 
Zic1            ASAGQTAFTSQAPG------YAAAAALGHHHHPGHVGSYS----SAAFNSTRDFLFRNRG 106 
Zic2            SPGQSSAFTSQGPGAYPGSAAAAAAAAALGPHAAHVGSYS----GPPFNSTRDFLFRSRG 125 
Zic3            SSGQSSAFTPQGSG--YANALGHHHHHHHHHHASQVPTYARR-ASAAFNSTRDFLFRQRG 123 
Zic4            ------------------------------------MKYK----TSLVMRKRLRLYRN-- 18 
Zic5            GAQASAPPPPAPPLPPSQSSSPPPPPPPPPALSGYTATNSGGGSSSGKGHSRDFVLRRDL 180 
                                                     .       .    .*  : *    
 
Zic1            --------------FG-DAAAAASAQHSLFAASAGGFGG----PHGHTDAAGHLLFSGLH 147 
Zic2            --------------FG-DSAPGG-GQHGLFGPGAGGLH------HAHSDAQGHLLFPGLP 163 
Zic3            --------------SGLSEAASGGGQHGLFAGSASSLHA----PAGIPEPPSYLLFPGLH 165 
Zic4            ---------------TLKESSSSCGHHGPQLAAS-------------SNPS---VLPGLH 47 
Zic5            SATAPAAAMHGAPLGGEQRSGSSSPQHPTPPPHPAGMFISASGTYAGRDGGGSALFPALH 240 
                                 . : ..  :*      .              :     ::..*  
 
Zic1            EQAAG-HASPN--VVNGQMRLGFSGDMYPRPEQYGQVTS---PRSE-------HYAAPQL 194 
Zic2            PEQHGPHASQN--VLNGQMRLGLPGEVFGRSEQYRQVAS---PRTD-------PYSAAQL 211 
Zic3            EQGAG-HPSPTGHVDNNQVHLGLRGELFGRADPYRPVAS---PRTD-------PYAASAQ 214 
Zic4            EQPPQASHSRP---LNGLLRLGIPGDMYARSEPFAPGPM---ARSD-------TLATATA 94 
Zic5            DSPGAPGGHP----LNGQMRLGLAAAAAAAAELYGRAEPPFAPRSGDAHYGAVAAAAAAA 296 
                 .             *. ::**: .     .: :        .*:          ::.   
 
Zic1            HG-YGPMNVNMAA-----------------HHGAG---------------------AFFR 215 
Zic2            HNQYGPMNMNMGMNMAAAAAHHHH-----HHHHPG---------------------AFFR 245 
Zic3            FPNYSPMNMNMGVN--------VA-----AHHGPG---------------------AFFR 240 
Zic4            LHGYGGMNLTMNLT---------------APHGPG---------------------AFFR 118 
Zic5            LHGYGAVNLNLNLAAAAAAAAAAGPGPHLQHHAPPPAPPPAPAPHPHHPHLPGAAGAFLR 356 
                   *. :*:.:                    * .                      **:* 
 
Zic1            YMRQP-IKQELICKWIEPEQLANPKK-------SCNKTFSTMHELVTHVTVEHVGGPEQS 267 
Zic2            YMRQQCIKQELICKWIDPEQLSNPKK-------SCNKTFSTMHELVTHVSVEHVGGPEQS 298 
Zic3            YMRQP-IKQELSCKWIEEAQLSRPKK-------SCDRTFSTMHELVTHVTMEHVGGPEQN 292 
Zic4            YMRQP-IKQELICKWLGDDSPMSPR--------PCSKTFSTMHELVTHVTVEHVGGPEQA 169 
Zic5            YMRQP-IKRELICKWLDPEELAGPPASADSGVKPCSKTFGTMHELVNHVTVEHVGGPEQS 415 
                ****  **:** ***:   .   *         .*.:**.******.**::********  
 
Zic1            NHICFWEECPREGKPFKAKYKLVNHIRVHTGEKPFPCPFPGCGKVFARSENLKIHKRTHT 327 
Zic2            NHVCFWEECPREGKPFKAKYKLVNHIRVHTGEKPFPCPFPGCGKVFARSENLKIHKRTHT 358 
Zic3            NHVCYWEECPREGKSFKAKYKLVNHIRVHTGEKPFPCPFPGCGKIFARSENLKIHKRTHT 352 
Zic4            NHICFWEECPRQGKPFKAKYKLVNHIRVHTGEKPFPCPFPGCGKVFARSENLKIHKRTHT 229 
Zic5            SHVCFWEDCPREGKPFKAKYKLINHIRVHTGEKPFPCPFPGCGKVFARSENLKIHKRTHT 475 
                .*:*:**:***:**.*******:*********************:*************** 
 
Zic1            GEKPFKCEFEGCDRRFANSSDRKKHMHVHTSDKPYLCKM--CDKSYTHPSSLRKHMKVHE 385 
Zic2            GEKPFQCEFEGCDRRFANSSDRKKHMHVHTSDKPYLCKM--CDKSYTHPSSLRKHMKVHE 416 
Zic3            GEKPFKCEFEGCDRRFANSSDRKKHMHVHTSDKPYICKV--CDKSYTHPSSLRKHMKVHE 410 
Zic4            GEKPFRCEFEGCERRFANSSDRKKHSHVHTSDKPYMCKVRGCDKCYTHPSSLRKHMKVHG 289 
Zic5            GEKPFKCEFDGCDRKFANSSDRKKHSHVHTSDKPYYCKIRGCDKSYTHPSSLRKHMKIHC 535 
                *****:***:**:*:********** ********* **:  ***.************:*  
  76
Figure 16. Zic family protien sequence alignment (Clustal W). The Zic3 
protein sequence is indicated in grey, and the Zic3 antibody was raised 
against a unique 13 amino acid region (yellow) that is not conserved amongst 
the Zic family members  
Zic family CLUSTAL W (1.83) multiple sequence alignment (Page 2 of 2)
 
Zic1            SSSQGSQPSPAASSGYESSTPPTIVSPTTDNPTTSSMSPSS---------------SAVH 430 
Zic2            SSPQGSESSPAASSGYESSTPPGLVSPSAEPQSSSNLSPAAAAAAAAAAAAAA-AVSAVH 475 
Zic3            S--QGSDSSPAASSGYESSTPPAIASANSKD---TTKTP-----------------SAVQ 448 
Zic4            R-------SPPPSSGYDSAITSALASPSLESGREPSVAC-----------------SAAV 325 
Zic5            KSPPPSPGALGYSSVGTPVGDPLSPVLDPTRSRSSTLSPQVTNLNEWYVCQASGAPSHLH 595 
                        :   **   .   .            .. :                  *    
 
Zic1            HTAG--------------------------------------HSALSSNFNEWYV----- 447 
Zic2            RGAGSGSSGSGGGSAAGSGGGGGGAGGGGGGSSGGGSGTTGGHSGLSSNFNEWYV----- 530 
Zic3            TSTS-------------------------------------HNPGLPPNFNEWYV----- 466 
Zic4            VVRG-------------------------------------------TDVSE-------- 334 
Zic5            TPSS-------------------------------------NGTTSESEDEEMYGNPEVM 618 
                   .                                           .: .*         
 
Zic1            ---- 
Zic2            ---- 
Zic3            ---- 
Zic4            ---- 




centrifugation at low speed for 1 minute at 4°C. The ChIP material was eluted 
from the beads at 65°C for 30 minutes, and cross-links were reversed overnight 
by incubation at 65°C. The following day, the samples were treated with RNaseA 
(0.2mg/ml) for 2 hours at 37°C, and then Proteinase K (0.2 mg/ml) at 55 °C for 1 
hour. Finally, the samples were treated twice with phenol/chloroform/Isoamyl 
alcohol (25:24:1), then precipitated and rinsed once in 70% ethanol before re-
suspension in 70μl of 10mM Tris-HCl, pH 8.0.  
 
2.9.2 Quantitative PCR for ChIP enrichment 
Quantitative PCR for ChIP enrichment was performed on the ABI PRISM 7900 
machine with 1x SYBR Green PCR mastermix (Applied Biosystems), under the 
following conditions: 50°C for 2 minutes, 95°C for 10 minutes, and 40 cycles of 
95°C for 15s and 60°C for 1 minute. Fluorescence from the amplified products 
was measured by laser spectral analyses on the ABI Prism 7900 machine, and 
the data were processed and displayed in the form of real-time amplification plots 
generated by the SDS software (v2.2; Applied Biosystems). ChIP fold-enrichment 
was determined by normalizing Threshold cycle (Ct) values of ChIP samples 
against sonicated whole cell DNA extract, and then subsequently to a non-
enriched ChIP control region set at a value of 1. Details of primers are provided 
as Appendix 1.  
 
All PCR primers gave a single product as confirmed by agarose gel 
electrophoresis and heat dissociation analysis185 on the ABI Prism 7900 (Applied 
Biosystems), under the following conditions: 95°C for 15s, 60°C for 20s, 20 
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minute ramp to 95°C and 95°C for 15s. The data from this analysis were compiled 
by the SDS software (v2.2; Applied Biosystems) and displayed as melting curve 
graphs. The graphs were checked for specificity of PCR amplified product as 
indicated by a single, well-defined melting curve peak185. 
 
2.9.3 ChIP-chip assays, data processing, and statistical analysis 
For analysis on mouse Agilent ChIP-on chip promoter arrays, the purified ChIP 
material (Section 2.9.1) was blunt-ended, ligated to linkers and PCR amplified. 
DNA was flurophore-labeled using Invitrogen’s CGH Labeling kit (ChIP samples 
with Cy5; whole-cell extract with Cy3). The labeled DNA was hybridized to Agilent 
mouse promoter ChIP-on-chip arrays for 40 hours at 65°C (Agilent Technologies, 
Santa Clara, CA). Chips were washed and scanned as per manufacturer’s 
protocol and the results were processed with Agilent's ChIP Analytics software 
v1.3. A p-value cutoff <0.001 was specified in this analysis.  
 
To further minimize false positives, a “neighborhood voting” algorithm19 was 
applied to filter for high confidence Zic3- or Sox2-enriched sites, wherein binding 
was considered genuine only in the presence of a second significantly enriched 
neighboring probe (p < 0.005). For analysis of ChIP-chip false discovery rate 
(FDR), 33 ChIP positive regions reported by the Agilent array were selected at 
random for PCR verification (ref. section 2.9.2). One gene out of the 33 did not 
give a PCR enrichment greater than our 2.5-fold threshold for positive 
enrichment, giving an FDR < 0.03 (Appendix 2). 
 
  80
2.10 Luciferase reporter assays 
2.10.1 Nanog promoter assays 
The 300bp Zic3 enhancer region containing the Nanog-binding site was cloned 
from mouse genomic DNA (Section 2.1.6). The primers used were: forward, 5’ 
ATATAacgcgtTTAGAGGTCAAACCAT-3’, and reverse, 5’-TATATagatctTAGT 
AGTCAAACTGGATT-3’ with restriction sites indicated in lowercase. The PCR 
fragment was digested with MluI and BglII, and cloned into the pGL3-Basic vector 
(Promega) containing a basal promoter comprising the 500bp region immediately 
upstream of the mouse Oct4 gene. The following constructs were transfected into 
cells 2.5 x 104 cells in 96-well plates for the luciferase assay: 100ng firefly 
luciferase reporter, 1.0 ng of the Renilla luciferase vector, pRL-SV40 plasmid 
normalization control, and 250ng of the respective knock-down construct. 
Puromycin selection (1.0µg/ml) was introduced 20 hours post-transfection and 
cultured for 2 days. Luciferase activity measured using the Dual Luciferase 
System (Promega) in a Centro LB960 96-well luminometer (Berthold 
Technologies). 
 
2.10.2 Zic3 ChIP-identified promoter assays 
Zic3 target regions were amplified by PCR from genomic DNA (Section 2.1.6) and 
sub-cloned into the NheI/BglII sites of the ProMega luciferase reporter vector 
pGL3. Sequences lacking a native minimal promoter were cloned upstream of the 
SV40 promoter for enhancer assays. DNA sequences were amplified by PCR 
from mouse genomic DNA with the primers listed in Appendix 3. All transfections 
and luciferase assays were performed as described above, and the unpaired 
Student's t test was used to determine statistical significance.  
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2.11 Co-immunoprecipitation experiments 
The Seize-X Protein G immunoprecipitation kit (#45210, Pierce Biotechnology, 
Rockford, IL) was used according to the manufacturer’s protocol. Briefly, 
antibodies were cross-linked to immobilized protein G sepharose in spin columns. 
Confluent 15cm2 dishes of E14 cells (1 x 108 cells) were rinsed twice with PBS, 
and then gently scraped and pelleted at 500 rpm for 5 minutes. The cells were 
lysed in Co-IP lysis buffer (50 mM Tris, pH 7.6, 150 mM NaCl, 2 mM EDTA, 1% 
NP-40, 0.1% SDS, and 1 x EDTA-free Protease inhibitor, Roche), and centrifuged 
at maximum speed for 15 minutes at 4°C. The supernatant containing 
endogenous complexes was applied to the antibody-linked columns and 
incubated overnight at 4°C. Immunoprecipitated complexes were washed the 
following day and eluted twice from the spin columns, and the samples were 
resolved in 10% SDS-PAGE gels with reducing buffer.  
 
2.12 Gene Expression arrays  
2.12.1 Illumina mouse arrays 
The whole-genome Illumina Mouse Ref-8 v1.1 beadchips were used for 
microarray analysis of RNAi-treated and Ainv18-Zic3 overexpression samples. 
These Illumina beadchips allow interrogation of approximately 25,600 well-
annotated mouse refseq transcripts. For the microarray analyses, mRNA was 
harvested from 3 biological replicates per experiment. These samples were 
reverse-transcribed, Cy3-labeled, and hybridized to Illumina MouseRef-8 v1.1 
Expression Beadchips according to the manufacturer’s protocol (Illumina Inc., 
San Diego). Following the wash of Illumina chips, microarray signals were 
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scanned with an Illumina BeadStation array reader, and the data were 
background-normalized and assessed for quality with cluster dendrograms and 
DirectHyb control plots (Beadstudio v1.5, Illumina).  
 
2.12.2  Statistical analysis of microarray data 
The microarray data were processed with Genespring GX v7.3.1 (Agilent 
Technologies, Santa Clara). The unpaired Student's t test was used to determine 
statistical significance with Benjamini and Hochberg multiple-testing correction 
(FDR<0.1), and genes demonstrating ≥ 1.5-fold change were reported as 
statistically significant.  
 
For statistical analysis of overlapping genes between RNAi samples, computer 
simulations were conducted as follows: a number of genes corresponding to the 
actual number of genes within each list were randomly sampled from the Illumina 
mouse Ref-8 v1.1 beadchip. The random gene lists were overlapped to derive a 
percentage, and this process was repeated 100 times to yield an average 
percentage overlap by chance. Finally, p-values were computed by comparing 
the 100 simulated overlaps to the actual overlap percentage using one-sample t-
tests. 
 
2.12.3  Functional annotations using the Panther database 
The microarray gene lists were uploaded to the Panther database for functional 
annotations (http://www.pantherdb.org). In this analysis, the Panther Gene 
Expression tool set was used to classify differentially-regulated genes under 
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biological process groups using the “Compare Gene List” function, relative to the 
25,600 Illumina mouse Ref-8 v1.1 transcripts, and the binomial test was used to 
identify statistically significant over- or under-represented functional categories 














CHAPTER 3:    
Zic3 is involved in transcriptional 
regulation of ES cell pluripotency 
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3.1 Introduction 
Embryonic stem (ES) cell pluripotency is dependent upon sustained expression of 
the key transcriptional regulators Oct4, Nanog and Sox2. These core factors 
contribute to the hallmark characteristics of ES cells by: (1) activation of target 
genes that encode pluripotency and self-renewal mechanisms, and (2) repression 
of signaling pathways that promote differentiation42. In ES cells Oct4, Nanog and 
Sox2 co-occupy promoters of hundreds of genes that are both expressed and 
repressed in the pluripotent state 19,20. This suggests complex regulatory circuitry 
in which Oct4, Nanog and Sox2 collectively and uniquely regulate downstream 
genes to control ES cell differentiation. However, it remains unclear what are the 
downstream effectors of these transcription factors that contribute to maintaining 
the pluripotent status of ES cells.  It also is not understood how these ‘master 
regulators’ of pluripotency are involved in controlling lineage-specific 
differentiation of ES cells.  It is therefore useful to elucidate the transcriptional 
networks surrounding Oct4, Nanog and Sox2, where detailed knowledge of these 
pathways remain key to harnessing the potential to direct differentiation of ES 
cells into therapeutically useful cell types. 
 
To expand our understanding of the transcriptional networks that control stem cell 
differentiation, I have focused on transcription factors whose expression is directly 
regulated by Oct4, Nanog and Sox2. Zic3 (Zinc finger protein of the cerebellum 3) 
was identified as a transcription factor of interest for two reasons. Firstly, Oct4, 
Nanog and Sox2 binding have been mapped to the Zic3 promoter regions in ES 
cells 19,20, implying that these key factors may regulate Zic3 expression. The 
overlap between mouse and human ES cells further highlights the significance of 
  86
Zic3, and suggests possible conservation of the gene’s pathways between the 
two species. Secondly, Zic3 demonstrates differential gene expression between 
the pluripotent and early differentiation phases, where its expression is higher in 
the pluripotent state 85,86. The changes in gene expression between these states 
suggest a potential role for Zic3 in controlling differentiation of mouse and human 
ES cells. 
 
Zic3 belongs to the GLI superfamily of transcription factors and is a vertebrate 
homologue of the Drosophila pair-rule gene odd-paired (opa)98. The five known 
mammalian Zic genes (Zic1 – 5) encode five tandem C2H2 zinc finger domains 
that are highly conserved across species186,187, and show distinct and partially 
overlapping expression patterns during development115,116. Zic3 shares overall 
64% and 59% homology with Zic1 and Zic2 respectively, and this homology 
increases to 91% within the zinc finger domain. Thus members of Zic family are 
strong candidates for redundancy in molecular signaling owing to the high degree 
of homology and overlapping expression observed among the members of this 
family. 
 
In this study, I examined the function of Zic3 as a regulatory target of Oct4, 
Nanog and Sox2 in ES cells. The Zic3 gene has been identified as a target of 
Oct4, Nanog and Sox2 in ES cells19,20, and Zic3 is preferentially expressed in 
pluripotent state 85,86. Questions arising from these data are: (1) How do Oct4, 
Nanog and Sox2 interact with the Zic3 regulatory region, and what results from 
this interaction, and, (2) What role does Zic3 play in the embryonic stem cell? In 
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this chapter, I have addressed these questions using the loss-of-function 
approach for Zic3 and the key regulatory genes in ES cells.  
 
3.2 Results 
3.2.1 Zic3 expression is associated with ES cell pluripotency 
Comprehensive expression profiling of mouse and human ES cells has resulted 
in the identification of numerous genes that are expressed in undifferentiated cells 
and quickly repressed upon differentiation85,86.  Among these genes are 
transcription factors Oct4, Nanog, and Sox2, which are required to maintain 
pluripotency of ES cells.  Zic3 was also found to be expressed in undifferentiated 
ES cells and suppressed in differentiated cells, and thus, may play a role in 
regulating ES cell differentiation.  To further characterize the expression profile of 
Zic3, I assayed its expression in mouse ES cells which were induced to 
differentiate over 6 days by the addition of retinoic acid (RA) (Figure 17A). Similar 
to the trend demonstrated by Oct4, Nanog and Sox2 in differentiating ES cells, 
Zic3 transcript levels decreased between 1.5- to 10-fold for each two-day interval 
(D2, D4, and D6) relative to the undifferentiated control (Figure 17A), and this 
decrease in Zic3 mRNA levels also correlated with a downregulation of Zic3 
protein expression (Figure 17B). In addition, Zic3 expression was significantly 
decreased in mouse ES cells differentiated by treatment with HMBA (N,N'-
Hexamethylenebisacetamide)or DMSO (Dimethyl Sulfoxide), and by aggregation 
into embryoid bodies (Figure 18). Collectively, these results indicate that Zic3 is 
associated with mouse ES pluripotency and that its expression decreases as the 
ES cells differentiate.  
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Figure 17. Profile of Zic3 expression during retinoic acid 
differentiation of E14 cells. (A) Real-time PCR analysis of differentiation 
induced by Retinoic Acid. Samples were assayed at two-day intervals 
(Untreated control, and treated samples Day 2, Day 4, Day 6). Mean 
levels ± S.E. are expressed as percentages relative to undifferentiated 
E14 cells (100%). The assays were conducted in duplicate and 
normalized to Beta-actin control. (B) Verification of Zic3 protein 





















































































Control Day 2 Day 4 Day 6
Figure 18. Zic3 expression during DMSO, HMBA and embryoid body 
differentiation of E14 cells. Samples were assayed at two-day intervals 
(Untreated control, and treated samples Day 2, Day 4, Day 6). Mean 
levels ± S.E. are expressed as percentages relative to undifferentiated 
E14 cells (100%). The assays were conducted in duplicate and 














In further support of the importance of Zic3 in ES cell pluripotency, chromatin 
immunoprecipitation (ChIP) experiments in both mouse and human ES cells have 
identified binding sites for the transcription factors Oct4, Nanog and Sox2 at the 
Zic3 gene locus (Figure 19)19,20. The binding of these transcription factors, which 
are demonstrated regulators of pluripotency, suggests that Zic3 is a direct target 
for regulation by these TFs and may play a role in regulating ES cell 
differentiation. 
 
3.2.2 Zic3 is regulated by Oct4, Nanog and Sox2 
To further validate that Oct4, Sox2 and Nanog regulate Zic3 expression, I 
performed gene expression knock-down experiments in mouse ES cells using 
RNA interference. Mouse ES cells were transfected with gene-specific siRNAs 
against Oct4, Sox2, and Nanog on alternate days to achieve 80-90% reduction in 
expression of the specific target gene as detailed in Section 2.3.1 (Figure 20A).  
Down-regulation of Oct4 and Sox2 reduced the level of endogenous Zic3 to less 
than 25%, while Nanog RNAi reduced the level of Zic3 to 70% (Figure 20B).  
These data indicate that Zic3 expression is regulated by Oct4, Sox2, and Nanog. 
 
It has been shown that Nanog over-expressing ES cells are resistant to 
differentiation induced by LIF withdrawal and RA addition188. As the endogenous 
levels of Zic3 decreased upon RA induced differentiation (Figure 17), I was 
interested to determine if Nanog over-expression would sustain Zic3 levels under 
RA treatment. ES cells with constitutive overexpression of Nanog were treated for 
two days with 0.3uM RA, alongside empty vector controls.  The control cells 
showed a decrease in Zic3 RNA levels typical of RA-induced differentiation.  In 
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Figure 19. Oct4, Nanog and Sox2 binding sites on the Zic3 promoter. 
(Loh et al., 2006; Sox2, H.H Ng, unpublished data) and (Boyer et al., 
2005). Transcription factor binding sites within 100kb up- and downstream 
of the Zic3 coding region are represented here. In human ES cells, Oct4, 
Nanog and Sox2 binding sites were located within 3.5kb upstream of the 
Zic3 transcription start site, while in mouse ES cells, the Nanog binding 
site was found within 18.5kb upstream, and the Oct4 and Sox2 binding 
sites were within 9.5 kb downstream of the gene respectively (Loh et al., 
2006). Each unit on the scale represents 10 kb.
Transcription start
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Figure 20. Oct4, Sox2 and Nanog regulate Zic3 expression. (A) Changes in endogenous 
gene expression levels of Oct4, Nanog and Sox2 following gene-specific RNA 
interference, and (B) corresponding changes in endogenous Zic3 gene levels. cDNAs
were prepared from the RNAi knockdown ES cells and analyzed using real-time PCR. 
The levels of the transcripts were normalized against values derived from control RNAi 
transfected ES cells (100%).  (C) Changes in ES cell endogenous Zic3 gene level 
following Nanog over-expression with RA induced differentiation. Nanog over-expression 
cell line and control cell line were treated with no RA or 0.3μM RA for 2 days. Transcript 
levels of 0.3μM RA treated sample were normalized against no RA treatment sample. (D) 
Diagram of the construct with putative Zic3 enchancer region fused upstream of a 
minimal Pou5f1 promoter and firefly luciferase gene (E) The effects of luciferase activity 
in the absence of the putative Nanog binding site on Zic3 enhancer were tested by 
transfecting into ES cells. Activity were measured relative to the minimal promoter only 
(MP) construct without the Nanog enhancer  (F) Effects of Nanog RNAi on Zic3 enhancer 
activity were tested by co-transfecting the Nanog RNAi with the reporter construct into ES 
cells and luciferase activity measured. Activity were normalized against the Control RNAi 
with mOct4 promoter-only construct. An RNAi targeting the GFP sequence was used as 
a nonspecific control.
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contrast, mouse ES cells over-expressing Nanog sustained the level of Zic3 at 
greater than 80% relative to the control ES cell line (Figure 20C).  Thus, over-
expression and knockdown of Nanog in ES cells results in an increase and 
decrease, respectively, of Zic3, suggesting that Zic3 expression is regulated by 
Nanog, perhaps directly or indirectly.   
 
A previous study identified a Nanog binding site in the enhancer region, 16.4 kb 
upstream of the transcription start site, of the Zic3 gene20. Using this DNA region, 
I sought to determine if Zic3 expression was directly regulated by Nanog. A 
292bp portion of the Zic3 enhancer containing the Nanog binding site was fused 
upstream of a minimal Pou5f1 promoter that drives the firefly luciferase gene 
(Figure 20D). The minimal promoter was weakly active in ES cells, while activity 
of the Zic3 enhancer region linked to the minimal promoter was 9-fold up-
regulated as quantified by luciferase (Figure 20E). When the sequences of this 
putative Nanog binding site were deleted from the Zic3 enhancer the 
corresponding reporter activity decreased (Figure 20E). Nanog RNAi was then 
transfected together with the wild-type reporter construct and the results indicated 
a 4-fold decrease in Zic3 enhancer activity relative to the controls (Figure 20F).  
Collectively, the data show that Zic3 expression is directly regulated by Nanog 
and, thus, may be a downstream effector in controlling ES cell differentiation.    
 
3.2.3 Zic3 RNA interference in ES cells 
3.2.3.1   Loss of Zic3 leads to ES cell differentiation 
To investigate the role of Zic3 in ES cells I used RNA interference to achieve 
knockdown of gene expression. Both the siRNA and shRNA methods resulted in 
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a 70% reduction of Zic3 transcript levels relative to the non-targeting controls 
(Figure 21A). Zic3 protein levels reflect this decrease in gene expression 
following Zic3 RNAi treatment, while protein expression remained high in vector-
only treated cells (Figure 21B).  
 
Zic3 RNAi transfections resulted in a marked decrease in pluripotent colonies that 
stained for the stem cell surface marker alkaline phosphatase (AP)189 relative to 
the mock RNAi control (Figures 22A & 22B). Following AP staining, the extent of 
differentiation was quantified with secondary re-plating assays that revealed a 3- 
to 5- fold increase in differentiated colonies in comparison with the non-targeting 
control (Figure 22C). In order to assess the differentiation state of Zic3 
knockdown cells, I assayed the changes in expression of key pluripotency genes 
(Figure 21A). Though the mouse ES cells showed clear morphological changes 
(Figures 22A & 22B), there were only modest decreases (15-20% siRNA 
experiment; 20-25% shRNA experiment) in the expression of the key pluripotency 
genes Oct4 and Sox2 (Figure 21A), while Nanog expression decreased 40% 
relative to the non-targeting control.  I then performed the same experiment with 
human ES cells (HuES9).  Although there was 70% decrease in Zic3 transcript 
levels, Oct4 and Sox2 transcript levels remained unchanged and Nanog levels 
decreased by 25% (Figure 21A). These results suggest that Zic3 plays a role in 
maintaining ES cell pluripotency and its action is downstream of the dominant 
pluripotency factors Oct4, Sox2, and Nanog. 
 
It is interesting that targeted repression of Zic3 induced morphological 


































































Figure 21. Effect of Zic3 RNAi on endogenous Oct4, Nanog and Sox2 levels. (A) Zic3 levels 
were depleted by RNA interference using siRNA and shRNA in mouse E14 cells and siRNA in 
human HuES9 cells. RNA was harvested between 4 to 5 days of transfection and transcript 
levels assayed by Real-time PCR. Shown in this figure are the levels of Zic3 transcript and the 
corresponding changes in Oct4, Nanog and Sox2 expression. Mean values ± S.E. are plotted 
as percentages relative to the non-targeting control (100%). The samples were assayed in 
duplicate and normalized to endogenous Beta-actin. (B) Corresponding decrease in protein 
levels following Zic3 RNAi treatment. Details of antibody specificity are provided in Table 6. The 
Zic3 protein species was depleted in the Zic3 RNAi sample, while B-actin protein levels 
remained high in the control. Beta-actin protein was used as a loading control.
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Figure 22. Effect of Zic3 RNAi on ES cell pluripotency. (A) & (B) Alkaline 
phosphatase staining revealed that the extent of differentiation in Zic3 RNAi-
treated cells was greater than non-targeting RNAi control cells. (C) Secondary re-
plating assays were used to quantitate the extent of differentiation in Zic3 RNAi 
cells. A 3-to-5 fold increase in differentiated colonies were observed with Zic3 
RNAi relative to the non-targeting control. Scale bars, 50 μm.
















































genes in the transient knockdown experiments. To understand the molecular 
state of these cells, I examined a series of markers that represent lineage-specific 
ES cell differentiation. Zic3 knockdown in mouse and human ES cells resulted in 
an up-regulation of a panel of endodermal markers assayed by real-time PCR 
(Section 2.6.3): Sox17 (3.5-fold), Pdgfra (3.2- to 5.5-fold in mouse ES cells; 2.7-
fold in human ES cells) and Gata6 (2.5- to 3.5-fold) (Figure 23). In addition, two 
more endodermal lineage genes Gata4 and Foxa2 were up-regulated in the E14 
RNAi cells (2.5-fold). I also assayed the expression of mesendodermal, 
mesodermal, ectodermal, trophectodermal and Wnt-pathway markers in Zic3 
RNAi cells. These markers remained unchanged relative to the non-targeting 
control in both mouse and human RNAi experiments (Figure 23) and were not 
statistically significant.  These results indicate that Zic3 could play a specific role 
in maintaining ES cell pluripotency by suppressing endoderm marker expression.   
 
3.2.3.2    Specificity of Zic3 knockdown 
There was a possibility that ES cell differentiation and marker gene expression 
were due to off-target effects of the RNA interference. To address this concern, I 
designed a Zic3 expression construct that was immune to RNA interference and 
tested whether this construct could rescue the knock-down phenotypes.  The Zic3 
RNAi-immune expression construct was engineered with 5 silent mutations in 
protein coding domain sequence (Figure 24). As such, this construct (mutZic3) 
produces functional Zic3 protein, but due to codon degeneracy, remains resistant 
to RNAi targeting and degradation. This mutZic3 construct was therefore used to 







































































































































































ENDO MESENDO MESO ECTO TROPH WNT
ENDO MESENDO MESO ECTO
Figure 23. Effect of Zic3 RNAi on lineage marker gene expression. The panel of 
genes above was selected for their lineage-specificity. Transcript levels of genes from 
the endodermal (ENDO), mesendodermal (MESENDO), mesdodermal (MESO), 
ectodermal (ECTO), trophectordermal (TROPH) and Wnt pathways in mouse and 
human ES cells were assayed by Real-time PCR following Zic3 depletion by RNA 
interference. (A) siRNA in mouse E14 cells.  (B) shRNA in mouse E14 cells. (C) 
siRNA in human HuES9 cells. Mean levels ± S.E. are expressed as percentages 
relative to the non-targeting control (100%). The assays were read in duplicate and 




Figure 24. Zic3 RNAi-immune construct. Diagram of the Zic3-
RNAi wildtype targeted region (WT target) and the Zic3 target 
sequence modified to encode mutations that render immunity to 
RNAi targeting, while preserving functional viability due to 
degeneracy of the genetic code (red codons; RNAi-immune). 
Acknowledgements: This construct was greated by Jonathan Loh. 
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The expression of endodermal markers Foxa2, Gata4 and Sox17 was first 
induced in ES cells by co-transfection of an empty overexpression vector with 
Zic3-RNAi, relative to cells co-transfected with empty vector and GFP-RNAi (6.5-, 
10.1-, and 8.7-fold, for Foxa2, Gata4 and Sox17, respectively, Figure 25, A-C). In 
contrast, when ES cells the RNAi-immune construct (mutZic3) was introduced 
into ES cells with Zic3 RNAi, no endodermal markers were induced. (Figure 25, 
A-C). These experiments indicate that the RNA interference results are not due to 
off-target effects and further support the conclusion that Zic3 plays a role in 
maintaining the pluripotency of ES cells.  
 
3.2.4 Zic3 clonal knockdown lines express endoderm lineage markers 
3.2.4.1    Zic3 clonal knockdown lines 
To determine if endodermal markers were upregulated in the same cells in which 
Zic3 was depleted, three clonal lines were generated that stably expressed Zic3 
shRNA. Figure 26 shows the morphology of these clonal lines. Panels A and B 
show non-targeting control lines which propagated rapidly and demonstrated the 
typical compact, phase-bright colonies of ES cells, suggesting that transfection of 
non-targeting shRNA and long-term antibiotic selection did not affect the ES-like 
morphology of the cells. In contrast, Panels C and D reflect the differentiated 
morphology of Zic3 clonal knockdown lines. These cell lines contained a mixture 
of phase-bright ES-like colonies and phase-dark, flattened cells with extended 
processes (Figure 26C and 26D). The Zic3 knockdown lines propagated more 
slowly, as observed by their slower rate at attaining confluency relative to the 
control lines when an equal number of cells were seeded. This appeared to be a 
result of decreased rate of proliferation rather than increased cell death (where a 
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Figure 25. Zic3-immune construct specifically reverses changes in lineage marker
expression levels caused by Zic3 RNAi. (A) – (C) Zic3 Rescue experiments demonstrating 
the specificity of Zic3 RNAi and reversibility of lineage marker expression. E14 cells co-
transfected with the Zic3 RNAi-immune overexpression contruct and Zic3 RNAi vector 
demonstrated notable suppression of endodermal markers Foxa2, Gata4 and Sox17, 
relative to Zic3 RNAi co-transfected with the empty vector control). Zic3 immune real-time 
PCR analysis was conducted 3 days post-transfection. ß-actin was used as an internal 
control for normalization. The measurements were performed in biological triplicate with two 
technical replicates each and the average of the normalized ratio of target gene/ß-actin was 
calculated and presented with standard deviation. Relative expressions calculated with 
respect to the control experiment (Vector + GFP RNAi) at 100%. Transfection schemes are 






Non-targeting clonal lines Zic3 clonal knockdown lines
Figure 26. Morphology of Zic3 clonal knockdown lines. (A – B) 
Brightfield pictographs of two control lines transfected with a non-targeting 
control vector. These cell lines had the typical morphology of ES cells that 
form compact, phase-bright colonies. (C – D) Zic3 clonal knockdown lines 
contained a mixture of phase-bright ES-like cells and phase-dark, 
flattened cells with processes extended. This indicates that the Zic3 clonal 
knockdown lines are differentiated relative to the control lines. Scale bars, 
50 μm.
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significant increase in dead and floating cells was not observed in the culture 
media), and is a further indication of the differentiated status of the Zic3 
knockdown lines. 
 
It was interesting that clonal cell lines with proliferative capacity could be derived 
from differentiated Zic3 knockdown cells. I hypothesized that the clonal lines 
resulted from a subset of cells that were successfully transfected but maintained 
Zic3 shRNA expression at lower levels. It was possible that this decreased 
amount of Zic3 knockdown in ES cells was compatible with long-term passaging. 
To examine this possibility, a pSUPER shRNA construct containing EGFP 
(pSUPER.GFP) was used to generate Zic3 knockdown cells (Figure 27), to 
enable tracking of transfected cells by GFP expression. This construct was similar 
to the pSUPER construct used previously, with the exception of a GFP transgene 
inserted upstream of the antibiotic resistance cassette. This construct has been 
extensively tested in our lab and produces a knockdown efficiency equivalent to 
that of the pSUPER vector. In addition, GFP fluorescence has been observed as 
a reliable indicator of vector expression.  
 
Three days following transfection of the pSUPER.GFP constructs (Figures 28A 
and 29A), GFP was expressed in approximately 80% of ES cells, indicating a 
high rate of transfection efficiency. The non-targeting cells proliferated quickly and 
gave rise to small ES cell colonies at this stage (Figure 28B). In contrast, the Zic3 
knockdown cells showed differentiated morphology (Figure 29B) and were 
proliferating at a slower rate. This observation is consistent with the previous data 
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Figure 27. pSUPER.GFP.neo construct from Oligoengine. 
This construct features an shRNA cloning site (MCS) 
downstream of the RNA pol III H1 promoter for endogenous 
production of siRNA. In addition, EGFP expression and 






Figure 28. GFP fluorescence in mES cells transfected with 
non-targeting pSUPER-GFP shRNA vector. (A – B) The non-
targeting control cells demonstrated robust GFP expression 3 
days after transfection, with antibiotic selection introduced 24 
hours post-transfection. (C – D) Three weeks post-transfection, 
the non-targetting pSUPER-GFP cells continued to 
demonstrate robust GFP expression, indicating that the shRNA






Figure 29. GFP fluorescence in mES cells transfected with the 
Zic3-pSUPER-GFP shRNA vector. (A – B) The Zic3 RNAi cells 
demonstrated robust GFP expression 3 days after transfection. 
The decreased proliferation rates following Zic3 knockdown 
resulted in smaller cell colonies compared to the controls in Figure 
11. (C – D) Three weeks following transfection, the Zic3-pSUPER-
GFP cells gave rise to colonies were non-fluorescent for GFP, 
suggesting that the cells that survived selection did not express a 
significant amount of shRNA. (E) Two clonal lines derived from 
each of the non-targetting pSUPER.GFP or Zic3-pSUPER.GFP 
vectors were assayed for expression of Zic3. The results indicated 
that, despite lack of GFP fluorescence, Zic3 expression was 









































demonstrating that Zic3 transient knockdown resulted in ES cell differentiation 
(Figure 22B).  
 
Following three weeks of antibiotic selection, robust levels of GFP expression 
were observed in the non-targeting knockdown cells (Figure  28C), indicating that 
the pSUPER.GFP vector was stably expressed in cells undergoing long-term 
passage. In contrast, the Zic3 knockdown cells revealed a striking lack of GFP 
expression (Figure 29C). This observation was surprising as colonies emerging 
from long-term passage of pSUPER.GFP cell lines were generally observed to 
have high levels of GFP fluorescence (See Appendix 4 for illustration of GFP-
expressing colonies derived from knockdown an unrelated gene, CoupTFII). The 
lack of GFP expression is therefore unique to the Zic3 knockdown cells, and it 
suggests that colonies present after three weeks resulted from low expression 
levels from the shRNA construct that conferred sufficient antibiotic resistance for 
cell survival, but reduced knockdown efficiency. 
 
Clonal cell lines were derived from the non-targeting and Zic3 knockdown cells by 
expansion of individual colonies at 3 weeks. Two cell lines per construct were 
assayed for Zic3 expression, and the results indicate that Zic3 was 
downregulated by 60% in the Zic3 knockdown lines relative to the control lines. 
This knockdown is less robust than in the transient Zic3 knockdowns where 
depletion of Zic3 expression by 70% to 80% was observed (Figure 21a). The 
results therefore support the hypothesis that the Zic3 clonal lines resulted from a 
subset of transfected cells that maintained Zic3 shRNA expression at decreased 
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levels, thus allowing a degree of proliferation that was compatible with long-term 
passage.  
 
3.2.4.2    Endoderm genes are upregulated in Zic3 clonal knockdown lines 
The Zic3 knockdown lines derived from the non-fluorescent construct (pSUPER-
Zic3) were assayed to determine the expression profile of pluripotency and 
lineage marker genes. As observed with the cell lines from pSUPER.GFP (Figure 
29E), Zic3 expression was downregulated approximately 60% relative to vector-
only lines (Figure 30a). The pluripotency genes Oct4 and Sox2 were reduced 
between 20% to 30% relative to controls in all three clonal knockdown lines, while 
Nanog was reduced by 80% (Figure 30a). The endodermal genes Pdgfra, Gata4, 
Gata6, and Sox7 were 30-fold higher than in the controls, while Sox17 was 
upregulated between 60- to 80-fold, and FoxA2 was increased by 80- to 120-fold 
in all three Zic3 knockdown lines (Figure 30b). The induction of endodermal 
markers here was substantially greater than observed in the transient Zic3 knock-
downs. Expression of mesendoderm, mesoderm, ectoderm, trophectoderm and 
Wnt-related genes remained essentially unchanged (<2-fold) in the Zic3 
knockdown lines (Figure 30c). Thus the specific upregulation of endodermal gene 
expression in the clonal lines is consistent, and in fact more pronounced, with the 
observations in the transient knockdowns (Figure 23). It would be interesting to 
evaluate the Zic3 knockdown effect in a range of clonal lines in further 




3.2.4.2    Endoderm protein expression is upregulated in Zic3 clonal 
knockdown lines 
To ascertain if there were corresponding increases in endodermal protein levels, 
immunocytochemistry was performed against FoxA2, Gata6 and PDGFRA in the 
clonal lines. The Zic3 knockdown lines consistently demonstrated robust 
endodermal marker staining (Figure 31A) that was absent in the vector control 
lines (Figure 32). Oct4 staining was also observed in the cells that were positive 
for endodermal marker expression (Figure 31A). Interestingly, although the Zic3 
clonal knockdown lines expressed Oct4 and SSEA-1 (Figure 31B), Nanog protein 
expression was significantly reduced relative to the vector control lines (Figure 
33). This corroborated with my earlier observation that Nanog gene expression 
levels were down-regulated in the Zic3 knockdown lines (Figure 30A) and raises 
the possibility that Nanog gene expression is directly regulated by Zic3.  
 
3.2.5 Zic2 is able to partially compensate for the function of Zic3 
Zic3 belongs to a family of transcription factors with five member proteins (Zic1 – 
Zic5)  encoding five consecutive C2H2 zinc finger domains which are highly 
conserved across species186,187. In addition, the Zic family members show distinct 
and partially overlapping expression patterns during development115,116. Zic3 
shares 64% and 59% homology with the Zic1 and Zic2 genes respectively, and 
this homology increases to 91% within the zinc finger domain. It was therefore 



































































































































































ZIC3 clonal knockdown 
lines
Vector Controls
Figure 30. Zic3 knockdown clonal lines demonstrate endodermal gene marker specification. 
Three Zic3 knockdown clonal lines and 2 vector controls were assayed as indicated in the 
diagrams. (A) The pluripotency markers Oct4 and Sox2 were slightly down-regulated between 
20 to 30%, while Zic3 and Nanog decreased significantly between 60 to 80% relative to the 
vector controls. (B) All endodermal markers assayed in the knockdown lines were significantly 
upregulated between 20- and 120-fold relative to the control lines. (C) Mesendodermal, 
mesodermal, ectodermal, trophectodermal and Wnt pathway genes did not change 
significantly in knockdown lines, demonstrating less than 2-fold changes relative to the vector 
controls. Gene expression levels were assayed by Real-time PCR. The experiments were 
performed in biological triplicate with two technical duplicates and normalized to endogenous 
Beta-actin. Mean values ± S.E. are plotted as percentages relative to the vector control.
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raising the possibility that Zic2 may be compensating for the reduction in Zic3 
levels. Zic2 is expressed in ES cells and its expression is downregulated upon 
differentiation85,86. Zic2 may also be regulated by Nanog as binding sites for this 
TF have been mapped to the Zic2 gene by chromatin immunoprecipitation (Figure 
35); however the functional regulation of Zic2 by Nanog remains to be tested. 
Knockdown of Zic2 expression by siRNA (75% reduction in RNA levels) did not 
produce any effect on lineage marker expression (Fig 34b).  
 
In order to determine if Zic2 compensated for the absence of Zic3, I performed a 
double RNAi experiment against Zic2 and Zic3 in ES cells. The double 
knockdown prevented Zic2 levels from increasing in a compensatory manner as 
observed in the Zic3 single knockdown (Figure 34c). Interestingly, endodermal 
specification was markedly enhanced following the Zic2 and Zic3 double 
knockdown as demonstrated by increased expression of Sox17 (4.7-fold), Pdgfra 
(8.7-fold) and Gata4 (3.1-fold), which is more robust than observed for all three 
markers (Sox17, 3.1-fold; Pdgfra, 3.3-fold; Gata4, 1.5-fold) when Zic3 alone was 
reduced (Figure 34d). The results therefore indicate that, in the absence of Zic3, 
Zic2 is able to partially compensate and downregulate endoderm gene 




Figure 31. Protein expression in Zic3 knockdown clonal lines. (A) Oct4 
protein expression was high in all three Zic3 knockdown lines, and the 
expression of specific endodermal marker proteins Foxa2, Gata6 and Sox17 
was observed in the same cells. (B) The Zic3 knockdown lines expressed 
stem cell surface protein, SSEA-1, which is specific to murine ES cells. Scale 
bars represent 100 μm.
DAPI Oct4 EndodermalA





Figure 32. Endodermal marker staining for E14 cells. The 
negative staining here demonstrates specificity of positive 
staining for Zic3 knockdown clonal lines in Figure 31. 
Scale bars, 100 μm.
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Figure 33. Nanog expression in the Zic3 
knockdown lines. The Zic3 clonal knockdown 






















































































































Non-targeting Zic2 + Zic3 Zic3 only
Zic2 + Zic3 RNAi
D
Figure 34. Effect of Zic2 and Zic3 double knockdown. The genes were assayed by Real-time 
PCR in triplicate and normalized to a Beta-actin control. Mean levels ± S.E. are expressed as 
percentages relative to the non-targeting control. (A) Zic2 gene expression increased 2-fold 
with Zic3 transient knockdown four days after transfection. (B) Zic2 knockdown by siRNA
was specific but did not produce changes in lineage markers assayed. (C)  Zic2 and Zic3 co-
knockdown produced specific knockdown of Zic3 and at the same time prevented 
compensatory increase of Zic2 expression in ES cells. (D) The expression of endodermal
lineage markers Sox17, PDGFRA and Gata4 showed a similar pattern of up-regulation as in 
















































































Figure 35. A summary of Oct4, Nanog and Sox2 binding sites on 
the Zic2 promoter. Oct4 and Sox2 binding sites were not present in 
this region, and three Nanog binding sites were located upstream of 
the Zic3 transcription start site (Loh et al., 2006; Sox2). Each unit on 
the scale represents 10 kb.
Transcription start
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3.3  Discussion 
3.3.1 Zic3 expression is associated with the key regulators of pluripotency 
in ES cells.  
The work presented in this chapter demonstrates that Zic3 plays a key regulatory 
role in controlling ES cell differentiation.  Here I have demonstrated that the 
expression pattern of Zic3 in ES cells corresponds closely with that of known 
regulators of pluripotency Oct4, Nanog, Sox2, which have high levels of 
expression in the undifferentiated state and decrease rapidly upon differentiation 
(Figure 17). The findings in mouse ES cells are consistent with results from 
human ES cells85. The differences observed in Zic3 expression levels between 
pluripotent and early differentiation phases imply a potentially significant role for 
Zic3 in ES cell pluripotency. In addition, chromatin-IP mapping by us and others 
has revealed Oct4, Nanog and Sox2 co-occupancy on the Zic3 regulatory region, 
suggesting that Zic3 may be co-ordinately regulated by Oct4, Nanog and Sox2 in 
mouse and human ES cells19,20 (Figure 19). These observations together led to 
my hypothesis that Zic3 functions to maintain the pluripotent state of ES cells. 
Here I characterized the relationship of Zic3 with that of the key stem cell 
regulatory factors, and uncovered a role for Zic3 in the maintenance of ES cell 
pluripotency. 
 
3.3.2 Zic3 functions downstream of Oct4, Nanog and Sox2 and is 
positively regulated by these factors. 
My first objective was to assess the nature of interactions between Oct4, Nanog 
and Sox2 with the Zic3 regulatory region. This was addressed using a 
combinatorial approach that encompassed the results of chromatin-IP mapping 
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and RNAi, to demonstrate that ablation of Oct4, Nanog and Sox2 in mouse ES 
cells resulted in a significant decrease in Zic3 expression (Figure 20 A-B). Since 
Zic3 was previously implicated as a target of Oct4, Nanog and Sox2 in ChIP 
experiments19,20, the concern of non-direct or secondary effects of RNAi was 
significantly reduced45. Thus it is likely that the binding of Oct4, Nanog and Sox2 
to the Zic3 gene regulatory region serves to enhance target gene expression, 
such that the key pluripotency regulators function as transcriptional activators of 
Zic3 in ES cells (Figure 36). This point is underscored by the results with Nanog 
over-expression and binding site mutagenesis assays, which indicate a positive 
association between Nanog binding and Zic3 expression (Figure 20 D-F). These 
results therefore reveal positive functional interactions between the key 
pluripotency regulators and the Zic3 gene regulatory region.  
 
Since transcriptional networks are also known to feature auto-regulatory 
loops45,48, I also asked if the inverse relationship was true – that is, whether Zic3 
regulates expression of the key regulatory genes. Here I observed that Oct4 and 
Sox2 levels remained slightly perturbed by the ablation of Zic3 expression 
(Figures 521A and 30A). In the absence of clear changes despite a robust Zic3 
knockdown, the above data places Zic3 downstream of Oct4 and Sox2 in the ES 
cell transcriptional networks as illustrated in Figure 36. In addition, the 
immunostaining experiments revealed a significant decrease in Nanog expression 





Figure 36. A model of Zic3 function in embryonic stem cells. 
Zic3 contributes to the maintenance of pluripotency by operating
downstream of Oct4, Nanog and Sox2 to inhibit endoderm lineage 
specification as characterized by endodermal markers Sox17, 
PDGFRA, Gata4, Gata6, Foxa2 and Sox7. The presence of Zic3 
also maintains the expression of the homeodomain protein Nanog, a 









3.3.3 Zic3 maintains pluripotency by blocking endodermal differentiation in ES cells 
Embryonic stem cells are derived from the inner cell mass of the blastocyst and, 
as such, are able to undergo unlimited self-renewal and differentiation into the 
three germ layers of the embryo – mesoderm, ectoderm and endoderm2,3. In the 
pluripotent state, ES cells remain undifferentiated and do not express specific 
lineage markers. I was interested in examining the effect of Zic3 knockdown on 
the maintenance of ES pluripotency using specific lineage markers as an 
assessment of differentiation following Zic3 knockdown. Here I demonstrate that 
ablation of Zic3 expression in both mouse and human ES cells resulted in a 
significant increase in markers of endodermal lineage (Figures 23, 30B and 31). 
These results suggest that Zic3 may have an important role in preventing 
endodermal specification in ES cells.  
 
Many reports support this observation: Firstly, Zic3 knockdown in ES cells 
induced expression of Gata4 and Gata6, and forced expression of Gata4 and 
Gata6in ES cells result in differentiation towards extraembryonic 
endoderm84. Further strengthening this association is the fact that all other 
endodermal markers assayed (Pdgfra, Sox17 and FoxA2) are also expressed in 
extraembryonic endoderm derivatives190. Secondly, Zic3 regulates Nodal 
expression through direct interaction with its promoter during gastrulation and it 
has been shown that Nodal expression is essential in proper specification of the 
embryonic visceral endoderm191. This significance is underscored by studies 
reporting that the earliest abnormalities observed in Zic3-null mice are defects in 
proper patterning of the anterior visceral endoderm158. Finally, Zic3 clonal 
knockdown lines exhibit a significant decrease in Nanog gene expression (Figure 
  121
30A and 33), and several groups have reported that RNAi-mediated depletion of 
Nanog expression resulted in an induction of extraembryonic endoderm markers 
Gata4 and Gata639,192,193.  
 
The results in this chapter indicate that Zic3 functions as a gatekeeper of 
pluripotency in ES cells by preventing their differentiation into cells that express 
endodermal markers. Corroborating with this, a significant reduction in Nanog 
expression was observed in the Zic3 clonal lines. This reduction is noteworthy as 
Nanog is a key regulator of pluripotency in ES cells78, and it is well-established 
that disruption of Nanog expression results in development of extraembryonic 
endoderm character in ES cells39,192,193. Thus, I demonstrate here an important 
role for Zic3 in the maintenance of pluripotency in ES cells through prevention of 
endodermal lineage specification, and suggest that its action may in part be 
mediated through the key pluripotency regulator Nanog (Figure 36).  
 
The role of Zic3 in preventing endodermal specification is further supported by 
evidence indicating its restricted expression within the mesoderm and ectoderm 
lineages during gastrulation186. In addition, Zic3 activity has been specifically 
implicated in the mesodermal and ectodermal molecular pathways in the early 
developing embryo123,126-128. These data in combination with the results in this 
chapter suggest that while Zic3 is instructive for mesodermal and ectodermal 
specification in embryonic development, it may simultaneously function as a 
repressor of ectopic endodermal induction in these tissues. To determine this it 
would be interesting to examine the differentiation capacity of Zic3 knockdown 
and overexpressing cells in teratoma formation in vivo. In addition Zic3-null ES 
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cells may be assayed for their lineage markers under conditions that maintain ES 
cell pluripotency and when induced to differentiate. 
 
3.3.4 Zic2 works in concert with Zic3 to reduce endodermal specification in 
ES cells 
The transcription factor Zic3 shares five highly-conserved Zinc finger domains 
with family members Zic1, Zic2, Zic4 and Zic598,101,102,106. Their partially 
overlapping spatial and temporal patterns of expression during early development 
suggests potential functional redundancy between the Zic family members115,116. 
When Zic3 expression was reduced in ES cells, an increase in Zic2 gene levels 
was observed (Figure 34A). The mechanism for this upregulation remains 
unknown and may be addressed by an investigation of transcriptional regulators 
which occupy the Zic2 promoter in ES cells. However, since Zic2 is also 
differentially expressed between pluripotent and differentiation states of ES 
cells85,86 and binding of the key pluripotency transcription factor Nanog has been 
mapped to the Zic2 regulatory region (Figure 35), I reasoned that Zic2 may 
participate in the regulation of ES cell pluripotency along with Zic3.  
 
In order to unveil the possible effects of functional redundancy between Zic2 and 
Zic3, a double knockdown was performed in mouse ES cells. The results indicate 
that repression of Zic2 and Zic3 expression significantly enhanced endoderm 
specification in ES cells (Figure 34C). The evidence that Nanog binds to the Zic2 
regulatory region suggests that it may be involved in similar pathways as Zic3 in 
repressing endoderm expression. Thus, Zic2 and Zic3 may participate in 
redundant or partially overlapping networks to silence endoderm specifying gene 
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expression and contribute to the maintenance of pluripotency in ES cells. It would 
be interesting to examine the binding targets of Zic2 to determine if it shares 
common targets with Zic3 to account for this redundancy. 
 
3.4 Summary 
I have demonstrated in this chapter that Zic3 is present in ES cells and that its 
expression is quickly repressed as the cells begin to differentiate. The expression 
of Zic3 in pluripotent ES cells is also directly regulated by Oct4, Sox2, and Nanog. 
In addition, targeted repression of Zic3 in both human and mouse ES cells by 
RNAi induced expression of several markers of the endodermal lineage. Notably, 
the expression of Nanog, a key pluripotency regulator and repressor of 
extraembryonic endoderm specification in ES cells, was significantly reduced in 
Zic3 knockdown cells. This suggests that Zic3 may prevent endodermal marker 
expression through Nanog-regulated pathways, and that it is important in 
maintaining ES cell pluripotency by preventing differentiation of cells into 








CHAPTER 4:  




Zic3 operates directly downstream of Oct4, Nanog and Sox2, and maintains the 
pluripotent state by preventing ES cells from differentiating into the endoderm 
lineage. These results place Zic3 within an important loop in association with the 
key pluripotent factors. In addition, it was recently shown that retrovirus-mediated 
infection of four ES cell transcription factors (Oct-3/4, Sox2, KLF4 and c-Myc) into 
mouse fibroblasts resulted in induced pluripotent stem (iPS) cells93. A recent 
microarray analysis of fully and partially re-programmed iPS cells revealed an 
upregulation of Zic3 in these cells relative to their original differentiated fibroblast 
states194. This further supports the idea that Zic3 may be at least partially involved 
in the process of restoring the properties of self-renewal and pluripotency during 
reprogramming of differentiated cells.  
 
While the role of Zic3 in maintenance of the pluripotent state has been 
established, the detailed molecular pathways in which Zic3 operates in ES cells 
remain as yet unknown. I was therefore interested to elucidate the network of 
global targets regulated by Zic3, and to uncover its hitherto unknown interactions 
with other ES cell-associated proteins. To this end, I reported in the previous 
chapter that Zic3 positively regulates the expression of Nanog in ES cells in a 
manner similar to that of the Oct4/Sox2 heterodimer on the Nanog promoter82,83. 
Here I conducted experiments to address my hypothesis that Zic3 binds with Oct4 
and/or Sox2 protein to regulate activity of the Nanog promoter, and in extension, 




4.2.1 Zic3 interacts with Sox2 in embryonic stem cells 
In order to address my hypothesis that Zic3 is an interacting partner of the 
Oct4/Sox2 transcription complex, experiments were conducted to examine the 
capacity of Zic3 to associate with the core ES cell regulatory proteins. Here Zic3 
co-immunoprecipitation (Co-IP) was performed using the Seize-X Protein G Co-IP 
kit (Pierce Biotechnology). This method allowed the cross-linking of Co-IP 
antibodies to the column to prevent their elution with the target protein complex, 
hence eliminating the problem of contaminating antibody heavy/light chain bands 
in the sample (Figure 37). To ensure adequate release of captured proteins, 
immunoprecipitated complexes from ES cell nuclear extracts were eluted from the 
column in two consecutive fractions. Following Zic3 co-IP (Figure 38), western 
blots were used to confirm the presence of Zic3 (55 kDa) in both eluted fractions. 
I subsequently checked for the presence of Sox2 and Oct4 within these fractions 
and found a clear Sox2 band (32 kDa) in the first eluted fraction. The Oct4 protein 
(47 kDa), in contrast, was not detected in the samples. These results indicate that 
Zic3 and Sox2 are interacting partners in ES cells.  
 
Inverse experiments were performed to verify these observations. Corroborating 
with results from the Zic3 pull-down, the Oct4 co-IP yielded Oct4 protein at 47 
kDa but no trace of Zic3 protein in both fractions (Figure 38). In contrast, the Sox2 
co-IP yielded Sox2 and Zic3 protein in both eluted fractions (Figure 38; 32 kDa 
and 55 kDa respectively). To ensure that the Co-IP proteins were specifically 
pulled down by the antibodies used, a control pull-down was performed using 
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Figure 37. Sox2 Co-immunoprecipition with the Seize-X Protein G 
Co-IP kit (Pierce Biotechnology). Fractions 1 - 3 are displayed. (A) 
Presence of Sox2 protein in Sox2 Co-IP samples at 32 kDa. (B) 
Presence of Zic3 protein in Sox2 Co-IP samples at 55 kDa. Detection of 
a single protein species at the expected size confirms the specificity of 
the assay. Unlike traditional Co-IPs, antibodies are cross-linked to 
Seize-X columns and do not elute with protein complexes. The absence 
of additional bands in the Sox2 blot (A), for which the secondary 
antibody used is cross-reactive with the original co-IP antibody, indicates 
the lack of contamination by the Co-IP antibody’s heavy and light chains 









































Figure 38. Zic3 and Sox2 interact in embryonic stem 
cells. Zic3 and Sox2 are co-immunoprecipitated in 
mouse ES cells (55 kDa and 32 kDa respectively), 
while pull-downs for Oct4 and GST did not result in Zic3 
or Sox2 precipitation. Positive controls for Zic3, Oct4 
and Sox3 were included to ensure sensitivity and 
specificity of the assay.
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antibodies against GST. In these control samples, no Zic3, Oct4 or Sox2 was 
detected (Figure 38). Total mouse ES nuclear extract was included to confirm that 
western blot conditions were specific and sensitive to detect Oct4, Sox2 and Zic3. 
Taken together, the above results suggest that Zic3 interacts specifically with 
Sox2 in ES cells. 
 
4.2.2 Zic3 shares regulatory pathways with Sox2 in ES cells 
I hypothesized that as interacting partners, Zic3 and Sox2 will share regulatory 
pathways in mouse ES cells. To test this possibility, RNA interference of Sox2 
and Zic3 were performed in biological triplicate to identify commonly regulated 
genes. After 4 days of Zic3 knockdown, the expression of Zic3 was reduced by 
80% relative to the non-targeting control (Figure 39A). In response to Zic3 
knockdown, Oct4, Nanog and Sox2 expression levels were down-regulated 20%, 
40% and 30%, respectively (Figure 39A).  
 
Global gene expression changes in the RNAi samples were assayed with Illumina 
bead chip arrays. In response to the depletion of endogenous Zic3, a total of 
1122 genes were found to be significantly regulated, of which 609 genes were up-
regulated and 513 genes were down-regulated (≥1.5 fold, FDR 0.1). The 
complete list of genes is provided in Supplementary Tables 1A and 1B. A parallel 
analysis of gene expression changes was performed in ES cells after 4 days of 
Sox2 knockdown, where I found that the levels of Sox2, Oct4, Nanog and Zic3 
were down-regulated by 80% or greater relative to the non-targeting control 















































































Figure 39. Gene expression profiles for Sox2 and Zic3 RNAi (A) Zic3 RNAi 
results in significant downregulation of endogenous Zic3 expression. The 
expression of Oct4, Nanog and Sox2 were also downregulated in response to 
Zic3 knockdown. (B) Sox2 RNAi results in significant downregulation of Sox2 
expression in mouse ES cells with Oct4, Nanog and Zic3 levels 
correspondingly  downregulated. (C) Zic3 and Sox2 RNAi samples reveal 














identified a total of 5445 genes that were differentially expressed  (≥1.5-fold, FDR 
0.1), with 2733 genes significantly up-regulated and 2712 genes down-regulated 
(gene lists provided in Supplementary Tables 2A and 2B). Overall, more genes 
were regulated by the Sox2 knockdown (5445 vs.1122) and the Sox2 knockdown 
generally resulted in greater gene expression changes than Zic3 knockdown. This 
suggests that while Zic3 and Sox2 co-regulate a subset of genes, the Zic3 
transcriptional network is slightly less influential than that of Sox2. 
 
The sets of differentially expressed genes from the Zic3 and Sox2 knockdowns 
were then compared, and the results indicated that 557 genes were similarly 
regulated in the Zic3 and Sox2 knock-down cells (Figure 39C). To assess the 
statistical significance of the 557 similarly regulated genes, I examined the Zic3 
and Sox2 RNAi overlaps in greater detail (Figure 40). Amongst the genes that 
were up-regulated 1.5-fold or greater, 304 out of 609 genes (50%) that changed 
as a result of Zic3 RNAi were similarly regulated by Sox2 RNAi (Figure 40A). An 
overlap of only 11% ± 1.3 was expected by random sampling, thus indicating that 
the actual 50% overlap is highly significant (p-value = 1.9725x10-147). Likewise, 
253 of 513 genes (49%) that were down-regulated by Zic3 RNAi were similarly 
affected by Sox2 knockdown, while an overlap of 10.7% ± 1.3 was expected by 
chance (p < 6.9763x10-146; Figure 40B). These results demonstrate that Zic3 and 
Sox2, which we have shown to physically interact, co-regulate hundreds of genes 
in ES cells19,20. 
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Figure 40. Significant overlap of Zic3 and Sox2 RNAi-regulated genes (A) 
Zic3 and Sox2 RNAi genes 1.5-fold upregulated and above show statistically 
significant overlap. (B) An overlap of Zic3 and Sox2 RNAi 1.5-fold 
downregulated and below is statistically significant.







Expected overlap: 11% ± 1.3








Expected overlap: 10.7% ± 1.3
p-value = 6.9763 E-146 
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To understand the biological implications of  the gene network co-regulated by 
Sox2 and Zic3, the list of 557 genes was uploaded to the Panther database for 
biological process annotations195. In this analysis, the genes were clustered into 
functional themes and compared to a reference list to look for statistically over (+) 
and under-represented (-) pathways. Here I found 26 biological processes that 
were significantly over- or under-represented relative to all genes on the Illumina 
bead arrays (p < 0.01, Supplementary Table 3). Of these 26 pathways, the 12 
highlighted in Table 7 may be broadly clustered under developmental- or stem 
cell-related themes. For comparison, the total number of genes from the Illumina 
reference list for each category is presented (#Ref list). Based on random 
sampling of 557 genes from the reference list (equivalent to the total number of 
genes in input list), the number of genes expected to cluster under each pathway 
is calculated (#Expected). The actual number of genes that changed as a result 
of RNAi (#Observed) was then compared with the #Expected to derive a p-value 
by Binomial testing. The biological processes in Table 7 are significantly over-
represented in both the Zic3 and Sox2 RNAi gene sets. Supplementary tables 4 A 
- D provide the full lists of genes that cluster under each pathway. These 
annotations suggest that Zic3 and Sox2 are interacting partners that co-regulate 
pathways involved in early embryonic development, ectoderm and mesoderm 
specification, oncogenesis and stem-cell related functions. The genes belonging 
to the endoderm development pathway (Sox17, Gata6, Pdgfra) were also found 
in the overlapping upregulated gene set between Zic3 and Sox2 RNAi. However 
the endoderm pathway did not rank as statistically significant (p > 0.05) with 




















# OBSERVED# EXPECTED# REF. LIST(Illumina)
PANTHER
BIOLOGICAL PROCESS
Table 7. Panther Biological Process annotations for significantly co-regulated genes by 
Zic3 and Sox2 RNAi
P-value - Probability that the number of genes observed in this category occurred by chance (Categories with 
p<0.01 are highlighted)
OVER/UNDER - No. of observed genes vs. expected (indication of over or underrepresentation)
# EXPECTED - No. of  ChIP target genes that were expected under specfic category
# OBSERVED - No. of  ChIP target genes that clustered under specfic category
Table Legend
# REFERENCE - No. of genes from Reference list that clustered under specfic Panther category (Agilent mouse 
promoter array gene list)
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4.2.3   Zic3 and Sox2 co-occupy physical binding sites in mouse ES cells 
Given the evidence that Zic3 and Sox2 physically interact and co-regulate 
developmental pathways, I hypothesized that common binding locations exist 
between Zic3 and Sox2 in the mouse ES genome. To address this hypothesis, 
chromatin immunoprecipitation (ChIP) experiments were conducted for both Zic3 
and Sox2, and subsequently assayed for enriched binding sites using a mouse 
promoter array (Agilent Technologies, CA). These ChIP-chip arrays contain 2 x 
244K probes, which interrogate promoter regions of ~17,000 transcripts. Two 
biological replicates were performed for each experiment. 
 
The Zic3 ChIP-chip analysis yielded 665 significantly enriched probes at the 
stringent cut-off p < 0.001 (Supplementary Table 5). Due to the fact that 
maximum chromatin shear size was 500 bp, multiple 60-mer probes on the tiled 
array were often enriched in close proximity to each other. To account for 
redundant probe enrichments, each 60-bp probe was extended equally on each 
end to a length of 500 bp. These extended regions were then compared, and 
overlapping regions were merged to define unique Zic3 target regions. Using this 
analysis, a total of 379 Zic3 unique target promoter sites were identified 
(Appendix 5). A similar analysis was conducted for the Sox2 ChIP-chip samples; 
a total of 4400 60-mer probes were significantly enriched at p < 0.001 
(Supplementary Table 6). These probes were extended to 500bp and then 
overlapped to yield a total of 1764 unique genomic locations that are occupied by 
Sox2 in ES cells (Appendix 6). 
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I was interested to determine the extent of co-binding between Zic3 and Sox2. 
Thus, the ChIP-chip results for Sox2 and Zic3 were compared and I found that 
48.8% (185 out of 379) Zic3-enriched sites were also occupied by Sox2 (Figure 
41A; details in Supplementary Table 7). This overlap was highly significant (p < 
3.69e-187) relative to an expected overlap of 5.95 ± 2.42 sites based on 100 
simulations. I examined the overlaps in greater detail to determine the physical 
binding distance between the most highly enriched Zic3 and Sox2 probes. Figure 
41B indicates that the location of the highest enriched probes for both Zic3 and 
Sox2 ChIPs coincided in 87 out of 185 co-bound regions (48%). This resulted in a 
sharp peak in the graph at 0 bp which rapidly declined further away from the Zic3 
probe. These results suggest that Zic3 and Sox2 bind in very close proximity 
within the mouse ES genome. 
 
Based on the degree of overlap between the most highly-enriched Zic3 and Sox2 
probes, I hypothesized that Zic3 and Sox2 binding motifs would occur close to 
each other. The Sox2 motif has been well-characterized20,49; however, there were 
no known Zic3 motifs in the context of the ES genome. Thus, I used the binding 
site data described above to derive a Zic3 consensus binding motif (Figure 42A). 
In this analysis, 332 high-quality (normalized log2 ratio > 2) enriched 60-mer 
probes were selected from the list of 665 enriched probes for a de novo motif 
search. The probe sequences were equally extended on both ends to a final 
length of 300 bp and uploaded to the Weeder search function196. From the 
results, ubiquitously-occurring sequence motifs within promoters were filtered 






























































Sox2 ChIP Zic3 ChIP
Expected overlap = 5.96 ± 2.42
Actual overlap = 185
p-value = 3.69e-187
B
Figure 41. Zic3 and Sox2 bind common targets 
in mouse ES cells. (A) Chromatin-IP revealed 
1764 promoter regions occupied by Sox2, and 379 
regions occupied by Zic3. An overlap of these Sox2 
and Zic3 chromatin-IP target regions is statistically 
significant. (B) Zic3 and Sox2 ChIP-chip peaks 






Figure 42. The Zic3 consensus DNA binding sequence. (A) A Zic3 
consensus binding motif was derived from 212 Zic3 target regions using 
the Weeder motif search function. (B) A Zic3 binding motif from the T2G 
database established by Mizugishi et al. 2001. In this assay, 30 random 
oligonucleotides were incubated with GST-fused Zic3 protein. The DNA 
sequences bound by Zic3 protein were sequenced to determine the 




within Zic3-bound sites using a method previously described20. From this analysis 
I identified 3 highly analogous binding motifs that correlated strongly with Zic3 
enrichment. An independent search was then conducted for these 3 motifs within 
all Zic3 enriched regions which identified 212 positive-scoring sites. The native 
motif sequences were extracted from these 212 sites and aligned to generate the 
final Position Weight Matrix shown in Figure 42A. This motif shares some 
similarity with a previously reported Zic3 consensus binding site (Figure 42B; 
Transfac #T04671105). In particular, they both demonstrate heavy preference for 
the guanine (G) nucleotide. However, due to the fact that a greater number of 
Zic3 binding sequences were analyzed in these experiments, the Zic3 consensus 
motif presented here shows overall greater weight, and hence specificity, at each 
nucleotide position (Figure 42A). The binding affinity of Zic3 to this newly-defined 
motif may be tested by gel-shift assays and compared to that of the previously 
established Zic3 motif. 
 
To determine the extent of Zic3 and Sox2 motif co-occurrence, two reciprocal 
analyses were performed. First, I identified the locations of Sox2 motifs within the 
1764 unique Sox2 target regions described in Figure 41A (Appendix 6). I then 
searched for the presence of Zic3 motifs within 100 bp of the Sox2 motifs and 
found a total of 945 co-occurring motif regions. Figure 43A shows the relationship 
between the number of co-occurring motifs identified and their distance relative to 
the nearest Sox2 motif. Most Zic3 motifs (123 regions) were found within 10 bp of 
Sox2 motifs. A high number of co-occurring motifs were also found 11 to 20 bp 
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apart (101 regions). Beyond 20 bp, the frequency of Zic3 and Sox2 co-occurring 
motifs declined sharply as seen in Figure 43A.  
 
An inverse analysis was performed with the Zic3 target regions described in 
Figure 41A (Appendix 5). The Zic3 motifs within these regions were identified and 
their sites scanned for the presence of Sox2 motifs. A total of 158 Sox2 motifs 
were identified within 100 bp of the Zic3 motif. Similar to the earlier observation 
(Figure 43A), the greatest number of Sox2 motifs were identified within 10 bps of 
the Zic3 motif (30 regions) and this frequency declined with separation distance 
(Figure 43B). Taken together, the above results indicate that Zic3 and Sox2 co-
occupy physical sites in the mouse ES genome. 
 
 
4.3 Discussion  
4.3.1 Zic3 and Sox2 regulate a common set of pathways in ES cells 
The results in this chapter demonstrate for the first time a physical interaction 
between Zic3 and Sox2, and evidence for their co-regulation of pathways in ES 
cells. Sox2 has an extended network involving a greater number of genes that 
change when its expression is perturbed in ES cells. Although Zic3 appears to 
directly or indirectly regulate fewer genes than Sox2, a significant proportion of 
genes that are dependent on Zic3 expression are also similarly regulated by 
Sox2. These genes cluster into biological pathways that reveal similar roles for 























































































































Figure 43. Zic3 and Sox2 motifs occur in close 
proxmity in the mouse ES genome. (A) Zic3-Sox2 
motif distances in Sox2 target regions. (B) Zic3-Sox2 
motif distances in Zic3 target regions.
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development, ectoderm and mesoderm development. Evidence exists in the 
literature for the independent roles of Sox2 and Zic3 in several of these pathways, 
and in particular for neural differentiation72,106,116,126,198,199. These data provides 
further validation for the separately established functions of the two transcription 
factors, and present unique evidence for their co-operative action on genes 
related to the abovementioned contexts. 
 
In further support of the interaction between Zic3 and Sox2, I highlight binding 
data demonstrating that they share a significant subset of target genes. Zic3 and 
Sox2 bind in close proximity on the promoters of their common targets, 
suggesting that they function as part of what is, at minimum, a heterodimer unit. 
The idea that Zic3 may associate with an ES cell protein complex is a plausible 
one, as reports in the literature suggest that many of the core ES cell proteins 
bind closely to each other 49,51, and Sox2 in particular is known to be a binding 
partner of Oct4 19,83. Hence I examined if Zic3 is associated with the Sox2-Oct4 
heterodimer in ES cells. The distance between Zic3-Sox2 ChIP-chip peak 
enrichments was compared with that of Oct4 ChIP-sequencing peaks49, and no 
significant association between the Sox2 and Oct4 binding sites (Supplementary 
table 8). These results suggest that Sox2 and Zic3 interact to regulate a separate 
subset of pathways from that of the Sox2-Oct4 heterodimer in ES cells. 
 
4.3.2 Zic3 and Sox2 are interacting partners in ES cells 
There are two possible ways in which Zic3 may bind with Sox2, either by direct 
contact with DNA or indirectly via Sox2 (Figure 44). A previous report suggests 
that Zic3 is a transcription factor with low binding affinity and is dependent on its 
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co-partners for specificity105. Thus I established three criteria to determine if Zic3 
binding is dependent on that of Sox2 in ES cells: First, I assessed whether Zic3 
binding sites are always located in close proximity with Sox2, and found that Zic3 
sites were distinct from Sox2 in slightly over 50% of Zic3 binding targets (Figure 
41A). Second, I examined if it was possible to derive an independent Zic3 motif 
from its ChIP-determined binding sites, and found that a consensus sequence 
could be detected in at least 212 Zic3 binding regions.  
 
Third, I reasoned that if Zic3 binding was solely mediated by the binding of Sox2, 
then a significant association should not exist between the Zic3 and Sox2 motifs. 
The Sox2 binding motif has been reported as a half-site in the context of 
heterodimerization with Oct419,20,83 and more recently on its own with the use of 
in-depth ChIP-sequencing techiniques49. These Sox2 binding motifs are highly 
similar and many occurrences of these motifs were found within the Sox2 ChIP-
chip peak binding sites, providing further validation of the accuracy of the ChIP 
results. Upon examination of the Zic3 and Sox2 consensus binding regions, an 
association between DNA binding motifs for the two transcription factors was 
observed (Figure 43A & B). Based on this, it is possible to conclude that the Zic3 
binding motif is distinct from the Sox2 motif and yet closely associated with it, 
suggesting that Zic3 binds both in close proximity with Sox2 and comes in direct 
contact with DNA. It is still possible, however, that the binding of Zic3 is enhanced 
by the presence of Sox2 or that it is binding to an as yet unknown partner that is 
responsible for its specificity in ES cells, and these notions remain to be further 
elucidated with affinity purification and mass spectrometry to identify binding 








Figure 44. Possible binding schemes for Zic3 and 
Sox2 in ES cells. Zic3 and Sox2 interact in mouse ES 
cells. Zic3 binds to Sox2 in one of two ways: 1) By direct 
contact with DNA, or 2) indirectly via Sox2. Our results 
indicate that Zic3 has a consensus binding motif that is 
found in close proximity with Sox2, suggesting that Zic3 
binds directly to DNA in mouse ES cells.
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4.4 Summary  
Little was previously known about the regulatory networks that Zic3 employs to 
maintain pluripotency in ES cells. Thus I have established the global regulatory 
targets of Zic3 in ES cells and investigated its interactions with other ES cell-
associated proteins. A Zic3 consensus binding motif was defined based on DNA 
sequences isolated by Zic3 chromatin immunoprecipitation (ChIP), and evidence 
for the co-operative action of Zic3 with Sox2 was presented. These results 
include: (1) physical interaction between Zic3 and Sox2 proteins, (2) evidence for 
their common regulatory pathways, and (3) a significant overlap between their 
target genes. These results suggest that Zic3 binds both in close proximity with 
Sox2 in ES cells and comes in direct contact with DNA. This chapter therefore 
presents new evidence for the hitherto unknown interaction between Zic3 and 
Sox2 in ES cells, and provides unique molecular insight into the question of how 











Zic3 is a regulator of lineage 




In addition to its role in pluripotency, Zic3 is a positive regulator of embryonic 
morphogenesis and cardiac, skeletal and neural development106,115,124,126,129,158. 
During early embryogenesis, Zic3 is involved in the initiation of gastrulation and 
the specification of left-right asymmetry. Zic3 null mouse models manifest early 
embryonic patterning failures that encompass defects in the anterior visceral 
endoderm and primitive streak formation129,158, indicating an important role for 
Zic3 in embryonic patterning. Complex cardiac defects also result from abnormal 
left-right axis formation during embryonic morphogenesis in Zic3 knockout mice, 
and Zic3 has been shown to interact with Nodal in left–right patterning that gives 
rise to subsequent cardiac development in the mouse124. These studies have 
further indicated a Zic3-responsive enhancer that mediates Nodal expression at 
the node124. 
 
Zic3 expression has also been identified in developing mouse ectoderm during 
gastrulation115, within the embryonic brain during organogenesis, and in the 
cerebellum of adult mice186. In addition, neural tube defects have been observed 
in the developing hindbrain of Zic3 knockout mouse models129,200. Interestingly, 
the overexpression of Zic3 in the ventricular zone of the embryonic mouse 
telencephalon, where cortical neurons are generated during development, results 
in an increase of proliferating neuronal progenitors201. These data strongly 
suggest a role for Zic3 in the early specification and maintenance of neural 
identity. Previous reports have also demonstrated the ability of Zic3 to activate 
the neural differentiation program through induction of proneural gene expression 
in Xenopus tissue126. However, there is to date no clear understanding of the 
  148
global regulatory networks within which Zic3 operates to determine lineage 
specificity. Here I investigate how Zic3 confers lineage specificity during ES cell 
differentiation. 
 
5.2 Results  
5.2.1 Zic3 regulates the promoters of lineage-specific genes 
Amongst the list of Zic3 target genes identified by chromatin-immunoprecipitation 
(Appendix 5) were many lineage-specific genes. In order to determine if these 
genes were responsive to regulation by Zic3, five arbitrarily selected target 
regions were tested for functional response to perturbations of Zic3 levels. Table 
8 provides details on these regions including the location of Zic3 binding, the 
gene associated with the target region, and the response of the gene to Zic3 
RNAi or overexpression in ES cells. With the exception of Nanog, the other four 
promoter regions belonged to genes that specify lineage development. These 
regions were amplified from mouse ES cell genomic DNA and linked to a 
luciferase reporter to test for transcriptional responsiveness. The length of the 
target region and type of luciferase vector used, enhancer or promoter, is shown 
in Table 8. The Nanog promoter region that was cloned contained the native 
Nanog minimal promoter, while the other 4 target regions were cloned upstream 
of an SV40 minimal promoter to test for enhancer activity. 
 
Zic3 enrichment was firstly verified at these 5 target regions by ChIP-PCR. Two 
DNA fragments approximately 200bp in length were selected for PCR 










Down with Zic3 RNAi
Up with Zic3 overexpression
Up with Zic3 overexpression
Downregulated with Zic3 
overexpression
Zic2 upregulated with Zic3 RNAi
Regulation by Zic3 in ES cells
Promoter / 383 bp
Enhancer / 390 bp
Enhancer / 471 bp
Enhancer / 592 bp
Enhancer / 980 bp









Table 8.  Luciferase assays for Zic3 target regions. DNA fragments were cloned into the pGL3 basic 
vector (Promoter assay) or pGL3-SV40 vector (Enhancer essay)
  150
the other was located within 300 bps of the motif-containing fragment. The 
sequences of all PCR primers used are provided in Appendix 1. Figure 45 
presents the fold enrichments at the 5 target regions by ChIP-PCR. The Zic5-Zic2 
divergent promoter (Zic5/2) and Nanog promoter regions were enriched between 
10- to 20-fold by ChIP-PCR, while the Cortistatin, Mbtps2 and Fgf5 promoter 
regions were enriched greater than 50-fold each. These results were normalized 
to a region on the mouse Chst1 promoter (NM_003654) that was not enriched by 
Zic3 ChIP. In contrast, a control ChIP experiment performed with a non-specific 
GST antibody did not enrich any of the target regions tested. Two further controls 
were performed with PCR primers that amplified non-Zic3 binding regions of the 
Nanog enhancer regions (Controls A and B). No Zic3 enrichment was detected at 
these regions, relative to the GST control. These results together confirm that the 
target regions selected for functional characterization are indeed occupied by 
Zic3 in the mouse ES genome. 
 
Transcriptional reporter assays were performed on the five promoter regions to 
test for functional regulation by Zic3. Figure 46 shows the activity of the promoter 
regions in response Zic3 overexpression in 293T cells. The Zic5/2 divergent 
promoter demonstrated the greatest increase (11-fold) in activity with Zic3 
overexpression relative to the no overexpression control (p < 0.01). Similar to the 
Zic5/2 divergent promoter, the activities of the Fgf5 (6-fold), Mbtps2 (8.5-fold), 
Cortistatin (4-fold) and Nanog (4.5-fold) promoters were also significantly up-












































































 - Zic3 binding motif present
Figure 45. PCR validation of five Zic3 binding targets. Zic3 
enrichment is positive by ChIP-PCR for the five target regions 

































Figure 46. Transciptional responsiveness of the five Zic3 
target promoter regions (HEK293T). The promoter regions 
were cloned into cloned into luciferase reporter vectors, and co-
transfection with a  Zic3 overexpression vector resulted in a 
significant upregulation of promoter activities in HEK 293T cells. 
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Zinc finger transcription factor, Zfp212, did not result in a significant increase in 
promoter activities (Figure 46). 
 
The five promoter regions demonstrated robust increases in activity in 293T cells, 
indicating that Zic3 is an activator of these regions. However, I observed in ES 
cells that Zic2 expression was up-regulated in response to Zic3 RNAi and Fgf5 
was down-regulated with Zic3 overexpression (Table 8), suggesting in contrast 
that Zic3 functions as a repressor in ES cells at these loci. To validate these 
observations, I performed luciferase experiments on the five promoter regions in 
mouse ES cells that were engineered for inducible Zic3 expression. Two Zic3 
doxycycline-inducible clonal lines were used in this analysis and three biological 
replicates were executed per experiment. In accordance with the earlier 
observations in ES cells, the activities of the Zic5/2 divergent promoter (0.5-fold) 
and the Fgf5 promoter (0.4-fold) were significantly (p < 0.01) down-regulated in 
both clonal lines in response to Zic3 overexpression (Figure 47A). As expected, 
the Mbtps2 (3-fold), Cortistatin (2.5-fold) and Nanog (2.2-fold) promoter activities 
in both clonal lines were significantly up-regulated in response to Zic3 
overexpression (Figure 47A). To confirm that the presence of doxycycline in the 
media did not interfere with luciferase readings, control experiments were 
performed with the empty vectors (pGL3 and pGL3-SV40) to demonstrate that 























































*  p < 0.01
Figure 47. Transciptional responsiveness of the five Zic3 target promoter 
regions in mES cells. (A) The promoter regions were cloned into cloned into 
luciferase reporter vectors. Zic3 overexpression in mouse ES cells resulted in a 
downregulation of the activities of the Zic5/2 divergent promoter and the Fgf5
promoter, and an upregulation of Mbtps2, Cortistatin and Nanog promoter 
activities. (B) Controls for doxycycline induction in mouse ES cells, 
demonstrating that doxycycline does not affect the intrinsic activities of the 
luciferase vectors.
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Finally, luciferase reporter experiments were performed in ES cells to test the 
activities of the five promoter regions in response to Zic3 RNAi. The promoter 
activities of Zic5/2 (2.3-fold) and Fgf5 (2-fold) were significantly up-regulated with 
Zic3 RNAi, while the activities of the Mbtps2 (0.65-fold), Cortistatin (0.4-fold) and 
Nanog (0.25-fold) promoters were significantly down-regulated relative to no-
RNAi controls (Figure 48). To check that the promoter activities were authentic, 
control experiments were performed with non-specific GFP RNAi. The five 
promoter activities were not significantly regulated by GFP RNAi relative to the 
no-RNAi experiments. The above results collectively indicate that the five 
promoter regions, where were identified by Zic3 ChIP experiments, are 
functionally responsive to Zic3 in both 293T and mouse ES cells. 
 
5.2.2 Zic3 binds to promoters of mesoderm, ectoderm and early 
developmental genes 
In addition to verifying the functional activity of Zic3 target regions, I was 
interested to define Zic3 regulated pathways in ES cells. Here I reasoned that the 
individual Zic3 target genes would group in specific functional pathways that 
reflect their function in ES cells. The list of Zic3 ChIP-chip genes was therefore 
analyzed by the Babelomics Fatigo+ search function 
(http://babelomics2.bioinfo.cipf.es/fatigoplus/ cgi-bin/fatigoplus.cgi) and classified 
under their relevant Gene Ontology (GO) terms for various biological 
processes202. The list of annotations at level 6 was selected for further analysis as 
it provided sufficient depth for functional classifications (Supplementary Table 9). 

























**  p < 0.01

















Figure 48. Transciptional responsiveness of the five Zic3 target promoter 
regions in mES cells. Zic3 RNAi resulted in an upregulation of Zic5/2 and Fgf5 
promoter activities, and a downregulation in activities of the Mbtps2, Cortistatin 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































the GO search that may be broadly grouped under the following themes: 
Neuronal development and function, mesoderm development, Wnt signalling, and 
early embryonic development. As the GO database does not include annotations 
for pluripotency-related genes, I conducted an additional manual search for genes 
known to be involved in ES cell maintenance203. 
 
The pluripotency genes in Figure 49 provide insight into the mechanisms of Zic3 
function in ES cells. To further explore the biological significance of these data, I 
sought to identify specific pathways in which Zic3 target genes are significantly 
over-represented. Hence the list of individual Zic3 target genes were compared to 
the Panther database of biological process annotations195. This list was assessed 
for statistically significant over (+) or under (-) representation within a pathway, 
relative to an expected number of genes derived from a reference list comprising 
the population of Agilent mouse promoter array genes. Table 9 reflects the 
biological pathways that are most significantly implicated by the Zic3 target genes 
(p ≤ 0.01). Based on random sampling from the reference list, the processes of 
mRNA transcription, development, chromatin packaging and remodelling, and 
ectoderm development were most significantly over-represented within the Zic3 
target genes.  
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5.2.3 Zic3 overexpression increases mesoderm and ectoderm 
specification 
5.2.3.1   Zic3-inducible overexpression cell lines  
A Zic3 inducible-expression cell line (Zic3 O/E) was established using mouse ES 
cells engineered for targeted gene insertion at the transcriptionally open HPRT 
locus183. Figure 50 demonstrates the specificity of regulation by doxycycline in 
two Zic3-overexpressing clones. Upon exposure to doxycycline for 4 days, Zic3 
gene expression was specifically upregulated 5-fold in the Zic3-overexpressing 
lines relative to control lines that overexpressed GFP (Figure 50A). Corroborating 
with this observation, Zic3 protein expression was not detected in the clones 
without exposure to doxycycline (Day 0) while strong Zic3 protein expression 
(55kDa) was observed at days 2 and 4 in response to addition of doxycycline to 
the ES cell culture media (Figure 50B). These results indicate that overexpression 
of Zic3 in the engineered cell lines was specific and sensitive to doxycycline 
induction. 
 
5.2.3.2   Zic3 overexpression leads to upregulation of ectodermal and 
mesodermal lineage markers  
In order to assess the potential of Zic3 to induce ES cell differentiation, the GFP- 
and Zic3-overexpressing lines were exposed to doxycycline in the absence of 
LIF. This provided conditions that were conducive for general differentiation so 
that the lineage specification properties of Zic3 could be determined. After 4 days 
of doxycycline treatment in ES cell media lacking LIF, the GFP-overexpressing 
cells showed a mixture of phase-dark differentiated cells and phase-bright 
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0.010+12.722595Ectoderm development
0.001+3.5911168Chromatin packaging and remodeling
0.000+39.8661864Developmental processes
0.000+53.85942522Nucleoside, nucleotide and nucleic acid metabolism
0.000+29.7641391mRNA transcription
0.000+22.87561071mRNA transcription regulation
p-valueOVER / UNDER# EXPECTED#OBSERVED# REF. LIST(Agilent)PANTHER BIOLOGICAL PROCESS
Table 9. Panther Biological Process annotations for Zic3 ChIP-chip target genes relative to the 





































Figure 50. Expression profile of Zic3-doxcycyline inducible cell lines. 
(A) Zic3 overexpression cell lines are sensitive to induction by doxycycline in 
an overexpression cell line engineered for targeted insertion at the HPRT 
locus. Zic3 gene expression is upregulated in Zic3-overexpressing but not 
GFP control cells 4 days after exposure to doxcycline. (B) HA-tagged Zic3 
protein is not detected in mouse ES without exposure to doxycyline, and is 
upregulated in cells exposed to doxycyline for 2 and 4 days
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compact ES cell colonies (Figure 51A). In contrast, the Zic3-overexpressing cells 
showed very distinct signs of differentiation including phase-dark cells with 
extended processes, and a decreased rate of proliferation (Figure 51B). No overt 
increase in cell death was observed from a general survey of floating cells in the 
culture medium, and the rate of cell death appeared to be consistent between the 
GFP- and Zic3-overexpressing lines. 
 
The GFP- and Zic3-overexpressing lines in Figure 51 were assayed for global 
gene expression changes. The cells at Day 4 of doxycycline induction were 
selected for microarray analysis as the cells earlier time-points did not 
demonstrate substantial change in morphology or marker expression in a 
preliminary real-time PCR assay. Three biological replicates were used per cell 
line. In this experiment, the genes that were significantly regulated in the Zic3-
overexpressing lines were determined relative to the GFP-overexpressing control 
cells. The list of significantly regulated genes (≥ 1.5-fold; FDR 0.1, Supplementary 
Tables 10-11) was then uploaded to the Panther database for Biological Process 
annotations. In line with the functional pathways represented by Zic3 target genes 
(Figure 49), the results indicated a significant increase in the mesoderm and 
ectoderm pathways in Zic3-overexpressing cells (Table 10). These results 
suggest that Zic3 has the ability to confer mesoderm and ectoderm properties 
during ES cell differentiation. 
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5.2.4 Zic3 upregulates neurogenesis during ES cell neural derivation 
The chromatin-IP and overexpression data suggest that Zic3 may be a significant 
regulator of the ectoderm specification pathway during ES cell differentiation. To 
determine the functional significance of these data, I examined if Zic3 
overexpression was able to enhance neural induction of ES cells.  Due to the fact 
that Zic3 is involved in the earliest stages of neural differentiation in the Xenopus 
embryo126, I postulated that the presence of Zic3 during early stages of ES cell 
neural differentiation would enhance the rate of neurogenesis. 
 
The N2B27 neural induction protocol was used as it involves a monolayer culture 
process, and is known to work with mouse ES cells184. Two clones each of the 
Zic3-overexpressing and control GFP-overexpressing cells were seeded on 
gelatin-coated plates and exposed to N2B27 media. The cells were induced to 
overexpress Zic3 or GFP by exposure to doxycycline during the first 2 days of 
N2B27 treatment and subsequently allowed to persist in N2B27 media without 
doxycycline for a further 6 days. Doxycyline induction was performed for the first 
two days as initial experiments indicated that maintainence of Zic3 
overexpression beyond day 2 in N2B27 prevented cells from neuronal 
differentiation. Corroborating with this observation, prior studies have 
demonstrated that Zic3 functions to maintain cells in the early undifferentiated 
neural progenitor state and may serve to expand the pool of neural cell numbers 
during embryonic ectoderm development201. 
 
  164
Figure 51. Zic3 overexpression cell lines 
differentiated more rapidly in the absence of LIF. 
(A) GFP-overexpressing lines show a mixture of ES-
like phase-bright cells and flattened cells with 
extended processes after 4 days of culture in ES cell 
media without LIF. (B) The majority of cells in the 
Zic3-overexpressing cultures showed differentiated 
morphology with phase-dark extended processes. 







p-valueOVER / UNDER# OBSERVED# EXPECTED
# REF. LIST
(Agilent)PANTHER BIOLOGICAL PROCESS
Table 10. Panther Biological Process annotations for significantly regulated genes in the 
Zic3 overexpression samples grown in –LIF conditions, relative to the Illumina mouse Ref8-
v1.1 reference gene list.
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Figure 52 shows the cells after 3 days of N2B27 treatment. As doxycycline was 
withdrawn just 24 hours prior to this time-point, residual GFP fluorescence was 
observed in the control cell lines from the earlier induction. In contrast the Zic3 
overexpressing lines did not contain GFP and as such were not fluorescent. I also 
examined the cells at Day 3 for Nestin expression. Prior reports have indicated 
that the expression of this neural progenitor marker emerges between 48 to 72 
hours of N2B27 treatment 184. In accordance with previous reports184, a small 
amount of Nestin in the control lines was observed at 72 hours (Day 3) while the 
Zic3-overexpressing lines demonstrated more intense staining for Nestin 
expression. 
 
Next I examined the expression of an early neurogenesis marker, TuJ1 (β-III 
tubulin), and a mature neuronal marker MAP2 (microtubule associated protein 2) 
at days 5 and 8 of N2B27 treatment respectively. The control GFP lines  
expressed little TuJ1 at day 5 while the Zic3 overexpressing lines showed strong 
staining for this marker (Figure 53A). The expression of TuJ1 was examined at 
this stage in accordance with the report by Ying et al. (2003) suggesting that TuJ1 
is first detected 5 days after exposure to N2B27 media. An analysis of MAP2 
expression at day 8 showed a similar trend. The control GFP lines showed a 
small amount of MAP2 staining while the Zic3 lines demonstrated robust MAP2 
expression (Figure 53B). These results show that Zic3 has the ability to enhance 
the process of neurogenesis and thus, is a positive regulator of neural 
differentiation in ES cells. Further characterization of the effect of Zic3 









GFP control, 3 days Zic3 O/E, 3 days
Figure 52. Zic3 overexpression enhances 
early neurogenesis during mouse ES 
differentiation. Nestin protein expression 
is enhanced in Zic3-overexpressing cells 
treated with N2B27 for 3 days. Scale bars, 
100 μm.
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and glial differentiation markers across different time-points, as well as 
fluorescence-activated cell sorting (FACs) to quantify the extent of neurogenesis. 
 
5.3 Discussion 
5.3.1 Zic3 is a regulator of lineage-specific pathways 
Zic3 has clearly established roles in the context of development, and its function 
has been identified in embryonic morphogenesis and cardiac, skeletal, and neural 
differentiation106,115,124,126,129,158. However, the underlying Zic3 molecular networks 
giving rise to these processes have not been properly elucidated to date. This 
chapter presents novel data demonstrating the molecular pathways that Zic3 
regulates in the context of development. Corroborating with observations in the 
literature, the chromatin-immunoprecipitation data presented here suggest that 
Zic3 binds to the promoters of genes involved in ectoderm development, 
mesoderm development, and general early embryonic development (Figure 49). 
In particular, the functional pathways that regulate general embryonic 
development and ectoderm development, encompassing genes such as Nodal 
and Lhx1 in gastrulation, and Fgf5 and Zic2 in neurogenesis, are significantly 
over-represented amongst the target pathways identified by chromatin-IP (Table 
9). 
Many novel targets of Zic3 were identified, and several of these regions were 
tested at random for transcriptional responsiveness to Zic3. These target regions 
were selected to represent the diversity of pathways that Zic3 potentially 
regulates in both the ES cell and differentiated contexts. Amongst these target 






GFP control, 5 days Zic3 O/E, 5 days
TuJ1 TuJ1
DAPI DAPI
GFP control, 8 days Zic3 O/E, 8 days
MAP2 MAP2
B
Figure 53. Zic3-overexpressing cell lines show 
earlier onset of neurogenesis markers. (A) An 
early neuronal marker, Beta-III tubulin (TuJ1), is 
upregulated in N2B27-treated Zic3-overexpressing 
cells at Day 5. (B) Mouse ES cells were treated with 
N2B27 for 8 days and stained for the mature 
neuronal marker, microtubule-associated protein 2 
(MAP2). The cells overexpressing Zic3 
demonstrated increased intensity of MAP2 staining. 
Scale bars, 100 μm.
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positively regulated by Zic3 in both ES cells and HEK293T cells. Mbtps2 is an 
enzyme that catalyzes critical steps in cell signalling, and it is known to be 
involved in intra-membrane proteolysis that regulates both cholesterol 
homeostasis and the pathogenesis of Alzheimer’s disease and Hepatitis C 
infections204-206. Mbtps2 mediates the second cleavage step in the processing of 
Sterol Regulatory Element-binding Proteins (SREBPs) which, when released from 
cell membranes, are responsible for transcriptional control of genes involved in 
cholesterol biosynthesis and uptake from plasma lipoproteins207. To date no 
evidence exists for Zic3 in the regulation of intra-membrane protein cleavage or 
cholesterol biosynthesis. Thus the sensitivity of the Mbtps2 promoter to Zic3 
regulation could form the basis of further studies to determine the relationship 
between Zic3, Mbtps2 and the catalysis of SREBP peptide cleavage within 
membranes. 
 
The functional assays also demonstrated the capacity of Zic3 to regulate the 
promoters of neural genes Zic5/Zic2, Cortistatin, and Fgf5. This suggests that 
Zic3 has the potential to regulate the expression of these genes during ES cell 
differentiation and embryonic development. Zic2 and Zic5 belong to the Zic-family 
of transcription factors which share high structural homology with Zic3106, and 
their expression is transcribed from a divergent promoter on chromosome 14 that 
is approximately 9800bp in length (Appendix 7). The functional assays in this 
chapter indicate that Zic3 downregulates the activity of the Zic5/Zic2 promoter 
region in ES cells, while activating it in HEK293T cells. These results validate my 
earlier observation that Zic2 expression is upregulated upon knockdown of Zic3 in 
ES cells (Figure 34A), and suggest that Zic3 functions as a negative regulator of 
  171
Zic2 in ES cells. In addition, the capacity of Zic3 to activate the Zic5/Zic2 
divergent promoter region in HEK293T cells indicates that Zic3 may activate 
these genes in the context of differentiation. The significance of this is highlighted 
by data indicating that Zic2, Zic3 and Zic5 share highly overlapping expression 
domains in the developing dorsal brain and spinal cord116,208. In association with 
their significant structural homology, this new knowledge on the potential for Zic3 
to function as a positive regulator of Zic2 and Zic5 in differentiated cell types may 
contribute to further understanding of the functional redundancy106 between these 
genes. The capacity of Zic3 to function as an activator or repressor of the 
Zic5/Zic2 promoter may be dependent on the presence of different binding 
partners between the pluripotent and differentiated cell contexts. 
 
During development, Fgf5 expression is associated the emergence of primitive 
ectoderm cells in the earliest stages of embryonic differentiation29,209. Primitive 
ectoderm cells arise from the inner cell mass of the embryonic blastocyst from 
which pluripotent ES cells are derived (Figure 1). The ability of Zic3 to 
downregulate Fgf5 expression in ES cells, indicated by repression of Fgf5 in 
response to Zic3 overexpression and functional assays for Fgf5 promoter activity 
(Table 8 & Figure 47), represents a pathway in which Zic3 may function to 
maintain the pluripotent state. During later stages of development, the presence 
of Fgf5 is known to promote neurotrophic activity in septal cholinergic and raphe 
serotonergic neurons208. Fgf5 strongly enhances the uptake of serotonin in 
cholinergic and serotonergic neurons, and upregulates the choline 
acetyltransferase activity of rat septal cholinergic neurons210. Here the ability of 
Zic3 to upregulate Fgf5 promoter activity in differentiated cells (Figure 46) 
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suggests that Zic3 promotes Fgf5 expression and contributes to neuronal function 
beyond the early stages of development. Further work is required to determine 
the presence of Zic3 in cholinergic and serotonergic cell types, and to examine if 
a role exists for Zic3 in the specification of neuronal function. 
 
Zic3 is a positive regulator of Cortistatin in both HEK293T and mouse ES cells. 
Cortistatin (CST) is a neuropeptide belonging to the somatostatin family with 
predominantly cortical and hippocampal expression in the central nervous 
system211, and its presence is found within a subset of γ-aminobutyric acid 
(GABA)-releasing interneurons and hippocampal cells212. It has been suggested 
that CST-treated mice spend nearly twice the length of time in slow-wave sleep 
compared to saline-treated control animals211, and it is thought that CST induces 
sleep by enhancing cortical neuron activity through hyperpolarization of principal 
cells211,212. In addition, it has been shown that regulated release of CST 
antagonizes the excitatory effects of acetylcholine neurotransmitter to promote 
sleep211. Zic3 expression has been observed in the adult cerebellum186; however 
no functional role to date has been identified for Zic3 in this context. The capacity 
of Zic3 to activate the Cortistatin promoter represents initial evidence for a role 
Zic3 upstream of neuropeptide signalling, and further studies are required to 
verify the positive effect of Zic3 on Cortistatin expression in the developed brain. 
 
 
5.3.2 Zic3 enhances neurogenesis during ES cell differentiation 
In order to determine the role of Zic3 in early ES cell differentiation, a Zic3-
inducible overexpression cell line was cultured in ES cell media without LIF. LIF is 
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able to prevent ES cell differentiation by activation of the Stat3 signalling 
pathway25,31, and ES cells grown in the absence of LIF or a supporting layer of 
feeder cells rapidly lose their pluripotency and capacity for self-renewal. After 4 
days of culture in –LIF conditions, Zic3-overexpressing cells demonstrated overt 
differentiated morphology with phase-dark extended processes (Figure 51). An 
analysis of its gene expression profile revealed that both ectoderm and 
mesoderm markers were significantly increased in the Zic3-overexpressing cells 
relative to the controls. These data suggest that Zic3 is able to confer both 
ectoderm and mesoderm properties on ES cells as they begin to differentiate.  
 
In this chapter, I have provided an illustration of the principle that Zic3 is able to 
enhance neural specification in early ES cell differentiation. Overexpression of 
Zic3 resulted in an increased rate of neurogenesis when ES cells were exposed 
to neural differentiation conditions (Figures 52 & 53), denoted by the earlier onset 
of neural markers Nestin, TuJ1 (Beta-III tubulin), and MAP2 at days 3, 5 and 8 
respectively. In support of the above, Zic3 is known in particular to be involved in 
neural development, and the overexpression of Zic3 in the ventricular zone of the 
embryonic mouse telencephalon, where cortical neurons are generated during 
development, results in an increase of proliferating neuronal progenitors201. A 
previous report has also demonstrated the ability of Zic3 to activate the neural 
differentiation program through induction of proneural gene expression in 
Xenopus tissue126. Furthermore, gene expression assays in our lab reveal that 
Zic3 expression is high in embryonic development and then specifically restricted 
to the adult brain in the mouse (Appendix 7). Taken together, these data suggest 
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a role for Zic3 in the early specification and maintenance of neural identity, and 
demonstrates conclusively that Zic3 is a potent activator of ES cell neurogenesis. 
 
5.4 Summary 
Zic3 is a positive regulator of embryonic morphogenesis, cardiac and skeletal 
patterning, and neural differentiation during embryonic 
development106,115,124,126,129,158. However, little is known about the networks 
regulated by Zic3 to determine the lineage specificity. Here I establish the target 
genes of Zic3 that are important during the process of development. This 
investigation has uncovered many novel Zic3 targets that may shed more light on 
its function of Zic3 in the development and function of non-pluripotent cells. In 
addition, the data indicate that Zic3 occupies promoters of genes involved in early 
embryonic patterning, and mesoderm and ectoderm formation, suggesting that 
Zic3 may confer ectoderm and mesoderm specificity during differentiation of ES 
cells. In support of this, Zic3 overexpression in differentiation-promoting 
conditions resulted in an over-representation of activated genes in the mesoderm 
and ectoderm lineage pathways. To illustrate the functional relevance of these 
data, I have demonstrated that transient drug-induced overexpression of Zic3 in 
ES cells enhances the rate of neurogenesis under conditions that promote neural 
differentiation. In summary, this work has elucidated a set of Zic3-regulated 
pathways that have the potential to influence the critical lineage decisions made 










Discussion & Future Directions 
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6.1 How does Zic3 maintain ES cell pluripotency? 
Embryonic stem cells have the potential to generate replacement cells for 
damaged and diseased organs, and thus hold great promise in the field of 
regenerative medicine. The transcriptional networks governing the unique 
properties of ES cells have been the focus of many large-scale studies19,20,51,203, 
and the insight gained from this work has resulted in the ability to regulate the 
processes of self-renewal, early differentiation, and more recently, the 
reprogramming of differentiated cells to the pluripotent state93-95,213-215.  
 
The transcriptional regulators Oct4, Nanog, and Sox2 are required for the 
propagation of undifferentiated ES cells in culture. These core factors contribute 
to the hallmark characteristics of ES cells by activating genes involved in self-
renewal and pluripotency, while concurrently repressing genes involved in lineage 
specification19,20. To further elucidate the transcriptional networks that contribute 
to stem cell pluripotency, I have focused on transcription factors whose 
expression is directly regulated by Oct4, Nanog and Sox2.  
 
Zic3 (Zinc finger protein of the cerebellum 3) is a transcription factor that encodes 
five tandem C2H2 zinc finger domains with demonstrated capacity for DNA and 
protein interaction105,119,120,124. Gene expression profiling in this thesis initially 
revealed that Zic3 is highly expressed in the ES cell pluripotent state and is 
quickly repressed upon differentiation, an observation which suggests a potential 
role for Zic3 in controlling differentiation of mouse and human ES cells. In 
addition, Oct4, Nanog and Sox2 binding have been mapped to the Zic3 promoter 
regions in ES cells19,20, implying that these key factors may regulate Zic3 
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expression. I have demonstrated in Chapter 3 that Zic3 is directly regulated by 
Oct4, Nanog and Sox2 and sustains the pluripotent state through Nanog-
mediated pathways. Here Zic3 functions as a gatekeeper that blocks the 
specification of the endoderm lineage genes, and in doing so, prevents 
differentiation in ES cells.  
 
The chromatin-immunoprecipitation assays have additionally revealed that Zic3 
occupies the promoters of other genes associated with the pluripotent state, 
including Nanog, Oct4, Sox2, Klf2, Rif1 and Phc1. Zic3 may therefore function to 
maintain pluripotency through upregulation of key pluripotent genes Nanog, Oct4 
and Sox2. Here I have demonstrated a significant overlap beween Zic3, Oct4, 
Nanog and Sox2 pathways (Figure 39 & Appendix 8). Furthermore, the Krüppel-
like factor Klf2 shares many gene targets with Nanog, and also directly 
upregulates Nanog expression in ES cells21. Thus the association of Zic3 with the 
Klf2 promoter may represent another pathway by which Zic3 further modulates 
the expression of Nanog and may in part explain why Nanog, in particular, is 
substantially downregulated by Zic3 knockdown. Nanog is known to prevent 
differentiation of ES cells into endoderm, and downregulation of Nanog in ES 
cells leads to an upregulation of Gata4 and Gata6 expression and endoderm 
lineage specification39,192,193. It is therefore likely that Zic3 prevents differentiation 
of ES cells into endoderm through its maintainence of Nanog expression.  
 
Zic3 also binds to the promoter of telomere-associated protein Rif1, which 
regulates telomere length and is hypothesized to be important for self-renewal216, 
and a member of the polycomb group proteins, Phc1, which functions to silence 
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the transcription of developmental regulators in ES cells,  In addition, Zic3 
occupies the promoter regions of chromatin modifiers Jarid2 and Smarcad1217-219, 
which are known to be highly expressed in ES cells, though their roles in 
pluripotency and self-renewal remain as yet unknown. Zic3 may also regulate the 
expression of the histone methyltransferase gene, Ehmt2 (also known as G9a), 
which is associated with early embryonic development and transcriptional 
silencing in ES cells220,221.  
 
To date, no evidence exists for the role of Zic3 in regulating the expression of 
chromatin modifier genes. The above data may therefore represent additional 
pathways by which Zic3 could maintain the pluripotent state in ES cells, and it 
would be interesting to determine if Zic3 directly regulates these chromatin 
remodelling genes by conducting binding and mutational assays on their 
promoters. 
 
6.2 Does cellular context determine activator or repressor functions 
of Zic3? 
The question of how Zic3 operates in the opposing contexts of pluripotency and 
differentiation remains unresolved. Here I conceived two putative models for the 
role of Zic3 in pluripotency and differentiation: Firstly, Zic3 may specifically 
occupy the promoters of genes related to self-renewal and pluripotency in ES 
cells, and only bind to and regulate the promoters of lineage-specific genes as the 
cells exit the pluripotent phase. This model of context-dependent binding is 
particularly relevant given the propensity for transcription factors to associate with 
different partners in various spatial and temporal milieus. In support of this idea, 
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Zic3 is known to dimerize with the Gli proteins during development to function 
specifically in neural and skeletal development105,131. Alternatively, in a manner 
similar to that of Oct4, Nanog and Sox219,20, I postulated that Zic3 may co-occupy 
the epigenetically silenced promoters of developmental regulators in ES cells, 
thus serving to confer lineage-specific capabilities as chromatin repressive marks 
are relieved during differentiation. 
 
To address this question, I examined the Zic3 targets identified by chromatin-
immunoprecipitation and determined that the list comprises both ES cell-related 
and lineage-specific genes. It is therefore likely that Zic3 interacts with 
pluripotency-maintaining complexes to activate self-renewal genes and repress 
differentiation-specific genes in the undifferentiated state. Concurrently, Zic3 may 
prime the cells for differentiation into ectoderm and mesoderm lineages during 
differentiation by its occupancy of lineage specific promoters (Figure 49). This 
idea is supported by my data indicating that Zic3 represses the promoter of an 
early primitive ectoderm gene, Fgf529, and the divergent promoter of the neuronal 
differentiation genes Zic2 and Zic5106 in the ES cell state, while, in contrast, 
strongly activating these promoters in the differentiated HEK293T cell state 
(Figures 46 & 47). Thus although these Zic3-bound developmental regulators are 
transcriptionally silent in ES cells, the functional assays here suggest that Zic3 is 
able to activate these genes outside the pluripotent state. Zic3 therefore appears 
to function in two capacities: firstly to maintain the pluripotent state in ES cells, 
and secondly, to confer lineage specificity through activation of lineage 
development genes upon initiation of differentiation (Figure 54). 
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To test this hypothesis, it would be interesting to perform Zic3 chromatin-
immunoprecipitation assays on embryos during axis formation and 
organogenesis158. Zic3 null embryos at these stages demonstrate abnormalities in 
embryonic patterning and abnormal mesoderm and neuroectoderm allocation. 
This could be the result of an abnormally lateralized location of the node which 
normally instructs proper specification of the neuroectoderm and paraxial 
mesoderm222. The Zic3 target genes identified in ES cells that are relevant to this 
developmental stage include Nodal, Lhx1, Pax6, Lmx1b, Hes7, and Dll1 (Figure 
49). Amongst these genes, evidence exists for a genetic interaction between Zic3 
and Nodal in left–right patterning and subsequent cardiac development, where 
significantly reduced numbers of Zic3 +/−  / Nodal +/− compound heterozygous mice 
are born124. In addition, Zic3 is known to mediate Nodal expression at the node 
through an upstream Nodal enhancer that is responsive to Zic3124. Apart from 
Nodal, all other Zic3 targets at this stage (Figure 49) represent newly identified 
pathways by which Zic3 may contribute to axis patterning and gastrulation. It 
therefore would be interesting to examine the genetic interaction of these genes 
with Zic3 using compound heterozygous mice, validate the binding of Zic3 to their 
promoters in embryonic tissue with chromatin-immunoprecipitation, and assay 
their response to Zic3 via promoter assays in vitro or injection into the early 
embryo. 
 
The contrasting activity of Zic3 in retaining pluripotency in ES cells versus that of 










Figure 54. Illustration of the function of Zic3 in mouse ES cells. 
Zic3 contributes to ES cell pluripotency by: 1) Positively regulating 
Nanog expression and preventing mouse ES cells from expressing 
endodem markers, and 2) Conferring endodermal and mesodermal 
properties on mouse ES cells during early differentiation. 
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 ability to associate with different factors in varying contexts. A similar molecular 
paradigm is observed with Sox2, which associates with Oct4 in ES cells to 
maintain pluripotency, while interacting with Pou2f1 to enhance lens and olfactory 
placode development, and with β-catenin to inhibit osteoblast differentiation223,224. 
 
6.3 Is Zic3 able to reprogram differentiated cells to pluripotency? 
ES cells have the capacity to generate all the cells within an organism225, and are 
therefore a potential donor source for cell transplantation therapies. Possible 
human ES cell applications include treatment of Parkinson’s disease, cardiac 
failure and juvenile diabetes. However, the destruction of human embryos in the 
process of harvesting ES cells, and potential tissue rejection by the transplant 
recipient, pose barriers to successful ES cell therapy. One strategy to circumvent 
such issues is to reprogram differentiated adult cells to an ES cell-like pluripotent 
state and generate from them the histocompatible required tissue for therapy. It 
has recently been shown that differentiated cells can be reprogrammed to 
pluripotency through ectopic expression of ES cell transcription factors Oct4, 
Sox2, c-Myc, and Klf418,93-95,213,226.  These induced pluripotent cells (iPS) are 
similar to ES cells in morphology, rate of proliferation, and capacity for 
pluripotency indicated by teratoma formation and chimera contribution in mice93. 
 
A recent analysis of gene expression patterns within fully and partially 
reprogrammed fibroblasts revealed the presence of Zic3 in these cells95, 
suggesting that Zic3 may be at least partially involved in the process of restoring 
the properties of self-renewal and pluripotency as fibroblasts are reprogrammed 
  183
to an iPS state. Thus it would be interesting to assay the capacity of Zic3 to 
reprogram differentiated fibroblast cells.  
 
A preliminary reprogramming assay in our lab indicated that ectopic expression of 
Zic3 in fibroblast cells did not yield significant numbers of ES-like colonies 
(Appendix 9). Overexpression of Oct4, Sox2, c-Myc, and Klf4 resulted in 
approximately 1000 alkaline phosphatase (AP) positive ES-like colonies, while 
overexpression of Zic3 in a variety of combinations with Oct4, Sox2, c-Myc, and 
Klf4 did not give rise to an increased number of AP-positive colonies relative to 
controls (Appendix 9 for details). Several factors may account for this 
observation. Firstly, the number of Zic3 targets in ES cells is significantly smaller 
than that of the key pluripotent ES cell factor Sox2 (Appendices 7 - 8), suggesting 
that Zic3 may regulate only a partial set of genes required for pluripotency and 
self-renewal. Secondly, a microarray analysis of partially reprogrammed cells 
expressing high levels of Zic395 revealed the presence of lineage-specific genes 
which were not detected in the fully reprogrammed state. These results suggest 
that Zic3 may promote the expression of lineage-specific factors in partially 
reprogrammed cells, and is supported by my data indicating that while Zic3 
represses the promoter activity of lineage-specific factors in ES cells, it has 
potential to activate them in differentiated cells (Section 6.2). Therefore, Zic3 may 
not fully activate the program required for restoring pluripotency in differentiated 
fibroblast cells, due to its ability to function either as an activator or repressor of 
lineage-specific factors in context-dependent roles.   
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It is important to note that the Zic3 reprogramming assay in our lab utilized 
staining of a stem cell surface marker, alkaline phosphatase, to identify iPS 
colonies. However, it has been suggested that stem cell surface markers do not 
distinguish between significantly different cell states in a heterogeneous 
population of reprogrammed cells. For instance, both Stage-specific embryonic 
antigen 1 (SSEA1)-positive and -negative cells demonstrated similar gene 
expression profiles and DNA methylation patterns in partially reprogrammed 
populations194. Moreover, while stem cell surface antigens may serve as markers 
for the early reprogramming stages, activation of endogenous Oct4, Nanog, and 
Sox2 is required for late reprogramming events194,227, and the endogenous 
upregulation of these key pluripotent factors may thus be a better indicator of 
successful reprogramming. It would therefore be important to repeat the Zic3 
reprogramming experiments using Oct4- or Nanog-GFP fibroblast lines228 that 
enable identification of endogenous gene activation and quantification of stable 
ES-like induced pluripotent cell colonies.  
 
6.4 Does Zic3 interact with Sox2 to confer neurogenic potential on ES 
cells? 
This thesis presents evidence for a previously unknown physical interaction 
between Zic3 and Sox2. These transcription factors are both known to be 
involved in the regulation of neural progenitor cells198,229,230, and the significance 
of their interaction is highlighted by reports indicating that Sox272,198,199 and 
Zic3106,116,126 share similar patterns of expression during early development of the 
central nervous system. A role for Sox2 in particular has been implicated in CNS 
formation, primary neurons, and neural crest cells231, and these data establish a 
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role for Sox2 in the initial specification of neural fate and maintenance of neural 
progenitor properties198. My results demonstrate that Zic3 and Sox2 share a 
subset of signalling networks in ES cells and highlight their common roles in 
ectoderm development, suggesting that their shared pathways may be important 
in neuronal specification during ES cell differentiation and embryonic 
development. 
 
Due to their similar expression profiles in neural progenitors and early CNS 
development, it would be interesting to examine if Zic3 and Sox2 are co-localised 
in neural progenitor cells in vivo, and neural stem cells in vitro. To address my 
speculation that Zic3 and Sox2 interact and regulate common pathways during 
early neuronal development, chromatin-immunoprecipitation may be used to 
define the common targets of Zic3 and Sox2 within these cells. As the interaction 
between Zic3 and Sox2 is a new discovery, the dynamics of their physical 
association are not known. Thus it would be interesting to assay the equilibrium 
binding constant (Kd) of the Zic3/Sox2 dimer on a nucleotide sequence 
comprising both binding motifs to determine their binding affinity.  
 
The question also remains as to whether Zic3 and Sox2 interact as a heterodimer 
or as part of a larger complex in the context of neural differentiation. If Zic3 and 
Sox2 are found to interact during neuronal development, it would be useful to 
explore their protein network using affinity purification and mass spectrometry. 
This would potentially yield insight into the protein regulatory mechanisms for 
maintenance of early neuronal properties of progenitor cells in embryonic 
development. Further work in this area could therefore contribute to validation of 
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the shared molecular roles of Zic3 and Sox2 potentially in the expansion of neural 
stem cells or promoting ectodermal specification of neural progenitors during 
early development, which may lead to further understanding of the process of 
derivation of neuronal cells from ES cells for therapeutic purposes. 
 
 
6.5 Concluding remarks 
This thesis highlights a role for Zic3 in the maintenance of pluripotency 
downstream of Oct4 and Sox2, and presents unique evidence for its function as a 
gatekeeper controlling differentiation of ES cells into the endoderm lineage 
through Nanog-mediated pathways. Having demonstrated that Zic3 plays an 
important role in maintenance of pluripotency, I have further mapped the target 
genes of Zic3 to extend our understanding of the transcriptional network that 
governs pluripotency and lineage specification. This has contributed to a more 
detailed understanding of how Zic3 may regulate pluripotency in ES cells, and 
identified novel pathways through which it may mediate its effects.  
 
In addition, many lineage-specific genes were identified within the targets of Zic3. 
Numerous reports exist for the role of Zic3 development116,126,158,229, and the 
elucidation of Zic3 binding targets in this thesis represents unique molecular 
insight into the function of Zic3 in these processes. These results therefore 
provide foundational knowledge for the dissection of transcriptional networks in 
Zic3-regulated developmental pathways. The data representing an interaction 
between Zic3 and the key stem cell pluripotent factor and neural progenitor gene, 
Sox2, also highlight a novel mechanism for the role of Zic3 in the maintenance of 
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ES cell pluripotency. In addition, it may explain how Zic3 subsequently confers 
neural specific properties during ES cell differentiation.  
 
A detailed knowledge of ES cell transcriptional circuitry is fundamental to a 
comprehensive understanding of embryonic development and the realization of 
ES cell therapeutic potential. To this end, my work presents novel molecular 
insight into Zic3-regulated pathways that influence the state of ES cell 
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Appendix 1. Primers for ChIP-PCR assay
No. Name SEQUENCE  ( 5'  ->  3' ) Grade Quantity
1 60_Rik_375_F TTCCGGGTCGCAAACGGAAGTG PCRGrade 50nmole
2 60_Rik_375_R AGTCCCAGGCTCGCCGCGTTAC PCRGrade 50nmole
3 Agtrap_109F AGAAGCCATATGGGAACCCATG PCRGrade 50nmole
4 Agtrap_109R ATTAAATTAGGTCTGCCCCGCC PCRGrade 50nmole
5 Anxa11_432_F GTCCTGGGGCGTCAGTTGAAAG PCRGrade 50nmole
6 Anxa11_432_R CCCCAGCTCACATTTAGGCACC PCRGrade 50nmole
7 Btn2a2_399_F GGCGGGCACCATAGGTCCTTTAAAG PCRGrade 50nmole
8 Btn2a2_399_R TAGTGCTGAGCCAGGAGACACGTGG PCRGrade 50nmole
9 Cacna2d1_112F TAAGTCGCTCTGGGGTGCCTTTG PCRGrade 50nmole
10 Cacna2d1_112R GGTTAGCTTTCCCGTCCCCCTT PCRGrade 50nmole
11 Cd109_219_F GCAGGAGGTGGCCAACCACACC PCRGrade 50nmole
12 Cd109_219_R CGCGCACAAGCAGAGAAGGTGG PCRGrade 50nmole
13 Commd3_25_F AGGTGTCAAGCTGCGGAGCTTTTC PCRGrade 50nmole
14 Commd3_25_R TATTCCACTTGCCCTTTGGCCC PCRGrade 50nmole
15 D11Ertd636e_F GCAGGCCAGAAGCATCGGAAAC PCRGrade 50nmole
16 D11Ertd636e_R CAGTGGATTCCTCGCTGGGAGG PCRGrade 50nmole
17 Dido1_60_F CAGAGCCACCTTTCAATTTTATG PCRGrade 50nmole
18 Dido1_60_R GGGCAATTAGGGTAGCTCTAGG PCRGrade 50nmole
19 Dll1_523_F CCCTCCCCCTATGCCTCTCCTTC PCRGrade 50nmole
20 Dll1_523_R CGGGCTGCAGCCGCAGGTAAAC PCRGrade 50nmole
21 Emb_423_F GTAGGGTCAGCTCATTTGCAGGAG PCRGrade 50nmole
22 Emb_423_R GCTTGCTAATTCACACCGGTGC PCRGrade 50nmole
23 Fgf5_129_F TCTTGTCTTCCTGGTGGCTCTCGG PCRGrade 50nmole
24 Fgf5_129_R TTTCCAAACCCTCCCCACAGGC PCRGrade 50nmole
25 Fgfbp1_125_F GCTGTGGAAGGAGGCAGACTGAG PCRGrade 50nmole
26 Fgfbp1_125_R TTCTTAGATTGATTCAGAATCG PCRGrade 50nmole
27 Gja1_251_F AGCTGTGCGCTTTGTCTTGGAG PCRGrade 50nmole
28 Gja1_251_R TGCCTAGGCAAAGGTAGCCAAG PCRGrade 50nmole
29 Hesx1_434_F TAACTCCTTAAGCCGCTGGCTG PCRGrade 50nmole
30 Hesx1_434_R TGGGATCTTCCAGCAGTTCACC PCRGrade 50nmole
31 Hlf_333_F TTCCTTCTAGCCCCACTGCATATCC PCRGrade 50nmole
32 Hlf_333_R TTAATTCCCTCGGACAGCGTGG PCRGrade 50nmole
33 Hoxb13_339_F CTGTGAAGCTGGAGAAAGGACTGGG PCRGrade 50nmole
34 Hoxb13_339_R CGGGGGTCCCACACAGAAACTG PCRGrade 50nmole
35 Hs6st2_642_F GGTTGACACAGTAGGTAGCTATCC PCRGrade 50nmole
36 Hs6st2_642_R TGTGGGCTTGAATGTGTGAACC PCRGrade 50nmole
37 Hs6st2_644_F AGGGTCCTTCAGTCACTTGACTGC PCRGrade 50nmole
38 Hs6st2_644_R AGCAAGGAAGTGGTTTCCCTGG PCRGrade 50nmole
39 Itga1_421_F AAGGCTGTGAGCTTAGCTACTG PCRGrade 50nmole
40 Itga1_421_R ACCCAAATGTCGCAGTGCTGTC PCRGrade 50nmole
41 Jarid2_405_F AACCACAAAGGACAATCCATTTTCC PCRGrade 50nmole
42 Jarid2_405_R CTCCAAGTCCCAGGCAAGTGTG PCRGrade 50nmole
43 Klf2_202_F ACACACACACACACACACACAC PCRGrade 50nmole
44 Klf2_202_R TTTTTTCCTGGTAGGTGGCCGG PCRGrade 50nmole
45 Klf6_394_F ACAGGGAAACCTGCGGGCACGTTTG PCRGrade 50nmole
46 Klf6_394_R TGTTCCCGGATCCTTCCCTGAC PCRGrade 50nmole
47 Klf9_617_F TCCCAATGTGAGGTCTGACACGTG PCRGrade 50nmole
48 Klf9_617_R CTGCCGATTCTGGCTTTTCTCG PCRGrade 50nmole
49 Lbxcor1_211_F GTGCGAGGGGGTTACTTGGCAG PCRGrade 50nmole
50 Lbxcor1_211_R CCTTTTCCTCCCTTAGCCCCCC PCRGrade 50nmole
51 Liph_507_F TAATGAACCTGCCCTGGAATGTGC PCRGrade 50nmole
52 Liph_507_R TGAGGATCGGATAGTTTCGCCC PCRGrade 50nmole
53 Lmx1b_29_F TGTCTTGATAACCACTACTCCGCCC PCRGrade 50nmole
54 Lmx1b_29_R AAAGGACCCCGGCTTTATCCTC PCRGrade 50nmole
55 Map4k4_6_F TGAAAGGGAGCCCTGTTAACAGC PCRGrade 50nmole
56 Map4k4_6_R CCGTGCTTAAACAAACTCTGGAGC PCRGrade 50nmole
202
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57 Mllt6-342_F ATCTCCTCTCCGAGCCCTCTGC PCRGrade 50nmole
58 Mllt6-342_R AATACCCCCTCAGCGGGAGGTT PCRGrade 50nmole
59 Mycn_371_F AGCAGGGGCTGTATGGTAAGTGTTC PCRGrade 50nmole
60 Mycn_371_R AAAAGGTTCTGGGAGCCACACC PCRGrade 50nmole
61 Nid2_430_F ACATTTCAGAGGGTGGCAGTGTCC PCRGrade 50nmole
62 Nid2_430_R GGCCCTCGGATAAAGAATCAAAGG PCRGrade 50nmole
63 Nodal_255_F GGCAGCTGCTAATGTGCTAGTTGG PCRGrade 50nmole
64 Nodal_255_R TTCAAAAGGGAAGGCGGGATAG PCRGrade 50nmole
65 Pax6_40_F GAGTGAGGAGGACAGAGGTCCAATG PCRGrade 50nmole
66 Pax6_40_R TCAGCCCAAACCCCTAGCCTAG PCRGrade 50nmole
67 Pax9_376_F GCGCTGCCCTACAACCACATTTAC PCRGrade 50nmole
68 Pax9_376_R GAGTGAGAGGAGGGCCAGGTGC PCRGrade 50nmole
69 Pdpn_106_F AACAGCGGGGGACCCTTTGTTC PCRGrade 50nmole
70 Pdpn_106_R AGAAGTGCAGCCCACCGCTCTC PCRGrade 50nmole
71 Phc1_150_F CCTTTGGGAAGGCTGAGCATATG PCRGrade 50nmole
72 Phc1_150_R GCTGTCTTTGCTAACAATGCTCTGG PCRGrade 50nmole
73 Porcn_639_F TGTGAACGGAGAAACACACCCAG PCRGrade 50nmole
74 Porcn_639_R TTAACAGAAAGGGACACCGCCC PCRGrade 50nmole
75 Pou5f1_552_F GGTTGGGGAGCAGGAAGTTGTCC PCRGrade 50nmole
76 Pou5f1_552_R AGGACAATGGCCTTGGCTGGAC PCRGrade 50nmole
77 Pou5f1_550_F CTGGGTGTGGGGAGGTTGTAGC PCRGrade 50nmole
78 Pou5f1_550_R AACCATCTTCTCTGCCCCCAGG PCRGrade 50nmole
79 Pou5f1_549_F GCTAACACGAGTGATTTCCCTGCTC PCRGrade 50nmole
80 Pou5f1_549_R AACAATAGGCGTTGACCCCCAC PCRGrade 50nmole
81 Ppp2r5b_612F AGCTCAGAACTGGACTCCCGAATTC PCRGrade 50nmole
82 Ppp2r5b_612R CAAATTGTGGGCCTGGCACATC PCRGrade 50nmole
83 Rif1_30_F CTCTACACCTGGGGTCCAATGGAAG PCRGrade 50nmole
84 Rif1_30_R TGGCGTGCATAACAAAGGCCTG PCRGrade 50nmole
85 Ror1_92_F CTGAGCCTGCACACAATGAGAGG PCRGrade 50nmole
86 Ror1_92_R AGAGTTCAGGGGCTCCAACACC PCRGrade 50nmole
87 Sall4_57_F AACCTGCATTCTCCTACAGACCGAC PCRGrade 50nmole
88 Sall4_57_R GGACCTCGATTGTGGTTTTGGG PCRGrade 50nmole
89 Smarcd1_495F ACTGCAGTTCACCACTCCTGCTGG PCRGrade 50nmole
90 Smarcd1_495R TCAACAGCAACCCAGACCCCAG PCRGrade 50nmole
91 Snapc5_213_F ACCACCACAGCTATGGCCACTG PCRGrade 50nmole
92 Snapc5_213_R AGGAACTGCCTTGTCTCAGGGAGT PCRGrade 50nmole
93 Sox2_65_F AACCCACTCAAATGCAGATGCAGG PCRGrade 50nmole
94 Sox2_65_R TGACAATGTTGTGGAGGTGCGG PCRGrade 50nmole
95 Tcea1_2_F CACCTTAACTTTGCCTTAGGCAGC PCRGrade 50nmole
96 Tcea1_2_R TTTCCTGCCTCCACCCAAGTAC PCRGrade 50nmole
97 Tdgf1_223_F TGAGACTGGAGGAGTGGAGAAGGG PCRGrade 50nmole
98 Tdgf1_223_R CCCCAAGTGATCATGGAAAGGC PCRGrade 50nmole
99 Thbs2_518_F GGTTCTCCCCGCCCTGTACATT PCRGrade 50nmole
100 Thbs2_518_R AGGAATGTCAAGAGATCTCTTG PCRGrade 50nmole
101 Trp53_305_F CTCCCTGCTCTTGCAATCTCTTTG PCRGrade 50nmole
102 Trp53_305_R TAAACAAGATGGGGCCTAGG PCRGrade 50nmole
103 Twsg1_581_F TAAAGGTAGAGGACCAAGTCACGG PCRGrade 50nmole
104 Twsg1_581_R TGTGTTCTGCCCCCCTCTATGTAG PCRGrade 50nmole
105 Upp1_282_F GAAAGGGCCAGTCTTTTCCGGG PCRGrade 50nmole
106 Upp1_282_R TCAGAGGTCACACCTGCCCCCT PCRGrade 50nmole
107 Vegfc_198_F GCAGAGTTCCTAGGTGCTTTTC PCRGrade 50nmole
108 Vegfc_198_R GACACACCCAAACTGTATCTGC PCRGrade 50nmole
109 Vim_20_F GCAGCATTCCCAGAACTGACTGAG PCRGrade 50nmole
110 Vim_20_R TGGAGCACAGAGTGTTCCCAGC PCRGrade 50nmole
111 Vmp_403_F AGGATTTTGCCTGGGGCTTACC PCRGrade 50nmole
112 Vmp_403_R TCCATCTGGCTGTCAAACCCAG PCRGrade 50nmole
113 Zcrb1_492_F ACAATGGACCCGGCACCCCGGAG PCRGrade 50nmole
114 Zcrb1_492_R TCCGGCCCCAGGAACGTCCAGC PCRGrade 50nmole
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115 Zfp206_527_F GGGGTGTAGGCTTACAGCACTGTG PCRGrade 50nmole
116 Zfp206_527_R TGCTGTGTGGCCTTGGAGTCTC PCRGrade 50nmole
117 Zfp36l1_383F GGGAATCGGTAACCCTGTAACCG PCRGrade 50nmole
118 Zfp36l1_383R GCTGCCCCGCTCTTTGATCTAT PCRGrade 50nmole
119 Zfp36l1_385F CACTGCACGGCCTTCGACTTTTC PCRGrade 50nmole
120 Zfp36l1_385R TTGGGGCAGCGACTTCAGACAG PCRGrade 50nmole
121 Zfp499_171_F GACCTTACCCCCTGCTGTTTAAACC PCRGrade 50nmole
122 Zfp499_171_R CAAGGGAAGGTGACAGGGACTAAGA PCRGrade 50nmole
123 Zic5_471_F TGGTCATCAGGAAGGCTCACTGTG PCRGrade 50nmole
124 Zic5_471_R TTAAGTGCGTTTCGGCTGGCTC PCRGrade 50nmole
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Appendix 2. FDR Analysis: ChIP-PCR results for Zic3/Sox2 common targets





































































































































































































Zic3 ChIP-PCR GST control



















































































































































































Sox2 ChIP-PCR GST control





























































































































Zic3 ChIP Enrichment GST Control











































































































































Sox2 ChIP Enrichment GST Control
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Appendix 3. Luciferase cloning primers for Zic3 chip-chip validation 
No. Name SEQUENCE  ( 5'  ->  3' ) Grade Quantity
1 Mbtps2Luc-F GCG-CGC-TAG-CACT-TTA-TTT-TTT-GAT-TTG-ACC-TTT-G PCRGrade 50nmole
2 Mbtps2Luc-R GCG-CAG-ATC-TCAA-AAT-GTT-TTG-CCA-ATT-AAG-C PCRGrade 50nmole
3 Cort-Luc-F GTC-AGC-TAG-CAC-TTG-CAC-GAG-GAG-AAG-GTT-TTC-C PCRGrade 50nmole
4 Cort-Luc-R GCT-AAG-ATC-TTGA-GCA-GTT-TCT-CTA-GAG-TCC-G PCRGrade 50nmole
5 Zic5-2-Luc-F GTC-AGC-TAG-CTT-CGT-TTC-CTT-GAA-GGA-CAT-TTC PCRGrade 50nmole
6 Zic5-2-Luc-R GCT-AAG-ATC-TTT-CAA-CGC-TCT-GGA-AAT-TGT-TG PCRGrade 50nmole
7 NanogLuc-F GTC-AGC-TAG-CAA-ATG-AGG-TAA-AGC-CTC-TTT-TT PCRGrade 50nmole
8 NanogLuc-R GCT-AAG-ATC-TGA-AGA-GTT-AAA-TGT-CTA-ATG-CA PCRGrade 50nmole
9 Fgf5-Luc-F GTC-AGC-TAG-CCT-GTG-TGC-ATG-CAT-GGG-ACT PCRGrade 50nmole
10 Fgf5-Luc-R GCT-AAG-ATC-TCG-AAC-GTC-AAG-AGA-AGG-GGT PCRGrade 50nmole
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Brightfield GFP
Appendix 4. GFP fluorescence in mES cells transfected with 
the pSUPER-GFP shRNA vector. (A – B) Three weeks post-
transfection, non-targetting shRNA cells demonstrated robust 
GFP expression (C – D) mES cells were transfected with a 
pSUPER.GFP shRNA vector targetting the CoupTFII gene. As 
observed with the non-targetting cells, the CoupTFII knockdown 
cells expressed high levels of GFP protein. (E - F) In contrast to 
the non-targetting and CoupTFII RNAi cells, Zic3 shRNA
transfected cells did not express GFP after 3 weeks in culture. 
This suggests that the lack of GFP expression is unique to the 
Zic3 knockdown cells, and could be an indicator that the colonies 
emerging from long-term selection were a result of low levels of 
expression from the shRNA construct, which conferred antibiotic 





Appendix 5. Zic3 ChIP target gene and their associated promoter regions in mouse ES cells
"Bound Region" (column E) - the annotation assigned to each unique region
Genomic co-ordinates are with reference to UCSC build mm7 (August 2005)
Chr Start End Length Bound Region First Gene Accession # Second gene Accession # Primary Annotation
chr1 4850110 4850610 500 Zic3_extended:1 Tcea1 NM_011541 NA NA PROMOTER
chr1 4850939 4851565 626 Zic3_extended:2 Tcea1 NM_011541 NA NA PROMOTER
chr1 36925610 36926110 500 Zic3_extended:3 BC050210 NM_201365 Cox5b NM_009942 DIVERGENT
chr1 40141150 40141878 728 Zic3_extended:4 Map4k4 NM_008696 NA NA INSIDE
chr1 65548530 65549030 500 Zic3_extended:5 Pthr2 NM_139270 NA NA PROMOTER
chr1 96722860 96723535 675 Zic3_extended:6 Slco4c1 NM_172658 NA NA INSIDE
chr1 1.32E+08 1.32E+08 500 Zic3_extended:7 Slc26a9 NM_177243 NA NA INSIDE
chr1 1.33E+08 1.33E+08 649 Zic3_extended:8 Lrrn2 NM_010732 NA NA PROMOTER
chr1 1.34E+08 1.34E+08 500 Zic3_extended:9 Chi3l1 NM_007695 NA NA INSIDE
chr1 1.57E+08 1.57E+08 652 Zic3_extended:10 Ralgps2 NM_023884 NA NA INSIDE
chr1 1.66E+08 1.66E+08 500 Zic3_extended:11 Dusp27 NM_001033344 NA NA INSIDE
chr1 1.89E+08 1.89E+08 500 Zic3_extended:12 Kctd3 NM_172650 NA NA INSIDE
chr2 13511256 13512164 908 Zic3_extended:13 Vim NM_011701 NA NA PROMOTER
chr2 18738918 18739815 897 Zic3_extended:14 Commd3 NM_147778 NA NA INSIDE
chr2 22604814 22605497 683 Zic3_extended:15 Gad2 NM_008078 NA NA PROMOTER
chr2 26306168 26306668 500 Zic3_extended:16 4932418E24Rik NM_177841 NA NA PROMOTER
chr2 33644475 33644975 500 Zic3_extended:17 Lmx1b NM_010725 NA NA INSIDE
chr2 52079235 52079735 500 Zic3_extended:18 Rif1 NM_175238 NA NA PROMOTER
chr2 69062444 69063255 811 Zic3_extended:19 Nostrin NM_181547 NA NA PROMOTER
chr2 69152456 69153109 653 Zic3_extended:20 G6pc2 NM_021331 NA NA INSIDE
chr2 80291887 80292541 654 Zic3_extended:21 Frzb NM_011356 NA NA PROMOTER
chr2 1.02E+08 1.02E+08 500 Zic3_extended:22 E430002G05Rik NM_173749 NA NA PROMOTER
chr2 1.06E+08 1.06E+08 948 Zic3_extended:23 Pax6 NM_013627 NA NA INSIDE
chr2 1.17E+08 1.17E+08 718 Zic3_extended:24 Spred1 NM_033524 NA NA PROMOTER
chr2 1.21E+08 1.21E+08 796 Zic3_extended:25 Trp53bp1 NM_013735 NA NA PROMOTER
chr2 1.26E+08 1.26E+08 626 Zic3_extended:26 Slc27a2 NM_011978 NA NA PROMOTER
chr2 1.3E+08 1.3E+08 500 Zic3_extended:27 Stk35 NM_001038635 NA NA PROMOTER
chr2 1.47E+08 1.47E+08 500 Zic3_extended:28 Xrn2 NM_011917 NA NA PROMOTER
chr2 1.47E+08 1.47E+08 500 Zic3_extended:29 Nkx2-2 NM_010919 NA NA PROMOTER
chr2 1.48E+08 1.48E+08 500 Zic3_extended:30 Zfp336 NM_028986 NA NA PROMOTER
chr2 1.49E+08 1.49E+08 694 Zic3_extended:31 Cst3 NM_009976 NA NA INSIDE
chr2 1.53E+08 1.53E+08 500 Zic3_extended:32 Asxl1 NM_001039939 NA NA INSIDE
chr2 1.69E+08 1.69E+08 500 Zic3_extended:33 Sall4 NM_201396 NA NA INSIDE
chr2 1.72E+08 1.72E+08 614 Zic3_extended:34 Tcfap2c NM_009335 NA NA PROMOTER
chr2 1.81E+08 1.81E+08 500 Zic3_extended:35 Dido1 NM_177852 2310003C23Rik NM_029607 DIVERGENT
chr3 9009634 9010406 772 Zic3_extended:36 Tpd52 NM_001025263 NA NA INSIDE
chr3 34453440 34454092 652 Zic3_extended:37 Sox2 NM_011443 NA NA PROMOTER
chr3 51347657 51348396 739 Zic3_extended:38 Ccrn4l NM_009834 NA NA PROMOTER
chr3 81139550 81140250 700 Zic3_extended:39 Pdgfc NM_019971 NA NA PROMOTER
chr3 95534005 95534505 500 Zic3_extended:40 Mcl1 NM_008562 NA NA INSIDE
chr3 96432490 96433120 630 Zic3_extended:41 Txnip NM_023719 NA NA INSIDE
chr3 97031441 97032125 684 Zic3_extended:42 Acp6 NM_019800 NA NA INSIDE
chr3 1.02E+08 1.02E+08 662 Zic3_extended:43 Casq2 NM_009814 NA NA PROMOTER
chr3 1.03E+08 1.03E+08 786 Zic3_extended:44 Dennd2c NM_177857 NA NA INSIDE
chr3 1.05E+08 1.05E+08 680 Zic3_extended:45 Mov10 NM_008619 NA NA PROMOTER
chr3 1.21E+08 1.21E+08 644 Zic3_extended:46 Alg14 NM_024178 NA NA INSIDE
chr3 1.27E+08 1.27E+08 689 Zic3_extended:47 D3Wsu161e NM_138593 mmu-mir-302 NA DIVERGENT
chr4 35027618 35028342 724 Zic3_extended:48 Cga NM_009889 NA NA PROMOTER
chr4 47107367 47107867 500 Zic3_extended:49 Galnt12 NM_172693 NA NA INSIDE
chr4 57961424 57962248 824 Zic3_extended:50 D630039A03Rik NM_178727 NA NA PROMOTER
chr4 99473183 99474693 1510 Zic3_extended:51 Ror1 NM_013845 NA NA INSIDE
chr4 1.17E+08 1.17E+08 615 Zic3_extended:52 Plk3 NM_013807 NA NA INSIDE
chr4 1.23E+08 1.23E+08 745 Zic3_extended:53 Rragc NM_017475 NA NA INSIDE
chr4 1.3E+08 1.3E+08 500 Zic3_extended:54 Pef1 NM_026441 NA NA PROMOTER
chr4 1.34E+08 1.34E+08 500 Zic3_extended:55 Stmn1 NM_019641 NA NA INSIDE
chr4 1.43E+08 1.43E+08 895 Zic3_extended:56 Pdpn NM_010329 NA NA PROMOTER
chr4 1.47E+08 1.47E+08 794 Zic3_extended:57 Agtrap NM_009642 NA NA PROMOTER
chr4 1.48E+08 1.48E+08 500 Zic3_extended:58 Cort NM_007745 NA NA INSIDE
chr5 14920688 14921188 500 Zic3_extended:59 Cacna2d1 NM_009784 NA NA PROMOTER
chr5 28770547 28771193 646 Zic3_extended:60 Dnajb6 NM_001037941 NA NA INSIDE
chr5 32165192 32165692 500 Zic3_extended:61 Slc5a1 NM_019810 NA NA PROMOTER
chr5 37356800 37357725 925 Zic3_extended:62 Otop1 NM_178139 NA NA PROMOTER
chr5 43189306 43190241 935 Zic3_extended:63 Cd38 NM_007646 NA NA INSIDE
chr5 43303018 43304226 1208 Zic3_extended:64 Fgfbp1 NM_008009 NA NA PROMOTER
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chr5 88619489 88620142 653 Zic3_extended:65 Grsf1 NM_178700 NA NA PROMOTER
chr5 97470559 97471301 742 Zic3_extended:66 Fgf5 NM_010203 NA NA INSIDE
chr5 99258407 99259361 954 Zic3_extended:67 2310057D15Rik NM_026421 NA NA INSIDE
chr5 1.06E+08 1.06E+08 500 Zic3_extended:68 Tgfbr3 NM_011578 NA NA INSIDE
chr5 1.09E+08 1.09E+08 651 Zic3_extended:69 D5Ertd585e NM_027922 NA NA PROMOTER
chr5 1.17E+08 1.17E+08 729 Zic3_extended:70 Wsb2 NM_021539 NA NA PROMOTER
chr5 1.47E+08 1.47E+08 895 Zic3_extended:71 Ubl3 NM_011908 NA NA INSIDE
chr6 28058167 28058667 500 Zic3_extended:72 Grm8 NM_008174 NA NA PROMOTER
chr6 92329962 92330617 655 Zic3_extended:73 Trh NM_009426 NA NA PROMOTER
chr6 92899650 92900333 683 Zic3_extended:74 8430417A20Rik NM_175209 NA NA PROMOTER
chr6 97296454 97297220 766 Zic3_extended:75 Ube1c NM_011666 Arl6ip5 NM_022992 DIVERGENT
chr6 1.15E+08 1.15E+08 500 Zic3_extended:76 Timp4 NM_080639 NA NA PROMOTER
chr6 1.22E+08 1.22E+08 1212 Zic3_extended:77 Phc1 NM_007905 NA NA PROMOTER
chr6 1.22E+08 1.22E+08 804 Zic3_extended:78 Phc1 NM_007905 NA NA PROMOTER
chr6 1.27E+08 1.27E+08 653 Zic3_extended:79 Fgf23 NM_022657 NA NA INSIDE
chr6 1.37E+08 1.37E+08 717 Zic3_extended:80 Rerg NM_181988 NA NA PROMOTER
chr6 1.41E+08 1.41E+08 500 Zic3_extended:81 Aebp2 NM_178803 NA NA PROMOTER
chr6 1.43E+08 1.43E+08 500 Zic3_extended:82 Ldhb NM_008492 NA NA PROMOTER
chr7 6290797 6291881 1084 Zic3_extended:83 Usp29 NM_021323 NA NA INSIDE
chr7 11600570 11601510 940 Zic3_extended:84 Zfp499 NM_001024699 Trim28 NM_011588 DIVERGENT
chr7 24792012 24792512 500 Zic3_extended:85 4732475C15Rik NM_001024726 NA NA PROMOTER
chr7 25367850 25368350 500 Zic3_extended:86 Samd4b NM_175021 NA NA INSIDE
chr7 32228061 32228724 663 Zic3_extended:87 Rhpn2 NM_027897 NA NA INSIDE
chr7 41416413 41416913 500 Zic3_extended:88 Cd37 NM_007645 NA NA PROMOTER
chr7 55753819 55754609 790 Zic3_extended:89 Snurf NM_033174 NA NA PROMOTER
chr7 93773043 93773543 500 Zic3_extended:90 Aqp11 NM_175105 NA NA PROMOTER
chr7 1.06E+08 1.06E+08 500 Zic3_extended:91 D930014E17Rik NM_020616 NA NA PROMOTER
chr7 1.14E+08 1.14E+08 743 Zic3_extended:92 Arl6ip1 NM_019419 NA NA INSIDE
chr7 1.37E+08 1.37E+08 863 Zic3_extended:93 Ifitm2 NM_030694 Ifitm1 NM_026820 DIVERGENT
chr8 11608449 11609055 606 Zic3_extended:94 Ankrd10 NM_133971 NA NA PROMOTER
chr8 18819898 18820661 763 Zic3_extended:95 Agpat5 NM_026792 NA NA PROMOTER
chr8 23223678 23224286 608 Zic3_extended:96 1810011O10Rik NM_026931 NA NA INSIDE
chr8 25840152 25840981 829 Zic3_extended:97 Gpr124 NM_054044 NA NA PROMOTER
chr8 52844954 52845644 690 Zic3_extended:98 Vegfc NM_009506 NA NA PROMOTER
chr8 68450734 68451563 829 Zic3_extended:99 Gatad2a NM_145596 NA NA PROMOTER
chr8 70838696 70839196 500 Zic3_extended:100 Klf2 NM_008452 NA NA PROMOTER
chr9 35452948 35453448 500 Zic3_extended:101 Ddx25 NM_013932 NA NA INSIDE
chr9 44239945 44240445 500 Zic3_extended:102 Mizf NM_172162 NA NA PROMOTER
chr9 50637857 50638357 500 Zic3_extended:103 Dlat NM_145614 NA NA INSIDE
chr9 52025216 52025716 500 Zic3_extended:104 Rdx NM_009041 NA NA PROMOTER
chr9 59683361 59683861 500 Zic3_extended:105 Pkm2 NM_011099 NA NA INSIDE
chr9 61971493 61972167 674 Zic3_extended:106 Kif23 NM_024245 NA NA INSIDE
chr9 63174592 63175307 715 Zic3_extended:107 Lbxcor1 NM_172446 NA NA INSIDE
chr9 64051160 64051660 500 Zic3_extended:108 Smad6 NM_008542 NA NA PROMOTER
chr9 64206873 64207485 612 Zic3_extended:109 Snapc5 NM_183316 NA NA PROMOTER
chr9 70173572 70174072 500 Zic3_extended:110 6430514L14Rik NM_029784 NA NA PROMOTER
chr9 73017831 73018331 500 Zic3_extended:111 Ccpg1 NM_028181 NA NA INSIDE
chr9 77583464 77583964 500 Zic3_extended:112 Lrrc1 NM_172528 NA NA PROMOTER
chr9 78663384 78663884 500 Zic3_extended:113 Slc17a5 NM_172773 NA NA INSIDE
chr9 78691267 78691767 500 Zic3_extended:114 Cd109 NM_153098 NA NA INSIDE
chr9 95051189 95051807 618 Zic3_extended:115 Chst2 NM_018763 NA NA INSIDE
chr9 98627445 98628296 851 Zic3_extended:116 Faim NM_011810 NA NA PROMOTER
chr9 98884980 98885480 500 Zic3_extended:117 Cep70 NM_023873 NA NA INSIDE
chr9 1.06E+08 1.06E+08 500 Zic3_extended:118 Pcbp4 NM_021567 NA NA PROMOTER
chr9 1.08E+08 1.08E+08 500 Zic3_extended:119 Dag1 NM_010017 NA NA PROMOTER
chr9 1.08E+08 1.08E+08 500 Zic3_extended:120 Usp19 NM_027804 NA NA INSIDE
chr9 1.1E+08 1.1E+08 609 Zic3_extended:121 Mtap4 NM_008633 NA NA INSIDE
chr9 1.11E+08 1.11E+08 1085 Zic3_extended:122 Tdgf1 NM_011562 Lrrc2 NM_028838 DIVERGENT
chr9 1.12E+08 1.12E+08 626 Zic3_extended:123 Arpp21 NM_033264 NA NA INSIDE
chr9 1.18E+08 1.18E+08 636 Zic3_extended:124 Itga9 NM_133721 NA NA INSIDE
chr10 4540427 4540927 500 Zic3_extended:125 Fbxo5 NM_025995 NA NA PROMOTER
chr10 4795929 4796429 500 Zic3_extended:126 Syne1 NM_153399 NA NA INSIDE
chr10 13667365 13668247 882 Zic3_extended:127 Hivep2 NM_010437 NA NA PROMOTER
chr10 24587560 24588060 500 Zic3_extended:128 Enpp3 NM_134005 NA NA INSIDE
chr10 40087864 40088364 500 Zic3_extended:129 Amd2 NM_007444 NA NA INSIDE
chr10 43287733 43288387 654 Zic3_extended:130 AK122525 NM_199028 NA NA PROMOTER
chr10 56191057 56192221 1164 Zic3_extended:131 Gja1 NM_010288 NA NA PROMOTER
chr10 59469793 59470293 500 Zic3_extended:132 Ddit4 NM_029083 NA NA PROMOTER
chr10 60934099 60934599 500 Zic3_extended:133 Nodal NM_013611 NA NA PROMOTER
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chr10 61300254 61300930 676 Zic3_extended:134 H2afy2 NM_207000 NA NA INSIDE
chr10 61651300 61651917 617 Zic3_extended:135 Neurog3 NM_009719 NA NA PROMOTER
chr10 63609168 63609826 658 Zic3_extended:136 Lrrtm3 NM_178678 NA NA PROMOTER
chr10 66687292 66687909 617 Zic3_extended:137 D10Ucla1 NM_178606 NA NA PROMOTER
chr10 69847135 69847635 500 Zic3_extended:138 Slc16a9 NM_025807 NA NA PROMOTER
chr10 70886885 70887385 500 Zic3_extended:139 Ube2d1 NM_145420 NA NA INSIDE
chr10 75593367 75593995 628 Zic3_extended:140 Gm867 NM_001037714 NA NA INSIDE
chr10 79546773 79547388 615 Zic3_extended:141 Rnf126 NM_144528 NA NA PROMOTER
chr10 80131024 80131524 500 Zic3_extended:142 Adamtsl5 NM_025629 6330514A18Rik NM_183152 DIVERGENT
chr10 85475173 85475673 500 Zic3_extended:143 Prdm4 NM_181650 NA NA PROMOTER
chr10 93101056 93101556 500 Zic3_extended:144 Ccdc38 NM_175488 NA NA INSIDE
chr10 94976124 94976827 703 Zic3_extended:145 Socs2 NM_007706 NA NA INSIDE
chr10 99577178 99577678 500 Zic3_extended:146 Kitl NM_013598 NA NA INSIDE
chr10 1.17E+08 1.17E+08 500 Zic3_extended:147 Frs2 NM_177798 NA NA PROMOTER
chr10 1.2E+08 1.2E+08 500 Zic3_extended:148 Wif1 NM_011915 NA NA PROMOTER
chr10 1.27E+08 1.27E+08 500 Zic3_extended:149 Nab2 NM_008668 BC030440 NM_173732 DIVERGENT
chr10 1.28E+08 1.28E+08 500 Zic3_extended:150 Dgka NM_016811 NA NA INSIDE
chr11 4112303 4112803 500 Zic3_extended:151 Sf3a1 NM_026175 NA NA INSIDE
chr11 6369586 6370086 500 Zic3_extended:152 Ppia NM_008907 NA NA INSIDE
chr11 9067943 9068443 500 Zic3_extended:153 Upp1 NM_009477 NA NA PROMOTER
chr11 9069187 9069687 500 Zic3_extended:154 Upp1 NM_009477 NA NA PROMOTER
chr11 29644701 29645201 500 Zic3_extended:155 Rtn4 NM_194052 NA NA PROMOTER
chr11 31323146 31323646 500 Zic3_extended:156 Stc2 NM_011491 NA NA PROMOTER
chr11 34267223 34267723 500 Zic3_extended:157 MGC99845 NM_001025382 NA NA INSIDE
chr11 48827727 48828670 943 Zic3_extended:158 Irgm NM_008326 NA NA PROMOTER
chr11 50167019 50167755 736 Zic3_extended:159 Sqstm1 NM_011018 NA NA INSIDE
chr11 50333864 50334576 712 Zic3_extended:160 Hnrph1 NM_021510 NA NA PROMOTER
chr11 51594711 51595211 500 Zic3_extended:161 Rmnd5b NM_025346 NA NA PROMOTER
chr11 51607066 51607566 500 Zic3_extended:162 D930048N14Rik NM_175289 NA NA PROMOTER
chr11 53721599 53722099 500 Zic3_extended:163 Irf1 NM_008390 NA NA PROMOTER
chr11 59531447 59531947 500 Zic3_extended:164 Jmjd4 NM_178659 NA NA INSIDE
chr11 64516893 64517393 500 Zic3_extended:165 F930015N05Rik NM_001039541 NA NA INSIDE
chr11 68934435 68934935 500 Zic3_extended:166 Ndel1 NM_023668 NA NA PROMOTER
chr11 69199253 69199753 500 Zic3_extended:167 Hes7 NM_033041 NA NA PROMOTER
chr11 69662788 69664152 1364 Zic3_extended:168 Trp53 NM_011640 NA NA INSIDE
chr11 69686816 69687316 500 Zic3_extended:169 Atp1b2 NM_013415 NA NA INSIDE
chr11 72123511 72124346 835 Zic3_extended:170 Aipl1 NM_053245 6720460F02Rik NM_144526 DIVERGENT
chr11 72491980 72492480 500 Zic3_extended:171 D130058I21Rik NM_177776 NA NA INSIDE
chr11 73241691 73242191 500 Zic3_extended:172 P2rx5 NM_033321 NA NA PROMOTER
chr11 74126654 74127154 500 Zic3_extended:173 Olfr139 NM_147003 NA NA PROMOTER
chr11 74730687 74731419 732 Zic3_extended:174 E130309D14Rik NM_001013784 NA NA DOWNSTREAM
chr11 74911605 74912105 500 Zic3_extended:175 Mnt NM_010813 NA NA PROMOTER
chr11 75254608 75255258 650 Zic3_extended:176 Hic1 NM_010430 mmu-mir-212 NA DIVERGENT
chr11 75276497 75277201 704 Zic3_extended:177 Rtn4rl1 NM_177708 NA NA INSIDE
chr11 75612874 75613724 850 Zic3_extended:178 Slc43a2 NM_173388 NA NA PROMOTER
chr11 82469836 82470475 639 Zic3_extended:179 Tmem132e NM_023438 NA NA PROMOTER
chr11 84595929 84596429 500 Zic3_extended:180 Lhx1 NM_008498 NA NA PROMOTER
chr11 84939558 84940274 716 Zic3_extended:181 Ggnbp2 NM_153144 NA NA INSIDE
chr11 88169680 88170287 607 Zic3_extended:182 Cuedc1 NM_198013 NA NA INSIDE
chr11 89108200 89108822 622 Zic3_extended:183 Trim25 NM_009546 NA NA PROMOTER
chr11 90500291 90500791 500 Zic3_extended:184 Hlf NM_172563 NA NA PROMOTER
chr11 95420611 95421258 647 Zic3_extended:185 Myst2 NM_177619 NA NA PROMOTER
chr11 95951212 95951712 500 Zic3_extended:186 Abi3 NM_025659 Gngt2 NM_023121 DIVERGENT
chr11 96116149 96116649 500 Zic3_extended:187 Igf2bp1 NM_009951 NA NA PROMOTER
chr11 96299162 96300038 876 Zic3_extended:188 Hoxb13 NM_008267 NA NA PROMOTER
chr11 97229180 97229680 500 Zic3_extended:189 Tbx21 NM_019507 NA NA PROMOTER
chr11 97770838 97771831 993 Zic3_extended:190 Mllt6 NM_139311 NA NA PROMOTER
chr11 99339714 99340338 624 Zic3_extended:191 Smarce1 NM_020618 NA NA PROMOTER
chr11 1.01E+08 1.01E+08 500 Zic3_extended:192 Jup NM_010593 NA NA INSIDE
chr11 1.03E+08 1.03E+08 500 Zic3_extended:193 BC050840 BC050840 NA NA Unknown
chr11 1.1E+08 1.1E+08 833 Zic3_extended:194 Abca8b NM_013851 NA NA PROMOTER
chr11 1.14E+08 1.14E+08 927 Zic3_extended:195 D11Ertd636e NM_029794 NA NA PROMOTER
chr11 1.15E+08 1.15E+08 899 Zic3_extended:196 Slc9a3r1 NM_012030 NA NA PROMOTER
chr11 1.16E+08 1.16E+08 500 Zic3_extended:197 Grb2 NM_008163 NA NA INSIDE
chr11 1.16E+08 1.16E+08 500 Zic3_extended:198 Grb2 NM_008163 NA NA PROMOTER
chr11 1.16E+08 1.16E+08 500 Zic3_extended:199 H3f3b NM_008211 NA NA INSIDE
chr11 1.17E+08 1.17E+08 500 Zic3_extended:200 St6galnac2 NM_009180 NA NA INSIDE
chr11 1.21E+08 1.21E+08 500 Zic3_extended:201 Pycr1 NM_144795 NA NA PROMOTER
chr12 8798692 8799433 741 Zic3_extended:202 Sdc1 NM_011519 NA NA INSIDE
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chr12 11329562 11330209 647 Zic3_extended:203 Smc6l1 NM_025695 NA NA INSIDE
chr12 13005608 13006590 982 Zic3_extended:204 Mycn NM_008709 NA NA PROMOTER
chr12 49359490 49360307 817 Zic3_extended:205 6030408C04Rik NM_001015099 NA NA PROMOTER
chr12 49361345 49362049 704 Zic3_extended:206 6030408C04Rik NM_001015099 NA NA PROMOTER
chr12 54627184 54627684 500 Zic3_extended:207 Pax9 NM_011041 NA NA INSIDE
chr12 68767854 68768354 500 Zic3_extended:208 Frmd6 NM_028127 NA NA PROMOTER
chr12 74328029 74328828 799 Zic3_extended:209 Zbtb25 NM_028356 Zbtb1 NM_178744 DIVERGENT
chr12 74920901 74921401 500 Zic3_extended:210 Max NM_008558 NA NA PROMOTER
chr12 74923581 74924081 500 Zic3_extended:211 Max NM_008558 NA NA PROMOTER
chr12 78074365 78074865 500 Zic3_extended:212 Zfp36l1 NM_007564 NA NA INSIDE
chr12 78079547 78080223 676 Zic3_extended:213 Zfp36l1 NM_007564 NA NA PROMOTER
chr12 78223037 78223537 500 Zic3_extended:214 Actn1 NM_134156 NA NA PROMOTER
chr12 81483154 81483654 500 Zic3_extended:215 Dpf3 NM_058212 NA NA INSIDE
chr12 82640889 82641389 500 Zic3_extended:216 7420416P09Rik NM_001033776 NA NA PROMOTER
chr12 99453434 99454042 608 Zic3_extended:217 Mjd NM_029705 NA NA PROMOTER
chr12 1.03E+08 1.03E+08 500 Zic3_extended:218 C630028L02Rik NM_176899 NA NA INSIDE
chr12 1.04E+08 1.04E+08 500 Zic3_extended:219 Vrk1 NM_001029843 NA NA PROMOTER
chr12 1.08E+08 1.08E+08 500 Zic3_extended:220 2310040A13Rik NM_027149 NA NA PROMOTER
chr13 5745679 5746179 500 Zic3_extended:221 Klf6 NM_011803 NA NA PROMOTER
chr13 21148419 21148919 500 Zic3_extended:222 Hist1h1b NM_020034 NA NA PROMOTER
chr13 21155988 21156488 500 Zic3_extended:223 Hist1h2bp NM_178202 NA NA DOWNSTREAM
chr13 21156519 21157406 887 Zic3_extended:224 Hist1h2bp NM_178202 NA NA DOWNSTREAM
chr13 22858042 22858542 500 Zic3_extended:225 Btn2a2 NM_175938 NA NA PROMOTER
chr13 23105115 23105615 500 Zic3_extended:226 Hist1h1c NM_015786 NA NA INSIDE
chr13 23110286 23110786 500 Zic3_extended:227 Hist1h3h NM_178206 NA NA INSIDE
chr13 24197468 24197968 500 Zic3_extended:228 Ttrap NM_019551 NA NA INSIDE
chr13 24640675 24641175 500 Zic3_extended:229 Vmp NM_009513 NA NA PROMOTER
chr13 43054988 43055488 500 Zic3_extended:230 Rnf182 NM_183204 NA NA PROMOTER
chr13 44178546 44179261 715 Zic3_extended:231 Jarid2 NM_021878 NA NA PROMOTER
chr13 48671827 48672327 500 Zic3_extended:232 Ninj1 NM_013610 NA NA INSIDE
chr13 53693147 53693647 500 Zic3_extended:233 Cltb NM_028870 NA NA INSIDE
chr13 54918449 54918949 500 Zic3_extended:234 Pitx1 NM_011097 NA NA INSIDE
chr13 61391226 61391915 689 Zic3_extended:235 Ptch1 NM_008957 NA NA PROMOTER
chr13 64425224 64425724 500 Zic3_extended:236 Mterfd1 NM_025547 NA NA PROMOTER
chr13 80810937 80811548 611 Zic3_extended:237 C130071C03Rik NM_177100 NA NA INSIDE
chr13 94266754 94267254 500 Zic3_extended:238 Hexb NM_010422 NA NA INSIDE
chr13 95885463 95885963 500 Zic3_extended:239 Fcho2 NM_172591 NA NA PROMOTER
chr13 1.1E+08 1.1E+08 693 Zic3_extended:240 Il6st NM_010560 NA NA PROMOTER
chr13 1.12E+08 1.12E+08 500 Zic3_extended:241 Pelo NM_134058 NA NA PROMOTER
chr13 1.12E+08 1.12E+08 627 Zic3_extended:242 Itga1 NM_001033228 Pelo NM_134058 PROMOTER
chr13 1.14E+08 1.14E+08 500 Zic3_extended:243 Isl1 NM_021459 NA NA PROMOTER
chr13 1.14E+08 1.14E+08 947 Zic3_extended:244 Emb NM_010330 NA NA PROMOTER
chr13 1.15E+08 1.15E+08 678 Zic3_extended:245 Hcn1 NM_010408 NA NA INSIDE
chr14 17407826 17408326 500 Zic3_extended:246 Nid2 NM_008695 NA NA PROMOTER
chr14 17408365 17409155 790 Zic3_extended:247 Nid2 NM_008695 NA NA PROMOTER
chr14 23512539 23513039 500 Zic3_extended:248 Anxa11 NM_013469 NA NA PROMOTER
chr14 24432904 24433818 914 Zic3_extended:249 Hesx1 NM_010420 NA NA INSIDE
chr14 24471440 24472072 632 Zic3_extended:250 Il17rd NM_134437 NA NA PROMOTER
chr14 32320601 32321422 821 Zic3_extended:251 mmu-mir-346 mmu-mir-346 NA NA PROMOTER
chr14 40705759 40706259 500 Zic3_extended:252 Gnpnat1 NM_019425 NA NA INSIDE
chr14 47659796 47660296 500 Zic3_extended:253 Sall2 NM_015772 NA NA INSIDE
chr14 47665712 47666212 500 Zic3_extended:254 Sall2 NM_015772 NA NA PROMOTER
chr14 49278127 49278836 709 Zic3_extended:255 Slc7a7 NM_011405 NA NA INSIDE
chr14 50427122 50427881 759 Zic3_extended:256 Wdr23 NM_133734 NA NA INSIDE
chr14 51535675 51536380 705 Zic3_extended:257 4930548G07Rik NM_023773 NA NA PROMOTER
chr14 52389235 52389735 500 Zic3_extended:258 Il17d NM_145837 NA NA PROMOTER
chr14 58372276 58373106 830 Zic3_extended:259 Tdh NM_021480 NA NA INSIDE
chr14 60983009 60983509 500 Zic3_extended:260 Ephx2 NM_007940 NA NA INSIDE
chr14 64996184 64997102 918 Zic3_extended:261 Slc39a14 NM_144808 NA NA PROMOTER
chr14 65279249 65279890 641 Zic3_extended:262 Epb4.9 NM_013514 NA NA PROMOTER
chr14 82130067 82130834 767 Zic3_extended:263 Tdrd3 NM_172605 NA NA INSIDE
chr14 97412017 97412632 615 Zic3_extended:264 Kctd12 NM_177715 NA NA INSIDE
chr14 1E+08 1E+08 697 Zic3_extended:265 Spry2 NM_011897 NA NA INSIDE
chr14 1.15E+08 1.15E+08 500 Zic3_extended:266 Rap2a NM_029519 NA NA PROMOTER
chr14 1.17E+08 1.17E+08 500 Zic3_extended:267 Clybl NM_029556 NA NA INSIDE
chr14 1.17E+08 1.17E+08 674 Zic3_extended:268 Zic5 NM_022987 Zic2 NM_009574 DIVERGENT
chr15 25468138 25468798 660 Zic3_extended:269 Basp1 NM_027395 NA NA PROMOTER
chr15 55172354 55172854 500 Zic3_extended:270 Depdc6 NM_145470 NA NA INSIDE
chr15 58278092 58278836 744 Zic3_extended:271 Fbxo32 NM_026346 NA NA INSIDE
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chr15 79066470 79066970 500 Zic3_extended:272 Triobp NM_001024716 NA NA INSIDE
chr15 79689154 79689973 819 Zic3_extended:273 Dmc1h NM_010059 NA NA PROMOTER
chr15 82359817 82360317 500 Zic3_extended:274 Sep-03 NM_011889 NA NA INSIDE
chr15 84747325 84748166 841 Zic3_extended:275 BC024991 BC024991 NA NA Unknown
chr15 89157846 89158507 661 Zic3_extended:276 5730502D15Rik NM_026485 NA NA PROMOTER
chr15 89278423 89278923 500 Zic3_extended:277 1700027J05Rik NM_027081 NA NA INSIDE
chr15 93477634 93478595 961 Zic3_extended:278 Zcrb1 NM_026025 NA NA INSIDE
chr15 95791823 95792323 500 Zic3_extended:279 Tmem16f NM_175344 NA NA INSIDE
chr15 99689343 99690118 775 Zic3_extended:280 Smarcd1 NM_031842 NA NA INSIDE
chr15 1.02E+08 1.02E+08 500 Zic3_extended:281 AI507495 NM_213728 NA NA PROMOTER
chr15 1.02E+08 1.02E+08 500 Zic3_extended:282 Eif4b NM_145625 NA NA PROMOTER
chr15 1.04E+08 1.04E+08 500 Zic3_extended:283 Ppp1r1a NM_021391 NA NA PROMOTER
chr16 10461960 10462763 803 Zic3_extended:284 Socs1 NM_009896 NA NA INSIDE
chr16 16695536 16696036 500 Zic3_extended:285 1810015A11Rik NM_026940 NA NA PROMOTER
chr16 16759773 16760273 500 Zic3_extended:286 Gm603 NM_001033338 NA NA INSIDE
chr16 20282287 20282787 500 Zic3_extended:287 Thpo NM_009379 NA NA INSIDE
chr16 21647513 21648253 740 Zic3_extended:288 Liph NM_153404 NA NA PROMOTER
chr16 22092011 22092673 662 Zic3_extended:289 Etv5 NM_023794 NA NA PROMOTER
chr16 24055235 24055735 500 Zic3_extended:290 Lpp NM_178665 NA NA INSIDE
chr16 32283306 32283806 500 Zic3_extended:291 Tfrc NM_011638 NA NA INSIDE
chr16 32551851 32552351 500 Zic3_extended:292 1700021K19Rik NM_172615 Fyttd1 NM_027226 DIVERGENT
chr16 45502007 45502716 709 Zic3_extended:293 Tagln3 NM_019754 NA NA PROMOTER
chr16 49616441 49617086 645 Zic3_extended:294 Cd47 NM_010581 NA NA INSIDE
chr17 12975566 12976632 1066 Zic3_extended:295 Thbs2 NM_011581 NA NA INSIDE
chr17 13241510 13242010 500 Zic3_extended:296 Phf10 NM_024250 NA NA INSIDE
chr17 13242296 13242904 608 Zic3_extended:297 Phf10 NM_024250 NA NA PROMOTER
chr17 13617464 13617964 500 Zic3_extended:298 Dll1 NM_007865 NA NA PROMOTER
chr17 13763847 13764347 500 Zic3_extended:299 Pdcd2 NM_008799 NA NA INSIDE
chr17 13940963 13941633 670 Zic3_extended:300 Chd1 NM_007690 NA NA PROMOTER
chr17 21780670 21781286 616 Zic3_extended:301 Zfp206 NM_001033425 NA NA INSIDE
chr17 21824850 21825510 660 Zic3_extended:302 Mmp25 NM_001033339 NA NA PROMOTER
chr17 24293450 24294656 1206 Zic3_extended:303 Tmem8 NM_021793 NA NA PROMOTER
chr17 25824460 25824960 500 Zic3_extended:304 Rps10 NM_025963 NA NA PROMOTER
chr17 26875656 26876156 500 Zic3_extended:305 Slc26a8 NM_146076 NA NA INSIDE
chr17 29577155 29577655 500 Zic3_extended:306 Pde9a NM_008804 NA NA INSIDE
chr17 30584537 30585037 500 Zic3_extended:307 Wiz NM_212438 NA NA PROMOTER
chr17 31758569 31759069 500 Zic3_extended:308 Hnrpm NM_029804 NA NA INSIDE
chr17 31987259 31987907 648 Zic3_extended:309 Daxx NM_007829 NA NA PROMOTER
chr17 31998414 31998914 500 Zic3_extended:310 Tapbp NM_001025313 NA NA INSIDE
chr17 32008137 32008637 500 Zic3_extended:311 Rgl2 NM_009059 NA NA INSIDE
chr17 33008002 33008615 613 Zic3_extended:312 Ehmt2 NM_145830 NA NA INSIDE
chr17 33078929 33079429 500 Zic3_extended:313 Lsm2 NM_030597 NA NA PROMOTER
chr17 33156548 33157048 500 Zic3_extended:314 Ddah2 NM_016765 NA NA INSIDE
chr17 33300611 33301111 500 Zic3_extended:315 Lta NM_010735 NA NA INSIDE
chr17 33603233 33603848 615 Zic3_extended:316 Pou5f1 NM_013633 NA NA PROMOTER
chr17 33605076 33605576 500 Zic3_extended:317 Pou5f1 NM_013633 NA NA PROMOTER
chr17 33605923 33606959 1036 Zic3_extended:318 Pou5f1 NM_013633 NA NA PROMOTER
chr17 34022197 34022837 640 Zic3_extended:319 Ppp1r10 NM_175934 NA NA INSIDE
chr17 34023624 34024124 500 Zic3_extended:320 Ppp1r10 NM_175934 NA NA INSIDE
chr17 35133524 35134024 500 Zic3_extended:321 2410137M14Rik NM_029747 NA NA PROMOTER
chr17 35148896 35149508 612 Zic3_extended:322 Zfp57 NM_001013745 NA NA PROMOTER
chr17 38062191 38064808 2617 Zic3_extended:323 Pigt NM_133779 NA NA PROMOTER
chr17 38066618 38067280 662 Zic3_extended:324 Pigt NM_133779 NA NA DOWNSTREAM
chr17 45576769 45577374 605 Zic3_extended:325 1700001C19Rik NM_029296 NA NA PROMOTER
chr17 54447794 54448610 816 Zic3_extended:326 M6prbp1 NM_025836 NA NA INSIDE
chr17 64173647 64174147 500 Zic3_extended:327 Twsg1 NM_023053 NA NA PROMOTER
chr17 65968212 65968712 500 Zic3_extended:328 Lama1 NM_008480 NA NA PROMOTER
chr17 77352355 77352855 500 Zic3_extended:329 BC020023 BC020023 NA NA Unknown
chr17 78357716 78358216 500 Zic3_extended:330 Hnrpll NM_144802 NA NA PROMOTER
chr18 3551386 3551886 500 Zic3_extended:331 Cul2 NM_029402 NA NA INSIDE
chr18 3673646 3674259 613 Zic3_extended:332 Bambi NM_026505 NA NA INSIDE
chr18 9414755 9415255 500 Zic3_extended:333 Fzd8 NM_008058 NA NA PROMOTER
chr18 9417236 9417873 637 Zic3_extended:334 Fzd8 NM_008058 NA NA INSIDE
chr18 9914004 9914504 500 Zic3_extended:335 Colec12 NM_130449 NA NA INSIDE
chr18 24587517 24588381 864 Zic3_extended:336 Galnt1 NM_013814 NA NA PROMOTER
chr18 34382606 34383106 500 Zic3_extended:337 Epb4.1l4a NM_013512 NA NA PROMOTER
chr18 34749125 34749625 500 Zic3_extended:338 Reep5 NM_007874 NA NA PROMOTER
chr18 36037883 36038494 611 Zic3_extended:339 5133400G04Rik NM_029485 NA NA PROMOTER
chr18 38977778 38978475 697 Zic3_extended:340 9630014M24Rik NM_001033771 NA NA INSIDE
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chr18 47746645 47747145 500 Zic3_extended:341 Sema6a NM_018744 NA NA PROMOTER
chr18 61403019 61403684 665 Zic3_extended:342 Slc6a7 NM_201353 NA NA INSIDE
chr18 62115508 62116008 500 Zic3_extended:343 Grpel2 NM_021296 NA NA INSIDE
chr18 66335073 66335744 671 Zic3_extended:344 Rax NM_013833 NA NA PROMOTER
chr18 67733626 67734310 684 Zic3_extended:345 Cidea NM_007702 NA NA PROMOTER
chr19 4292818 4293318 500 Zic3_extended:346 9430078G10Rik NM_001033811 NA NA INSIDE
chr19 4706247 4706747 500 Zic3_extended:347 Rbm14 NM_019869 NA NA PROMOTER
chr19 4962093 4962593 500 Zic3_extended:348 Cd248 NM_054042 NA NA PROMOTER
chr19 6130680 6131456 776 Zic3_extended:349 Ppp2r5b NM_198168 1810013C15Rik NM_194348 DIVERGENT
chr19 12474829 12475329 500 Zic3_extended:350 Zfp91 NM_053009 NA NA INSIDE
chr19 14298746 14299246 500 Zic3_extended:351 Tle4 NM_011600 NA NA PROMOTER
chr19 22834538 22835038 500 Zic3_extended:352 Klf9 NM_010638 NA NA PROMOTER
chr19 24600029 24600529 500 Zic3_extended:353 Foxd4 NM_008022 NA NA INSIDE
chr19 24602138 24602638 500 Zic3_extended:354 Foxd4 NM_008022 NA NA PROMOTER
chr19 29728705 29729393 688 Zic3_extended:355 Uhrf2 NM_144873 NA NA PROMOTER
chr19 30253011 30253511 500 Zic3_extended:356 Dkk1 NM_010051 NA NA PROMOTER
chr19 40164894 40165394 500 Zic3_extended:357 Pdlim1 NM_016861 NA NA INSIDE
chr19 41636979 41637479 500 Zic3_extended:358 Slit1 NM_015748 NA NA INSIDE
chr19 44187418 44187918 500 Zic3_extended:359 Scd2 NM_009128 NA NA PROMOTER
chr19 46044741 46045390 649 Zic3_extended:360 Pitx3 NM_008852 Gbf1 NM_178930 DIVERGENT
chr19 46225002 46225774 772 Zic3_extended:361 Fbxl15 NM_133694 NA NA INSIDE
chr19 46469726 46470226 500 Zic3_extended:362 Arl3 NM_019718 Sfxn2 NM_053196 DIVERGENT
chr19 53211495 53211995 500 Zic3_extended:363 Mxi1 NM_001008542 NA NA PROMOTER
chr19 55230271 55230968 697 Zic3_extended:364 Zdhhc6 NM_025883 Vti1a NM_016862 DIVERGENT
chrX 6197914 6198414 500 Zic3_extended:365 Tcfe3 NM_172472 NA NA INSIDE
chrX 6639825 6640889 1064 Zic3_extended:366 Porcn NM_145908 NA NA PROMOTER
chrX 46775012 46775824 812 Zic3_extended:367 Hs6st2 NM_015819 NA NA PROMOTER
chrX 46776734 46777586 852 Zic3_extended:368 Hs6st2 NM_015819 NA NA PROMOTER
chrX 47837278 47838363 1085 Zic3_extended:369 mmu-mir-106a mmu-mir-106a NA NA PROMOTER
chrX 48870422 48870922 500 Zic3_extended:370 Zfp36l3 NM_001009549 NA NA PROMOTER
chrX 96411551 96412051 500 Zic3_extended:371 Slc7a3 NM_007515 NA NA INSIDE
chrX 96964440 96964940 500 Zic3_extended:372 Ogt NM_139144 NA NA PROMOTER
chrX 1.03E+08 1.03E+08 500 Zic3_extended:373 Itm2a NM_008409 NA NA PROMOTER
chrX 1.39E+08 1.39E+08 1064 Zic3_extended:374 Glt28d1 NM_026247 NA NA INSIDE
chrX 1.46E+08 1.46E+08 754 Zic3_extended:375 ORF34 NM_198105 NA NA INSIDE
chrX 1.52E+08 1.52E+08 500 Zic3_extended:376 Sms NM_009214 NA NA PROMOTER
chrX 1.52E+08 1.52E+08 686 Zic3_extended:377 Mbtps2 NM_178266 NA NA PROMOTER
chrX 1.55E+08 1.55E+08 500 Zic3_extended:378 Pdha1 NM_008810 NA NA PROMOTER
chrX 1.58E+08 1.58E+08 500 Zic3_extended:379 Rbbp7 NM_009031 NA NA PROMOTER
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Appendix 6. Sox2 ChIP target gene and their associated promoter regions in mouse ES cells
"Bound Region" (column E) - the annotation assigned to each unique region
Genomic co-ordinates are with reference to UCSC build mm7 (August 2005)
Chr  Start End Bound Region First Gene Accession # Second gene Accession # Primary Annotation
chr1 4850939 4851875 Sox2_bound:1 Tcea1 NM_011541 NA NA PROMOTER
chr1 5014069 5014840 Sox2_bound:2 Rgs20 NM_021374 NA NA INSIDE
chr1 7097722 7098222 Sox2_bound:3 BC110360 BC110360 NA NA Unknown
chr1 9844280 9845013 Sox2_bound:4 Mybl1 NM_008651 NA NA PROMOTER
chr1 9845140 9845834 Sox2_bound:5 Mybl1 NM_008651 NA NA PROMOTER
chr1 1.3E+07 1.3E+07 Sox2_bound:6 Sulf1 NM_172294 NA NA PROMOTER
chr1 1.3E+07 1.3E+07 Sox2_bound:7 Slco5a1 NM_172841 NA NA PROMOTER
chr1 1.4E+07 1.4E+07 Sox2_bound:8 Eya1 NM_010164 NA NA PROMOTER
chr1 1.7E+07 1.7E+07 Sox2_bound:9 Tceb1 NM_026456 Tmem70 NM_027415 DIVERGENT
chr1 1.9E+07 1.9E+07 Sox2_bound:10 Tcfap2b NM_001025305 NA NA PROMOTER
chr1 3.5E+07 3.5E+07 Sox2_bound:11 C230030N03Rik NM_172847 NA NA PROMOTER
chr1 3.6E+07 3.6E+07 Sox2_bound:12 Hs6st1 NM_015818 NA NA PROMOTER
chr1 4E+07 4E+07 Sox2_bound:13 Map4k4 NM_008696 NA NA INSIDE
chr1 4.1E+07 4.1E+07 Sox2_bound:14 Slc9a2 NM_001033289 NA NA PROMOTER
chr1 4.3E+07 4.3E+07 Sox2_bound:15 Tgfbrap1 NM_001013025 NA NA INSIDE
chr1 4.4E+07 4.4E+07 Sox2_bound:16 Nck2 NM_010879 NA NA INSIDE
chr1 5.2E+07 5.2E+07 Sox2_bound:17 5830411E10Rik NM_028696 NA NA PROMOTER
chr1 5.2E+07 5.2E+07 Sox2_bound:18 Stat4 NM_011487 NA NA INSIDE
chr1 5.2E+07 5.2E+07 Sox2_bound:19 Stat4 NM_011487 NA NA INSIDE
chr1 5.5E+07 5.5E+07 Sox2_bound:20 Gtf3c3 NM_001033194 NA NA PROMOTER
chr1 5.5E+07 5.5E+07 Sox2_bound:21 Prei3 NM_025283 NA NA INSIDE
chr1 5.5E+07 5.5E+07 Sox2_bound:22 BC026871 BC026871 NA NA Unknown
chr1 5.7E+07 5.7E+07 Sox2_bound:23 Satb2 NM_139146 NA NA PROMOTER
chr1 5.9E+07 5.9E+07 Sox2_bound:24 Ppil3 NM_027351 Nif3l1 NM_022988 DIVERGENT
chr1 5.9E+07 5.9E+07 Sox2_bound:25 BC049806 NM_172513 Ndufb3 NM_025597 DIVERGENT
chr1 6E+07 6E+07 Sox2_bound:26 Fzd7 NM_008057 NA NA PROMOTER
chr1 6E+07 6E+07 Sox2_bound:27 Nol5 NM_018868 NA NA INSIDE
chr1 6.3E+07 6.3E+07 Sox2_bound:28 Nrp2 NM_010939 NA NA INSIDE
chr1 6.4E+07 6.4E+07 Sox2_bound:29 Klf7 NM_033563 NA NA PROMOTER
chr1 6.5E+07 6.5E+07 Sox2_bound:30 Crygd NM_007776 NA NA INSIDE
chr1 6.7E+07 6.7E+07 Sox2_bound:31 Rpe NM_025683 NA NA PROMOTER
chr1 7.2E+07 7.2E+07 Sox2_bound:32 Fn1 NM_010233 NA NA INSIDE
chr1 7.2E+07 7.2E+07 Sox2_bound:33 Fn1 NM_010233 NA NA PROMOTER
chr1 7.2E+07 7.2E+07 Sox2_bound:34 Wdt2 NM_001005423 NA NA PROMOTER
chr1 7.3E+07 7.3E+07 Sox2_bound:35 Smarcal1 NM_018817 NA NA PROMOTER
chr1 7.3E+07 7.3E+07 Sox2_bound:36 Igfbp2 NM_008342 NA NA PROMOTER
chr1 7.3E+07 7.3E+07 Sox2_bound:37 Igfbp2 NM_008342 NA NA INSIDE
chr1 7.3E+07 7.3E+07 Sox2_bound:38 Igfbp5 NM_010518 NA NA INSIDE
chr1 7.3E+07 7.3E+07 Sox2_bound:39 Igfbp5 NM_010518 NA NA INSIDE
chr1 7.5E+07 7.5E+07 Sox2_bound:40 Wnt6 NM_009526 NA NA INSIDE
chr1 7.6E+07 7.6E+07 Sox2_bound:41 Inha NM_010564 NA NA INSIDE
chr1 7.6E+07 7.6E+07 Sox2_bound:42 Stk11ip NM_027886 NA NA INSIDE
chr1 7.8E+07 7.8E+07 Sox2_bound:43 Epha4 NM_007936 NA NA INSIDE
chr1 8.6E+07 8.6E+07 Sox2_bound:44 Itm2c NM_022417 NA NA INSIDE
chr1 8.6E+07 8.6E+07 Sox2_bound:45 Ptma NM_008972 NA NA PROMOTER
chr1 8.6E+07 8.6E+07 Sox2_bound:46 Ptma NM_008972 NA NA PROMOTER
chr1 8.8E+07 8.8E+07 Sox2_bound:47 6430706D22Rik NM_198652 NA NA PROMOTER
chr1 8.9E+07 8.9E+07 Sox2_bound:48 Sh3bp4 NM_133816 NA NA INSIDE
chr1 9E+07 9E+07 Sox2_bound:49 Gbx2 NM_010262 NA NA PROMOTER
chr1 9E+07 9E+07 Sox2_bound:50 Gbx2 NM_010262 NA NA PROMOTER
chr1 9E+07 9E+07 Sox2_bound:51 Cmkor1 NM_007722 NA NA PROMOTER
chr1 9.1E+07 9.1E+07 Sox2_bound:52 Hes6 NM_019479 NA NA PROMOTER
chr1 9.7E+07 9.7E+07 Sox2_bound:53 Slco4c1 NM_172658 NA NA PROMOTER
chr1 1.2E+08 1.2E+08 Sox2_bound:54 Tcfcp2l1 NM_023755 NA NA PROMOTER
chr1 1.2E+08 1.2E+08 Sox2_bound:55 Tcfcp2l1 NM_023755 NA NA PROMOTER
chr1 1.2E+08 1.2E+08 Sox2_bound:56 Tmem37 NM_019432 NA NA PROMOTER
chr1 1.3E+08 1.3E+08 Sox2_bound:57 Cxcr4 NM_009911 NA NA PROMOTER
chr1 1.3E+08 1.3E+08 Sox2_bound:58 Dyrk3 NM_145508 NA NA PROMOTER
chr1 1.3E+08 1.3E+08 Sox2_bound:59 Lgtn NM_010709 NA NA PROMOTER
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chr1 1.3E+08 1.3E+08 Sox2_bound:60 Slc26a9 NM_177243 NA NA INSIDE
chr1 1.3E+08 1.3E+08 Sox2_bound:61 Rab7l1 NM_144875 NA NA PROMOTER
chr1 1.3E+08 1.3E+08 Sox2_bound:62 Nucks1 NM_175294 NA NA PROMOTER
chr1 1.3E+08 1.3E+08 Sox2_bound:63 mmu-mir-135b mmu-mir-135b NA NA PROMOTER
chr1 1.3E+08 1.3E+08 Sox2_bound:64 mmu-mir-135b mmu-mir-135b NA NA PROMOTER
chr1 1.3E+08 1.3E+08 Sox2_bound:65 Tmcc2 NM_178874 NA NA INSIDE
chr1 1.3E+08 1.3E+08 Sox2_bound:66 Rbbp5 NM_172517 NA NA PROMOTER
chr1 1.3E+08 1.3E+08 Sox2_bound:67 Lrrn2 NM_010732 NA NA PROMOTER
chr1 1.3E+08 1.3E+08 Sox2_bound:68 Ppp1r15b NM_133819 NA NA PROMOTER
chr1 1.3E+08 1.3E+08 Sox2_bound:69 Ppp1r15b NM_133819 NA NA PROMOTER
chr1 1.3E+08 1.3E+08 Sox2_bound:70 Ppp1r15b NM_133819 NA NA PROMOTER
chr1 1.3E+08 1.3E+08 Sox2_bound:71 Chi3l1 NM_007695 NA NA INSIDE
chr1 1.3E+08 1.3E+08 Sox2_bound:72 4931440L10Rik NM_183292 Jarid1b NM_152895 DIVERGENT
chr1 1.4E+08 1.4E+08 Sox2_bound:73 5730559C18Rik NM_028872 NA NA INSIDE
chr1 1.4E+08 1.4E+08 Sox2_bound:74 5730559C18Rik NM_028872 NA NA PROMOTER
chr1 1.4E+08 1.4E+08 Sox2_bound:75 Lhx9 NM_010714 NA NA PROMOTER
chr1 1.4E+08 1.4E+08 Sox2_bound:76 Rgs2 NM_009061 NA NA PROMOTER
chr1 1.5E+08 1.5E+08 Sox2_bound:77 B830045N13Rik NM_153539 NA NA INSIDE
chr1 1.5E+08 1.5E+08 Sox2_bound:78 1200016B10Rik NM_025819 NA NA INSIDE
chr1 1.5E+08 1.5E+08 Sox2_bound:79 Rgs16 NM_011267 NA NA INSIDE
chr1 1.6E+08 1.6E+08 Sox2_bound:80 Mr1 NM_008209 Stx6 NM_021433 DIVERGENT
chr1 1.6E+08 1.6E+08 Sox2_bound:81 Ralgps2 NM_023884 NA NA INSIDE
chr1 1.6E+08 1.6E+08 Sox2_bound:82 BC026585 NM_001033284 NA NA INSIDE
chr1 1.6E+08 1.6E+08 Sox2_bound:83 6430517E21Rik NM_207583 Astn1 NA INSIDE
chr1 1.6E+08 1.6E+08 Sox2_bound:84 4930523C07Rik NM_001024470 NA NA PROMOTER
chr1 1.6E+08 1.6E+08 Sox2_bound:85 Zbtb37 NM_173424 NA NA PROMOTER
chr1 1.6E+08 1.6E+08 Sox2_bound:86 Zbtb37 NM_173424 NA NA PROMOTER
chr1 1.6E+08 1.6E+08 Sox2_bound:87 Dars2 NM_172644 NA NM_027429 DIVERGENT
chr1 1.7E+08 1.7E+08 Sox2_bound:88 Mpzl1 NM_001001880 NA NA PROMOTER
chr1 1.7E+08 1.7E+08 Sox2_bound:89 Pou2f1 NM_198932 NA NA PROMOTER
chr1 1.7E+08 1.7E+08 Sox2_bound:90 Dusp27 NM_001033344 NA NA INSIDE
chr1 1.7E+08 1.7E+08 Sox2_bound:91 Uck2 NM_030724 NA NA PROMOTER
chr1 1.7E+08 1.7E+08 Sox2_bound:92 Uck2 NM_030724 NA NA PROMOTER
chr1 1.7E+08 1.7E+08 Sox2_bound:93 Rxrg NM_009107 NA NA INSIDE
chr1 1.7E+08 1.7E+08 Sox2_bound:94 Hsd17b7 NM_010476 NA NA PROMOTER
chr1 1.7E+08 1.7E+08 Sox2_bound:95 Ndufs2 NM_153064 Adamts4 NM_172845 DIVERGENT
chr1 1.7E+08 1.7E+08 Sox2_bound:96 Usf1 NM_009480 NA NA INSIDE
chr1 1.7E+08 1.7E+08 Sox2_bound:97 Refbp2 NM_019484 NA NA PROMOTER
chr1 1.7E+08 1.7E+08 Sox2_bound:98 Refbp2 NM_019484 NA NA PROMOTER
chr1 1.7E+08 1.7E+08 Sox2_bound:99 Tagln2 NM_178598 NA NA INSIDE
chr1 1.8E+08 1.8E+08Sox2_bound:10 Hnrpu NM_016805 NA NA PROMOTER
chr1 1.8E+08 1.8E+08Sox2_bound:10 Efcab2 NM_026626 NA NA INSIDE
chr1 1.8E+08 1.8E+08Sox2_bound:10 Parp1 NM_007415 NA NA INSIDE
chr1 1.8E+08 1.8E+08Sox2_bound:10 BC031781 NM_145943 NA NA PROMOTER
chr1 1.8E+08 1.8E+08Sox2_bound:10 Lefty2 NM_177099 NA NA PROMOTER
chr1 1.8E+08 1.8E+08Sox2_bound:10 Lefty1 NM_010094 NA NA PROMOTER
chr1 1.8E+08 1.8E+08Sox2_bound:10 LOC433384 NM_001007587 NA NA PROMOTER
chr1 1.8E+08 1.8E+08Sox2_bound:10 Enah NM_010135 NA NA INSIDE
chr1 1.8E+08 1.8E+08Sox2_bound:10 Enah NM_010135 NA NA PROMOTER
chr1 1.9E+08 1.9E+08Sox2_bound:10 Kctd3 NM_172650 NA NA INSIDE
chr1 1.9E+08 1.9E+08Sox2_bound:11 Prox1 NM_008937 NA NA INSIDE
chr1 1.9E+08 1.9E+08Sox2_bound:11 mmu-mir-205 mmu-mir-205 NA NA PROMOTER
chr2 3337229 3338193Sox2_bound:11 Meig1 NM_008579 NA NA INSIDE
chr2 9821702 9822582Sox2_bound:11 Gata3 NM_008091 NA NA PROMOTER
chr2 1.1E+07 1.1E+07Sox2_bound:11 Prkcq NM_008859 NA NA PROMOTER
chr2 1.4E+07 1.4E+07Sox2_bound:11 Vim NM_011701 NA NA PROMOTER
chr2 1.8E+07 1.8E+07Sox2_bound:11 2810030E01Rik NM_028317 Mllt10 NM_010804 DIVERGENT
chr2 1.8E+07 1.8E+07Sox2_bound:11 Mllt10 NM_010804 NA NA INSIDE
chr2 1.9E+07 1.9E+07Sox2_bound:11 Commd3 NM_147778 NA NA INSIDE
chr2 2.3E+07 2.3E+07Sox2_bound:11 Gad2 NM_008078 NA NA PROMOTER
chr2 2.5E+07 2.5E+07Sox2_bound:12 Nrarp NM_025980 NA NA PROMOTER
chr2 2.6E+07 2.6E+07Sox2_bound:12 Btbd14a NM_001037098 NA NA INSIDE
chr2 2.6E+07 2.6E+07Sox2_bound:12 4932418E24Rik NM_177841 NA NA PROMOTER
chr2 2.7E+07 2.7E+07Sox2_bound:12 Notch1 NM_008714 NA NA INSIDE
chr2 2.7E+07 2.7E+07Sox2_bound:12 Notch1 NM_008714 NA NA PROMOTER
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chr2 2.9E+07 2.9E+07Sox2_bound:12 Ralgds NM_009058 NA NA INSIDE
chr2 2.9E+07 2.9E+07Sox2_bound:12 Als4 NM_198033 NA NA PROMOTER
chr2 3E+07 3E+07 Sox2_bound:12 Coq4 NM_178693 NA NA PROMOTER
chr2 3E+07 3E+07 Sox2_bound:12 Set NM_023871 NA NA PROMOTER
chr2 3E+07 3E+07 Sox2_bound:12 Set NM_023871 NA NA INSIDE
chr2 3E+07 3E+07 Sox2_bound:13 Tbc1d13 NM_146252 NA NA INSIDE
chr2 3E+07 3E+07 Sox2_bound:13 Ier5l NM_030244 NA NA PROMOTER
chr2 3.1E+07 3.1E+07Sox2_bound:13 1700001O22Rik NM_198000 2610205E22RikNM_170592 DIVERGENT
chr2 3.2E+07 3.2E+07Sox2_bound:13 Fubp3 NM_001033389 NA NA PROMOTER
chr2 3.2E+07 3.2E+07Sox2_bound:13 Lcn2 NM_008491 Ptges2 NM_133783 DIVERGENT
chr2 3.3E+07 3.3E+07Sox2_bound:13 C230093N12Rik NM_153560 NA NA INSIDE
chr2 3.4E+07 3.4E+07Sox2_bound:13 Lmx1b NM_010725 NA NA INSIDE
chr2 3.7E+07 3.7E+07Sox2_bound:13 Zbtb6 NM_146253 NA NA PROMOTER
chr2 3.9E+07 3.9E+07Sox2_bound:13 Nr6a1 NM_010264 NA NA INSIDE
chr2 4.5E+07 4.5E+07Sox2_bound:13 Zfhx1b NM_015753 NA NA INSIDE
chr2 4.5E+07 4.5E+07Sox2_bound:14 Zfhx1b NM_015753 NA NA PROMOTER
chr2 5.2E+07 5.2E+07Sox2_bound:14 Rif1 NM_175238 NA NA PROMOTER
chr2 5.2E+07 5.2E+07Sox2_bound:14 Rif1 NM_175238 NA NA PROMOTER
chr2 5.3E+07 5.3E+07Sox2_bound:14 Cacnb4 NM_146123 NA NA INSIDE
chr2 5.4E+07 5.4E+07Sox2_bound:14 Rprm NM_023396 NA NA INSIDE
chr2 6E+07 6E+07 Sox2_bound:14 Ly75 NM_013825 NA NA PROMOTER
chr2 6.2E+07 6.2E+07Sox2_bound:14 Dpp4 NM_010074 NA NA PROMOTER
chr2 6.3E+07 6.3E+07Sox2_bound:14 Kcnh7 NM_133207 NA NA PROMOTER
chr2 6.4E+07 6.4E+07Sox2_bound:14 Fign NM_021716 NA NA PROMOTER
chr2 6.6E+07 6.6E+07Sox2_bound:14 A330102K23Rik NM_153409 NA NA PROMOTER
chr2 6.6E+07 6.6E+07Sox2_bound:15 A330102K23Rik NM_153409 NA NA INSIDE
chr2 6.9E+07 6.9E+07Sox2_bound:15 G6pc2 NM_021331 NA NA INSIDE
chr2 7.1E+07 7.1E+07Sox2_bound:15 4833418A01Rik NM_198005 NA NA INSIDE
chr2 7.1E+07 7.1E+07Sox2_bound:15 Dlx1 NM_010053 NA NA INSIDE
chr2 7.2E+07 7.2E+07Sox2_bound:15 Pdk1 NM_172665 NA NA PROMOTER
chr2 7.3E+07 7.3E+07Sox2_bound:15 Sp3 NM_001018042 NA NA PROMOTER
chr2 7.5E+07 7.5E+07Sox2_bound:15 Evx2 NM_007967 NA NA INSIDE
chr2 7.5E+07 7.5E+07Sox2_bound:15 Hoxd13 NM_008275 NA NA INSIDE
chr2 7.5E+07 7.5E+07Sox2_bound:15 Hoxd12 NM_008274 NA NA PROMOTER
chr2 7.5E+07 7.5E+07Sox2_bound:15 Hoxd11 NM_008273 NA NA PROMOTER
chr2 7.5E+07 7.5E+07Sox2_bound:16 Hoxd10 NM_013554 NA NA PROMOTER
chr2 7.5E+07 7.5E+07Sox2_bound:16 Hoxd10 NM_013554 NA NA PROMOTER
chr2 7.5E+07 7.5E+07Sox2_bound:16 Hoxd10 NM_013554 NA NA PROMOTER
chr2 7.5E+07 7.5E+07Sox2_bound:16 Hoxd10 NM_013554 NA NA INSIDE
chr2 7.5E+07 7.5E+07Sox2_bound:16 Hoxd4 NM_010469 NA NA PROMOTER
chr2 7.6E+07 7.6E+07Sox2_bound:16 Hnrpa3 NM_198090 NA NA PROMOTER
chr2 7.6E+07 7.6E+07Sox2_bound:16 Nfe2l2 NM_010902 NA NA PROMOTER
chr2 7.7E+07 7.7E+07Sox2_bound:16 Fkbp7 NM_010222 NA NA INSIDE
chr2 7.9E+07 7.9E+07Sox2_bound:16 Neurod1 NM_010894 NA NA PROMOTER
chr2 8E+07 8E+07 Sox2_bound:16 Pde1a NM_016744 NA NA INSIDE
chr2 8E+07 8E+07 Sox2_bound:17 Nup35 NM_027091 NA NA INSIDE
chr2 8.5E+07 8.5E+07Sox2_bound:17 2700094K13Rik NM_001033166 NA NA INSIDE
chr2 8.5E+07 8.5E+07Sox2_bound:17 Zdhhc5 NM_144887 NA NA PROMOTER
chr2 8.5E+07 8.5E+07Sox2_bound:17 P2rx3 NM_145526 Ssrp1 NM_182990 DIVERGENT
chr2 9.2E+07 9.2E+07Sox2_bound:17 Chrm4 NM_007699 NA NA PROMOTER
chr2 9.2E+07 9.2E+07Sox2_bound:17 Mdk NM_010784 NA NA PROMOTER
chr2 9.4E+07 9.4E+07Sox2_bound:17 2610203E10Rik NM_183220 NA NA INSIDE
chr2 1E+08 1E+08 Sox2_bound:17 B230118H07Rik NM_026592 NA NA PROMOTER
chr2 1E+08 1E+08 Sox2_bound:17 Nat10 NM_153126 NA NA PROMOTER
chr2 1E+08 1E+08 Sox2_bound:17 Gpiap1 NM_016739 NA NA PROMOTER
chr2 1.1E+08 1.1E+08Sox2_bound:18 Rcn1 NM_009037 NA NA INSIDE
chr2 1.1E+08 1.1E+08Sox2_bound:18 Pax6 NM_013627 NA NA PROMOTER
chr2 1.1E+08 1.1E+08Sox2_bound:18 Pax6 NM_013627 NA NA INSIDE
chr2 1.1E+08 1.1E+08Sox2_bound:18 Kif18a NM_139303 NA NA INSIDE
chr2 1.1E+08 1.1E+08Sox2_bound:18 Bdnf NM_007540 NA NA PROMOTER
chr2 1.1E+08 1.1E+08Sox2_bound:18 Slc12a6 NM_133648 NA NA PROMOTER
chr2 1.1E+08 1.1E+08Sox2_bound:18 Arhgap11a NM_181416 NA NA PROMOTER
chr2 1.2E+08 1.2E+08Sox2_bound:18 BC052040 NM_207264 NA NA PROMOTER
chr2 1.2E+08 1.2E+08Sox2_bound:18 Mrg1 NM_010825 NA NA INSIDE
chr2 1.2E+08 1.2E+08Sox2_bound:18 Spred1 NM_033524 NA NA PROMOTER
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chr2 1.2E+08 1.2E+08Sox2_bound:19 Spred1 NM_033524 NA NA INSIDE
chr2 1.2E+08 1.2E+08Sox2_bound:19 2610510H03Rik NM_026620 NA NA PROMOTER
chr2 1.2E+08 1.2E+08Sox2_bound:19 Bmf NM_138313 NA NA PROMOTER
chr2 1.2E+08 1.2E+08Sox2_bound:19 Bub1b NM_009773 NA NA PROMOTER
chr2 1.2E+08 1.2E+08Sox2_bound:19 Ivd NM_019826 NA NA PROMOTER
chr2 1.2E+08 1.2E+08Sox2_bound:19 BC100358 BC100358 NA NA Unknown
chr2 1.2E+08 1.2E+08Sox2_bound:19 Rpusd2 NM_173450 NA NA DOWNSTREAM
chr2 1.2E+08 1.2E+08Sox2_bound:19 Dll4 NM_019454 NA NA PROMOTER
chr2 1.2E+08 1.2E+08Sox2_bound:19 Itpka NM_146125 NA NA PROMOTER
chr2 1.2E+08 1.2E+08Sox2_bound:19 Pla2g4e NM_177845 NA NA INSIDE
chr2 1.2E+08 1.2E+08Sox2_bound:20 Pla2g4e NM_177845 NA NA INSIDE
chr2 1.2E+08 1.2E+08Sox2_bound:20 Trp53bp1 NM_013735 NA NA PROMOTER
chr2 1.2E+08 1.2E+08Sox2_bound:20 BC019755 NM_145395 NA NA INSIDE
chr2 1.2E+08 1.2E+08Sox2_bound:20 Shf NM_001013829 NA NA PROMOTER
chr2 1.2E+08 1.2E+08Sox2_bound:20 Shf NM_001013829 NA NA PROMOTER
chr2 1.3E+08 1.3E+08Sox2_bound:20 Shc4 NM_199022 NA NA PROMOTER
chr2 1.3E+08 1.3E+08Sox2_bound:20 Slc27a2 NM_011978 NA NA PROMOTER
chr2 1.3E+08 1.3E+08Sox2_bound:20 1810024B03Rik NM_198630 Ascc3l1 NM_177214 DIVERGENT
chr2 1.3E+08 1.3E+08Sox2_bound:20 Zc3h8 NM_020594 NA NA PROMOTER
chr2 1.3E+08 1.3E+08Sox2_bound:20 BC058173 BC058173 NA NA Unknown
chr2 1.3E+08 1.3E+08Sox2_bound:21 Sirpa NM_007547 NA NA PROMOTER
chr2 1.3E+08 1.3E+08Sox2_bound:21 Stk35 NM_001038635 NA NA PROMOTER
chr2 1.3E+08 1.3E+08Sox2_bound:21 Tgm3 NM_009374 NA NA PROMOTER
chr2 1.3E+08 1.3E+08Sox2_bound:21 4930402H24Rik NM_029432 NA NA INSIDE
chr2 1.3E+08 1.3E+08Sox2_bound:21 D430028G21Rik NM_144888 NA NA PROMOTER
chr2 1.3E+08 1.3E+08Sox2_bound:21 Pcna NM_011045 Cds2 NM_138651 DIVERGENT
chr2 1.3E+08 1.3E+08Sox2_bound:21 B430119L13Rik NM_177303 NA NA PROMOTER
chr2 1.4E+08 1.4E+08Sox2_bound:21 Jag1 NM_013822 NA NA PROMOTER
chr2 1.4E+08 1.4E+08Sox2_bound:21 2900006F19Rik NM_028387 NA NA INSIDE
chr2 1.4E+08 1.4E+08Sox2_bound:21 Flrt3 NM_178382 NA NA PROMOTER
chr2 1.4E+08 1.4E+08Sox2_bound:22 LOC433479 NM_001013802 NA NA PROMOTER
chr2 1.4E+08 1.4E+08Sox2_bound:22 Dstn NM_019771 NA NA INSIDE
chr2 1.5E+08 1.5E+08Sox2_bound:22 Insm1 NM_016889 NA NA PROMOTER
chr2 1.5E+08 1.5E+08Sox2_bound:22 Insm1 NM_016889 NA NA PROMOTER
chr2 1.5E+08 1.5E+08Sox2_bound:22 Xrn2 NM_011917 NA NA PROMOTER
chr2 1.5E+08 1.5E+08Sox2_bound:22 Nkx2-2 NM_010919 NA NA PROMOTER
chr2 1.5E+08 1.5E+08Sox2_bound:22 Nkx2-2 NM_010919 NA NA PROMOTER
chr2 1.5E+08 1.5E+08Sox2_bound:22 Pax1 NM_008780 NA NA PROMOTER
chr2 1.5E+08 1.5E+08Sox2_bound:22 Cst3 NM_009976 NA NA INSIDE
chr2 1.5E+08 1.5E+08Sox2_bound:22 2310001A20Rik NM_027977 NA NA PROMOTER
chr2 1.5E+08 1.5E+08Sox2_bound:23 Nanp NM_026086 NA NA INSIDE
chr2 1.5E+08 1.5E+08Sox2_bound:23 Gm123 NM_001009948 NA NA PROMOTER
chr2 1.5E+08 1.5E+08Sox2_bound:23 Id1 NM_010495 NA NA DOWNSTREAM
chr2 1.5E+08 1.5E+08Sox2_bound:23 Hck NM_010407 NA NA PROMOTER
chr2 1.5E+08 1.5E+08Sox2_bound:23 Asxl1 NM_001039939 NA NA INSIDE
chr2 1.6E+08 1.6E+08Sox2_bound:23 Gdf5 NM_008109 NA NA PROMOTER
chr2 1.6E+08 1.6E+08Sox2_bound:23 Tgif2 NM_173396 NA NA INSIDE
chr2 1.6E+08 1.6E+08Sox2_bound:23 Src NM_001025395 NA NA PROMOTER
chr2 1.6E+08 1.6E+08Sox2_bound:23 Gm691 NM_198627 NA NA PROMOTER
chr2 1.6E+08 1.6E+08Sox2_bound:23 Ppp1r16b NM_153089 NA NA INSIDE
chr2 1.6E+08 1.6E+08Sox2_bound:24 Mafb NM_010658 NA NA PROMOTER
chr2 1.6E+08 1.6E+08Sox2_bound:24 Mybl2 NM_008652 NA NA PROMOTER
chr2 1.6E+08 1.6E+08Sox2_bound:24 Sdc4 NM_011521 NA NA PROMOTER
chr2 1.6E+08 1.6E+08Sox2_bound:24 Spint4 NM_030058 NA NA INSIDE
chr2 1.6E+08 1.6E+08Sox2_bound:24 Zswim3 NM_178375 NA NA INSIDE
chr2 1.6E+08 1.6E+08Sox2_bound:24 Ppgb NM_001038492 NA NA INSIDE
chr2 1.6E+08 1.6E+08Sox2_bound:24 Ncoa5 NM_144892 NA NA PROMOTER
chr2 1.7E+08 1.7E+08Sox2_bound:24 Prkcbp1 NM_027230 NA NA INSIDE
chr2 1.7E+08 1.7E+08Sox2_bound:24 Sulf2 NM_028072 NA NA PROMOTER
chr2 1.7E+08 1.7E+08Sox2_bound:24 Sulf2 NM_028072 NA NA PROMOTER
chr2 1.7E+08 1.7E+08Sox2_bound:25 Snai1 NM_011427 NA NA INSIDE
chr2 1.7E+08 1.7E+08Sox2_bound:25 Sall4 NM_201396 NA NA INSIDE
chr2 1.7E+08 1.7E+08Sox2_bound:25 Sall4 NM_175303 NA NA PROMOTER
chr2 1.7E+08 1.7E+08Sox2_bound:25 Sall4 NM_175303 NA NA PROMOTER
chr2 1.7E+08 1.7E+08Sox2_bound:25 Zfp64 NM_009564 NA NA PROMOTER
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chr2 1.7E+08 1.7E+08Sox2_bound:25 Cbln4 NM_175631 NA NA INSIDE
chr2 1.7E+08 1.7E+08Sox2_bound:25 F730031O20Rik NM_001033538 NA NA PROMOTER
chr2 1.7E+08 1.7E+08Sox2_bound:25 Tcfap2c NM_009335 NA NA PROMOTER
chr2 1.7E+08 1.7E+08Sox2_bound:25 Gnas NM_010309 NA NA PROMOTER
chr2 1.8E+08 1.8E+08Sox2_bound:25 Dido1 NM_011805 2310003C23Rik NA PROMOTER
chr2 1.8E+08 1.8E+08Sox2_bound:26 Dido1 NM_177852 NA NM_029607 DIVERGENT
chr2 1.8E+08 1.8E+08Sox2_bound:26 BC019537 NM_183161 NA NA PROMOTER
chr2 1.8E+08 1.8E+08Sox2_bound:26 BC019537 NM_183161 NA NA INSIDE
chr2 1.8E+08 1.8E+08Sox2_bound:26 C030019F02Rik NM_021426 NA NA INSIDE
chr2 1.8E+08 1.8E+08Sox2_bound:26 C030019F02Rik NM_021426 NA NA INSIDE
chr2 1.8E+08 1.8E+08Sox2_bound:26 Chrna4 NM_015730 NA NA PROMOTER
chr2 1.8E+08 1.8E+08Sox2_bound:26 Kcnq2 NM_001006678 NA NA INSIDE
chr2 1.8E+08 1.8E+08Sox2_bound:26 2700038C09Rik NM_025598 NA NA PROMOTER
chr2 1.8E+08 1.8E+08Sox2_bound:26 Myt1 NM_008665 NA NA PROMOTER
chr3 7374346 7375296Sox2_bound:26 Pkia NM_008862 NA NA INSIDE
chr3 8515904 8517611Sox2_bound:27 Stmn2 NM_025285 NA NA INSIDE
chr3 8970645 8971423Sox2_bound:27 Tpd52 NM_001025262 NA NA PROMOTER
chr3 9009906 9010406Sox2_bound:27 Tpd52 NM_001025263 NA NA INSIDE
chr3 9014630 9015320Sox2_bound:27 Tpd52 NM_009412 NA NA PROMOTER
chr3 9616498 9617838Sox2_bound:27 Gig1 NM_133218 NA NA PROMOTER
chr3 1E+07 1E+07 Sox2_bound:27 Fabp5 NM_010634 NA NA INSIDE
chr3 1E+07 1E+07 Sox2_bound:27 Zfand1 NM_025512 NA NA PROMOTER
chr3 1.4E+07 1.4E+07Sox2_bound:27 Slc7a12 NM_080852 NA NA PROMOTER
chr3 1.5E+07 1.5E+07Sox2_bound:27 Car3 NM_007606 NA NA PROMOTER
chr3 1.8E+07 1.8E+07Sox2_bound:27 Bhlhb5 NM_021560 NA NA INSIDE
chr3 2E+07 2E+07 Sox2_bound:28 Smarca3 NM_144959 NA NA INSIDE
chr3 2.2E+07 2.2E+07Sox2_bound:28 Tbl1xr1 NM_030732 NA NA PROMOTER
chr3 2.7E+07 2.7E+07Sox2_bound:28 Ect2 NM_007900 NA NA PROMOTER
chr3 3E+07 3E+07 Sox2_bound:28 Arpm1 NM_029690 Mynn NM_030557 DIVERGENT
chr3 3E+07 3E+07 Sox2_bound:28 4930558O21Rik NM_026668 NA NA INSIDE
chr3 3.1E+07 3.1E+07Sox2_bound:28 Prkci NM_008857 NA NA PROMOTER
chr3 3.1E+07 3.1E+07Sox2_bound:28 Skil NM_001039090 NA NA PROMOTER
chr3 3.2E+07 3.2E+07Sox2_bound:28 Kcnmb2 NM_028231 NA NA INSIDE
chr3 3.3E+07 3.3E+07Sox2_bound:28 Actl6a NM_019673 NA NA INSIDE
chr3 3.3E+07 3.3E+07Sox2_bound:28 Mrpl47 NM_029017 Ndufb5 NM_025316 DIVERGENT
chr3 3.4E+07 3.4E+07Sox2_bound:29 Sox2 NM_011443 NA NA PROMOTER
chr3 3.4E+07 3.4E+07Sox2_bound:29 Sox2 NM_011443 NA NA PROMOTER
chr3 3.4E+07 3.4E+07Sox2_bound:29 Sox2 NM_011443 NA NA PROMOTER
chr3 3.4E+07 3.4E+07Sox2_bound:29 Sox2 NM_011443 NA NA INSIDE
chr3 4.5E+07 4.5E+07Sox2_bound:29 Pcdh10 NM_011043 NA NA PROMOTER
chr3 5.1E+07 5.1E+07Sox2_bound:29 Ccrn4l NM_009834 NA NA PROMOTER
chr3 5.2E+07 5.2E+07Sox2_bound:29 Setd7 NM_080793 NA NA PROMOTER
chr3 7E+07 7E+07 Sox2_bound:29 B3galt3 NM_020026 NA NA INSIDE
chr3 7E+07 7E+07 Sox2_bound:29 1110032A04Rik NM_133675 NA NA PROMOTER
chr3 8.1E+07 8.1E+07Sox2_bound:29 Pdgfc NM_019971 NA NA PROMOTER
chr3 8.2E+07 8.2E+07Sox2_bound:30 Accn5 NM_021370 NA NA PROMOTER
chr3 8.5E+07 8.5E+07Sox2_bound:30 9930117H01Rik NM_177260 NA NA PROMOTER
chr3 8.6E+07 8.6E+07Sox2_bound:30 Pet112l NM_144896 NA NA INSIDE
chr3 8.6E+07 8.6E+07Sox2_bound:30 Gm1019 NM_001001650 NA NA PROMOTER
chr3 8.8E+07 8.8E+07Sox2_bound:30 Prcc NM_033573 NA NA PROMOTER
chr3 8.8E+07 8.8E+07Sox2_bound:30 Cct3 NM_009836 NA NA PROMOTER
chr3 8.9E+07 8.9E+07Sox2_bound:30 Thbs3 NM_013691 NA NA INSIDE
chr3 8.9E+07 8.9E+07Sox2_bound:30 Muc1 NM_013605 NA NA PROMOTER
chr3 9E+07 9E+07 Sox2_bound:30 Creb3l4 NM_030080 Slc39a1 NM_013901 DIVERGENT
chr3 9.1E+07 9.1E+07Sox2_bound:30 Ints3 NM_178876 NA NA PROMOTER
chr3 9.3E+07 9.3E+07Sox2_bound:31 2300002G24Rik NM_028798 NA NA INSIDE
chr3 9.4E+07 9.4E+07Sox2_bound:31 2310007A19Rik NM_025506 Tnrc4 NM_172434 DIVERGENT
chr3 9.5E+07 9.5E+07Sox2_bound:31 Scnm1 NM_027013 NA NA INSIDE
chr3 9.5E+07 9.5E+07Sox2_bound:31 Gabpb2 NM_172512 NA NA PROMOTER
chr3 9.5E+07 9.5E+07Sox2_bound:31 Cdc42se1 NM_001038708 NA NA INSIDE
chr3 9.5E+07 9.5E+07Sox2_bound:31 Arnt NM_001037737 NA NA PROMOTER
chr3 9.6E+07 9.6E+07Sox2_bound:31 Za20d1 NM_001025613 NA NA PROMOTER
chr3 9.6E+07 9.6E+07Sox2_bound:31 Hist2h3c1 NM_178216 NA NA DOWNSTREAM
chr3 9.6E+07 9.6E+07Sox2_bound:31 Hist2h4 NM_033596 Hist2h3c1 NA DOWNSTREAM
chr3 9.6E+07 9.6E+07Sox2_bound:31 Hist2h4 NM_033596 NA NM_019469 DIVERGENT
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chr3 9.6E+07 9.6E+07Sox2_bound:32 Polr3gl NM_027241 NA NA INSIDE
chr3 9.7E+07 9.7E+07Sox2_bound:32 Acp6 NM_019800 NA NA INSIDE
chr3 1E+08 1E+08 Sox2_bound:32 Ptgfrn NM_011197 NA NA PROMOTER
chr3 1E+08 1E+08 Sox2_bound:32 Casq2 NM_009814 NA NA PROMOTER
chr3 1E+08 1E+08 Sox2_bound:32 Csde1 NM_144901 NA NA INSIDE
chr3 1E+08 1E+08 Sox2_bound:32 Dennd2c NM_177857 NA NA PROMOTER
chr3 1E+08 1E+08 Sox2_bound:32 Dennd2c NM_177857 NA NA INSIDE
chr3 1E+08 1E+08 Sox2_bound:32 Trim33 NM_053170 NA NA PROMOTER
chr3 1E+08 1E+08 Sox2_bound:32 Syt6 NM_018800 NA NA PROMOTER
chr3 1E+08 1E+08 Sox2_bound:32 Ppm1j NM_027982 NA NA INSIDE
chr3 1E+08 1E+08 Sox2_bound:33 Cttnbp2nl NM_030249 NA NA INSIDE
chr3 1.1E+08 1.1E+08Sox2_bound:33 Wdr77 NM_027432 NA NA PROMOTER
chr3 1.1E+08 1.1E+08Sox2_bound:33 Tmem77 NM_001025582 NA NA INSIDE
chr3 1.1E+08 1.1E+08Sox2_bound:33 Sypl2 NM_008596 NA NA PROMOTER
chr3 1.1E+08 1.1E+08Sox2_bound:33 Sars NM_011319 NA NA PROMOTER
chr3 1.1E+08 1.1E+08Sox2_bound:33 Wdr47 NM_181400 NA NA PROMOTER
chr3 1.2E+08 1.2E+08Sox2_bound:33 BC072644 BC072644 NA NA Unknown
chr3 1.2E+08 1.2E+08Sox2_bound:33 Cnn3 NM_028044 NA NA INSIDE
chr3 1.2E+08 1.2E+08Sox2_bound:33 Gclm NM_008129 NA NA PROMOTER
chr3 1.3E+08 1.3E+08Sox2_bound:33 Ank2 NM_178655 NA NA PROMOTER
chr3 1.3E+08 1.3E+08Sox2_bound:34 D3Wsu161e NM_138593 mmu-mir-302 mmu-mir-302 DIVERGENT
chr3 1.3E+08 1.3E+08Sox2_bound:34 Neurog2 NM_009718 NA NA PROMOTER
chr3 1.3E+08 1.3E+08Sox2_bound:34 Pitx2 NM_011098 NA NA INSIDE
chr3 1.3E+08 1.3E+08Sox2_bound:34 Pitx2 NM_011098 NA NA INSIDE
chr3 1.3E+08 1.3E+08Sox2_bound:34 Lef1 NM_010703 NA NA PROMOTER
chr3 1.3E+08 1.3E+08Sox2_bound:34 Lef1 NM_010703 NA NA INSIDE
chr3 1.3E+08 1.3E+08Sox2_bound:34 Hadhsc NM_008212 NA NA INSIDE
chr3 1.3E+08 1.3E+08Sox2_bound:34 Scye1 NM_007926 A630047E20RikNM_173032 DIVERGENT
chr3 1.3E+08 1.3E+08Sox2_bound:34 Cxxc4 NM_001004367 NA NA PROMOTER
chr3 1.4E+08 1.4E+08Sox2_bound:34 Ddit4l NM_030143 NA NA PROMOTER
chr3 1.4E+08 1.4E+08Sox2_bound:35 Adh7 NM_009626 NA NA PROMOTER
chr3 1.4E+08 1.4E+08Sox2_bound:35 Tspan5 NM_019571 NA NA INSIDE
chr3 1.4E+08 1.4E+08Sox2_bound:35 Pdlim5 NM_019809 NA NA PROMOTER
chr3 1.4E+08 1.4E+08Sox2_bound:35 Ccbl2 NM_173763 NA NA PROMOTER
chr3 1.4E+08 1.4E+08Sox2_bound:35 Pkn2 NM_178654 NA NA PROMOTER
chr3 1.4E+08 1.4E+08Sox2_bound:35 Lmo4 NM_010723 NA NA INSIDE
chr3 1.4E+08 1.4E+08Sox2_bound:35 Lmo4 NM_010723 NA NA INSIDE
chr3 1.5E+08 1.5E+08Sox2_bound:35 Cyr61 NM_010516 NA NA PROMOTER
chr3 1.5E+08 1.5E+08Sox2_bound:35 Ddah1 NM_026993 NA NA PROMOTER
chr3 1.5E+08 1.5E+08Sox2_bound:35 Ddah1 NM_026993 NA NA INSIDE
chr3 1.5E+08 1.5E+08Sox2_bound:36 Gipc2 NM_016867 NA NA INSIDE
chr3 1.5E+08 1.5E+08Sox2_bound:36 Lhx8 NM_010713 NA NA INSIDE
chr3 1.6E+08 1.6E+08Sox2_bound:36 Sfrs11 NM_026989 Lrrc40 NM_024194 DIVERGENT
chr4 1.1E+07 1.1E+07Sox2_bound:36 Trp53inp1 NM_021897 NA NA PROMOTER
chr4 1.6E+07 1.6E+07Sox2_bound:36 Decr1 NM_026172 NA NA PROMOTER
chr4 1.6E+07 1.6E+07Sox2_bound:36 Nbn NM_013752 NA NA INSIDE
chr4 2.1E+07 2.1E+07Sox2_bound:36 E130310K16Rik NM_172987 NA NA INSIDE
chr4 2.2E+07 2.2E+07Sox2_bound:36 Coq3 NM_172687 NA NA INSIDE
chr4 2.2E+07 2.2E+07Sox2_bound:36 Pou3f2 NM_008899 NA NA PROMOTER
chr4 2.2E+07 2.2E+07Sox2_bound:36 Pou3f2 NM_008899 NA NA PROMOTER
chr4 2.6E+07 2.6E+07Sox2_bound:37 Fut9 NM_010243 NA NA INSIDE
chr4 3.3E+07 3.3E+07Sox2_bound:37 Ankrd6 NM_080471 NA NA PROMOTER
chr4 3.3E+07 3.3E+07Sox2_bound:37 Ankrd6 NM_001012451 NA NA INSIDE
chr4 4E+07 4E+07 Sox2_bound:37 Ddx58 NM_172689 NA NA INSIDE
chr4 4.1E+07 4.1E+07Sox2_bound:37 B4galt1 NM_022305 NA NA PROMOTER
chr4 4.1E+07 4.1E+07Sox2_bound:37 Aqp3 NM_016689 NA NA PROMOTER
chr4 4.1E+07 4.1E+07Sox2_bound:37 Aqp3 NM_016689 NA NA PROMOTER
chr4 4.1E+07 4.1E+07Sox2_bound:37 Nol6 NM_139236 Ube2r2 NM_026275 DIVERGENT
chr4 4.3E+07 4.3E+07Sox2_bound:37 Dnajb5 NM_019874 NA NA PROMOTER
chr4 4.3E+07 4.3E+07Sox2_bound:37 Fancg NM_053081 NA NA PROMOTER
chr4 4.4E+07 4.4E+07Sox2_bound:38 Gba2 NM_172692 NA NA INSIDE
chr4 4.5E+07 4.5E+07Sox2_bound:38 Pax5 NM_008782 NA NA PROMOTER
chr4 4.5E+07 4.5E+07Sox2_bound:38 D4Wsu132e NM_138590 NA NA PROMOTER
chr4 4.6E+07 4.6E+07Sox2_bound:38 Hemgn NM_053149 NA NA DOWNSTREAM
chr4 4.9E+07 4.9E+07Sox2_bound:38 Tmeff1 NM_021436 NA NA INSIDE
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chr4 5.8E+07 5.8E+07Sox2_bound:38 D630039A03Rik NM_178727 NA NA PROMOTER
chr4 5.8E+07 5.8E+07Sox2_bound:38 Musk NM_001037127 NA NA INSIDE
chr4 8E+07 8E+07 Sox2_bound:38 D4Bwg0951e NM_026821 NA NA INSIDE
chr4 8.2E+07 8.2E+07Sox2_bound:38 Nfib NM_008687 NA NA PROMOTER
chr4 8.3E+07 8.3E+07Sox2_bound:38 1810054D07Rik NM_027238 NA NA PROMOTER
chr4 8.3E+07 8.3E+07Sox2_bound:39 Snapc3 NM_029949 NA NA PROMOTER
chr4 8.3E+07 8.3E+07Sox2_bound:39 Snapc3 NM_029949 NA NA PROMOTER
chr4 8.5E+07 8.5E+07Sox2_bound:39 BC062814 BC062814 NA NA Unknown
chr4 8.6E+07 8.6E+07Sox2_bound:39 Rraga NM_178376 NA NA PROMOTER
chr4 8.6E+07 8.6E+07Sox2_bound:39 6230416J20Rik NM_173400 NA NA PROMOTER
chr4 9.1E+07 9.1E+07Sox2_bound:39 Elavl2 NM_207685 NA NA INSIDE
chr4 9.7E+07 9.7E+07Sox2_bound:39 Nfia NM_010905 NA NA PROMOTER
chr4 9.8E+07 9.8E+07Sox2_bound:39 Usp1 NM_146144 NA NA PROMOTER
chr4 9.9E+07 9.9E+07Sox2_bound:39 Itgb3bp NM_026348 BC020077 NM_145549 DIVERGENT
chr4 9.9E+07 9.9E+07Sox2_bound:39 Ror1 NM_013845 NA NA INSIDE
chr4 1E+08 1E+08 Sox2_bound:40 Cachd1 NM_198037 NA NA INSIDE
chr4 1E+08 1E+08 Sox2_bound:40 Dab1 NM_010014 NA NA INSIDE
chr4 1E+08 1E+08 Sox2_bound:40 Ppap2b NM_080555 NA NA INSIDE
chr4 1.1E+08 1.1E+08Sox2_bound:40 Ssbp3 NM_023672 NA NA PROMOTER
chr4 1.1E+08 1.1E+08Sox2_bound:40 Tmem48 NM_028355 NA NA PROMOTER
chr4 1.1E+08 1.1E+08Sox2_bound:40 Btf3l4 NM_027453 Txndc12 NM_025334 DIVERGENT
chr4 1.1E+08 1.1E+08Sox2_bound:40 Tal1 NM_011527 NA NA PROMOTER
chr4 1.2E+08 1.2E+08Sox2_bound:40 Rad54l NM_009015 NA NA PROMOTER
chr4 1.2E+08 1.2E+08Sox2_bound:40 Gpbp1l1 NM_029868 NA NA INSIDE
chr4 1.2E+08 1.2E+08Sox2_bound:40 Nasp NM_016777 NA NA INSIDE
chr4 1.2E+08 1.2E+08Sox2_bound:41 Mmachc NM_025962 0610037D15RikNM_026714 DIVERGENT
chr4 1.2E+08 1.2E+08Sox2_bound:41 Tesk2 NM_146151 NA NA PROMOTER
chr4 1.2E+08 1.2E+08Sox2_bound:41 Tesk2 NM_146151 NA NA INSIDE
chr4 1.2E+08 1.2E+08Sox2_bound:41 Zswim5 NM_001029912 NA NA PROMOTER
chr4 1.2E+08 1.2E+08Sox2_bound:41 Plk3 NM_013807 NA NA INSIDE
chr4 1.2E+08 1.2E+08Sox2_bound:41 Rps8 NM_009098 NA NA DOWNSTREAM
chr4 1.2E+08 1.2E+08Sox2_bound:41 Cdc20 NM_023223 NA NA PROMOTER
chr4 1.2E+08 1.2E+08Sox2_bound:41 Ybx1 NM_011732 NA NA INSIDE
chr4 1.2E+08 1.2E+08Sox2_bound:41 Hivep3 NM_010657 NA NA INSIDE
chr4 1.2E+08 1.2E+08Sox2_bound:41 Edn2 NM_007902 NA NA PROMOTER
chr4 1.2E+08 1.2E+08Sox2_bound:42 Smap1l NM_133716 NA NA PROMOTER
chr4 1.2E+08 1.2E+08Sox2_bound:42 Zmpste24 NM_172700 NA NA INSIDE
chr4 1.2E+08 1.2E+08Sox2_bound:42 Mycl1 NM_008506 NA NA INSIDE
chr4 1.2E+08 1.2E+08Sox2_bound:42 Bmp8a NM_007558 NA NA PROMOTER
chr4 1.3E+08 1.3E+08Sox2_bound:42 Eif2c1 NM_153403 NA NA INSIDE
chr4 1.3E+08 1.3E+08Sox2_bound:42 Gjb3 NM_008126 NA NA PROMOTER
chr4 1.3E+08 1.3E+08Sox2_bound:42 Trim62 NM_178110 NA NA PROMOTER
chr4 1.3E+08 1.3E+08Sox2_bound:42 Bsdc1 NM_133889 NA NA PROMOTER
chr4 1.3E+08 1.3E+08Sox2_bound:42 Tssk3 NM_080442 NA NA PROMOTER
chr4 1.3E+08 1.3E+08Sox2_bound:42 Pef1 NM_026441 NA NA PROMOTER
chr4 1.3E+08 1.3E+08Sox2_bound:43 Fabp3 NM_010174 NA NA PROMOTER
chr4 1.3E+08 1.3E+08Sox2_bound:43 Med18 NM_026039 NA NA INSIDE
chr4 1.3E+08 1.3E+08Sox2_bound:43 Sesn2 NM_144907 NA NA PROMOTER
chr4 1.3E+08 1.3E+08Sox2_bound:43 Rpa2 NM_011284 NA NA PROMOTER
chr4 1.3E+08 1.3E+08Sox2_bound:43 BC082554 BC082554 NA NA Unknown
chr4 1.3E+08 1.3E+08Sox2_bound:43 Lin28 NM_145833 NA NA INSIDE
chr4 1.3E+08 1.3E+08Sox2_bound:43 Slc30a2 NM_001039677 NA NA INSIDE
chr4 1.3E+08 1.3E+08Sox2_bound:43 Pafah2 NM_133880 NA NA PROMOTER
chr4 1.3E+08 1.3E+08Sox2_bound:43 Stmn1 NM_019641 NA NA INSIDE
chr4 1.3E+08 1.3E+08Sox2_bound:43 Stmn1 NM_019641 NA NA INSIDE
chr4 1.3E+08 1.3E+08Sox2_bound:44 Tmem57 NM_025382 NA NA INSIDE
chr4 1.3E+08 1.3E+08Sox2_bound:44 Grhl3 NM_001013756 NA NA PROMOTER
chr4 1.4E+08 1.4E+08Sox2_bound:44 Pnrc2 NM_026383 NA NA PROMOTER
chr4 1.4E+08 1.4E+08Sox2_bound:44 Id3 NM_008321 NA NA INSIDE
chr4 1.4E+08 1.4E+08Sox2_bound:44 Tcea3 NM_011542 NA NA PROMOTER
chr4 1.4E+08 1.4E+08Sox2_bound:44 Tcea3 NM_011542 NA NA PROMOTER
chr4 1.4E+08 1.4E+08Sox2_bound:44 6030445D17Rik NM_177079 NA NA INSIDE
chr4 1.4E+08 1.4E+08Sox2_bound:44 4930549C01Rik NM_026300 NA NA INSIDE
chr4 1.4E+08 1.4E+08Sox2_bound:44 Zbtb40 NM_198248 NA NA PROMOTER
chr4 1.4E+08 1.4E+08Sox2_bound:44 Akp2 NM_007431 NA NA PROMOTER
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chr4 1.4E+08 1.4E+08Sox2_bound:45 Eif4g3 NM_172703 NA NA PROMOTER
chr4 1.4E+08 1.4E+08Sox2_bound:45 C79267 NM_183148 NA NA PROMOTER
chr4 1.4E+08 1.4E+08Sox2_bound:45 Pax7 NM_011039 NA NA PROMOTER
chr4 1.4E+08 1.4E+08Sox2_bound:45 Rcc2 NM_173867 NA NA PROMOTER
chr4 1.4E+08 1.4E+08Sox2_bound:45 Rcc2 NM_173867 NA NA INSIDE
chr4 1.4E+08 1.4E+08Sox2_bound:45 Arhgef19 NM_172520 NA NA PROMOTER
chr4 1.4E+08 1.4E+08Sox2_bound:45 Fblim1 NM_133754 NA NA PROMOTER
chr4 1.4E+08 1.4E+08Sox2_bound:45 Pdpn NM_010329 NA NA PROMOTER
chr4 1.4E+08 1.4E+08Sox2_bound:45 Pdpn NM_010329 NA NA PROMOTER
chr4 1.4E+08 1.4E+08Sox2_bound:45 Pdpn NM_010329 NA NA PROMOTER
chr4 1.5E+08 1.5E+08Sox2_bound:46 Agtrap NM_009642 NA NA INSIDE
chr4 1.5E+08 1.5E+08Sox2_bound:46 Agtrap NM_009642 NA NA PROMOTER
chr4 1.5E+08 1.5E+08Sox2_bound:46 Cort NM_007745 NA NA INSIDE
chr4 1.5E+08 1.5E+08Sox2_bound:46 Hes3 NM_008237 NA NA INSIDE
chr4 1.5E+08 1.5E+08Sox2_bound:46 D330010C22Rik NM_001033489 Rpl22 NM_009079 DIVERGENT
chr5 5564922 5565540Sox2_bound:46 BC034507 NM_153116 NA NA INSIDE
chr5 8092083 8092583Sox2_bound:46 Sri NM_025618 NA NA INSIDE
chr5 8461281 8462640Sox2_bound:46 B230315F11Rik NM_178766 NA NA INSIDE
chr5 1.5E+07 1.5E+07Sox2_bound:46 Cacna2d1 NM_009784 NA NA PROMOTER
chr5 1.5E+07 1.5E+07Sox2_bound:46 Cacna2d1 NM_009784 NA NA INSIDE
chr5 2E+07 2E+07 Sox2_bound:47 Phtf2 NM_172992 Tmem60 NM_177601 DIVERGENT
chr5 2E+07 2E+07 Sox2_bound:47 Ptpn12 NM_011203 NA NA INSIDE
chr5 2.1E+07 2.1E+07Sox2_bound:47 Pmpcb NM_028431 NA NA PROMOTER
chr5 2.7E+07 2.7E+07Sox2_bound:47 En2 NM_010134 NA NA INSIDE
chr5 2.9E+07 2.9E+07Sox2_bound:47 Dnajb6 NM_001037941 NA NA INSIDE
chr5 3E+07 3E+07 Sox2_bound:47 9430057O19Rik NM_174849 NA NA PROMOTER
chr5 3.1E+07 3.1E+07Sox2_bound:47 Fosl2 NM_008037 NA NA PROMOTER
chr5 3.2E+07 3.2E+07Sox2_bound:47 Slc5a1 NM_019810 NA NA PROMOTER
chr5 3.3E+07 3.3E+07Sox2_bound:47 Rnf4 NM_011278 NA NA INSIDE
chr5 3.4E+07 3.4E+07Sox2_bound:47 Lrpap1 NM_013587 NA NA INSIDE
chr5 3.6E+07 3.6E+07Sox2_bound:48 Crmp1 NM_007765 NA NA INSIDE
chr5 3.7E+07 3.7E+07Sox2_bound:48 Msx1 NM_010835 NA NA PROMOTER
chr5 3.7E+07 3.7E+07Sox2_bound:48 Otop1 NM_172709 NA NA PROMOTER
chr5 4.1E+07 4.1E+07Sox2_bound:48 Bapx1 NM_007524 NA NA PROMOTER
chr5 4.3E+07 4.3E+07Sox2_bound:48 Cd38 NM_007646 NA NA INSIDE
chr5 4.3E+07 4.3E+07Sox2_bound:48 Fgfbp1 NM_008009 NA NA PROMOTER
chr5 4.5E+07 4.5E+07Sox2_bound:48 Lap3 NM_024434 NA NA INSIDE
chr5 4.7E+07 4.7E+07Sox2_bound:48 Slit2 NM_178804 NA NA INSIDE
chr5 5.2E+07 5.2E+07Sox2_bound:48 Lgi2 NM_144945 NA NA PROMOTER
chr5 5.3E+07 5.3E+07Sox2_bound:48 Rbpsuh NM_009035 NA NA INSIDE
chr5 5.3E+07 5.3E+07Sox2_bound:49 Cckar NM_009827 NA NA PROMOTER
chr5 5.7E+07 5.7E+07Sox2_bound:49 Pcdh7 NM_018764 NA NA PROMOTER
chr5 6.3E+07 6.3E+07Sox2_bound:49 AA536743 NM_145923 NA NA PROMOTER
chr5 6.3E+07 6.3E+07Sox2_bound:49 AA536743 NM_145923 NA NA PROMOTER
chr5 6.4E+07 6.4E+07Sox2_bound:49 Tlr6 NM_011604 9130005N14RikNM_026667 DIVERGENT
chr5 6.4E+07 6.4E+07Sox2_bound:49 Klhl5 NM_175174 NA NA PROMOTER
chr5 6.5E+07 6.5E+07Sox2_bound:49 B3bp NM_001024917 NA NA PROMOTER
chr5 6.6E+07 6.6E+07Sox2_bound:49 BC013481 NM_178446 NA NA PROMOTER
chr5 6.6E+07 6.6E+07Sox2_bound:49 Uchl1 NM_011670 NA NA INSIDE
chr5 6.6E+07 6.6E+07Sox2_bound:49 Uchl1 NM_011670 NA NA INSIDE
chr5 6.6E+07 6.6E+07Sox2_bound:50 Phox2b NM_008888 NA NA PROMOTER
chr5 7.1E+07 7.1E+07Sox2_bound:50 Gabrb1 NM_008069 NA NA INSIDE
chr5 7.3E+07 7.3E+07Sox2_bound:50 9030227G01Rik NM_177136 NA NA PROMOTER
chr5 7.4E+07 7.4E+07Sox2_bound:50 Gsh2 NM_133256 NA NA PROMOTER
chr5 7.5E+07 7.5E+07Sox2_bound:50 Kit NM_021099 NA NA INSIDE
chr5 7.7E+07 7.7E+07Sox2_bound:50 Rest NM_011263 NA NA PROMOTER
chr5 8.9E+07 8.9E+07Sox2_bound:50 Rufy3 NM_027530 NA NA INSIDE
chr5 8.9E+07 8.9E+07Sox2_bound:50 Grsf1 NM_178700 NA NA PROMOTER
chr5 9.2E+07 9.2E+07Sox2_bound:50 E430034L04Rik NM_011816 NA NA PROMOTER
chr5 9.2E+07 9.2E+07Sox2_bound:50 Nup54 NM_183392 NA NA PROMOTER
chr5 9.2E+07 9.2E+07Sox2_bound:51 Scarb2 NM_007644 NA NA INSIDE
chr5 9.3E+07 9.3E+07Sox2_bound:51 4932413O14Rik NM_177230 Shrm NM_015756 DIVERGENT
chr5 9.3E+07 9.3E+07Sox2_bound:51 4932413O14Rik NM_177230 Shrm NM_015756 DIVERGENT
chr5 9.3E+07 9.3E+07Sox2_bound:51 Sept11 NM_001009818 NA NA INSIDE
chr5 9.3E+07 9.3E+07Sox2_bound:51 Ccni NM_017367 NA NA PROMOTER
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chr5 9.3E+07 9.3E+07Sox2_bound:51 Ccng2 NM_007635 NA NA INSIDE
chr5 9.7E+07 9.7E+07Sox2_bound:51 Fgf5 NM_010203 NA NA INSIDE
chr5 9.9E+07 9.9E+07Sox2_bound:51 2310057D15Rik NM_026421 NA NA INSIDE
chr5 1E+08 1E+08 Sox2_bound:51 Mrps18c NM_026826 NA NA PROMOTER
chr5 1E+08 1E+08 Sox2_bound:51 Arhgap24 NM_029270 NA NA PROMOTER
chr5 1E+08 1E+08 Sox2_bound:52 Dhrs8 NM_053262 NA NA PROMOTER
chr5 1E+08 1E+08 Sox2_bound:52 Spp1 NM_009263 NA NA PROMOTER
chr5 1E+08 1E+08 Sox2_bound:52 Lrrc8c NM_133897 NA NA PROMOTER
chr5 1.1E+08 1.1E+08Sox2_bound:52 Tgfbr3 NM_011578 NA NA INSIDE
chr5 1.1E+08 1.1E+08Sox2_bound:52 Mtf2 NM_013827 NA NA PROMOTER
chr5 1.1E+08 1.1E+08Sox2_bound:52 Dgkq NM_199011 Idua NM_008325 DIVERGENT
chr5 1.1E+08 1.1E+08Sox2_bound:52 D5Ertd585e NM_027922 NA NA PROMOTER
chr5 1.1E+08 1.1E+08Sox2_bound:52 D5Ertd585e NM_027922 NA NA PROMOTER
chr5 1.1E+08 1.1E+08Sox2_bound:52 Ulk1 NM_009469 NA NA INSIDE
chr5 1.1E+08 1.1E+08Sox2_bound:52 E130006D01Rik NM_207252 NA NA INSIDE
chr5 1.2E+08 1.2E+08Sox2_bound:53 Ccdc60 NM_177759 NA NA PROMOTER
chr5 1.2E+08 1.2E+08Sox2_bound:53 1500001A10Rik NM_026886 NA NA PROMOTER
chr5 1.2E+08 1.2E+08Sox2_bound:53 BC023744 NM_001033311 NA NA PROMOTER
chr5 1.2E+08 1.2E+08Sox2_bound:53 Wsb2 NM_021539 NA NA PROMOTER
chr5 1.2E+08 1.2E+08Sox2_bound:53 Tbx3 NM_011535 NA NA INSIDE
chr5 1.2E+08 1.2E+08Sox2_bound:53 Anapc7 NM_019805 NA NA PROMOTER
chr5 1.2E+08 1.2E+08Sox2_bound:53 Anapc5 NM_021505 NA NA PROMOTER
chr5 1.2E+08 1.2E+08Sox2_bound:53 Fbxl10 NM_001003953 NA NA PROMOTER
chr5 1.2E+08 1.2E+08Sox2_bound:53 Rhof NM_175092 NA NA PROMOTER
chr5 1.2E+08 1.2E+08Sox2_bound:53 Mlxip NM_177582 NA NA PROMOTER
chr5 1.2E+08 1.2E+08Sox2_bound:54 Zcchc8 NM_027494 NA NA PROMOTER
chr5 1.2E+08 1.2E+08Sox2_bound:54 1500011J06Rik NM_001005523 NA NA PROMOTER
chr5 1.2E+08 1.2E+08Sox2_bound:54 6330548G22Rik NM_029532 NA NA INSIDE
chr5 1.2E+08 1.2E+08Sox2_bound:54 Ncor2 NM_011424 NA NA INSIDE
chr5 1.3E+08 1.3E+08Sox2_bound:54 Fzd10 NM_175284 NA NA PROMOTER
chr5 1.3E+08 1.3E+08Sox2_bound:54 Gtf2i NM_010365 NA NA INSIDE
chr5 1.3E+08 1.3E+08Sox2_bound:54 Cldn4 NM_009903 NA NA INSIDE
chr5 1.3E+08 1.3E+08Sox2_bound:54 Baz1b NM_011714 NA NA PROMOTER
chr5 1.3E+08 1.3E+08Sox2_bound:54 Rhbdd2 NM_146002 NA NA PROMOTER
chr5 1.3E+08 1.3E+08Sox2_bound:54 Rhbdd2 NM_146002 NA NA PROMOTER
chr5 1.3E+08 1.3E+08Sox2_bound:55 Usmg1 NM_031398 NA NA INSIDE
chr5 1.3E+08 1.3E+08Sox2_bound:55 Ywhag NM_018871 NA NA PROMOTER
chr5 1.4E+08 1.4E+08Sox2_bound:55 Ars2 NM_031405 NA NA INSIDE
chr5 1.4E+08 1.4E+08Sox2_bound:55 Ephb4 NM_010144 NA NA INSIDE
chr5 1.4E+08 1.4E+08Sox2_bound:55 Actl6b NM_031404 NA NA PROMOTER
chr5 1.4E+08 1.4E+08Sox2_bound:55 Bcdin3 NM_144913 Zcwpw1 NM_001005426 DIVERGENT
chr5 1.4E+08 1.4E+08Sox2_bound:55 Zipro1 NM_011757 NA NA INSIDE
chr5 1.4E+08 1.4E+08Sox2_bound:55 Zfp113 NM_019747 Cops6 NM_012002 DIVERGENT
chr5 1.4E+08 1.4E+08Sox2_bound:55 Ap4m1 NM_021392 NA NA INSIDE
chr5 1.4E+08 1.4E+08Sox2_bound:55 Pdgfa NM_008808 NA NA PROMOTER
chr5 1.4E+08 1.4E+08Sox2_bound:56 Uncx4.1 NM_013702 NA NA PROMOTER
chr5 1.4E+08 1.4E+08Sox2_bound:56 Zfp469 NM_178242 NA NA PROMOTER
chr5 1.4E+08 1.4E+08Sox2_bound:56 Nptx2 NM_016789 NA NA PROMOTER
chr5 1.4E+08 1.4E+08Sox2_bound:56 Atp5j2 NM_020582 NA NA PROMOTER
chr5 1.5E+08 1.5E+08Sox2_bound:56 Wasf3 NM_145155 NA NA INSIDE
chr5 1.5E+08 1.5E+08Sox2_bound:56 Gsh1 NM_008178 NA NA PROMOTER
chr5 1.5E+08 1.5E+08Sox2_bound:56 Cdx2 NM_007673 NA NA INSIDE
chr5 1.5E+08 1.5E+08Sox2_bound:56 Cdx2 NM_007673 NA NA INSIDE
chr5 1.5E+08 1.5E+08Sox2_bound:56 1200006F02Rik NM_027872 NA NA INSIDE
chr5 1.5E+08 1.5E+08Sox2_bound:56 Ubl3 NM_011908 NA NA INSIDE
chr6 3450583 3451240Sox2_bound:57 1700034M03Rik NM_024260 NA NA INSIDE
chr6 4039057 4040037Sox2_bound:57 Bet1 NM_009748 NA NA PROMOTER
chr6 5333718 5334218Sox2_bound:57 Asb4 NM_023048 NA NA PROMOTER
chr6 6833226 6834122Sox2_bound:57 Dlx5 NM_010056 NA NA INSIDE
chr6 7646962 7647708Sox2_bound:57 Asns NM_012055 NA NA PROMOTER
chr6 1.4E+07 1.4E+07Sox2_bound:57 B630005N14Rik NM_175312 NA NA PROMOTER
chr6 1.4E+07 1.4E+07Sox2_bound:57 2610001J05Rik NM_183258 NA NA INSIDE
chr6 2.6E+07 2.6E+07Sox2_bound:57 Gpr37 NM_010338 NA NA INSIDE
chr6 2.9E+07 2.9E+07Sox2_bound:57 mmu-mir-129-1 mmu-mir-129-1 NA NA PROMOTER
chr6 2.9E+07 2.9E+07Sox2_bound:57 mmu-mir-129-1 mmu-mir-129-1 NA NA PROMOTER
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chr6 2.9E+07 2.9E+07Sox2_bound:58 mmu-mir-129-1 mmu-mir-129-1 NA NA PROMOTER
chr6 3E+07 3E+07 Sox2_bound:58 2700094F01Rik NM_178625 1700025E21RikNM_029373 DIVERGENT
chr6 3.8E+07 3.8E+07Sox2_bound:58 Trim24 NM_145076 NA NA INSIDE
chr6 3.8E+07 3.8E+07Sox2_bound:58 Zc3hav1 NM_028864 NA NA PROMOTER
chr6 3.8E+07 3.8E+07Sox2_bound:58 Zc3hav1 NM_028864 NA NA PROMOTER
chr6 3.8E+07 3.8E+07Sox2_bound:58 Ttc26 NM_153600 NA NA PROMOTER
chr6 3.8E+07 3.8E+07Sox2_bound:58 1110001J03Rik NM_025363 NA NA PROMOTER
chr6 3.9E+07 3.9E+07Sox2_bound:58 Mkrn1 NM_018810 NA NA PROMOTER
chr6 4.7E+07 4.7E+07Sox2_bound:58 Cntnap2 NM_025771 NA NA PROMOTER
chr6 4.9E+07 4.9E+07Sox2_bound:58 Gimap9 NM_174960 NA NA INSIDE
chr6 4.9E+07 4.9E+07Sox2_bound:59 Igf2bp3 NM_023670 NA NA PROMOTER
chr6 4.9E+07 4.9E+07Sox2_bound:59 Igf2bp3 NM_023670 NA NA PROMOTER
chr6 5E+07 5E+07 Sox2_bound:59 Npy NM_023456 NA NA PROMOTER
chr6 5.1E+07 5.1E+07Sox2_bound:59 Hnrpa2b1 NM_016806 NA NA INSIDE
chr6 5.2E+07 5.2E+07Sox2_bound:59 Scap2 NM_018773 NA NA PROMOTER
chr6 5.2E+07 5.2E+07Sox2_bound:59 Hoxa2 NM_010451 5730596B20Rik NA INSIDE
chr6 5.2E+07 5.2E+07Sox2_bound:59 Hoxa2 NM_010451 NA NM_175261 DIVERGENT
chr6 5.2E+07 5.2E+07Sox2_bound:59 5730596B20Rik NM_175261 NA NA PROMOTER
chr6 5.2E+07 5.2E+07Sox2_bound:59 Hoxa9 NM_010456 NA NA PROMOTER
chr6 5.2E+07 5.2E+07Sox2_bound:59 Hoxa10 NM_008263 NA NA INSIDE
chr6 5.2E+07 5.2E+07Sox2_bound:60 Hoxa10 NM_008263 NA NA PROMOTER
chr6 5.2E+07 5.2E+07Sox2_bound:60 Hoxa11 NM_010450 NA NA PROMOTER
chr6 5.2E+07 5.2E+07Sox2_bound:60 Hoxa11 NM_010450 NA NA PROMOTER
chr6 5.2E+07 5.2E+07Sox2_bound:60 Hoxa11 NM_010450 NA NA PROMOTER
chr6 5.2E+07 5.2E+07Sox2_bound:60 Hoxa11 NM_010450 NA NA PROMOTER
chr6 5.2E+07 5.2E+07Sox2_bound:60 Evx1 NM_007966 NA NA PROMOTER
chr6 5.2E+07 5.2E+07Sox2_bound:60 Evx1 NM_007966 NA NA INSIDE
chr6 7.1E+07 7.1E+07Sox2_bound:60 Fabp1 NM_017399 NA NA PROMOTER
chr6 7.1E+07 7.1E+07Sox2_bound:60 Smyd1 NM_009762 AA792894 NM_145568 DIVERGENT
chr6 7.2E+07 7.2E+07Sox2_bound:60 Jmjd1a NM_173001 NA NA PROMOTER
chr6 7.3E+07 7.3E+07Sox2_bound:61 Tcf3 NM_009332 NA NA INSIDE
chr6 7.3E+07 7.3E+07Sox2_bound:61 BC043330 BC043330 NA NA Unknown
chr6 7.3E+07 7.3E+07Sox2_bound:61 BC043330 BC043330 NA NA Unknown
chr6 7.8E+07 7.8E+07Sox2_bound:61 Reg3g NM_011260 NA NA INSIDE
chr6 8.3E+07 8.3E+07Sox2_bound:61 Hk2 NM_013820 NA NA INSIDE
chr6 8.6E+07 8.6E+07Sox2_bound:61 Figla NM_012013 NA NA DOWNSTREAM
chr6 8.8E+07 8.8E+07Sox2_bound:61 8430410A17Rik NM_173737 NA NA PROMOTER
chr6 9.2E+07 9.2E+07Sox2_bound:61 C130022K22Rik NM_172730 NA NA PROMOTER
chr6 9.2E+07 9.2E+07Sox2_bound:61 Trh NM_009426 NA NA PROMOTER
chr6 9.2E+07 9.2E+07Sox2_bound:61 Trh NM_009426 NA NA PROMOTER
chr6 9.3E+07 9.3E+07Sox2_bound:62 8430417A20Rik NM_175209 NA NA PROMOTER
chr6 9.7E+07 9.7E+07Sox2_bound:62 Ube1c NM_011666 Arl6ip5 NM_022992 DIVERGENT
chr6 9.7E+07 9.7E+07Sox2_bound:62 Ube1c NM_011666 Arl6ip5 NM_022992 DIVERGENT
chr6 9.9E+07 9.9E+07Sox2_bound:62NSMUST000000892MUST00000089 NA NA Unknown
chr6 1E+08 1E+08 Sox2_bound:62 Rybp NM_019743 NA NA INSIDE
chr6 1.1E+08 1.1E+08Sox2_bound:62 Setd5 NM_028385 NA NA PROMOTER
chr6 1.1E+08 1.1E+08Sox2_bound:62 Slc6a1 NM_178703 NA NA INSIDE
chr6 1.2E+08 1.2E+08Sox2_bound:62 Timp4 NM_080639 NA NA PROMOTER
chr6 1.2E+08 1.2E+08Sox2_bound:62 Rpl3 NM_172086 Syngr1 NA PROMOTER
chr6 1.2E+08 1.2E+08Sox2_bound:62 BC060267 NM_198603 NA NA INSIDE
chr6 1.2E+08 1.2E+08Sox2_bound:63 Adipor2 NM_197985 NA NA PROMOTER
chr6 1.2E+08 1.2E+08Sox2_bound:63 Adipor2 NM_197985 NA NA PROMOTER
chr6 1.2E+08 1.2E+08Sox2_bound:63 Wnk1 NM_198703 NA NA PROMOTER
chr6 1.2E+08 1.2E+08Sox2_bound:63 M6pr NM_010749 NA NA PROMOTER
chr6 1.2E+08 1.2E+08Sox2_bound:63 Phc1 NM_007905 NA NA PROMOTER
chr6 1.2E+08 1.2E+08Sox2_bound:63 Gdf3 NM_008108 NA NA INSIDE
chr6 1.2E+08 1.2E+08Sox2_bound:63 Gdf3 NM_008108 NA NA INSIDE
chr6 1.2E+08 1.2E+08Sox2_bound:63 Dppa3 NM_139218 NA NA PROMOTER
chr6 1.2E+08 1.2E+08Sox2_bound:63 Slc2a3 NM_011401 NA NA PROMOTER
chr6 1.2E+08 1.2E+08Sox2_bound:63 mmu-mir-141 mmu-mir-141 NA NA INSIDE
chr6 1.2E+08 1.2E+08Sox2_bound:64 Grcc10 NM_013535 NA NA INSIDE
chr6 1.2E+08 1.2E+08Sox2_bound:64 Usp5 NM_013700 NA NA INSIDE
chr6 1.3E+08 1.3E+08Sox2_bound:64 Ing4 NM_133345 NA NA INSIDE
chr6 1.3E+08 1.3E+08Sox2_bound:64 LOC14433 NM_008084 NA NA INSIDE
chr6 1.3E+08 1.3E+08Sox2_bound:64 Ntf3 NM_008742 NA NA INSIDE
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chr6 1.3E+08 1.3E+08Sox2_bound:64 Ndufa9 NM_025358 Akap3 NM_009650 DIVERGENT
chr6 1.3E+08 1.3E+08Sox2_bound:64 Rad51ap1 NM_009013 D6Wsu163e NM_138594 DIVERGENT
chr6 1.3E+08 1.3E+08Sox2_bound:64 Prmt8 NM_201371 NA NA PROMOTER
chr6 1.3E+08 1.3E+08Sox2_bound:64 Tspan9 NM_175414 NA NA INSIDE
chr6 1.3E+08 1.3E+08Sox2_bound:64 Etv6 NM_007961 NA NA PROMOTER
chr6 1.3E+08 1.3E+08Sox2_bound:65 Gpr19 NM_008157 NA NA PROMOTER
chr6 1.3E+08 1.3E+08Sox2_bound:65 Gpr19 NM_008157 NA NA PROMOTER
chr6 1.3E+08 1.3E+08Sox2_bound:65 Cdkn1b NM_009875 NA NA PROMOTER
chr6 1.4E+08 1.4E+08Sox2_bound:65 Gprc5a NM_181444 NA NA PROMOTER
chr6 1.4E+08 1.4E+08Sox2_bound:65 8430419L09Rik NM_028982 NA NA PROMOTER
chr6 1.4E+08 1.4E+08Sox2_bound:65 Atf7ip NM_019426 NA NA PROMOTER
chr6 1.4E+08 1.4E+08Sox2_bound:65 Pde6h NM_023898 NA NA INSIDE
chr6 1.4E+08 1.4E+08Sox2_bound:65 Rerg NM_181988 NA NA INSIDE
chr6 1.4E+08 1.4E+08Sox2_bound:65 BC027061 NM_183165 NA NA INSIDE
chr6 1.4E+08 1.4E+08Sox2_bound:65 Ldhb NM_008492 NA NA INSIDE
chr6 1.4E+08 1.4E+08Sox2_bound:66 Ldhb NM_008492 NA NA PROMOTER
chr6 1.4E+08 1.4E+08Sox2_bound:66 Ldhb NM_008492 NA NA PROMOTER
chr6 1.4E+08 1.4E+08Sox2_bound:66 Kcnj8 NM_008428 NA NA PROMOTER
chr6 1.4E+08 1.4E+08Sox2_bound:66 Cmas NM_009908 NA NA PROMOTER
chr6 1.4E+08 1.4E+08Sox2_bound:66 St8sia1 NM_011374 NA NA INSIDE
chr6 1.4E+08 1.4E+08Sox2_bound:66 St8sia1 NM_011374 NA NA PROMOTER
chr6 1.5E+08 1.5E+08Sox2_bound:66 Bcat1 NM_001024468 NA NA PROMOTER
chr6 1.5E+08 1.5E+08Sox2_bound:66 Lrmp NM_008511 NA NA PROMOTER
chr6 1.5E+08 1.5E+08Sox2_bound:66 4930469P12Rik NM_133688 NA NA INSIDE
chr6 1.5E+08 1.5E+08Sox2_bound:66 Tera NM_019643 NA NA PROMOTER
chr6 1.5E+08 1.5E+08Sox2_bound:67 2810474O19Rik NM_026054 NA NA INSIDE
chr7 3290067 3290567Sox2_bound:67 Leng1 NM_027203 NA NA PROMOTER
chr7 3326734 3327792Sox2_bound:67 Rps9 NM_029767 NA NA INSIDE
chr7 3712277 3712921Sox2_bound:67 Cdc42ep5 NM_021454 NA NA INSIDE
chr7 4108696 4110108Sox2_bound:67 6030429G01Rik NM_001033548 NA NA PROMOTER
chr7 4326084 4326774Sox2_bound:67 Cox6b2 NM_183406 NA NA INSIDE
chr7 4590686 4591186Sox2_bound:67 Fiz1 NM_011813 Zfp524 NM_025324 DIVERGENT
chr7 6287731 6288231Sox2_bound:67 Peg3 NM_001010988 NA NA INSIDE
chr7 6290903 6291681Sox2_bound:67 Usp29 NM_021323 NA NA INSIDE
chr7 9149609 9150109Sox2_bound:67 Zik1 NM_009577 NA NA PROMOTER
chr7 1.2E+07 1.2E+07Sox2_bound:68 Zfp499 NM_001024699 Trim28 NA INSIDE
chr7 1.2E+07 1.2E+07Sox2_bound:68 Zfp499 NM_001024699 Trim28 NM_011588 DIVERGENT
chr7 1.2E+07 1.2E+07Sox2_bound:68 Trim28 NM_011588 NA NA PROMOTER
chr7 1.2E+07 1.2E+07Sox2_bound:68 Zfp98 NM_145819 NA NA PROMOTER
chr7 1.5E+07 1.5E+07Sox2_bound:68 Slc1a5 NM_009201 NA NA PROMOTER
chr7 1.7E+07 1.7E+07Sox2_bound:68 Bloc1s3 NM_177692 Trappc6a NM_025960 DIVERGENT
chr7 1.7E+07 1.7E+07Sox2_bound:68 Gemin7 NM_027189 Zfp296 NM_022409 DIVERGENT
chr7 1.7E+07 1.7E+07Sox2_bound:68 Clptm1 NM_019649 NA NA PROMOTER
chr7 1.7E+07 1.7E+07Sox2_bound:68 Apoe NM_009696 NA NA PROMOTER
chr7 2.1E+07 2.1E+07Sox2_bound:68 Zfp93 NM_009567 NA NA PROMOTER
chr7 2.1E+07 2.1E+07Sox2_bound:69 2410005H09Rik NM_146183 NA NA PROMOTER
chr7 2.1E+07 2.1E+07Sox2_bound:69 2410005H09Rik NM_146183 NA NA PROMOTER
chr7 2.2E+07 2.2E+07Sox2_bound:69 Rps19 NM_023133 NA NA PROMOTER
chr7 2.2E+07 2.2E+07Sox2_bound:69 Rps19 NM_023133 NA NA PROMOTER
chr7 2.2E+07 2.2E+07Sox2_bound:69 Gsk3a NM_001031667 NA NA PROMOTER
chr7 2.3E+07 2.3E+07Sox2_bound:69 Hnrpul1 NM_144922 NA NA PROMOTER
chr7 2.4E+07 2.4E+07Sox2_bound:69 Mia1 NM_019394 NA NA INSIDE
chr7 2.5E+07 2.5E+07Sox2_bound:69 BC089491 NM_175033 NA NA INSIDE
chr7 2.5E+07 2.5E+07Sox2_bound:69 Samd4b NM_175021 Gmfg NM_022024 DIVERGENT
chr7 2.6E+07 2.6E+07Sox2_bound:69 Fbxo27 NM_207238 NA NA PROMOTER
chr7 2.6E+07 2.6E+07Sox2_bound:70 Hnrpl NM_177301 NA NA PROMOTER
chr7 2.6E+07 2.6E+07Sox2_bound:70 Neud4 NM_013874 NA NA INSIDE
chr7 2.7E+07 2.7E+07Sox2_bound:70 Zfp27 NM_001037707 NA NA INSIDE
chr7 2.7E+07 2.7E+07Sox2_bound:70 Zfp27 NM_011754 NA NA PROMOTER
chr7 2.7E+07 2.7E+07Sox2_bound:70 Zfp27 NM_011754 NA NA PROMOTER
chr7 2.7E+07 2.7E+07Sox2_bound:70 Zfp146 NM_011980 NA NM_001033540 DIVERGENT
chr7 2.7E+07 2.7E+07Sox2_bound:70 Capns1 NM_009795 NA NA PROMOTER
chr7 2.7E+07 2.7E+07Sox2_bound:70 Prodh2 NM_019546 NA NA PROMOTER
chr7 2.7E+07 2.7E+07Sox2_bound:70 Prodh2 NM_019546 NA NA PROMOTER
chr7 2.8E+07 2.8E+07Sox2_bound:70 Lsr NM_017405 NA NA INSIDE
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chr7 3.2E+07 3.2E+07Sox2_bound:71 Rhpn2 NM_027897 NA NA PROMOTER
chr7 3.2E+07 3.2E+07Sox2_bound:71 Rhpn2 NM_027897 NA NA INSIDE
chr7 3.5E+07 3.5E+07Sox2_bound:71 C80913 NM_011274 NA NA PROMOTER
chr7 4E+07 4E+07 Sox2_bound:71 BC043301 NM_001008549 NA NA PROMOTER
chr7 4E+07 4E+07 Sox2_bound:71 4933405K07Rik NM_028913 NA NA PROMOTER
chr7 4E+07 4E+07 Sox2_bound:71 4933405K07Rik NM_028913 NA NA INSIDE
chr7 4.1E+07 4.1E+07Sox2_bound:71 Napsa NM_008437 NA NA PROMOTER
chr7 4.1E+07 4.1E+07Sox2_bound:71 Med25 NM_029365 NA NA PROMOTER
chr7 4.1E+07 4.1E+07Sox2_bound:71 Prrg2 NM_022999 Nosip NM_025533 DIVERGENT
chr7 4.1E+07 4.1E+07Sox2_bound:71 Rps11 NM_013725 NA NA PROMOTER
chr7 4.1E+07 4.1E+07Sox2_bound:72 Nop17 NM_029406 NA NA PROMOTER
chr7 4.1E+07 4.1E+07Sox2_bound:72 Cd37 NM_007645 NA NA PROMOTER
chr7 4.2E+07 4.2E+07Sox2_bound:72 Snrp70 NM_009224 NA NA PROMOTER
chr7 4.2E+07 4.2E+07Sox2_bound:72 Ftl1 NM_010240 NA NA PROMOTER
chr7 4.2E+07 4.2E+07Sox2_bound:72 Dhrs10 NM_025330 NA NA PROMOTER
chr7 4.2E+07 4.2E+07Sox2_bound:72 Bcat2 NM_009737 NA NA PROMOTER
chr7 4.2E+07 4.2E+07Sox2_bound:72 Car11 NM_009800 NA NA INSIDE
chr7 4.2E+07 4.2E+07Sox2_bound:72 Pscd2 NM_011181 NA NA PROMOTER
chr7 4.2E+07 4.2E+07Sox2_bound:72 Tmem143 NM_144801 NA NA INSIDE
chr7 4.2E+07 4.2E+07Sox2_bound:72 Emp3 NM_010129 BC013491 NM_001033243 DIVERGENT
chr7 4.6E+07 4.6E+07Sox2_bound:73 Dbx1 NM_001005232 NA NA INSIDE
chr7 5.6E+07 5.6E+07Sox2_bound:73 Snurf NM_033174 NA NA INSIDE
chr7 5.6E+07 5.6E+07Sox2_bound:73 Snurf NM_033174 NA NA PROMOTER
chr7 5.6E+07 5.6E+07Sox2_bound:73 Snurf NM_033174 NA NA PROMOTER
chr7 6.9E+07 6.9E+07Sox2_bound:73 Rgma NM_177740 NA NA INSIDE
chr7 7.5E+07 7.5E+07Sox2_bound:73 Rlbp1 NM_020599 BC025462 NM_145946 DIVERGENT
chr7 7.6E+07 7.6E+07Sox2_bound:73 5730590G19Rik NM_029835 NA NA INSIDE
chr7 7.7E+07 7.7E+07Sox2_bound:73 Zscan2 NM_009553 NA NA PROMOTER
chr7 7.7E+07 7.7E+07Sox2_bound:73 Pde8a NM_008803 NA NA PROMOTER
chr7 7.7E+07 7.7E+07Sox2_bound:73 Pde8a NM_008803 NA NA PROMOTER
chr7 7.7E+07 7.7E+07Sox2_bound:74 Rps17 NM_009092 NA NA DOWNSTREAM
chr7 8E+07 8E+07 Sox2_bound:74 Mesdc1 NM_030705 Mesdc2 NM_023403 DIVERGENT
chr7 8E+07 8E+07 Sox2_bound:74 Mesdc2 NM_023403 NA NA INSIDE
chr7 8.3E+07 8.3E+07Sox2_bound:74 Tyr NM_011661 NA NA PROMOTER
chr7 8.4E+07 8.4E+07Sox2_bound:74 Rab38 NM_028238 NA NA PROMOTER
chr7 8.5E+07 8.5E+07Sox2_bound:74 Tmem135 NM_028343 NA NA PROMOTER
chr7 8.5E+07 8.5E+07Sox2_bound:74 Fzd4 NM_008055 NA NA INSIDE
chr7 8.9E+07 8.9E+07Sox2_bound:74 2310015N07Rik NM_025515 NA NA PROMOTER
chr7 8.9E+07 8.9E+07Sox2_bound:74 Rab30 NM_029494 NA NA PROMOTER
chr7 8.9E+07 8.9E+07Sox2_bound:74 Rab30 NM_029494 NA NA INSIDE
chr7 8.9E+07 8.9E+07Sox2_bound:75 Prcp NM_028243 NA NA PROMOTER
chr7 8.9E+07 8.9E+07Sox2_bound:75 Prcp NM_028243 NA NA INSIDE
chr7 9.2E+07 9.2E+07Sox2_bound:75 Timd4 NM_178759 NA NA PROMOTER
chr7 9.3E+07 9.3E+07Sox2_bound:75 Alg8 NM_199035 NA NA INSIDE
chr7 9.4E+07 9.4E+07Sox2_bound:75 1810020D17Rik NM_183251 NA NA PROMOTER
chr7 9.4E+07 9.4E+07Sox2_bound:75 Aqp11 NM_175105 NA NA PROMOTER
chr7 9.5E+07 9.5E+07Sox2_bound:75NSMUST000000868MUST00000086 NA NA Unknown
chr7 9.5E+07 9.5E+07Sox2_bound:75 Wnt11 NM_009519 NA NA PROMOTER
chr7 9.5E+07 9.5E+07Sox2_bound:75 Serpinh1 NM_009825 NA NA INSIDE
chr7 9.6E+07 9.6E+07Sox2_bound:75 Pgm2l1 NM_027629 NA NA INSIDE
chr7 9.6E+07 9.6E+07Sox2_bound:76 Ppme1 NM_028292 NA NA INSIDE
chr7 1E+08 1E+08 Sox2_bound:76 Prkcdbp NM_028444 NA NA INSIDE
chr7 1E+08 1E+08 Sox2_bound:76 Prkcdbp NM_028444 NA NA INSIDE
chr7 1.1E+08 1.1E+08Sox2_bound:76 Zfp143 NM_009281 NA NA PROMOTER
chr7 1.1E+08 1.1E+08Sox2_bound:76 Calca NM_001033954 NA NA PROMOTER
chr7 1.1E+08 1.1E+08Sox2_bound:76 Plekha7 NM_172743 NA NA INSIDE
chr7 1.1E+08 1.1E+08Sox2_bound:76 Rps15a NM_170669 NA NA PROMOTER
chr7 1.1E+08 1.1E+08Sox2_bound:76 Coq7 NM_009940 NA NA INSIDE
chr7 1.1E+08 1.1E+08Sox2_bound:76 9030624J02Rik NM_027815 NA NA PROMOTER
chr7 1.1E+08 1.1E+08Sox2_bound:76 Gprc5b NM_022420 NA NA INSIDE
chr7 1.2E+08 1.2E+08Sox2_bound:77 4930404J24Rik NM_029610 NA NA INSIDE
chr7 1.2E+08 1.2E+08Sox2_bound:77 4930404J24Rik NM_029610 NA NA INSIDE
chr7 1.2E+08 1.2E+08Sox2_bound:77 Eef2k NM_007908 NA NA INSIDE
chr7 1.2E+08 1.2E+08Sox2_bound:77 Polr3e NM_025298 NA NA PROMOTER
chr7 1.2E+08 1.2E+08Sox2_bound:77 Polr3e NM_025298 NA NA PROMOTER
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chr7 1.2E+08 1.2E+08Sox2_bound:77 Cdr2 NM_007672 NA NA PROMOTER
chr7 1.2E+08 1.2E+08Sox2_bound:77 Prkcb1 NM_008855 NA NA DOWNSTREAM
chr7 1.2E+08 1.2E+08Sox2_bound:77 Slc5a11 NM_146198 NA NA PROMOTER
chr7 1.2E+08 1.2E+08Sox2_bound:77 Slc5a11 NM_146198 NA NA INSIDE
chr7 1.2E+08 1.2E+08Sox2_bound:77 2210013K02Rik NM_023712 NA NA PROMOTER
chr7 1.2E+08 1.2E+08Sox2_bound:78 Sh2bpsm1 NM_011363 NA NA PROMOTER
chr7 1.2E+08 1.2E+08Sox2_bound:78 Ppp4c NM_019674 NA NA PROMOTER
chr7 1.2E+08 1.2E+08Sox2_bound:78 Qprt NM_133686 NA NA INSIDE
chr7 1.2E+08 1.2E+08Sox2_bound:78 Cd2bp2 NM_027353 NA NA PROMOTER
chr7 1.2E+08 1.2E+08Sox2_bound:78 Sept1 NM_017461 NA NA INSIDE
chr7 1.2E+08 1.2E+08Sox2_bound:78 Zfp553 NM_146201 NA NA PROMOTER
chr7 1.2E+08 1.2E+08Sox2_bound:78 Zfp689 NM_175163 NA NA PROMOTER
chr7 1.2E+08 1.2E+08Sox2_bound:78 Fbxl19 NM_172748 NA NA PROMOTER
chr7 1.2E+08 1.2E+08Sox2_bound:78 Zfp668 NM_146259 6820429M01 NM_172749 DIVERGENT
chr7 1.2E+08 1.2E+08Sox2_bound:78 Prss8 NM_133351 NA NA PROMOTER
chr7 1.3E+08 1.3E+08Sox2_bound:79 Brwd2 NM_172255 NA NA PROMOTER
chr7 1.3E+08 1.3E+08Sox2_bound:79 Fgfr2 NM_010207 NA NA INSIDE
chr7 1.3E+08 1.3E+08Sox2_bound:79 Plekha1 NM_133942 NA NA PROMOTER
chr7 1.3E+08 1.3E+08Sox2_bound:79 Ebf3 NM_010096 NA NA PROMOTER
chr7 1.4E+08 1.4E+08Sox2_bound:79 Ppp2r2d NM_026391 NA NA INSIDE
chr7 1.4E+08 1.4E+08Sox2_bound:79 Dpysl4 NM_011993 NA NA PROMOTER
chr7 1.4E+08 1.4E+08Sox2_bound:79 Utf1 NM_009482 NA NA DOWNSTREAM
chr7 1.4E+08 1.4E+08Sox2_bound:79 Msx3 NM_010836 NA NA INSIDE
chr7 1.4E+08 1.4E+08Sox2_bound:79 Drd1ip NM_026769 Prap1 NM_009475 DIVERGENT
chr7 1.4E+08 1.4E+08Sox2_bound:79 Ifitm2 NM_030694 Ifitm1 NM_026820 DIVERGENT
chr7 1.4E+08 1.4E+08Sox2_bound:80 Ifitm2 NM_030694 Ifitm1 NM_026820 DIVERGENT
chr7 1.4E+08 1.4E+08Sox2_bound:80 Ifitm2 NM_030694 Ifitm1 NM_026820 DIVERGENT
chr7 1.4E+08 1.4E+08Sox2_bound:80 Ifitm1 NM_026820 NA NA DOWNSTREAM
chr7 1.4E+08 1.4E+08Sox2_bound:80 Ifitm3 NM_025378 NA NA DOWNSTREAM
chr7 1.4E+08 1.4E+08Sox2_bound:80 Drd4 NM_007878 NA NA INSIDE
chr7 1.4E+08 1.4E+08Sox2_bound:80 Igf2 NM_010514 NA NA PROMOTER
chr7 1.4E+08 1.4E+08Sox2_bound:80 Mrgprg NM_203492 NA NA PROMOTER
chr7 1.4E+08 1.4E+08Sox2_bound:80 Fgf4 NM_010202 NA NA PROMOTER
chr8 3308637 3309559Sox2_bound:80 Arhgef18 NM_133962 NA NA INSIDE
chr8 1.1E+07 1.1E+07Sox2_bound:80 Col4a1 NM_009931 NA NA INSIDE
chr8 1.2E+07 1.2E+07Sox2_bound:81 Ankrd10 NM_133971 NA NA PROMOTER
chr8 1.3E+07 1.3E+07Sox2_bound:81 Tmco3 NM_172282 NA NA INSIDE
chr8 2.1E+07 2.1E+07Sox2_bound:81 Defb1 NM_007843 NA NA PROMOTER
chr8 2.6E+07 2.6E+07Sox2_bound:81 Gpr124 NM_054044 NA NA PROMOTER
chr8 2.6E+07 2.6E+07Sox2_bound:81 Got1l1 NM_029674 NA NA PROMOTER
chr8 2.6E+07 2.6E+07Sox2_bound:81 Adrb3 NM_013462 NA NA PROMOTER
chr8 3E+07 3E+07 Sox2_bound:81 Rnf122 NM_175136 NA NA PROMOTER
chr8 3E+07 3E+07 Sox2_bound:81 BC019943 NM_144927 NA NA PROMOTER
chr8 3E+07 3E+07 Sox2_bound:81 BC019943 NM_144927 NA NA PROMOTER
chr8 3.4E+07 3.4E+07Sox2_bound:81 Dusp4 NM_176933 NA NA PROMOTER
chr8 3.4E+07 3.4E+07Sox2_bound:82 Dusp4 NM_176933 NA NA INSIDE
chr8 4.2E+07 4.2E+07Sox2_bound:82 Zfp42 NM_009556 NA NA INSIDE
chr8 4.2E+07 4.2E+07Sox2_bound:82 Zfp42 NM_009556 NA NA PROMOTER
chr8 4.4E+07 4.4E+07Sox2_bound:82 F11 NM_028066 NA NA PROMOTER
chr8 4.5E+07 4.5E+07Sox2_bound:82 Helt NM_173789 NA NA PROMOTER
chr8 4.5E+07 4.5E+07Sox2_bound:82 Casp3 NM_009810 NA NA INSIDE
chr8 5.3E+07 5.3E+07Sox2_bound:82 Vegfc NM_009506 NA NA PROMOTER
chr8 5.6E+07 5.6E+07Sox2_bound:82 Hand2 NM_010402 NA NA INSIDE
chr8 5.9E+07 5.9E+07Sox2_bound:82 BC042740 BC042740 NA NA Unknown
chr8 6.3E+07 6.3E+07Sox2_bound:82 BC031142 BC031142 NA NA Unknown
chr8 6.7E+07 6.7E+07Sox2_bound:83 Ints10 NM_027590 NA NA PROMOTER
chr8 6.9E+07 6.9E+07Sox2_bound:83 Cspg3 NM_007789 NA NA PROMOTER
chr8 6.9E+07 6.9E+07Sox2_bound:83 Ddx49 NM_001024922 Cope NM_021538 DIVERGENT
chr8 6.9E+07 6.9E+07Sox2_bound:83 Fkbp8 NM_010223 NA NA PROMOTER
chr8 6.9E+07 6.9E+07Sox2_bound:83 Lsm4 NM_015816 NA NA INSIDE
chr8 7E+07 7E+07 Sox2_bound:83 2010315L10Rik NM_025917 NA NA PROMOTER
chr8 7E+07 7E+07 Sox2_bound:83 Insl3 NM_013564 NA NA PROMOTER
chr8 7.1E+07 7.1E+07Sox2_bound:83 Tpm4 NM_001001491 NA NA INSIDE
chr8 7.1E+07 7.1E+07Sox2_bound:83 Klf2 NM_008452 NA NA PROMOTER
chr8 7.1E+07 7.1E+07Sox2_bound:83 Calr3 NM_028500 700030K09RikNM_028170 DIVERGENT
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chr8 7.2E+07 7.2E+07Sox2_bound:84 Large NM_010687 NA NA PROMOTER
chr8 7.4E+07 7.4E+07Sox2_bound:84 Hmox1 NM_010442 NA NA PROMOTER
chr8 7.7E+07 7.7E+07Sox2_bound:84 Pou4f2 NM_138944 NA NA INSIDE
chr8 7.7E+07 7.7E+07Sox2_bound:84 Pou4f2 NM_138944 NA NA PROMOTER
chr8 7.7E+07 7.7E+07Sox2_bound:84 2410193C02Rik NM_001009980 NA NA INSIDE
chr8 7.7E+07 7.7E+07Sox2_bound:84 2410193C02Rik NM_001009980 NA NA INSIDE
chr8 7.9E+07 7.9E+07Sox2_bound:84 Hhip NM_020259 NA NA INSIDE
chr8 8.2E+07 8.2E+07Sox2_bound:84 Tbc1d9 NM_027758 NA NA PROMOTER
chr8 8.2E+07 8.2E+07Sox2_bound:84 Tbc1d9 NM_027758 NA NA PROMOTER
chr8 8.2E+07 8.2E+07Sox2_bound:84 Tbc1d9 NM_027758 NA NA PROMOTER
chr8 8.2E+07 8.2E+07Sox2_bound:85 Gipc1 NM_018771 NA NA PROMOTER
chr8 8.2E+07 8.2E+07Sox2_bound:85 Gipc1 NM_018771 NA NA INSIDE
chr8 8.3E+07 8.3E+07Sox2_bound:85 Ier2 NM_010499 NA NA INSIDE
chr8 8.4E+07 8.4E+07Sox2_bound:85 Prdx2 NM_011563 NA NA INSIDE
chr8 8.4E+07 8.4E+07Sox2_bound:85 Junb NM_008416 NA NA PROMOTER
chr8 8.4E+07 8.4E+07Sox2_bound:85 Tnpo2 NM_145390 NA NA PROMOTER
chr8 8.4E+07 8.4E+07Sox2_bound:85 BC056474 NM_001001493 NA NA INSIDE
chr8 8.6E+07 8.6E+07Sox2_bound:85 Cbln1 NM_019626 NA NA PROMOTER
chr8 8.8E+07 8.8E+07Sox2_bound:85 Sall1 NM_021390 NA NA PROMOTER
chr8 8.9E+07 8.9E+07Sox2_bound:85 Chd9 NM_177224 NA NA PROMOTER
chr8 9E+07 9E+07 Sox2_bound:86 Irx3 NM_008393 NA NA PROMOTER
chr8 9.3E+07 9.3E+07Sox2_bound:86 Amfr NM_011787 NA NA INSIDE
chr8 9.3E+07 9.3E+07Sox2_bound:86 Mt1 NM_013602 NA NA PROMOTER
chr8 9.3E+07 9.3E+07Sox2_bound:86 Cpne2 NM_153507 NA NA INSIDE
chr8 9.3E+07 9.3E+07Sox2_bound:86 Pllp NM_026385 NA NA PROMOTER
chr8 9.4E+07 9.4E+07Sox2_bound:86 Ccdc102a NM_001033533 Gpr114 NM_001033468 DIVERGENT
chr8 9.4E+07 9.4E+07Sox2_bound:86 Kifc3 NM_010631 NA NA PROMOTER
chr8 9.4E+07 9.4E+07Sox2_bound:86 Kifc3 NM_010631 NA NA PROMOTER
chr8 9.4E+07 9.4E+07Sox2_bound:86 BC031853 NM_172758 NA NA PROMOTER
chr8 9.8E+07 9.8E+07Sox2_bound:86 Cdh8 NM_007667 NA NA INSIDE
chr8 1E+08 1E+08 Sox2_bound:87 4931428F04Rik NM_028888 NA NA PROMOTER
chr8 1E+08 1E+08 Sox2_bound:87 Slc12a4 NM_009195 NA NA PROMOTER
chr8 1E+08 1E+08 Sox2_bound:87 Smpd3 NM_021491 NA NA PROMOTER
chr8 1E+08 1E+08 Sox2_bound:87 Smpd3 NM_021491 NA NA PROMOTER
chr8 1.1E+08 1.1E+08Sox2_bound:87 Zfp90 NM_011764 NA NA INSIDE
chr8 1.1E+08 1.1E+08Sox2_bound:87 6030452D12Rik NM_177904 NA NA INSIDE
chr8 1.1E+08 1.1E+08Sox2_bound:87 Cdh3 NM_007665 NA NA PROMOTER
chr8 1.1E+08 1.1E+08Sox2_bound:87 Cdh1 NM_009864 NA NA PROMOTER
chr8 1.1E+08 1.1E+08Sox2_bound:87 Cdh1 NM_009864 NA NA INSIDE
chr8 1.1E+08 1.1E+08Sox2_bound:87 Has3 NM_008217 NA NA INSIDE
chr8 1.1E+08 1.1E+08Sox2_bound:88 Has3 NM_008217 NA NA INSIDE
chr8 1.1E+08 1.1E+08Sox2_bound:88 Has3 NM_008217 NA NA INSIDE
chr8 1.1E+08 1.1E+08Sox2_bound:88 Sntb2 NM_009229 NA NA PROMOTER
chr8 1.1E+08 1.1E+08Sox2_bound:88 Nqo1 NM_008706 NA NA PROMOTER
chr8 1.1E+08 1.1E+08Sox2_bound:88 Dhx38 NM_178380 Txnl4b NM_175646 DIVERGENT
chr8 1.1E+08 1.1E+08Sox2_bound:88 2400003C14Rik NM_028018 NA NA INSIDE
chr8 1.1E+08 1.1E+08Sox2_bound:88 Zfp1 NM_001037665 NA NA INSIDE
chr8 1.1E+08 1.1E+08Sox2_bound:88 Wwox NM_019573 NA NA PROMOTER
chr8 1.1E+08 1.1E+08Sox2_bound:88 Maf NM_001025577 NA NA INSIDE
chr8 1.2E+08 1.2E+08Sox2_bound:88 Plcg2 NM_172285 NA NA PROMOTER
chr8 1.2E+08 1.2E+08Sox2_bound:89 Cdh13 NM_019707 NA NA INSIDE
chr8 1.2E+08 1.2E+08Sox2_bound:89 Gse1 NM_198671 NA NA PROMOTER
chr8 1.2E+08 1.2E+08Sox2_bound:89 Cox4i1 NM_009941 NA NA INSIDE
chr8 1.2E+08 1.2E+08Sox2_bound:89 Cox4i1 NM_009941 NA NA INSIDE
chr8 1.2E+08 1.2E+08Sox2_bound:89 Car5a NM_007608 Banp NM_016812 DIVERGENT
chr8 1.2E+08 1.2E+08Sox2_bound:89 Spire2 NM_172287 NA NA INSIDE
chr8 1.2E+08 1.2E+08Sox2_bound:89 Tubb3 NM_023279 NA NA PROMOTER
chr8 1.2E+08 1.2E+08Sox2_bound:89 Tubb3 NM_023279 NA NA INSIDE
chr8 1.2E+08 1.2E+08Sox2_bound:89 Rab4a NM_009003 NA NA INSIDE
chr8 1.2E+08 1.2E+08Sox2_bound:89 4933403G14Rik NM_028908 NA NA PROMOTER
chr8 1.3E+08 1.3E+08Sox2_bound:90 2610044O15Rik NM_153780 NA NA PROMOTER
chr9 4711313 4712169Sox2_bound:90 Gria4 NM_019691 NA NA INSIDE
chr9 1.4E+07 1.4E+07Sox2_bound:90 Sesn3 NM_030261 NA NA PROMOTER
chr9 1.9E+07 1.9E+07Sox2_bound:90 Zfp75 NM_172918 NA NA INSIDE
chr9 2.1E+07 2.1E+07Sox2_bound:90 Edg5 NM_010333 NA NA PROMOTER
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chr9 2.1E+07 2.1E+07Sox2_bound:90 Tmed1 NM_010744 NA NA PROMOTER
chr9 2.5E+07 2.5E+07Sox2_bound:90 Tbx20 NM_020496 NA NA PROMOTER
chr9 2.5E+07 2.5E+07Sox2_bound:90 Tbx20 NM_020496 NA NA PROMOTER
chr9 2.7E+07 2.7E+07Sox2_bound:90 Acad8 NM_025862 Thyn1 NM_144543 DIVERGENT
chr9 3.2E+07 3.2E+07Sox2_bound:90 Fli1 NM_008026 NA NA PROMOTER
chr9 3.7E+07 3.7E+07Sox2_bound:91 BC024479 NM_146222 NA NA PROMOTER
chr9 4.3E+07 4.3E+07Sox2_bound:91 Tmem136 NM_001034863 NA NA INSIDE
chr9 4.3E+07 4.3E+07Sox2_bound:91 Pou2f3 NM_011139 NA NA PROMOTER
chr9 4.3E+07 4.3E+07Sox2_bound:91 D9Ucla1 NM_178644 NA NA PROMOTER
chr9 4.4E+07 4.4E+07Sox2_bound:91 Pvrl1 NM_021424 NA NA PROMOTER
chr9 4.4E+07 4.4E+07Sox2_bound:91 Tmem24 NM_027909 Dpagt1 NM_007875 DIVERGENT
chr9 4.4E+07 4.4E+07Sox2_bound:91 Dpagt1 NM_007875 NA NA INSIDE
chr9 4.5E+07 4.5E+07Sox2_bound:91 Atp5l NM_013795 NA NA PROMOTER
chr9 4.5E+07 4.5E+07Sox2_bound:91 Amica1 NM_001005421 NA NA PROMOTER
chr9 4.9E+07 4.9E+07Sox2_bound:91 Zw10 NM_012039 NA NA PROMOTER
chr9 4.9E+07 4.9E+07Sox2_bound:92 Zw10 NM_012039 NA NA PROMOTER
chr9 5E+07 5E+07 Sox2_bound:92 Ncam1 NM_010875 NA NA INSIDE
chr9 5E+07 5E+07 Sox2_bound:92 1600029D21Rik NM_029639 NA NA INSIDE
chr9 5.1E+07 5.1E+07Sox2_bound:92 Dixdc1 NM_178118 NA NA INSIDE
chr9 5.1E+07 5.1E+07Sox2_bound:92 Dixdc1 NM_178118 NA NA PROMOTER
chr9 5.5E+07 5.5E+07Sox2_bound:92 Acsbg1 NM_053178 NA NA PROMOTER
chr9 5.6E+07 5.6E+07Sox2_bound:92 C230081A13Rik NM_172924 Hmg20a NM_025812 DIVERGENT
chr9 6E+07 6E+07 Sox2_bound:92 Pkm2 NM_011099 NA NA INSIDE
chr9 6E+07 6E+07 Sox2_bound:92 Pkm2 NM_011099 NA NA INSIDE
chr9 6.1E+07 6.1E+07Sox2_bound:92 Tle3 NM_009389 NA NA PROMOTER
chr9 6.1E+07 6.1E+07Sox2_bound:93 Tle3 NM_009389 NA NA PROMOTER
chr9 6.2E+07 6.2E+07Sox2_bound:93 Anp32a NM_009672 NA NA PROMOTER
chr9 6.3E+07 6.3E+07Sox2_bound:93 Fem1b NM_010193 NA NA PROMOTER
chr9 6.3E+07 6.3E+07Sox2_bound:93 Lbxcor1 NM_172446 NA NA INSIDE
chr9 6.4E+07 6.4E+07Sox2_bound:93 Snapc5 NM_183316 NA NA PROMOTER
chr9 6.4E+07 6.4E+07Sox2_bound:93 AV340375 NM_172519 NA NA INSIDE
chr9 6.6E+07 6.6E+07Sox2_bound:93 Plekhq1 NM_153119 AI449441 NM_172453 DIVERGENT
chr9 7E+07 7E+07 Sox2_bound:93 Foxb1 NM_022378 NA NA INSIDE
chr9 7E+07 7E+07 Sox2_bound:93 Foxb1 NM_022378 NA NA PROMOTER
chr9 7.3E+07 7.3E+07Sox2_bound:93 Nedd4 NM_010890 NA NA INSIDE
chr9 7.3E+07 7.3E+07Sox2_bound:94 BC003885 NM_198609 NA NA PROMOTER
chr9 7.5E+07 7.5E+07Sox2_bound:94 BC023444 BC023444 NA NA Unknown
chr9 7.5E+07 7.5E+07Sox2_bound:94 Gnb5 NM_010313 NA NA PROMOTER
chr9 7.8E+07 7.8E+07Sox2_bound:94 Gsta4 NM_010357 NA NA PROMOTER
chr9 7.8E+07 7.8E+07Sox2_bound:94 Gsta4 NM_010357 NA NA PROMOTER
chr9 7.8E+07 7.8E+07Sox2_bound:94 Dppa5 NM_025274 NA NA PROMOTER
chr9 7.9E+07 7.9E+07Sox2_bound:94 Cd109 NM_153098 NA NA PROMOTER
chr9 8E+07 8E+07 Sox2_bound:94 Col12a1 NM_007730 NA NA INSIDE
chr9 8.9E+07 8.9E+07Sox2_bound:94NSMUST000000937MUST00000093 NA NA Unknown
chr9 8.9E+07 8.9E+07Sox2_bound:94NSMUST000000937MUST00000093 NA NA Unknown
chr9 9E+07 9E+07 Sox2_bound:95 Rasgrf1 NM_001039655 NA NA PROMOTER
chr9 9E+07 9E+07 Sox2_bound:95 Tbc1d2b NM_194334 NA NA PROMOTER
chr9 9.2E+07 9.2E+07Sox2_bound:95 BC002017 BC002017 NA NA Unknown
chr9 9.4E+07 9.4E+07Sox2_bound:95 1190002N15Rik NM_001033145 NA NA INSIDE
chr9 9.4E+07 9.4E+07Sox2_bound:95 Slc9a9 NM_177909 NA NA PROMOTER
chr9 9.4E+07 9.4E+07Sox2_bound:95 Slc9a9 NM_177909 NA NA INSIDE
chr9 9.6E+07 9.6E+07Sox2_bound:95 BC043934 NM_177770 NA NA INSIDE
chr9 9.6E+07 9.6E+07Sox2_bound:95 Zbtb38 NM_175537 NA NA INSIDE
chr9 9.7E+07 9.7E+07Sox2_bound:95 Slc25a36 NM_138756 NA NA PROMOTER
chr9 1E+08 1E+08 Sox2_bound:95 Stag1 NM_009282 NA NA PROMOTER
chr9 1E+08 1E+08 Sox2_bound:96 Stag1 NM_009282 NA NA PROMOTER
chr9 1.1E+08 1.1E+08Sox2_bound:96 Rpl29 NM_009082 NA NA INSIDE
chr9 1.1E+08 1.1E+08Sox2_bound:96 Tex264 NM_011573 NA NA PROMOTER
chr9 1.1E+08 1.1E+08Sox2_bound:96 Zmynd10 NM_053253 NA NA INSIDE
chr9 1.1E+08 1.1E+08Sox2_bound:96 Gnat1 NM_008140 NA NA INSIDE
chr9 1.1E+08 1.1E+08Sox2_bound:96 Gnat1 NM_008140 NA NA INSIDE
chr9 1.1E+08 1.1E+08Sox2_bound:96 Camkv NM_145621 NA NA INSIDE
chr9 1.1E+08 1.1E+08Sox2_bound:96 Ihpk1 NM_013785 NA NA PROMOTER
chr9 1.1E+08 1.1E+08Sox2_bound:96 Amt NM_001013814 NA NA PROMOTER
chr9 1.1E+08 1.1E+08Sox2_bound:96 1700102P08Rik NM_053216 NA NA PROMOTER
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chr9 1.1E+08 1.1E+08Sox2_bound:97 Celsr3 NM_080437 NA NA PROMOTER
chr9 1.1E+08 1.1E+08Sox2_bound:97 Tdgf1 NM_011562 Lrrc2 NM_028838 DIVERGENT
chr9 1.1E+08 1.1E+08Sox2_bound:97 Lrrc2 NM_028838 NA NA INSIDE
chr9 1.1E+08 1.1E+08Sox2_bound:97 Arpp21 NM_033264 NA NA INSIDE
chr9 1.1E+08 1.1E+08Sox2_bound:97 Cnot10 NM_153585 NA NA PROMOTER
chr9 1.2E+08 1.2E+08Sox2_bound:97 Eomes NM_010136 NA NA PROMOTER
chr9 1.2E+08 1.2E+08Sox2_bound:97 Itga9 NM_133721 NA NA INSIDE
chr9 1.2E+08 1.2E+08Sox2_bound:97 BC060645 BC060645 NA NA Unknown
chr9 1.2E+08 1.2E+08Sox2_bound:97 Mobp NM_001039365 NA NA INSIDE
chr9 1.2E+08 1.2E+08Sox2_bound:97 Zfp105 NM_009544 NA NA INSIDE
chr9 1.2E+08 1.2E+08Sox2_bound:98 Tmem42 NM_025339 NA NA PROMOTER
chr1 4521461 4522150Sox2_bound:98 Mtrf1l NM_175374 NA NA PROMOTER
chr1 6078900 6079534Sox2_bound:98 Akap12 NM_031185 NA NA INSIDE
chr1 8585796 8586731Sox2_bound:98 Sash1 NM_175155 NA NA PROMOTER
chr1 8588747 8589372Sox2_bound:98 Sash1 NM_175155 NA NA PROMOTER
chr1 8589806 8590306Sox2_bound:98 Sash1 NM_175155 NA NA PROMOTER
chr1 1.4E+07 1.4E+07Sox2_bound:98 1110059P08Rik NM_025418 NA NA INSIDE
chr1 1.7E+07 1.7E+07Sox2_bound:98 Cited2 NM_010828 NA NA PROMOTER
chr1 1.8E+07 1.8E+07Sox2_bound:98 BC030842 BC030842 NA NA Unknown
chr1 1.9E+07 1.9E+07Sox2_bound:98 Olig3 NM_053008 NA NA PROMOTER
chr1 2.1E+07 2.1E+07Sox2_bound:99 Ahi1 NM_026203 NA NA PROMOTER
chr1 2.4E+07 2.4E+07Sox2_bound:99 Rps12 NM_011295 NA NA PROMOTER
chr1 2.4E+07 2.4E+07Sox2_bound:99 Ctgf NM_010217 NA NA PROMOTER
chr1 2.5E+07 2.5E+07Sox2_bound:99 Enpp3 NM_134005 NA NA INSIDE
chr1 2.9E+07 2.9E+07Sox2_bound:99 6330407J23Rik NM_026138 NA NA PROMOTER
chr1 3.7E+07 3.7E+07Sox2_bound:99 Marcks NM_008538 5930403N24RikNM_177177 DIVERGENT
chr1 4E+07 4E+07 Sox2_bound:99 Bxdc1 NM_023323 NA NA INSIDE
chr1 4E+07 4E+07 Sox2_bound:99 2410016F19Rik NM_026113 NA NA PROMOTER
chr1 4E+07 4E+07 Sox2_bound:99 Cdc2l6 NM_198164 NA NA PROMOTER
chr1 4.1E+07 4.1E+07Sox2_bound:99 Wasf1 NM_031877 NA NA PROMOTER
chr1 4.1E+07 4.1E+07 ox2_bound:100 Mical1 NM_138315 NA NA INSIDE
chr1 4.3E+07 4.3E+07 ox2_bound:100 AK122525 NM_199028 NA NA PROMOTER
chr1 4.3E+07 4.3E+07 ox2_bound:100 Cd24a NM_009846 NA NA INSIDE
chr1 4.3E+07 4.3E+07 ox2_bound:100 Cd24a NM_009846 NA NA INSIDE
chr1 4.4E+07 4.4E+07 ox2_bound:100 Prdm1 NM_007548 NA NA PROMOTER
chr1 4.5E+07 4.5E+07 ox2_bound:100 Lin28b NM_001031772 NA NA INSIDE
chr1 5.1E+07 5.1E+07 ox2_bound:100 Sim1 NM_011376 NA NA PROMOTER
chr1 5.6E+07 5.6E+07 ox2_bound:100 Gja1 NM_010288 NA NA PROMOTER
chr1 5.6E+07 5.6E+07 ox2_bound:100 Gja1 NM_010288 NA NA PROMOTER
chr1 5.6E+07 5.6E+07 ox2_bound:100 Gja1 NM_010288 NA NA PROMOTER
chr1 6E+07 6E+07 ox2_bound:101 Unc5b NM_029770 NA NA INSIDE
chr1 6.1E+07 6.1E+07 ox2_bound:101 Nodal NM_013611 NA NA PROMOTER
chr1 6.1E+07 6.1E+07 ox2_bound:101 Nodal NM_013611 NA NA PROMOTER
chr1 6.1E+07 6.1E+07 ox2_bound:101 Nodal NM_013611 NA NA PROMOTER
chr1 6.1E+07 6.1E+07 ox2_bound:101 H2afy2 NM_207000 NA NA INSIDE
chr1 6.2E+07 6.2E+07 ox2_bound:101 Tspan15 NM_197996 NA NA PROMOTER
chr1 6.4E+07 6.4E+07 ox2_bound:101 Lrrtm3 NM_178678 NA NA PROMOTER
chr1 6.7E+07 6.7E+07 ox2_bound:101 D10Ucla1 NM_178606 NA NA INSIDE
chr1 6.7E+07 6.7E+07 ox2_bound:101 D10Ucla1 NM_178606 NA NA PROMOTER
chr1 6.7E+07 6.7E+07 ox2_bound:101 D10Ucla1 NM_178606 NA NA PROMOTER
chr1 6.7E+07 6.7E+07 ox2_bound:102 D10Ucla1 NM_178606 NA NA PROMOTER
chr1 6.8E+07 6.8E+07 ox2_bound:102 Arid5b NM_023598 NA NA PROMOTER
chr1 7E+07 7E+07 ox2_bound:102 Ank3 NM_009670 NA NA INSIDE
chr1 7E+07 7E+07 ox2_bound:102 Phyhipl NM_178621 NA NA INSIDE
chr1 7.2E+07 7.2E+07 ox2_bound:102 Zwint NM_025635 NA NA PROMOTER
chr1 7.2E+07 7.2E+07 ox2_bound:102 Zwint NM_025635 NA NA INSIDE
chr1 7.5E+07 7.5E+07 ox2_bound:102 Ggtla1 NM_011820 NA NA PROMOTER
chr1 7.6E+07 7.6E+07 ox2_bound:102 Gm867 NM_001037714 NA NA INSIDE
chr1 7.6E+07 7.6E+07 ox2_bound:102 Gm867 NM_001037714 NA NM_009514 DIVERGENT
chr1 7.6E+07 7.6E+07 ox2_bound:102 Ftcd NM_080845 NA NA PROMOTER
chr1 7.8E+07 7.8E+07 ox2_bound:103 Aire NM_009646 Dnmt3l NM_019448 DIVERGENT
chr1 8E+07 8E+07 ox2_bound:103 Thrap5 NM_198107 NA NA PROMOTER
chr1 8E+07 8E+07 ox2_bound:103 Midn NM_021565 NA NA INSIDE
chr1 8E+07 8E+07 ox2_bound:103 Ndufs7 NM_029272 NA NA PROMOTER
chr1 8E+07 8E+07 ox2_bound:103 Tcfe2a NM_011548 NA NA PROMOTER
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chr1 8.1E+07 8.1E+07 ox2_bound:103 Atcay NM_178662 NA NA INSIDE
chr1 8.1E+07 8.1E+07 ox2_bound:103 Tle2 NM_019725 NA NA PROMOTER
chr1 8.1E+07 8.1E+07 ox2_bound:103 Sirt6 NM_181586 Ankrd24 NA INSIDE
chr1 8.4E+07 8.4E+07 ox2_bound:103 Rfx4 NM_001024918 NA NA PROMOTER
chr1 8.4E+07 8.4E+07 ox2_bound:103 Rfx4 NM_001024918 NA NA INSIDE
chr1 8.4E+07 8.4E+07 ox2_bound:104 Rfx4 NM_001024918 NA NA INSIDE
chr1 8.4E+07 8.4E+07 ox2_bound:104 Rfx4 NM_001024918 NA NA INSIDE
chr1 8.4E+07 8.4E+07 ox2_bound:104 Rfx4 NM_027689 NA NA PROMOTER
chr1 8.4E+07 8.4E+07 ox2_bound:104 Rfx4 NM_027689 NA NA INSIDE
chr1 8.4E+07 8.4E+07 ox2_bound:104 Ric8b NM_183172 NA NA PROMOTER
chr1 8.6E+07 8.6E+07 ox2_bound:104 Bpil2 NM_177772 Fbxo7 NM_153195 DIVERGENT
chr1 8.7E+07 8.7E+07 ox2_bound:104 Ascl1 NM_008553 NA NA PROMOTER
chr1 8.7E+07 8.7E+07 ox2_bound:104 Igf1 NM_010512 NA NA PROMOTER
chr1 8.8E+07 8.8E+07 ox2_bound:104 Spic NM_011461 NA NA PROMOTER
chr1 8.9E+07 8.9E+07 ox2_bound:104 Tmem16d NM_178773 NA NA INSIDE
chr1 9.3E+07 9.3E+07 ox2_bound:105 Ccdc38 NM_175488 NA NA INSIDE
chr1 9.3E+07 9.3E+07 ox2_bound:105 Usp44 NM_183199 NA NA PROMOTER
chr1 9.5E+07 9.5E+07 ox2_bound:105 Cradd NM_009950 NA NA INSIDE
chr1 9.5E+07 9.5E+07 ox2_bound:105 Socs2 NM_007706 NA NA INSIDE
chr1 9.5E+07 9.5E+07 ox2_bound:105 Socs2 NM_007706 NA NA INSIDE
chr1 9.5E+07 9.5E+07 ox2_bound:105 Nudt4 NM_027722 NA NA PROMOTER
chr1 9.9E+07 9.9E+07 ox2_bound:105 Dusp6 NM_026268 NA NA PROMOTER
chr1 9.9E+07 9.9E+07 ox2_bound:105 Dusp6 NM_026268 NA NA INSIDE
chr1 9.9E+07 9.9E+07 ox2_bound:105 B530045E10Rik NM_177302 NA NA INSIDE
chr1 1E+08 1E+08 ox2_bound:105 Mgat4c NM_026243 NA NA PROMOTER
chr1 1E+08 1E+08 ox2_bound:106 Cart1 NM_172553 NA NA INSIDE
chr1 1E+08 1E+08 ox2_bound:106 Slc6a15 NM_175328 NA NA INSIDE
chr1 1.1E+08 1.1E+08 ox2_bound:106 Thap2 NM_025780 NA NA INSIDE
chr1 1.2E+08 1.2E+08 ox2_bound:106 Frs2 NM_177798 NA NA PROMOTER
chr1 1.2E+08 1.2E+08 ox2_bound:106 Irak3 NM_028679 Tmbim4 NM_026617 DIVERGENT
chr1 1.2E+08 1.2E+08 ox2_bound:106 Hmga2 NM_178057 NA NA INSIDE
chr1 1.3E+08 1.3E+08 ox2_bound:106 4632413K17Rik NM_177614 NA NA PROMOTER
chr1 1.3E+08 1.3E+08 ox2_bound:106 Kif5a NM_008447 Dctn2 NM_027151 DIVERGENT
chr1 1.3E+08 1.3E+08 ox2_bound:106 Nxph4 NM_183297 NA NA PROMOTER
chr1 1.3E+08 1.3E+08 ox2_bound:106 Il23a NM_031252 Usp52 NM_133992 DIVERGENT
chr1 1.3E+08 1.3E+08 ox2_bound:107 Rpl41 NM_018860 NA NA INSIDE
chr1 1.3E+08 1.3E+08 ox2_bound:107 Rps26 NM_013765 NA NA PROMOTER
chr1 1.3E+08 1.3E+08 ox2_bound:107 Dgka NM_016811 Wibg NM_030100 DIVERGENT
chr1 3244576 3245076 ox2_bound:107 Zfp278 NM_019574 NA NA INSIDE
chr1 3915769 3916269 ox2_bound:107 Pes1 NM_022889 NA NA INSIDE
chr1 4656808 4657536 ox2_bound:107 Zmat5 NM_026015 NA NA INSIDE
chr1 7166409 7167017 ox2_bound:107 Igfbp3 NM_008343 NA NA PROMOTER
chr1 9067309 9067809 ox2_bound:107 Upp1 NM_009477 NA NA PROMOTER
chr1 9067943 9068443 ox2_bound:107 Upp1 NM_009477 NA NA PROMOTER
chr1 9069065 9069947 ox2_bound:107 Upp1 NM_009477 NA NA PROMOTER
chr1 9071367 9072240 ox2_bound:108 Upp1 NM_009477 NA NA INSIDE
chr1 1.2E+07 1.2E+07 ox2_bound:108 Cobl NM_172496 NA NA PROMOTER
chr1 1.9E+07 1.9E+07 ox2_bound:108 Meis1 NM_010789 NA NA PROMOTER
chr1 2E+07 2E+07 ox2_bound:108 Spred2 NM_033523 NA NA INSIDE
chr1 2E+07 2E+07 ox2_bound:108 Slc1a4 NM_018861 NA NA PROMOTER
chr1 2E+07 2E+07 ox2_bound:108 Sertad2 NM_021372 NA NA PROMOTER
chr1 2E+07 2E+07 ox2_bound:108 Sertad2 NM_021372 NA NA PROMOTER
chr1 2.2E+07 2.2E+07 ox2_bound:108 Otx1 NM_011023 NA NA INSIDE
chr1 2.2E+07 2.2E+07 ox2_bound:108 Otx1 NM_011023 NA NA PROMOTER
chr1 2.3E+07 2.3E+07 ox2_bound:108 Xpo1 NM_001035226 NA NA INSIDE
chr1 2.4E+07 2.4E+07 ox2_bound:109 4933435A13Rik NM_028304 NA NA INSIDE
chr1 2.4E+07 2.4E+07 ox2_bound:109 A830031A19Rik NM_207251 Bcl11a NM_016707 DIVERGENT
chr1 2.9E+07 2.9E+07 ox2_bound:109 Ccdc85a NM_181577 NA NA INSIDE
chr1 3E+07 3E+07 ox2_bound:109 Rtn4 NM_024226 NA NA PROMOTER
chr1 3.1E+07 3.1E+07 ox2_bound:109 2510006C20Rik NM_026527 NA NA PROMOTER
chr1 3.2E+07 3.2E+07 ox2_bound:109 Nsg2 NM_008741 NA NA INSIDE
chr1 3.3E+07 3.3E+07 ox2_bound:109 Fgf18 NM_008005 NA NA INSIDE
chr1 3.4E+07 3.4E+07 ox2_bound:109 MGC99845 NM_001025382 NA NA INSIDE
chr1 4.1E+07 4.1E+07 ox2_bound:109 Nudcd2 NM_026023 NA NA INSIDE
chr1 4.5E+07 4.5E+07 ox2_bound:109 Ebf1 NM_007897 NA NA PROMOTER
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chr1 4.6E+07 4.6E+07 ox2_bound:110 Sox30 NM_173384 NA NA PROMOTER
chr1 4.9E+07 4.9E+07 ox2_bound:110 Irgm NM_008326 NA NA INSIDE
chr1 4.9E+07 4.9E+07 ox2_bound:110 Zfp62 NM_001024846 NA NA INSIDE
chr1 5E+07 5E+07 ox2_bound:110 Scgb3a1 NM_054037 NA NA PROMOTER
chr1 5E+07 5E+07 ox2_bound:110 Canx NM_007597 NA NA PROMOTER
chr1 5E+07 5E+07 ox2_bound:110 Hnrph1 NM_021510 NA NA PROMOTER
chr1 5.1E+07 5.1E+07 ox2_bound:110 Zfp2 NM_178447 NA NA INSIDE
chr1 5.2E+07 5.2E+07 ox2_bound:110 Rmnd5b NM_025346 NA NA PROMOTER
chr1 5.2E+07 5.2E+07 ox2_bound:110 D930048N14Rik NM_175289 NA NA PROMOTER
chr1 5.2E+07 5.2E+07 ox2_bound:110 Ube2b NM_009458 Cdkl3 NM_153785 DIVERGENT
chr1 5.2E+07 5.2E+07 ox2_bound:111 Tcf7 NM_009331 NA NA PROMOTER
chr1 5.2E+07 5.2E+07 ox2_bound:111 Vdac1 NM_011694 NA NA PROMOTER
chr1 5.3E+07 5.3E+07 ox2_bound:111 Aff4 NM_033565 NA NA INSIDE
chr1 5.3E+07 5.3E+07 ox2_bound:111 Sept8 NM_033144 NA NA INSIDE
chr1 5.8E+07 5.8E+07 ox2_bound:111 Zfp692 NM_182996 NA NA PROMOTER
chr1 6E+07 6E+07 ox2_bound:111 Flcn NM_146018 NA NA PROMOTER
chr1 6.1E+07 6.1E+07 ox2_bound:111 Llgl1 NM_008502 NA NA PROMOTER
chr1 6.1E+07 6.1E+07 ox2_bound:111 Top3a NM_009410 Smcr8 NM_175491 DIVERGENT
chr1 6.1E+07 6.1E+07 ox2_bound:111 Aldh3a2 NM_007437 NA NA INSIDE
chr1 6.3E+07 6.3E+07 ox2_bound:111 Ubb NM_011664 NA NA PROMOTER
chr1 6.3E+07 6.3E+07 ox2_bound:112 Fbxw10 NM_001033669 NA NA INSIDE
chr1 6.4E+07 6.4E+07 ox2_bound:112 Hs3st3b1 NM_018805 NA NA PROMOTER
chr1 6.7E+07 6.7E+07 ox2_bound:112 A730055C05Rik NM_177392 NA NA PROMOTER
chr1 6.7E+07 6.7E+07 ox2_bound:112 A730055C05Rik NM_177392 NA NA PROMOTER
chr1 6.8E+07 6.8E+07 ox2_bound:112 Usp43 NM_173754 NA NA PROMOTER
chr1 6.9E+07 6.9E+07 ox2_bound:112 Aurkb NM_011496 NA NA PROMOTER
chr1 6.9E+07 6.9E+07 ox2_bound:112 Aloxe3 NM_011786 NA NA PROMOTER
chr1 6.9E+07 6.9E+07 ox2_bound:112 Trappc1 NM_001024206 NA NA INSIDE
chr1 6.9E+07 6.9E+07 ox2_bound:112 Jmjd3 NM_001017426 NA NA PROMOTER
chr1 7E+07 7E+07 ox2_bound:112 Trp53 NM_011640 NA NA INSIDE
chr1 7E+07 7E+07 ox2_bound:113 Cd68 NM_009853 NA NA PROMOTER
chr1 7E+07 7E+07 ox2_bound:113 Tnfsf13 NM_023517 NA NA INSIDE
chr1 7E+07 7E+07 ox2_bound:113 2810408A11Rik NM_027419 NA NA INSIDE
chr1 7E+07 7E+07 ox2_bound:113 Gabarap NM_019749 NA NA INSIDE
chr1 7E+07 7E+07 ox2_bound:113 Pelp1 NM_029231 NA NA PROMOTER
chr1 7.3E+07 7.3E+07 ox2_bound:113 Ube2g1 NM_025985 NA NA INSIDE
chr1 7.6E+07 7.6E+07 ox2_bound:113 Slc43a2 NM_173388 NA NA PROMOTER
chr1 7.8E+07 7.8E+07 ox2_bound:113 Nufip2 NM_001024205 NA NA PROMOTER
chr1 7.8E+07 7.8E+07 ox2_bound:113 Myo18a NM_011586 NA NA PROMOTER
chr1 7.8E+07 7.8E+07 ox2_bound:113 Pipox NM_008952 NA NA PROMOTER
chr1 7.8E+07 7.8E+07 ox2_bound:114 Sez6 NM_021286 NA NA PROMOTER
chr1 7.8E+07 7.8E+07 ox2_bound:114 Phf12 NM_174852 NA NA PROMOTER
chr1 7.9E+07 7.9E+07 ox2_bound:114 Wsb1 NM_019653 NA NA INSIDE
chr1 8.5E+07 8.5E+07 ox2_bound:114 Lhx1 NM_008498 NA NA INSIDE
chr1 8.7E+07 8.7E+07 ox2_bound:114 Cltc NM_001003908 NA NA INSIDE
chr1 8.7E+07 8.7E+07 ox2_bound:114 Cltc NM_001003908 NA NA PROMOTER
chr1 8.7E+07 8.7E+07 ox2_bound:114 Gdpd1 NM_025638 NA NA PROMOTER
chr1 8.7E+07 8.7E+07 ox2_bound:114 mmu-mir-301 mmu-mir-301 NA NA PROMOTER
chr1 8.8E+07 8.8E+07 ox2_bound:114 Mrps23 NM_024174 NA NA PROMOTER
chr1 8.9E+07 8.9E+07 ox2_bound:114 BC065135 BC065135 NA NA Unknown
chr1 8.9E+07 8.9E+07 ox2_bound:115 Trim25 NM_009546 NA NA PROMOTER
chr1 9E+07 9E+07 ox2_bound:115 Tmem100 NM_026433 NA NA INSIDE
chr1 9.1E+07 9.1E+07 ox2_bound:115 Hlf NM_172563 NA NA PROMOTER
chr1 9.4E+07 9.4E+07 ox2_bound:115 Nme1 NM_008704 NA NA INSIDE
chr1 9.4E+07 9.4E+07 ox2_bound:115 Spag9 NM_001025428 NA NA INSIDE
chr1 9.5E+07 9.5E+07 ox2_bound:115 Myst2 NM_177619 NA NA PROMOTER
chr1 9.5E+07 9.5E+07 ox2_bound:115 Myst2 NM_177619 NA NA PROMOTER
chr1 9.6E+07 9.6E+07 ox2_bound:115 Nxph3 NM_130858 NA NA PROMOTER
chr1 9.6E+07 9.6E+07 ox2_bound:115 Ngfr NM_033217 NA NA INSIDE
chr1 9.6E+07 9.6E+07 ox2_bound:115 Phb NM_008831 NA NA PROMOTER
chr1 9.6E+07 9.6E+07 ox2_bound:116 LOC544809 NM_001024710 NA NA PROMOTER
chr1 9.6E+07 9.6E+07 ox2_bound:116 Hoxb13 NM_008267 NA NA PROMOTER
chr1 9.6E+07 9.6E+07 ox2_bound:116 Hoxb13 NM_008267 NA NA PROMOTER
chr1 9.6E+07 9.6E+07 ox2_bound:116 Hoxb5 NM_008268 NA NA PROMOTER
chr1 9.6E+07 9.6E+07 ox2_bound:116 mmu-mir-10a mmu-mir-10a NA NA PROMOTER
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chr1 9.6E+07 9.6E+07 ox2_bound:116 Hoxb1 NM_008266 NA NA PROMOTER
chr1 9.7E+07 9.7E+07 ox2_bound:116 Snx11 NM_028965 Cbx1 NM_007622 DIVERGENT
chr1 9.7E+07 9.7E+07 ox2_bound:116 Npepps NM_008942 NA NA PROMOTER
chr1 9.7E+07 9.7E+07 ox2_bound:116 Mrpl45 NM_025927 NA NA PROMOTER
chr1 9.8E+07 9.8E+07 ox2_bound:116 Mllt6 NM_139311 NA NA PROMOTER
chr1 9.8E+07 9.8E+07 ox2_bound:117 Lasp1 NM_010688 NA NA PROMOTER
chr1 9.8E+07 9.8E+07 ox2_bound:117 Lasp1 NM_010688 NA NA INSIDE
chr1 9.8E+07 9.8E+07 ox2_bound:117 Stac2 NM_146028 NA NA PROMOTER
chr1 9.8E+07 9.8E+07 ox2_bound:117 Pparbp NM_134027 Crkrs NM_026952 DIVERGENT
chr1 9.9E+07 9.9E+07 ox2_bound:117 6330509G02Rik NM_172946 NA NA PROMOTER
chr1 1E+08 1E+08 ox2_bound:117 Krt1-17 NM_010663 NA NA PROMOTER
chr1 1E+08 1E+08 ox2_bound:117 Jup NM_010593 NA NA INSIDE
chr1 1E+08 1E+08 ox2_bound:117 Cnp1 NM_009923 NA NA PROMOTER
chr1 1E+08 1E+08 ox2_bound:117 Gcn5l2 NM_020004 NA NA PROMOTER
chr1 1E+08 1E+08 ox2_bound:117 Stat5a NM_011488 NA NA PROMOTER
chr1 1E+08 1E+08 ox2_bound:118 Stat3 NM_213660 NA NA PROMOTER
chr1 1E+08 1E+08 ox2_bound:118 Rnd2 NM_009708 NA NA INSIDE
chr1 1E+08 1E+08 ox2_bound:118 Brca1 NM_009764 Nbr1 NA INSIDE
chr1 1E+08 1E+08 ox2_bound:118 Brca1 NM_009764 NA NM_008676 DIVERGENT
chr1 1E+08 1E+08 ox2_bound:118 Nbr1 NM_008676 NA NA INSIDE
chr1 1E+08 1E+08 ox2_bound:118 Rdm1 NM_025654 NA NA PROMOTER
chr1 1E+08 1E+08 ox2_bound:118 Etv4 NM_008815 NA NA PROMOTER
chr1 1E+08 1E+08 ox2_bound:118 Etv4 NM_008815 NA NA PROMOTER
chr1 1E+08 1E+08 ox2_bound:118 BC030867 NM_153544 NA NA PROMOTER
chr1 1E+08 1E+08 ox2_bound:118 BC030867 NM_153544 NA NA INSIDE
chr1 1E+08 1E+08 ox2_bound:119 Rap2ip NM_016759 NA NA PROMOTER
chr1 1E+08 1E+08 ox2_bound:119 Fzd2 NM_020510 NA NA PROMOTER
chr1 1E+08 1E+08 ox2_bound:119 BC050840 BC050840 NA NA Unknown
chr1 1E+08 1E+08 ox2_bound:119 Acbd4 NM_025988 NA NA INSIDE
chr1 1E+08 1E+08 ox2_bound:119 Hexim1 NM_138753 NA NA PROMOTER
chr1 1E+08 1E+08 ox2_bound:119 Nsf NM_008740 Arf2 NM_007477 DIVERGENT
chr1 1.1E+08 1.1E+08 ox2_bound:119 2610204L23Rik NM_026009 Ddx42 NM_028074 DIVERGENT
chr1 1.1E+08 1.1E+08 ox2_bound:119 Pitpnc1 NM_145823 NA NA INSIDE
chr1 1.1E+08 1.1E+08 ox2_bound:119 Pitpnc1 NM_145823 NA NA INSIDE
chr1 1.1E+08 1.1E+08 ox2_bound:119 Gna13 NM_010303 NA NA PROMOTER
chr1 1.1E+08 1.1E+08 ox2_bound:120 Slc16a6 NM_001029842 NA NA PROMOTER
chr1 1.1E+08 1.1E+08 ox2_bound:120 Slc39a11 NM_027216 NA NA PROMOTER
chr1 1.1E+08 1.1E+08 ox2_bound:120 D11Ertd636e NM_029794 NA NA PROMOTER
chr1 1.2E+08 1.2E+08 ox2_bound:120 Galr2 NM_010254 NA NA INSIDE
chr1 1.2E+08 1.2E+08 ox2_bound:120 Sphk1 NM_025367 NA NA PROMOTER
chr1 1.2E+08 1.2E+08 ox2_bound:120 Tha1 NM_027919 NA NA PROMOTER
chr1 1.2E+08 1.2E+08 ox2_bound:120 Baiap2 NM_001037755 NA NA PROMOTER
chr1 1.2E+08 1.2E+08 ox2_bound:120 P4hb NM_011032 NA NA PROMOTER
chr1 8523865 8524705 ox2_bound:120 Rhob NM_007483 NA NA INSIDE
chr1 8947667 8948379 ox2_bound:120 Laptm4a NM_008640 NA NA INSIDE
chr1 9602816 9603316 ox2_bound:121 Osr1 NM_011859 NA NA INSIDE
chr1 1.2E+07 1.2E+07 ox2_bound:121 D12Ertd553e NM_029758 NA NA INSIDE
chr1 1.3E+07 1.3E+07 ox2_bound:121 Mycn NM_008709 NA NA PROMOTER
chr1 1.3E+07 1.3E+07 ox2_bound:121 Mycn NM_008709 NA NA PROMOTER
chr1 1.5E+07 1.5E+07 ox2_bound:121 BC058368 BC058368 NA NA Unknown
chr1 1.6E+07 1.6E+07 ox2_bound:121 Trib2 NM_144551 NA NA INSIDE
chr1 2E+07 2E+07 ox2_bound:121 Ywhaq NM_011739 NA NA PROMOTER
chr1 2.3E+07 2.3E+07 ox2_bound:121 Id2 NM_010496 NA NA PROMOTER
chr1 2.6E+07 2.6E+07 ox2_bound:121 Rps7 NM_011300 NA NA PROMOTER
chr1 3.2E+07 3.2E+07 ox2_bound:121 Twist1 NM_011658 NA NA INSIDE
chr1 3.2E+07 3.2E+07 ox2_bound:122 Hdac9 NM_024124 NA NA PROMOTER
chr1 3.3E+07 3.3E+07 ox2_bound:122 Snx13 NM_001014973 NA NA PROMOTER
chr1 3.4E+07 3.4E+07 ox2_bound:122 Bzw2 NM_025840 NA NA INSIDE
chr1 3.7E+07 3.7E+07 ox2_bound:122 Etv1 NM_007960 NA NA PROMOTER
chr1 3.7E+07 3.7E+07 ox2_bound:122 Etv1 NM_007960 NA NA INSIDE
chr1 4.9E+07 4.9E+07 ox2_bound:122 6030408C04Rik NM_001015099 NA NA PROMOTER
chr1 4.9E+07 4.9E+07 ox2_bound:122 6030408C04Rik NM_001015099 NA NA INSIDE
chr1 5E+07 5E+07 ox2_bound:122 Coch NM_007728 NA NA INSIDE
chr1 5.1E+07 5.1E+07 ox2_bound:122 Npas3 NM_013780 NA NA PROMOTER
chr1 5.1E+07 5.1E+07 ox2_bound:122 Npas3 NM_013780 NA NA INSIDE
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chr1 5.3E+07 5.3E+07 ox2_bound:123 1810011O16Rik NM_025456 NA NA PROMOTER
chr1 5.3E+07 5.3E+07 ox2_bound:123 Nfkbia NM_010907 NA NA PROMOTER
chr1 5.4E+07 5.4E+07 ox2_bound:123 Titf1 NM_009385 NA NA INSIDE
chr1 5.4E+07 5.4E+07 ox2_bound:123 Titf1 NM_009385 NA NA INSIDE
chr1 5.5E+07 5.5E+07 ox2_bound:123 Nkx2-9 NM_008701 NA NA PROMOTER
chr1 5.5E+07 5.5E+07 ox2_bound:123 Pax9 NM_011041 NA NA INSIDE
chr1 6.7E+07 6.7E+07 ox2_bound:123 Klhdc2 NM_027117 NA NA INSIDE
chr1 6.9E+07 6.9E+07 ox2_bound:123 Psma3 NM_011184 NA NA PROMOTER
chr1 6.9E+07 6.9E+07 ox2_bound:123 Timm9 NM_013896 NA NA PROMOTER
chr1 7E+07 7E+07 ox2_bound:123 1200003C05Rik NM_024205 NA NA INSIDE
chr1 7E+07 7E+07 ox2_bound:124 Rtn1 NM_001007596 NA NA INSIDE
chr1 7.1E+07 7.1E+07 ox2_bound:124 Mnat1 NM_008612 NA NA INSIDE
chr1 7.5E+07 7.5E+07 ox2_bound:124 Max NM_008558 NA NA PROMOTER
chr1 7.8E+07 7.8E+07 ox2_bound:124 Zfp36l1 NM_007564 NA NA INSIDE
chr1 7.8E+07 7.8E+07 ox2_bound:124 Zfp36l1 NM_007564 NA NA PROMOTER
chr1 7.8E+07 7.8E+07 ox2_bound:124 Zfp36l1 NM_007564 NA NA PROMOTER
chr1 7.8E+07 7.8E+07 ox2_bound:124 Actn1 NM_134156 NA NA INSIDE
chr1 7.9E+07 7.9E+07 ox2_bound:124 Gm1568 NM_001008423 NA NA INSIDE
chr1 8.1E+07 8.1E+07 ox2_bound:124 Dpf3 NM_058212 NA NA PROMOTER
chr1 8.2E+07 8.2E+07 ox2_bound:124 Papln NM_130887 NA NA PROMOTER
chr1 8.2E+07 8.2E+07 ox2_bound:125 Acot1 NM_012006 NA NA PROMOTER
chr1 8.3E+07 8.3E+07 ox2_bound:125 Abcd4 NM_008992 NA NA PROMOTER
chr1 8.3E+07 8.3E+07 ox2_bound:125 7420416P09Rik NM_001033776 NA NA PROMOTER
chr1 8.3E+07 8.3E+07 ox2_bound:125 7420416P09Rik NM_001033776 NA NA PROMOTER
chr1 8.3E+07 8.3E+07 ox2_bound:125 Acyp1 NM_025421 NA NA DOWNSTREAM
chr1 8.3E+07 8.3E+07 ox2_bound:125 Fos NM_010234 NA NA PROMOTER
chr1 8.3E+07 8.3E+07 ox2_bound:125 Fos NM_010234 NA NA INSIDE
chr1 8.5E+07 8.5E+07 ox2_bound:125 6430527G18Rik NM_145836 NA NA PROMOTER
chr1 8.5E+07 8.5E+07 ox2_bound:125 2310044G17Rik NM_173735 NA NA PROMOTER
chr1 9.3E+07 9.3E+07 ox2_bound:125 Flrt2 NM_201518 NA NA INSIDE
chr1 9.6E+07 9.6E+07 ox2_bound:126 Ptpn21 NM_011877 NA NA PROMOTER
chr1 9.8E+07 9.8E+07 ox2_bound:126 Rps6ka5 NM_153587 NA NA PROMOTER
chr1 1E+08 1E+08 ox2_bound:126 Itpk1 NM_172584 NA NA INSIDE
chr1 1E+08 1E+08 ox2_bound:126 Itpk1 NM_172584 NA NA PROMOTER
chr1 1E+08 1E+08 ox2_bound:126 Moap1 NM_022323 NA NA PROMOTER
chr1 1E+08 1E+08 ox2_bound:126 Gsc NM_010351 NA NA PROMOTER
chr1 1E+08 1E+08 ox2_bound:126 Tcl1 NM_009337 NA NA PROMOTER
chr1 1E+08 1E+08 ox2_bound:126 Tcl1 NM_009337 NA NA PROMOTER
chr1 1.1E+08 1.1E+08 ox2_bound:126 Rcor1 NM_198023 NA NA PROMOTER
chr1 1.1E+08 1.1E+08 ox2_bound:126 Ckb NM_021273 NA NA INSIDE
chr1 1.2E+08 1.2E+08 ox2_bound:127 Sp8 NM_177082 NA NA PROMOTER
chr1 1.2E+08 1.2E+08 ox2_bound:127 Sp8 NM_177082 NA NA PROMOTER
chr1 5745679 5746179 ox2_bound:127 Klf6 NM_011803 NA NA PROMOTER
chr1 1.3E+07 1.3E+07 ox2_bound:127 Tbce NM_178337 NA NA PROMOTER
chr1 1.7E+07 1.7E+07 ox2_bound:127 2810021B07Rik NM_025479 NA NA INSIDE
chr1 2.1E+07 2.1E+07 ox2_bound:127 Hist1h3h NM_178206 NA NA PROMOTER
chr1 2.1E+07 2.1E+07 ox2_bound:127 Hist1h2bm NM_178200 NA NA PROMOTER
chr1 2.1E+07 2.1E+07 ox2_bound:127 Hist1h4j NM_178210 NA NA PROMOTER
chr1 2.1E+07 2.1E+07 ox2_bound:127 Hist1h4j NM_178210 NA NA DOWNSTREAM
chr1 2.1E+07 2.1E+07 ox2_bound:127 Hist1h4k NM_178211 NA NA DOWNSTREAM
chr1 2.1E+07 2.1E+07 ox2_bound:128 Hist1h1b NM_020034 NA NA PROMOTER
chr1 2.1E+07 2.1E+07 ox2_bound:128 Hist1h3i NM_178207 NA NA PROMOTER
chr1 2.1E+07 2.1E+07 ox2_bound:128 Hist1h3i NM_178207 NA NA PROMOTER
chr1 2.1E+07 2.1E+07 ox2_bound:128 Hist1h2an NM_178184 Hist1h2bp NM_178202 DIVERGENT
chr1 2.1E+07 2.1E+07 ox2_bound:128 Hist1h2bp NM_178202 NA NA DOWNSTREAM
chr1 2.1E+07 2.1E+07 ox2_bound:128 Hist1h2bp NM_178202 NA NA DOWNSTREAM
chr1 2.1E+07 2.1E+07 ox2_bound:128 Zfp184 NM_183014 NA NA PROMOTER
chr1 2.1E+07 2.1E+07 ox2_bound:128 Hist1h2ah NM_175659 Hist1h2bk NA DOWNSTREAM
chr1 2.1E+07 2.1E+07 ox2_bound:128 Hist1h2ah NM_175659 NA NM_175665 DIVERGENT
chr1 2.1E+07 2.1E+07 ox2_bound:128 Hist1h2bk NM_175665 NA NA DOWNSTREAM
chr1 2.1E+07 2.1E+07 ox2_bound:129 Hist1h4i NM_175656 NA NA DOWNSTREAM
chr1 2.1E+07 2.1E+07 ox2_bound:129 Hist1h4i NM_175656 NA NA PROMOTER
chr1 2.1E+07 2.1E+07 ox2_bound:129 Hist1h2ag NM_178186 Hist1h2bj NM_178198 DIVERGENT
chr1 2.3E+07 2.3E+07 ox2_bound:129 Abt1 NM_013924 NA NA PROMOTER
chr1 2.3E+07 2.3E+07 ox2_bound:129 Btn2a2 NM_175938 NA NA PROMOTER
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chr1 2.3E+07 2.3E+07 ox2_bound:129 Hist1h4h NM_153173 NA NA PROMOTER
chr1 2.3E+07 2.3E+07 ox2_bound:129 Hist1h4h NM_153173 NA NA PROMOTER
chr1 2.3E+07 2.3E+07 ox2_bound:129 Hist1h2af NM_175661 NA NA PROMOTER
chr1 2.3E+07 2.3E+07 ox2_bound:129 Hist1h2af NM_175661 NA NA PROMOTER
chr1 2.3E+07 2.3E+07 ox2_bound:129 Hist1h3f NM_013548 NA NA INSIDE
chr1 2.3E+07 2.3E+07 ox2_bound:130 Hist1h3h NM_178206 NA NA INSIDE
chr1 2.3E+07 2.3E+07 ox2_bound:130 Hist1h1d NM_145713 NA NA INSIDE
chr1 2.3E+07 2.3E+07 ox2_bound:130 Hist1h3e NM_178205 NA NA PROMOTER
chr1 2.3E+07 2.3E+07 ox2_bound:130 Hist1h3e NM_178205 NA NA PROMOTER
chr1 2.3E+07 2.3E+07 ox2_bound:130 Hist1h2ae NM_178187 NA NM_178196 DIVERGENT
chr1 2.3E+07 2.3E+07 ox2_bound:130 Hist1h3h NM_178206 NA NA INSIDE
chr1 2.3E+07 2.3E+07 ox2_bound:130 Hist1h3d NM_178204 NA NA PROMOTER
chr1 2.3E+07 2.3E+07 ox2_bound:130 Hist1h4d NM_175654 NA NA INSIDE
chr1 2.3E+07 2.3E+07 ox2_bound:130 Hist1h2bc NM_023422 NA NA INSIDE
chr1 2.3E+07 2.3E+07 ox2_bound:130 Hist1h3h NM_178206 NA NA INSIDE
chr1 2.3E+07 2.3E+07 ox2_bound:131 Hist1h1c NM_015786 NA NA INSIDE
chr1 2.3E+07 2.3E+07 ox2_bound:131 Hist1h3h NM_178206 NA NA INSIDE
chr1 2.3E+07 2.3E+07 ox2_bound:131 Hist1h2ab NM_175660 NA NA PROMOTER
chr1 2.3E+07 2.3E+07 ox2_bound:131 Hist1h4a NM_178192 NA NA PROMOTER
chr1 2.3E+07 2.3E+07 ox2_bound:131 Hist1h1a NM_030609 NA NA DOWNSTREAM
chr1 2.3E+07 2.3E+07 ox2_bound:131 Scgn NM_145399 NA NA PROMOTER
chr1 2.5E+07 2.5E+07 ox2_bound:131 Vmp NM_009513 NA NA PROMOTER
chr1 3.4E+07 3.4E+07 ox2_bound:131 Tubb2b NM_023716 NA NA PROMOTER
chr1 3.4E+07 3.4E+07 ox2_bound:131 Tubb2b NM_023716 NA NA PROMOTER
chr1 3.4E+07 3.4E+07 ox2_bound:131 Tubb2b NM_023716 NA NA PROMOTER
chr1 4E+07 4E+07 ox2_bound:132 Tcfap2a NM_011547 NA NA INSIDE
chr1 4E+07 4E+07 ox2_bound:132 Gcnt2 NM_008105 NA NA PROMOTER
chr1 4E+07 4E+07 ox2_bound:132 Gcnt2 NM_133219 NA NA PROMOTER
chr1 4.2E+07 4.2E+07 ox2_bound:132 Edn1 NM_010104 NA NA PROMOTER
chr1 4.3E+07 4.3E+07 ox2_bound:132 Rnf182 NM_183204 NA NA PROMOTER
chr1 4.4E+07 4.4E+07 ox2_bound:132 Jarid2 NM_021878 NA NA PROMOTER
chr1 4.6E+07 4.6E+07 ox2_bound:132 Nup153 NM_175749 NA NA PROMOTER
chr1 4.6E+07 4.6E+07 ox2_bound:132 Kif13a NM_010617 NA NA INSIDE
chr1 4.9E+07 4.9E+07 ox2_bound:132 1700022C02Rik NM_025495 NA NA PROMOTER
chr1 5.1E+07 5.1E+07 ox2_bound:132 Shc3 NM_009167 NA NA PROMOTER
chr1 5.1E+07 5.1E+07 ox2_bound:133 Gadd45g NM_011817 NA NA INSIDE
chr1 5.3E+07 5.3E+07 ox2_bound:133 Msx2 NM_013601 NA NA INSIDE
chr1 5.3E+07 5.3E+07 ox2_bound:133 Sfxn1 NM_027324 NA NA PROMOTER
chr1 5.4E+07 5.4E+07 ox2_bound:133 Higd2a NM_025933 NA NA INSIDE
chr1 6E+07 6E+07 ox2_bound:133 Dapk1 NM_029653 NA NA INSIDE
chr1 6.1E+07 6.1E+07 ox2_bound:133 Ptch1 NM_008957 NA NA PROMOTER
chr1 6.1E+07 6.1E+07 ox2_bound:133 Ptch1 NM_008957 NA NA PROMOTER
chr1 6.5E+07 6.5E+07 ox2_bound:133 6820416H06Rik NM_198322 NA NA INSIDE
chr1 6.5E+07 6.5E+07 ox2_bound:133 BC048507 BC048507 NA NA Unknown
chr1 7E+07 7E+07 ox2_bound:133 Irx2 NM_010574 NA NA INSIDE
chr1 7.2E+07 7.2E+07 ox2_bound:134 Pcsk1 NM_013628 NA NA INSIDE
chr1 7.9E+07 7.9E+07 ox2_bound:134 Lysmd3 NM_030257 NA NA PROMOTER
chr1 8.1E+07 8.1E+07 ox2_bound:134 mmu-mir-9-2 mmu-mir-9-2 NA NA PROMOTER
chr1 8.1E+07 8.1E+07 ox2_bound:134 C130071C03Rik NM_177100 NA NA INSIDE
chr1 8.1E+07 8.1E+07 ox2_bound:134 C130071C03Rik NM_177100 NA NA INSIDE
chr1 8.8E+07 8.8E+07 ox2_bound:134 Rps23 NM_024175 NA NA DOWNSTREAM
chr1 9.3E+07 9.3E+07 ox2_bound:134 F2rl1 NM_007974 NA NA PROMOTER
chr1 9.4E+07 9.4E+07 ox2_bound:134 Hmgcr NM_008255 NA NA PROMOTER
chr1 9.4E+07 9.4E+07 ox2_bound:134 Hmgcr NM_008255 NA NA PROMOTER
chr1 9.4E+07 9.4E+07 ox2_bound:134 Hexb NM_010422 NA NA INSIDE
chr1 9.7E+07 9.7E+07 ox2_bound:135 Mtap1b NM_008634 NA NA INSIDE
chr1 1E+08 1E+08 ox2_bound:135 2410002O22Rik NM_025879 NA NA INSIDE
chr1 1.1E+08 1.1E+08 ox2_bound:135 Il6st NM_010560 NA NA PROMOTER
chr1 1.1E+08 1.1E+08 ox2_bound:135 mmu-mir-449 mmu-mir-449 NA NA PROMOTER
chr1 1.1E+08 1.1E+08 ox2_bound:135 mmu-mir-449 mmu-mir-449 NA NA PROMOTER
chr1 1.1E+08 1.1E+08 ox2_bound:135 Ndufs4 NM_010887 NA NA PROMOTER
chr1 1.1E+08 1.1E+08 ox2_bound:135 Itga1 NM_001033228 NA NA INSIDE
chr1 1.1E+08 1.1E+08 ox2_bound:135 Emb NM_010330 NA NA PROMOTER
chr1 1.1E+08 1.1E+08 ox2_bound:135 Emb NM_010330 NA NA PROMOTER
chr1 5985472 5985972 ox2_bound:135 Pdhb NM_024221 NA NA PROMOTER
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chr1 9368570 9369324 ox2_bound:136 Ptprg NM_008981 NA NA PROMOTER
chr1 1E+07 1E+07 ox2_bound:136 Zfp312 NM_080433 NA NA INSIDE
chr1 1E+07 1E+07 ox2_bound:136 Zfp312 NM_080433 NA NA INSIDE
chr1 1.7E+07 1.7E+07 ox2_bound:136 Nid2 NM_008695 NA NA PROMOTER
chr1 1.8E+07 1.8E+07 ox2_bound:136 Nudt13 NM_026341 NA NA INSIDE
chr1 2E+07 2E+07 ox2_bound:136 Zfp503 NM_145459 NA NA PROMOTER
chr1 2.3E+07 2.3E+07 ox2_bound:136 Rai17 NM_183208 NA NA PROMOTER
chr1 2.4E+07 2.4E+07 ox2_bound:136 Anxa11 NM_013469 NA NA PROMOTER
chr1 2.4E+07 2.4E+07 ox2_bound:136 Slmap NM_032008 NA NA PROMOTER
chr1 2.4E+07 2.4E+07 ox2_bound:136 E430028B21Rik NM_178668 NA NA INSIDE
chr1 2.4E+07 2.4E+07 ox2_bound:137 Hesx1 NM_010420 NA NA INSIDE
chr1 2.7E+07 2.7E+07 ox2_bound:137 Selk NM_019979 NA NA PROMOTER
chr1 3.2E+07 3.2E+07 ox2_bound:137 Glud1 NM_008133 NA NA INSIDE
chr1 3.2E+07 3.2E+07 ox2_bound:137 Mmrn2 NM_153127 NA NA INSIDE
chr1 3.2E+07 3.2E+07 ox2_bound:137 mmu-mir-346 mmu-mir-346 NA NA PROMOTER
chr1 3.8E+07 3.8E+07 ox2_bound:137 Sh2d4b NM_177816 NA NA INSIDE
chr1 3.8E+07 3.8E+07 ox2_bound:137 Sh2d4b NM_177816 NA NA INSIDE
chr1 4.1E+07 4.1E+07 ox2_bound:137 Gnpnat1 NM_019425 NA NA INSIDE
chr1 4.2E+07 4.2E+07 ox2_bound:137 Bmp4 NM_007554 NA NA PROMOTER
chr1 4.4E+07 4.4E+07 ox2_bound:137 Otx2 NM_144841 NA NA PROMOTER
chr1 4.4E+07 4.4E+07 ox2_bound:138 Otx2 NM_144841 NA NA PROMOTER
chr1 4.6E+07 4.6E+07 ox2_bound:138 Rnase9 NM_183032 NA NA PROMOTER
chr1 4.6E+07 4.6E+07 ox2_bound:138 Rnase4 NM_021472 NA NA PROMOTER
chr1 4.7E+07 4.7E+07 ox2_bound:138 Zfp219 NM_027248 NA NA PROMOTER
chr1 4.7E+07 4.7E+07 ox2_bound:138 Hnrpc NM_016884 Rpgrip1 NM_023879 DIVERGENT
chr1 4.8E+07 4.8E+07 ox2_bound:138 5730589K01Rik NM_023434 NA NA INSIDE
chr1 4.8E+07 4.8E+07 ox2_bound:138 Sall2 NM_015772 NA NA PROMOTER
chr1 4.9E+07 4.9E+07 ox2_bound:138 Slc7a7 NM_011405 Mrpl52 NA INSIDE
chr1 4.9E+07 4.9E+07 ox2_bound:138 Slc7a7 NM_011405 NA NA INSIDE
chr1 4.9E+07 4.9E+07 ox2_bound:138 Slc7a7 NM_011405 NA NM_026851 DIVERGENT
chr1 4.9E+07 4.9E+07 ox2_bound:139 Prmt5 NM_013768 NA NA PROMOTER
chr1 5E+07 5E+07 ox2_bound:139 1500001L15Rik NM_026890 NA NA PROMOTER
chr1 5E+07 5E+07 ox2_bound:139 Wdr23 NM_133734 NA NA INSIDE
chr1 5.1E+07 5.1E+07 ox2_bound:139 Nfatc4 NM_023699 NA NA PROMOTER
chr1 5.4E+07 5.4E+07 ox2_bound:139 Tmem46 NM_145463 NA NA PROMOTER
chr1 5.6E+07 5.6E+07 ox2_bound:139 Sacs NM_172809 NA NA PROMOTER
chr1 5.6E+07 5.6E+07 ox2_bound:139 Sacs NM_172809 NA NA INSIDE
chr1 5.7E+07 5.7E+07 ox2_bound:139 Dleu8 NM_026001 NA NA PROMOTER
chr1 5.8E+07 5.8E+07 ox2_bound:139 Fdft1 NM_010191 NA NA PROMOTER
chr1 5.8E+07 5.8E+07 ox2_bound:139 Tdh NM_021480 NA NA INSIDE
chr1 5.9E+07 5.9E+07 ox2_bound:140 mmu-mir-124a-1 mmu-mir-124a- NA NA PROMOTER
chr1 5.9E+07 5.9E+07 ox2_bound:140 mmu-mir-124a-1 mmu-mir-124a- NA NA DOWNSTREAM
chr1 6E+07 6E+07 ox2_bound:140 Hmbox1 NM_177338 D14Ertd231e NM_153414 DIVERGENT
chr1 6E+07 6E+07 ox2_bound:140 Fbxo16 NM_015795 NA NA PROMOTER
chr1 6.1E+07 6.1E+07 ox2_bound:140 Pbk NM_023209 NA NA INSIDE
chr1 6.1E+07 6.1E+07 ox2_bound:140 Ephx2 NM_007940 NA NA INSIDE
chr1 6.2E+07 6.2E+07 ox2_bound:140 Dpysl2 NM_009955 NA NA INSIDE
chr1 6.2E+07 6.2E+07 ox2_bound:140 Ebf2 NM_010095 NA NA PROMOTER
chr1 6.2E+07 6.2E+07 ox2_bound:140 Ebf2 NM_010095 NA NA PROMOTER
chr1 6.2E+07 6.2E+07 ox2_bound:140 Ebf2 NM_010095 NA NA INSIDE
chr1 6.3E+07 6.3E+07 ox2_bound:141 Nefl NM_010910 NA NA PROMOTER
chr1 6.4E+07 6.4E+07 ox2_bound:141 Chmp7 NM_134078 NA NA PROMOTER
chr1 6.4E+07 6.4E+07 ox2_bound:141 Chmp7 NM_134078 NA NA PROMOTER
chr1 6.5E+07 6.5E+07 ox2_bound:141 Slc39a14 NM_144808 NA NA PROMOTER
chr1 6.5E+07 6.5E+07 ox2_bound:141 Epb4.9 NM_013514 NA NA PROMOTER
chr1 6.8E+07 6.8E+07 ox2_bound:141 P2ry5 NM_175116 NA NA PROMOTER
chr1 6.8E+07 6.8E+07 ox2_bound:141 P2ry5 NM_175116 NA NA INSIDE
chr1 7.2E+07 7.2E+07 ox2_bound:141 LOC629678 NM_001037935 NA NA PROMOTER
chr1 7.4E+07 7.4E+07 ox2_bound:141 Pcdh8 NM_021543 NA NA PROMOTER
chr1 7.4E+07 7.4E+07 ox2_bound:141 Pcdh8 NM_021543 NA NA PROMOTER
chr1 8.2E+07 8.2E+07 ox2_bound:142 Tdrd3 NM_172605 NA NA INSIDE
chr1 1E+08 1E+08 ox2_bound:142 Spry2 NM_011897 NA NA PROMOTER
chr1 1.1E+08 1.1E+08 ox2_bound:142 Gpc6 NM_011821 NA NA INSIDE
chr1 1.1E+08 1.1E+08 ox2_bound:142 Tgds NM_029578 Gpr180 NM_021434 DIVERGENT
chr1 1.2E+08 1.2E+08 ox2_bound:142 Slc15a1 NM_053079 NA NA PROMOTER
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chr1 1.2E+08 1.2E+08 ox2_bound:142 6530402A20 NM_177817 NA NA INSIDE
chr1 1.2E+08 1.2E+08 ox2_bound:142 Zic5 NM_022987 Zic2 NM_009574 DIVERGENT
chr1 1.2E+08 1.2E+08 ox2_bound:142 Zic2 NM_009574 NA NA INSIDE
chr1 3853269 3853769 ox2_bound:142 Oxct1 NM_024188 NA NA PROMOTER
chr1 7639552 7640218 ox2_bound:142 Gdnf NM_010275 NA NA INSIDE
chr1 1.1E+07 1.1E+07 ox2_bound:143 Rai14 NM_030690 NA NA PROMOTER
chr1 1.1E+07 1.1E+07 ox2_bound:143 C1qtnf3 NM_030888 NA NA INSIDE
chr1 1.1E+07 1.1E+07 ox2_bound:143 C1qtnf3 NM_030888 NA NA INSIDE
chr1 1.1E+07 1.1E+07 ox2_bound:143 C1qtnf3 NM_030888 NA NA INSIDE
chr1 1.2E+07 1.2E+07 ox2_bound:143 Zfr NM_011767 NA NA PROMOTER
chr1 1.2E+07 1.2E+07 ox2_bound:143 Mtmr12 NM_172958 NA NA PROMOTER
chr1 1.2E+07 1.2E+07 ox2_bound:143 Mtmr12 NM_172958 NA NA INSIDE
chr1 1.2E+07 1.2E+07 ox2_bound:143 Golph3 NM_025673 NA NA INSIDE
chr1 1.3E+07 1.3E+07 ox2_bound:143 Cdh6 NM_007666 NA NA PROMOTER
chr1 1.3E+07 1.3E+07 ox2_bound:143 Cdh6 NM_007666 NA NA PROMOTER
chr1 2.5E+07 2.5E+07 ox2_bound:144 Basp1 NM_027395 NA NA PROMOTER
chr1 2.6E+07 2.6E+07 ox2_bound:144 LOC432939 NM_001013791 NA NA PROMOTER
chr1 3.2E+07 3.2E+07 ox2_bound:144 Cct5 NM_007637 A930016P21RikNM_026546 DIVERGENT
chr1 3.5E+07 3.5E+07 ox2_bound:144 Osr2 NM_054049 NA NA PROMOTER
chr1 3.5E+07 3.5E+07 ox2_bound:144 Osr2 NM_054049 NA NA PROMOTER
chr1 3.7E+07 3.7E+07 ox2_bound:144 Zfp706 NM_026521 NA NA PROMOTER
chr1 3.7E+07 3.7E+07 ox2_bound:144 Grhl2 NM_026496 NA NA INSIDE
chr1 4E+07 4E+07 ox2_bound:144 Dpys NM_022722 NA NA INSIDE
chr1 4.3E+07 4.3E+07 ox2_bound:144 Angpt1 NM_009640 NA NA INSIDE
chr1 5.3E+07 5.3E+07 ox2_bound:144 Ext1 NM_010162 NA NA INSIDE
chr1 5.5E+07 5.5E+07 ox2_bound:145 Depdc6 NM_145470 NA NA INSIDE
chr1 5.6E+07 5.6E+07 ox2_bound:145 Mtbp NM_134092 NA NA INSIDE
chr1 5.7E+07 5.7E+07 ox2_bound:145 Has2 NM_008216 NA NA INSIDE
chr1 5.9E+07 5.9E+07 ox2_bound:145 Mtss1 NM_144800 NA NA INSIDE
chr1 5.9E+07 5.9E+07 ox2_bound:145 Mtss1 NM_144800 NA NA PROMOTER
chr1 6.7E+07 6.7E+07 ox2_bound:145 Wisp1 NM_018865 NA NA PROMOTER
chr1 7.5E+07 7.5E+07 ox2_bound:145 Ly6e NM_008529 NA NA INSIDE
chr1 7.6E+07 7.6E+07 ox2_bound:145 Mafa NM_194350 NA NA PROMOTER
chr1 7.7E+07 7.7E+07 ox2_bound:145 Foxh1 NM_007989 Ppp1r16a NM_033371 DIVERGENT
chr1 7.8E+07 7.8E+07 ox2_bound:145 D15Bwg0759e NM_001017983 NA NA INSIDE
chr1 7.9E+07 7.9E+07 ox2_bound:146 Cdc42ep1 NM_027219 NA NA INSIDE
chr1 8E+07 8E+07 ox2_bound:146 Dmc1h NM_010059 NA NA PROMOTER
chr1 8E+07 8E+07 ox2_bound:146 Apobec3 NM_030255 NA NA PROMOTER
chr1 8E+07 8E+07 ox2_bound:146 Cbx7 NM_144811 NA NA PROMOTER
chr1 8E+07 8E+07 ox2_bound:146 Cbx7 NM_144811 NA NA PROMOTER
chr1 8E+07 8E+07 ox2_bound:146 Cbx7 NM_144811 NA NA PROMOTER
chr1 8E+07 8E+07 ox2_bound:146 Rpl3 NM_013762 Syngr1 NA INSIDE
chr1 8E+07 8E+07 ox2_bound:146 Rpl32 NM_013762 NA NM_009303 DIVERGENT
chr1 8E+07 8E+07 ox2_bound:146 Rpl36 NM_013762 NA NM_009303 DIVERGENT
chr1 8.2E+07 8.2E+07 ox2_bound:146 L3mbtl2 NM_145993 NA NA PROMOTER
chr1 8.2E+07 8.2E+07 ox2_bound:147 Tob2 NM_020507 NA NA PROMOTER
chr1 8.2E+07 8.2E+07 ox2_bound:147 Phf5a NM_026737 Aco2 NM_080633 DIVERGENT
chr1 8.3E+07 8.3E+07 ox2_bound:147 Poldip3 NM_178627 NA NA PROMOTER
chr1 8.4E+07 8.4E+07 ox2_bound:147 Samm50 NM_178614 NA NA PROMOTER
chr1 8.5E+07 8.5E+07 ox2_bound:147 BC024991 BC024991 NA NA Unknown
chr1 9E+07 9E+07 ox2_bound:147 Arsa NM_009713 NA NA PROMOTER
chr1 9E+07 9E+07 ox2_bound:147 Shank3 NM_021423 NA NA PROMOTER
chr1 9.3E+07 9.3E+07 ox2_bound:147 Zcrb1 NM_026025 NA NA INSIDE
chr1 9.6E+07 9.6E+07 ox2_bound:147 Tmem16f NM_175344 NA NA PROMOTER
chr1 9.7E+07 9.7E+07 ox2_bound:147 Slc38a2 NM_175121 NA NA PROMOTER
chr1 9.7E+07 9.7E+07 ox2_bound:148 Slc38a2 NM_175121 NA NA PROMOTER
chr1 9.8E+07 9.8E+07 ox2_bound:148 Col2a1 NM_031163 NA NA INSIDE
chr1 9.9E+07 9.9E+07 ox2_bound:148 Cacnb3 NM_007581 NA NA INSIDE
chr1 9.9E+07 9.9E+07 ox2_bound:148 Tuba1 NM_011653 NA NA INSIDE
chr1 1E+08 1E+08 ox2_bound:148 Smarcd1 NM_031842 NA NA INSIDE
chr1 1E+08 1E+08 ox2_bound:148 BC031490 BC031490 NA NA Unknown
chr1 1E+08 1E+08 ox2_bound:148 BC031490 BC031490 NA NA Unknown
chr1 1E+08 1E+08 ox2_bound:148 BC004728 NM_174992 NA NA INSIDE
chr1 1E+08 1E+08 ox2_bound:148 LOC432988 NM_001004171 NA NA INSIDE
chr1 1E+08 1E+08 ox2_bound:148 Aaas NM_153416 NA NA PROMOTER
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chr1 1E+08 1E+08 ox2_bound:149 Prr13 NM_025385 NA NA INSIDE
chr1 1E+08 1E+08 ox2_bound:149 Hoxc12 NM_010463 NA NA PROMOTER
chr1 1E+08 1E+08 ox2_bound:149 Hoxc5 NM_175730 NA NA INSIDE
chr1 1E+08 1E+08 ox2_bound:149 Smug1 NM_027885 NA NA PROMOTER
chr1 1E+08 1E+08 ox2_bound:149 Hnrpa1 NM_001039129 NA NA INSIDE
chr1 4558866 4559366 ox2_bound:149 Mgrn1 NM_029657 NA NA PROMOTER
chr1 1.3E+07 1.3E+07 ox2_bound:149 Parn NM_028761 Bfar NM_025976 DIVERGENT
chr1 1.3E+07 1.3E+07 ox2_bound:149 Pla2g10 NM_011987 NA NA PROMOTER
chr1 1.3E+07 1.3E+07 ox2_bound:149 Rrn3 NM_001039521 NA NA INSIDE
chr1 1.4E+07 1.4E+07 ox2_bound:149 2900011O08Rik NM_144518 NA NA INSIDE
chr1 1.6E+07 1.6E+07 ox2_bound:150 Yars2 NM_198246 NA NA PROMOTER
chr1 1.6E+07 1.6E+07 ox2_bound:150 Fgd4 NM_139234 NA NA PROMOTER
chr1 1.7E+07 1.7E+07 ox2_bound:150 Thap7 NM_026909 NA NA PROMOTER
chr1 1.7E+07 1.7E+07 ox2_bound:150 Slc25a1 NM_153150 NA NA PROMOTER
chr1 2E+07 2E+07 ox2_bound:150 Ap2m1 NM_009679 NA NA PROMOTER
chr1 2.2E+07 2.2E+07 ox2_bound:150 Liph NM_153404 NA NA PROMOTER
chr1 2.2E+07 2.2E+07 ox2_bound:150 Liph NM_153404 NA NA PROMOTER
chr1 2.2E+07 2.2E+07 ox2_bound:150 C330012H03Rik NM_183029 NA NA INSIDE
chr1 2.2E+07 2.2E+07 ox2_bound:150 Sfrs10 NM_009186 NA NA INSIDE
chr1 2.2E+07 2.2E+07 ox2_bound:150 Etv5 NM_023794 NA NA PROMOTER
chr1 2.2E+07 2.2E+07 ox2_bound:151 Etv5 NM_023794 NA NA PROMOTER
chr1 2.3E+07 2.3E+07 ox2_bound:151 Eif4a2 NM_013506 NA NA INSIDE
chr1 2.3E+07 2.3E+07 ox2_bound:151 B630019A10Rik NM_177072 NA NA PROMOTER
chr1 2.4E+07 2.4E+07 ox2_bound:151 Lpp NM_178665 NA NA PROMOTER
chr1 3.3E+07 3.3E+07 ox2_bound:151 Slc12a8 NM_134251 NA NA PROMOTER
chr1 3.6E+07 3.6E+07 ox2_bound:151 Parp14 NM_001039530 NA NA INSIDE
chr1 3.8E+07 3.8E+07 ox2_bound:151 Tmem39a NM_026407 NA NA PROMOTER
chr1 4.5E+07 4.5E+07 ox2_bound:151 Cd200r1 NM_021325 NA NA PROMOTER
chr1 4.6E+07 4.6E+07 ox2_bound:151 Tagln3 NM_019754 NA NA PROMOTER
chr1 4.6E+07 4.6E+07 ox2_bound:151 Tagln3 NM_019754 NA NA PROMOTER
chr1 4.8E+07 4.8E+07 ox2_bound:152 Dppa4 NM_001018002 NA NA PROMOTER
chr1 5.6E+07 5.6E+07 ox2_bound:152 Nfkbiz NM_030612 NA NA PROMOTER
chr1 8.5E+07 8.5E+07 ox2_bound:152 Jam2 NM_023844 NA NA PROMOTER
chr1 8.6E+07 8.6E+07 ox2_bound:152 Adamts1 NM_009621 NA NA PROMOTER
chr1 9E+07 9E+07 ox2_bound:152 BC065126 BC065126 NA NA Unknown
chr1 9.2E+07 9.2E+07 ox2_bound:152 Ifngr2 NM_008338 NA NA INSIDE
chr1 9.2E+07 9.2E+07 ox2_bound:152 Cryzl1 NM_133679 NA NA PROMOTER
chr1 9.2E+07 9.2E+07 ox2_bound:152 1190017O12Rik NM_138743 NA NA INSIDE
chr1 9.6E+07 9.6E+07 ox2_bound:152 Brwd1 NM_145125 NA NA PROMOTER
chr1 5385118 5385765 ox2_bound:152 5730437N04Rik NM_027457 NA NA INSIDE
chr1 5435942 5436570 ox2_bound:153 Zdhhc14 NM_146073 NA NA PROMOTER
chr1 1.3E+07 1.3E+07 ox2_bound:153 Thbs2 NM_011581 NA NA INSIDE
chr1 1.3E+07 1.3E+07 ox2_bound:153 Tcte3 NM_011560 NA NA INSIDE
chr1 1.4E+07 1.4E+07 ox2_bound:153 Dll1 NM_007865 NA NA PROMOTER
chr1 1.4E+07 1.4E+07 ox2_bound:153 Dll1 NM_007865 NA NA PROMOTER
chr1 1.4E+07 1.4E+07 ox2_bound:153 Dll1 NM_007865 NA NA PROMOTER
chr1 1.6E+07 1.6E+07 ox2_bound:153 Lnpep NM_172827 NA NA PROMOTER
chr1 1.9E+07 1.9E+07 ox2_bound:153 Zfp160 NM_145483 NA NA PROMOTER
chr1 2.2E+07 2.2E+07 ox2_bound:153 Zfp206 NM_001033425 NA NA INSIDE
chr1 2.2E+07 2.2E+07 ox2_bound:153 Zfp206 NM_001033425 NA NA INSIDE
chr1 2.2E+07 2.2E+07 ox2_bound:154 2810417J12Rik NM_029798 NA NA PROMOTER
chr1 2.2E+07 2.2E+07 ox2_bound:154 Tbc1d24 NM_173186 NA NA INSIDE
chr1 2.3E+07 2.3E+07 ox2_bound:154 Traf7 NM_153792 NA NA PROMOTER
chr1 2.3E+07 2.3E+07 ox2_bound:154 Fahd1 NM_023480 NA NA INSIDE
chr1 2.4E+07 2.4E+07 ox2_bound:154 Msln NM_018857 NA NA PROMOTER
chr1 2.4E+07 2.4E+07 ox2_bound:154 Tmem8 NM_021793 NA NA PROMOTER
chr1 2.5E+07 2.5E+07 ox2_bound:154 Dusp1 NM_013642 NA NA PROMOTER
chr1 2.5E+07 2.5E+07 ox2_bound:154 Itpr3 NM_080553 NA NA PROMOTER
chr1 2.6E+07 2.6E+07 ox2_bound:154 Grm4 NM_001013385 NA NA INSIDE
chr1 2.7E+07 2.7E+07 ox2_bound:154 Gm749 NM_001034871 NA NA PROMOTER
chr1 2.7E+07 2.7E+07 ox2_bound:155 Gm749 NM_001034871 NA NA PROMOTER
chr1 2.7E+07 2.7E+07 ox2_bound:155 Stk38 NM_134115 NA NA PROMOTER
chr1 2.7E+07 2.7E+07 ox2_bound:155 Stk38 NM_134115 NA NA PROMOTER
chr1 2.9E+07 2.9E+07 ox2_bound:155 Slc37a1 NM_153062 NA NA INSIDE
chr1 3.1E+07 3.1E+07 ox2_bound:155 Morc2b NM_177719 NA NA INSIDE
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chr1 3.1E+07 3.1E+07 ox2_bound:155 Zfp422 NM_029952 rs1 NA INSIDE
chr1 3.2E+07 3.2E+07 ox2_bound:155 Daxx NM_007829 NA NA PROMOTER
chr1 3.2E+07 3.2E+07 ox2_bound:155 Rps18 NM_011296 Vps52 NM_172620 DIVERGENT
chr1 3.3E+07 3.3E+07 ox2_bound:155 Notch4 NM_010929 NA NA INSIDE
chr1 3.4E+07 3.4E+07 ox2_bound:155 Pou5f1 NM_013633 NA NA PROMOTER
chr1 3.4E+07 3.4E+07 ox2_bound:156 Pou5f1 NM_013633 NA NA PROMOTER
chr1 3.4E+07 3.4E+07 ox2_bound:156 Cdsn NM_001008424 NA NA PROMOTER
chr1 3.4E+07 3.4E+07 ox2_bound:156 Tubb5 NM_011655 Myg1 NA INSIDE
chr1 3.4E+07 3.4E+07 ox2_bound:156 Tubb5 NM_011655 NA NM_021713 DIVERGENT
chr1 3.4E+07 3.4E+07 ox2_bound:156 Ppp1r10 NM_175934 NA NA INSIDE
chr1 3.5E+07 3.5E+07 ox2_bound:156 Ppp1r11 NM_029632 NA NA PROMOTER
chr1 3.5E+07 3.5E+07 ox2_bound:156 2410137M14Rik NM_029747 NA NA PROMOTER
chr1 3.5E+07 3.5E+07 ox2_bound:156 Zfp57 NM_001013745 NA NA PROMOTER
chr1 3.5E+07 3.5E+07 ox2_bound:156 Zfp57 NM_009559 NA NA PROMOTER
chr1 3.5E+07 3.5E+07 ox2_bound:156 Mog NM_010814 NA NA PROMOTER
chr1 4.4E+07 4.4E+07 ox2_bound:157 Hsp90ab1 NM_008302 NA NA PROMOTER
chr1 4.4E+07 4.4E+07 ox2_bound:157 Slc29a1 NM_022880 NA NA PROMOTER
chr1 4.5E+07 4.5E+07 ox2_bound:157 Slc22a7 NM_144856 NA NA PROMOTER
chr1 4.5E+07 4.5E+07 ox2_bound:157 Rpl7l1 NM_025433 NA NA PROMOTER
chr1 5E+07 5E+07 ox2_bound:157 Satb1 NM_009122 NA NA PROMOTER
chr1 5.1E+07 5.1E+07 ox2_bound:157 Kcnh8 NM_001031811 NA NA PROMOTER
chr1 5.2E+07 5.2E+07 ox2_bound:157 Pcaf NM_020005 NA NA PROMOTER
chr1 5.2E+07 5.2E+07 ox2_bound:157 Pcaf NM_020005 NA NA PROMOTER
chr1 5.2E+07 5.2E+07 ox2_bound:157 Pcaf NM_020005 NA NA PROMOTER
chr1 5.4E+07 5.4E+07 ox2_bound:157 BC031441 NM_146249 Ebi3 NM_015766 DIVERGENT
chr1 5.4E+07 5.4E+07 ox2_bound:158 Ccdc94 NM_028381 NA NA INSIDE
chr1 5.4E+07 5.4E+07 ox2_bound:158 M6prbp1 NM_025836 NA NA INSIDE
chr1 5.4E+07 5.4E+07 ox2_bound:158 Jmjd2b NM_172132 NA NA PROMOTER
chr1 5.5E+07 5.5E+07 ox2_bound:158 Rpl3 NM_018730 Syngr1 NA INSIDE
chr1 5.5E+07 5.5E+07 ox2_bound:158 Ranbp3 NM_027933 NA NA PROMOTER
chr1 5.5E+07 5.5E+07 ox2_bound:158 Nrtn NM_008738 Dus3l NM_144858 DIVERGENT
chr1 6.4E+07 6.4E+07 ox2_bound:158 E130009J12Rik NM_001008973 NA NA PROMOTER
chr1 6.4E+07 6.4E+07 ox2_bound:158 Twsg1 NM_023053 NA NA PROMOTER
chr1 6.6E+07 6.6E+07 ox2_bound:158 Lama1 NM_008480 NA NA PROMOTER
chr1 6.6E+07 6.6E+07 ox2_bound:158 Lama1 NM_008480 NA NA INSIDE
chr1 6.6E+07 6.6E+07 ox2_bound:159 Arhgap28 NM_172964 NA NA PROMOTER
chr1 6.9E+07 6.9E+07 ox2_bound:159 Tgif NM_009372 NA NA INSIDE
chr1 6.9E+07 6.9E+07 ox2_bound:159 Mylc2b NM_023402 NA NA PROMOTER
chr1 7.7E+07 7.7E+07 ox2_bound:159 Vit NM_028813 NA NA INSIDE
chr1 7.9E+07 7.9E+07 ox2_bound:159 Sfrs7 NM_146083 NA NA PROMOTER
chr1 8.3E+07 8.3E+07 ox2_bound:159 Ppm1b NM_011151 NA NA PROMOTER
chr1 8.4E+07 8.4E+07 ox2_bound:159 Six3os1 NM_175267 Six3 NA INSIDE
chr1 8.4E+07 8.4E+07 ox2_bound:159 Six3os1 NM_175267 Six3 NA INSIDE
chr1 8.4E+07 8.4E+07 ox2_bound:159 Six3os1 NM_175267 NA NM_011381 DIVERGENT
chr1 8.6E+07 8.6E+07 ox2_bound:159 Msh6 NM_010830 NA NA PROMOTER
chr1 6720080 6721211 ox2_bound:160 Epc1 NM_007935 NA NA PROMOTER
chr1 9414640 9415405 ox2_bound:160 Fzd8 NM_008058 NA NA PROMOTER
chr1 9418194 9419299 ox2_bound:160 Fzd8 NM_008058 NA NA DOWNSTREAM
chr1 1.3E+07 1.3E+07 ox2_bound:160 Npc1 NM_008720 NA NA INSIDE
chr1 1.3E+07 1.3E+07 ox2_bound:160 Cabyr NM_027687 NA NA PROMOTER
chr1 2.1E+07 2.1E+07 ox2_bound:160 Rnf125 NM_026301 NA NA PROMOTER
chr1 2.1E+07 2.1E+07 ox2_bound:160 Rnf125 NM_026301 NA NA PROMOTER
chr1 2.1E+07 2.1E+07 ox2_bound:160 Rnf125 NM_026301 NA NA PROMOTER
chr1 2.1E+07 2.1E+07 ox2_bound:160 Rnf125 NM_026301 NA NA INSIDE
chr1 3.4E+07 3.4E+07 ox2_bound:160 D0H4S114 NM_053078 NA NA INSIDE
chr1 3.5E+07 3.5E+07 ox2_bound:161 Wnt8a NM_009290 NA NA PROMOTER
chr1 3.6E+07 3.6E+07 ox2_bound:161 Paip2 NM_026420 NA NA INSIDE
chr1 3.7E+07 3.7E+07 ox2_bound:161 Pura NM_008989 NA NA PROMOTER
chr1 3.7E+07 3.7E+07 ox2_bound:161 Dnd1 NM_173383 NA NA INSIDE
chr1 3.7E+07 3.7E+07 ox2_bound:161 Pcdha12 NM_138663 NA NA PROMOTER
chr1 3.8E+07 3.8E+07 ox2_bound:161 Pcdhb1 NM_053126 NA NA INSIDE
chr1 3.8E+07 3.8E+07 ox2_bound:161 Pcdhb3 NM_053128 NA NA INSIDE
chr1 3.8E+07 3.8E+07 ox2_bound:161 Pcdhb11 NM_053136 NA NA INSIDE
chr1 3.8E+07 3.8E+07 ox2_bound:161 Pcdhb16 NM_053141 NA NA INSIDE
chr1 3.8E+07 3.8E+07 ox2_bound:161 Pcdhgb2 NM_033575 NA NA PROMOTER
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chr1 3.8E+07 3.8E+07 ox2_bound:162 Pcdhgb6 NM_033578 NA NA PROMOTER
chr1 3.8E+07 3.8E+07 ox2_bound:162 Diap1 NM_007858 NA NA INSIDE
chr1 3.9E+07 3.9E+07 ox2_bound:162 9630014M24Rik NM_001033771 NA NA INSIDE
chr1 4.3E+07 4.3E+07 ox2_bound:162 BC052715 BC052715 NA NA Unknown
chr1 4.4E+07 4.4E+07 ox2_bound:162 Stk32a NM_178749 NA NA INSIDE
chr1 4.4E+07 4.4E+07 ox2_bound:162 Spink3 NM_009258 NA NA PROMOTER
chr1 4.6E+07 4.6E+07 ox2_bound:162 Kcnn2 NM_080465 NA NA PROMOTER
chr1 4.7E+07 4.7E+07 ox2_bound:162 Trim36 NM_178872 NA NA PROMOTER
chr1 4.8E+07 4.8E+07 ox2_bound:162 Sema6a NM_018744 NA NA INSIDE
chr1 5.5E+07 5.5E+07 ox2_bound:162 BC092219 BC092219 NA NA Unknown
chr1 5.8E+07 5.8E+07 ox2_bound:163 Slc12a2 NM_009194 NA NA PROMOTER
chr1 6.1E+07 6.1E+07 ox2_bound:163 Slc6a7 NM_201353 NA NA INSIDE
chr1 6.1E+07 6.1E+07 ox2_bound:163 Cdx1 NM_009880 NA NA INSIDE
chr1 6.2E+07 6.2E+07 ox2_bound:163 BC060677 NM_172832 NA NA INSIDE
chr1 6.6E+07 6.6E+07 ox2_bound:163 Zfp532 NM_207255 NA NA PROMOTER
chr1 6.6E+07 6.6E+07 ox2_bound:163 Zfp532 NM_207255 NA NA INSIDE
chr1 6.6E+07 6.6E+07 ox2_bound:163 5330437I02Rik NM_177028 NA NA PROMOTER
chr1 6.6E+07 6.6E+07 ox2_bound:163 Rax NM_013833 NA NA PROMOTER
chr1 6.8E+07 6.8E+07 ox2_bound:163 Impa2 NM_053261 NA NA PROMOTER
chr1 6.8E+07 6.8E+07 ox2_bound:163 Cidea NM_007702 NA NA PROMOTER
chr1 6.8E+07 6.8E+07 ox2_bound:164 D18Ertd653e NM_172631 NA NA PROMOTER
chr1 6.9E+07 6.9E+07 ox2_bound:164 Mc5r NM_013596 NA NA PROMOTER
chr1 7.4E+07 7.4E+07 ox2_bound:164 Mapk4 NM_172632 NA NA INSIDE
chr1 7.5E+07 7.5E+07 ox2_bound:164 Lipg NM_010720 NA NA PROMOTER
chr1 7.5E+07 7.5E+07 ox2_bound:164 Rpl17 NM_001002239 NA NA INSIDE
chr1 8.1E+07 8.1E+07 ox2_bound:164 Sall3 NM_178280 NA NA INSIDE
chr1 8.5E+07 8.5E+07 ox2_bound:164 Fbxo15 NM_015798 NA NA PROMOTER
chr1 8.5E+07 8.5E+07 ox2_bound:164 Fbxo15 NM_015798 NA NA PROMOTER
chr1 8.9E+07 8.9E+07 ox2_bound:164 Rttn NM_175542 NA NA INSIDE
chr1 3470790 3471290 ox2_bound:164 Saps3 NM_029456 NA NA PROMOTER
chr1 3473388 3473888 ox2_bound:165 Saps3 NM_029456 NA NA PROMOTER
chr1 3953852 3954352 ox2_bound:165 BC021614 NM_144869 NA NA PROMOTER
chr1 4693633 4694133 ox2_bound:165 Rbm4 NM_009032 NA NA PROMOTER
chr1 4704473 4706060 ox2_bound:165 Rbm14 NM_019869 NA NA INSIDE
chr1 4822741 4823417 ox2_bound:165 Dpp3 NM_133803 NA NA PROMOTER
chr1 5261359 5261966 ox2_bound:165 Banf1 NM_011793 2010003J03Rik NM_027236 DIVERGENT
chr1 5382746 5383827 ox2_bound:165 Mus81 NM_027877 Cfl1 NA INSIDE
chr1 5979720 5980913 ox2_bound:165 Cdca5 NM_026410 NA NA INSIDE
chr1 6130680 6131180 ox2_bound:165 Ppp2r5b NM_198168 1810013C15RikNM_194348 DIVERGENT
chr1 6166232 6166896 ox2_bound:165 Ehd1 NM_010119 NA NA PROMOTER
chr1 7301904 7302404 ox2_bound:166 Rtn3 NM_001003930 NA NA INSIDE
chr1 8392938 8393984 ox2_bound:166 Slc3a2 NM_008577 NA NA INSIDE
chr1 9658526 9659531 ox2_bound:166 Fth1 NM_010239 NA NA PROMOTER
chr1 9693228 9693728 ox2_bound:166 Rab3il1 NM_144538 NA NA PROMOTER
chr1 1.1E+07 1.1E+07 ox2_bound:166 Tmem109 NM_134142 NA NA PROMOTER
chr1 1.1E+07 1.1E+07 ox2_bound:166 Ms4a10 NM_023529 NA NA INSIDE
chr1 1.6E+07 1.6E+07 ox2_bound:166 Cep78 NM_198019 NA NA INSIDE
chr1 1.6E+07 1.6E+07 ox2_bound:166 Gna14 NM_008137 NA NA INSIDE
chr1 1.7E+07 1.7E+07 ox2_bound:166 Foxb2 NM_008023 NA NA DOWNSTREAM
chr1 1.8E+07 1.8E+07 ox2_bound:166 2410127L17Rik NM_026120 NA NA INSIDE
chr1 2.3E+07 2.3E+07 ox2_bound:167 Klf9 NM_010638 NA NA PROMOTER
chr1 2.3E+07 2.3E+07 ox2_bound:167 Mamdc2 NM_174857 NA NA INSIDE
chr1 2.3E+07 2.3E+07 ox2_bound:167 1700028P14Rik NM_026188 NA NA PROMOTER
chr1 2.5E+07 2.5E+07 ox2_bound:167 Foxd4 NM_008022 NA NA INSIDE
chr1 2.5E+07 2.5E+07 ox2_bound:167 Foxd4 NM_008022 NA NA PROMOTER
chr1 3E+07 3E+07 ox2_bound:167 Uhrf2 NM_144873 NA NA PROMOTER
chr1 3E+07 3E+07 ox2_bound:167 Dkk1 NM_010051 NA NA PROMOTER
chr1 3E+07 3E+07 ox2_bound:167 Dkk1 NM_010051 NA NA PROMOTER
chr1 3.4E+07 3.4E+07 ox2_bound:167 Stambpl1 NM_029682 NA NA INSIDE
chr1 4E+07 4E+07 ox2_bound:167 Pdlim1 NM_016861 NA NA PROMOTER
chr1 4.1E+07 4.1E+07 ox2_bound:168 Tm9sf3 NM_133352 NA NA PROMOTER
chr1 4.1E+07 4.1E+07 ox2_bound:168 Morf4l1 NM_001039147 NA NA PROMOTER
chr1 4.2E+07 4.2E+07 ox2_bound:168 Frat2 NM_177603 NA NA PROMOTER
chr1 4.2E+07 4.2E+07 ox2_bound:168 Avpi1 NM_027106 NA NA PROMOTER
chr1 4.2E+07 4.2E+07 ox2_bound:168 D19Ertd386e NM_177464 NA NA PROMOTER
239
chr1 4.4E+07 4.4E+07 ox2_bound:168 Scd2 NM_009128 NA NA PROMOTER
chr1 4.6E+07 4.6E+07 ox2_bound:168 Ldb1 NM_010697 NA NA INSIDE
chr1 4.6E+07 4.6E+07 ox2_bound:168 BC066048 BC066048 NA NA Unknown
chr1 4.6E+07 4.6E+07 ox2_bound:168 Nolc1 NM_001039351 NA NA PROMOTER
chr1 4.6E+07 4.6E+07 ox2_bound:168 Cuedc2 NM_024192 NA NA INSIDE
chr1 4.6E+07 4.6E+07 ox2_bound:169 4930538D17Rik NM_029186 NA NA INSIDE
chr1 4.6E+07 4.6E+07 ox2_bound:169 Trim8 NM_053100 NA NA PROMOTER
chr1 4.6E+07 4.6E+07 ox2_bound:169 Trim8 NM_053100 NA NA INSIDE
chr1 4.7E+07 4.7E+07 ox2_bound:169 Nt5c2 NM_029810 NA NA INSIDE
chr1 4.8E+07 4.8E+07 ox2_bound:169 BC063749 NM_001001738 NA NA PROMOTER
chr1 5.5E+07 5.5E+07 ox2_bound:169 Acsl5 NM_027976 NA NA INSIDE
chr1 5.6E+07 5.6E+07 ox2_bound:169 Dclre1a NM_018831 Nhlrc2 NM_025811 DIVERGENT
chr1 5.9E+07 5.9E+07 ox2_bound:169 Hspa12a NM_175199 NA NA INSIDE
chrX6197699 6198537 ox2_bound:169 Tcfe3 NM_172472 NA NA INSIDE
chrX6359451 6360920 ox2_bound:169 Eras NM_181548 NA NA INSIDE
chrX6453322 6454137 ox2_bound:170 2010001H14Rik NM_027227 NA NA PROMOTER
chrX6639825 6641207 ox2_bound:170 Porcn NM_145908 NA NA PROMOTER
chrX1.2E+07 1.2E+07 ox2_bound:170 Usp9x NM_009481 NA NA PROMOTER
chrX1.6E+07 1.6E+07 ox2_bound:170 Fundc1 NM_028058 NA NA INSIDE
chrX1.9E+07 1.9E+07 ox2_bound:170 Cfp NM_008823 NA NA PROMOTER
chrX1.9E+07 1.9E+07 ox2_bound:170 Zfp182 NM_001013387 NA NA PROMOTER
chrX 2E+07 2E+07 ox2_bound:170 D930016N04Rik NM_183185 NA NA PROMOTER
chrX2.2E+07 2.2E+07 ox2_bound:170 BC068151 BC068151 NA NA Unknown
chrX3.3E+07 3.3E+07 ox2_bound:170 Zbtb33 NM_020256 NA NA PROMOTER
chrX3.6E+07 3.6E+07 ox2_bound:170 Gria3 NM_016886 NA NA INSIDE
chrX4.4E+07 4.4E+07 ox2_bound:171 Pdcd8 NM_012019 Rab33a NM_011228 DIVERGENT
chrX4.4E+07 4.4E+07 ox2_bound:171 Suhw3 NM_153532 NA NA PROMOTER
chrX4.7E+07 4.7E+07 ox2_bound:171 Hs6st2 NM_015819 NA NA PROMOTER
chrX4.7E+07 4.7E+07 ox2_bound:171 Hs6st2 NM_015819 NA NA PROMOTER
chrX4.7E+07 4.7E+07 ox2_bound:171 Gpc4 NM_008150 NA NA INSIDE
chrX4.7E+07 4.7E+07 ox2_bound:171 Gpc4 NM_008150 NA NA PROMOTER
chrX4.8E+07 4.8E+07 ox2_bound:171 mmu-mir-106a mmu-mir-106a NA NA PROMOTER
chrX5.3E+07 5.3E+07 ox2_bound:171 Rbmx NM_011252 NA NA PROMOTER
chrX5.4E+07 5.4E+07 ox2_bound:171 Zic3 NM_009575 NA NA INSIDE
chrX5.4E+07 5.4E+07 ox2_bound:171 Zic3 NM_009575 NA NA INSIDE
chrX5.6E+07 5.6E+07 ox2_bound:172 Mcf2 NM_133197 NA NA PROMOTER
chrX6.9E+07 6.9E+07 ox2_bound:172 Mecp2 NM_010788 NA NA PROMOTER
chrX 7E+07 7E+07 ox2_bound:172 Rpl10 NM_052835 NA NA PROMOTER
chrX7.3E+07 7.3E+07 ox2_bound:172 Tbl1x NM_020601 NA NA PROMOTER
chrX7.3E+07 7.3E+07 ox2_bound:172 Tbl1x NM_020601 NA NA PROMOTER
chrX8.2E+07 8.2E+07 ox2_bound:172 Nr0b1 NM_007430 NA NA PROMOTER
chrX8.2E+07 8.2E+07 ox2_bound:172 Nr0b1 NM_007430 NA NA INSIDE
chrX8.9E+07 8.9E+07 ox2_bound:172 Pcyt1b NM_211138 NA NA PROMOTER
chrX8.9E+07 8.9E+07 ox2_bound:172 Pcyt1b NM_211138 NA NA INSIDE
chrX 9E+07 9E+07 ox2_bound:172 Klhl15 NM_001039059 NA NA PROMOTER
chrX9.1E+07 9.1E+07 ox2_bound:173 Las1l NM_152822 NA NA PROMOTER
chrX9.6E+07 9.6E+07 ox2_bound:173 Slc7a3 NM_007515 NA NA INSIDE
chrX9.7E+07 9.7E+07 ox2_bound:173 Snx12 NM_018875 NA NA PROMOTER
chrX9.7E+07 9.7E+07 ox2_bound:173 Ogt NM_139144 NA NA PROMOTER
chrX9.7E+07 9.7E+07 ox2_bound:173 Ogt NM_139144 NA NA PROMOTER
chrX9.7E+07 9.7E+07 ox2_bound:173 Ogt NM_139144 NA NA PROMOTER
chrX9.9E+07 9.9E+07 ox2_bound:173 Cdx4 NM_007674 NA NA PROMOTER
chrX9.9E+07 9.9E+07 ox2_bound:173 Rnf12 NM_011276 NA NA PROMOTER
chrX9.9E+07 9.9E+07 ox2_bound:173 Rnf12 NM_011276 NA NA PROMOTER
chrX 1E+08 1E+08 ox2_bound:173 2610529C04Rik NM_025952 Cox7b NM_025379 DIVERGENT
chrX 1E+08 1E+08 ox2_bound:174 Pgk1 NM_008828 NA NA INSIDE
chrX 1E+08 1E+08 ox2_bound:174 Cysltr1 NM_021476 NA NA INSIDE
chrX 1E+08 1E+08 ox2_bound:174 Gpr23 NM_175271 NA NA PROMOTER
chrX 1E+08 1E+08 ox2_bound:174 Nsbp1 NM_016710 NA NA INSIDE
chrX 1E+08 1E+08 ox2_bound:174 Nsbp1 NM_016710 NA NA PROMOTER
chrX1.3E+08 1.3E+08 ox2_bound:174 Armcx1 NM_030066 NA NA PROMOTER
chrX1.3E+08 1.3E+08 ox2_bound:174 Gprasp1 NM_001004359 NA NA PROMOTER
chrX1.3E+08 1.3E+08 ox2_bound:174 2900062L11Rik NM_029823 NA NA PROMOTER
chrX1.3E+08 1.3E+08 ox2_bound:174 Zcchc18 NM_001035509 NA NA PROMOTER
chrX1.4E+08 1.4E+08 ox2_bound:174 Prps1 NM_021463 NA NA PROMOTER
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chrX1.4E+08 1.4E+08 ox2_bound:175 Prps1 NM_021463 NA NA INSIDE
chrX1.4E+08 1.4E+08 ox2_bound:175 AW547186 NM_177592 NA NA PROMOTER
chrX1.5E+08 1.5E+08 ox2_bound:175 Gnl3l NM_198110 NA NA PROMOTER
chrX1.5E+08 1.5E+08 ox2_bound:175 ORF34 NM_198105 NA NA INSIDE
chrX1.5E+08 1.5E+08 ox2_bound:175 Huwe1 NM_021523 NA NA INSIDE
chrX1.5E+08 1.5E+08 ox2_bound:175 Acot9 NM_019736 NA NA PROMOTER
chrX1.5E+08 1.5E+08 ox2_bound:175 Sms NM_009214 NA NA PROMOTER
chrX1.5E+08 1.5E+08 ox2_bound:175 Mbtps2 NM_178266 NA NA PROMOTER
chrX1.6E+08 1.6E+08 ox2_bound:175 Rbbp7 NM_009031 NA NA PROMOTER
chrX1.6E+08 1.6E+08 ox2_bound:175 4932441K18Rik NM_178935 NA NA PROMOTER
chrX1.6E+08 1.6E+08 ox2_bound:176 4932441K18Rik NM_178935 NA NA PROMOTER
chrX1.6E+08 1.6E+08 ox2_bound:176 4932441K18Rik NM_178935 NA NA PROMOTER
chrX1.6E+08 1.6E+08 ox2_bound:176 Glra2 NM_183427 NA NA PROMOTER
chrX1.6E+08 1.6E+08 ox2_bound:176 Tmsb4x NM_021278 NA NA INSIDE

















































































































































































Appendix 8. Zic3 shares regulatory pathways with Oct4 and 
Nanog in ES cells. RNA was harvested from mouse ES cells 
treated with Oct4 and Nanog shRNA for 4 days with 
puromycin selection. The transfected cells that survived were 
assayed for their gene expression profiles on Illumina mouse 
Ref8 microarrays. The number of significantly-regulated 
genes following each RNAi experiment is presented here and 
compared with that of the Zic3 gene expression profile.
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Appendix 9. Reprogramming assay with Oct4, Sox2, Klf4, C-Myc and Zic3. 
Oct4, Sox2, Klf4, C-Myc and Zic3 were ectopically expressed in mouse embryonic 
fibroblast cells (Balb/c; Passage 3), using combinations reflected in the graph 
above. Details of the reprogramming assay may be found in Section 2.3.5. Three 
weeks following infection of the reprogramming factors, pluripotent colonies were 
stained for alkaline phosphatase (AP) and quantified. Assays were performed in 
biological triplicate in 6 cm2 tissue culture dishes. Overexpression of Zic3 in a 
variety of combinations of Oct4, Sox2, Klf4 and C-Myc did not result in a significant 
increase in pluripotent AP-positive colonies, relative to the positive control (SOCK). 
Legend – S: Sox2, O: Oct4, C: C-Myc, K: Klf4, Z- Zic3. 
Credits: Zic3-pMXs vector created by Linda Lim; reprogramming assays optimized
by Linda Lim & Tahira Allapitchay; Zic3 reprogramming experiment and 
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Embryonic stem (ES) cell pluripotency is dependent upon sustained expression of the key transcriptional regulators Oct4,
Nanog, and Sox2. Dissection of the regulatory networks downstream of these transcription factors has provided critical
insight into the molecular mechanisms that regulate ES cell pluripotency and early differentiation. Here we describe a role
for Zic3, a member of the Gli family of zinc finger transcription factors, in the maintenance of pluripotency in ES cells.
We show that Zic3 is expressed in ES cells and that this expression is repressed upon differentiation. The expression of
Zic3 in pluripotent ES cells is also directly regulated by Oct4, Sox2, and Nanog. Targeted repression of Zic3 in human and
mouse ES cells by RNA interference–induced expression of several markers of the endodermal lineage. Notably, the
expression of Nanog, a key pluripotency regulator and repressor of extraembryonic endoderm specification in ES cells,
was significantly reduced in Zic3 knockdown cells. This suggests that Zic3 may prevent endodermal marker expression
through Nanog-regulated pathways. Thus our results extend the ES cell transcriptional network beyond Oct4, Nanog, and
Sox2, and further establish that Zic3 plays an important role in the maintenance of pluripotency by preventing endoder-
mal lineage specification in embryonic stem cells.
INTRODUCTION
The transcription factors Oct4, Nanog, and Sox2 are key
regulatory players in embryonic stem (ES) cell biology.
These core factors contribute to the hallmark characteristics
of ES cells by 1) activation of target genes that encode
pluripotency and self-renewal mechanisms and 2) repres-
sion of signaling pathways that promote differentiation
(Orkin, 2005). In ES cells Oct4, Nanog, and Sox2 co-occupy
promoters of hundreds of genes that are both expressed and
repressed in the pluripotent state (Boyer et al., 2005; Loh et
al., 2006). This suggests complex regulatory circuitry in
which Oct4, Nanog, and Sox2 collectively and uniquely
regulate downstream genes to control ES cell differentiation.
However, it remains unclear what are the downstream ef-
fectors of these transcription factors that contribute to main-
taining the pluripotent status of ES cells. It also not under-
stood how these “master regulators” of pluripotency are
involved in controlling lineage-specific differentiation of ES
cells. It is therefore useful to elucidate the transcriptional
networks surrounding Oct4, Nanog, and Sox2, where de-
tailed knowledge of these pathways remain key to harness-
ing the potential to direct differentiation of ES cells into
therapeutically useful cell types.
To expand our understanding of the transcriptional net-
works that control stem cell differentiation, we have looked
at transcription factors whose expression is directly regu-
lated by Oct4, Nanog, and Sox2. We have identified Zic3
(Zinc finger protein of the cerebellum 3) as a transcription
factor of interest for two main reasons. First, Oct4, Nanog,
and Sox2 binding have been mapped to the Zic3 promoter
regions in ES cells (Boyer et al., 2005; Loh et al., 2006),
implying that these key factors may regulate Zic3 expres-
sion. The overlap between mouse and human ES cells
further highlights the significance of Zic3 and suggests
possible conservation of the gene’s pathways between the
two species. Second, Zic3 demonstrates differential gene
expression between the pluripotent and early differentia-
tion phases, where its expression is higher in the pluripo-
tent state (Brandenberger et al., 2004; Wei et al., 2005). The
changes in gene expression between these states suggest a
potential role for Zic3 in controlling differentiation of mouse
and human ES cells.
Zic3 belongs to the GLI superfamily of transcription fac-
tors and is a vertebrate homologue of the Drosophila pair-
rule gene odd-paired (opa; Aruga et al., 1996a). The five
known mammalian Zic genes (Zic1-5) encode five tandem
C2H2 zinc finger domains that are highly conserved across
species (Herman and El-Hodiri, 2002; Grinberg and Millen,
2005). Although the expression of Zic3 is restricted to the
cerebellum of adult mammals, dynamic patterns of expres-
sion have been observed during embryonic development in
mouse (Herman and El-Hodiri, 2002), Xenopus (Nakata et al.,
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1997, 1998), chick (Warner et al., 2003), and zebrafish (Grinblat
and Sive, 2001). The expression of Zic3 in the embryonic
ectoderm and mesoderm during gastrulation (Kitaguchi et
al., 2002; Elms et al., 2004), and throughout the tailbud, retina
and limb bud during neurulation and organogenesis (Herman
and El-Hodiri, 2002; Orkin, 2005), suggests an important role
for this transcription factor in embryonic ectoderm and me-
soderm development. This is further supported by molecu-
lar pathways in which Zic3 has been implicated. For exam-
ple the mesoderm-associated gene Brachyury induces Zic3
expression in Xenopus (Kitaguchi et al., 2002), and the em-
bryonic patterning gene Nodal is regulated by Zic3 during
gastrulation through interaction with an upstream enhancer
region in mouse and Xenopus embryos (Ware et al., 2006a). In
ectodermal development, Zic3 is a potent inducer of Xenopus
proneural and neural crest genes (Nakata et al., 1997) and is
induced directly downstream of transcription factors Pbx1b
and Meis1 in the Xenopus ectoderm (Maeda et al., 2002; Kelly
et al., 2006).
Zic3 mutations are associated with X-linked heterotaxy, a
disorder characterized by disruptions in embryonic lateral-
ity and midline developmental field defect (Gebbia et al.,
1997). In Zic3 mutant organisms situs ambiguus is frequently
observed, encompassing failure in lateralization of internal
organs, mirror-image inversions, and left-right isomerism
(Aylsworth, 2001). Several mutations have been identified in
humans that render the Zic3 protein unstable and absent in
cells or incapable of nuclear localization where its transcrip-
tional effect is exerted (Gebbia et al., 1997; Ware et al., 2004).
Consistent with its expression in the involuting mesoderm
and presumptive neural plate during gastrulation, Zic3 is
involved in regulating left–right asymmetry and neural tube
development. Zic3-null mice exhibit a wide spectrum of
phenotypes. Fifty percent of null mice succumb to embry-
onic lethality over different gestational stages, and 30% to
perinatal lethality as a result of congenital heart defects,
pulmonary isomerism, and defects in the CNS (Purandare et
al., 2002). The earliest and most profound Zic3-null defects
have been attributed to failure in establishment of the ante-
rior-posterior axis by the anterior visceral endoderm (AVE)
before gastrulation (Ware et al., 2006b). In less severely af-
fected embryos, abnormalities are observed at gastrulation
in the distribution and accumulation of excess mesoderm
tissue. Taken together, the defects in embryonic lethal mice
demonstrate a key role for Zic3 in early embryonic pattern-
ing that encompasses anterior visceral endoderm formation,
initiation of gastrulation, and primitive streak morphogen-
esis (Ware et al., 2006b).
The varying degrees of severity in failure to complete
gastrulation displayed by Zic3 null mice may perhaps be
attributed to compensatory mechanisms in developing em-
bryos, as indicated by the distinct and partially overlapping
expression patterns exhibited by members of the Zic gene
family (Nagai et al., 1997; Elms et al., 2004). It is important to
note that Zic3 shares overall 64 and 59% homology with Zic1
and Zic2, respectively, and this homology increases to 91%
within the zinc finger domain. Thus members of Zic family
are strong candidates for redundancy in molecular signaling
owing to the high degree of homology and overlapping
expression observed among the members of this family.
Although Zic3 expression has been implicated in embry-
onic development, still lacking is a detailed understanding
of what regulates Zic3 expression and what the downstream
effectors of Zic3 are. The Zic3 gene has been identified as a
target of Oct4, Nanog, and Sox2 in ES cells (Boyer et al., 2005;
Loh et al., 2006), and Zic3 is preferentially expressed in
pluripotent state (Brandenberger et al., 2004; Wei et al., 2005).
Questions arising from these data are as follows: 1) How do
Oct4, Nanog, and Sox2 interact with the Zic3 regulatory
region, and what results from this interaction and, 2) what
Table 1. List of marker genes used to assess lineage development in ES cells
Gene symbol Description Lineage
Sox17 SRY-box containing gene 17 Endoderm
PDGFRA Platelet-derived growth factor receptor, alpha Endoderm
Gata4 GATA binding protein 4 Endoderm
Gata6 GATA binding protein 6 Endoderm
Foxa2 Forkhead box A2 Endoderm
GSC Goosecoid Mesendoderm
Nodal Nodal Mesendoderm
MixL1 Mix1 homeobox-like 1 Mesendoderm
Hand1 Heart and neural crest derivatives expressed 1 Mesoderm
Nkx2.5 NK2 transcription factor related, locus 5 Mesoderm
Gata2 GATA binding protein 2 Mesoderm
Nestin Nestin Ectoderm
GFAP Glial fibrillary acidic protein Ectoderm
Pax6 Paired box gene 6 Ectoderm
TDGF1 Teratocarcinoma-derived growth factor/Cripto Ectoderm
Sox1 SRY-box containing gene 1 Ectoderm
REST RE1-silencing transcription factor Ectoderm
CoREST REST Co-repressor 1 Ectoderm
FGF5 Fibroblast growth factor 5 Ectoderm
BMP4 Bone morphogenetic protein 4 Trophectoderm
CDX2 Caudal type homeobox 2 Trophectoderm
DKK3 Dickkopf homolog 3 Wnt pathway
Gsk3beta Glycogen synthase kinase 3 beta Wnt pathway
Zic3 Maintains ES Cell Pluripotency
Vol. 18, April 2007 1349
role does Zic3 play in the embryonic stem cell? We have
addressed these questions using the loss-of-function ap-
proach for Zic3 and the key regulatory genes in ES cells. In
this study, we examined the function of Zic3 as a regulatory
target of Oct4, Nanog, and Sox2 in ES cells. We report that
Zic3 shares significant overlap with the Oct4, Nanog, and
Sox2 transcriptional networks and is important in maintain-
ing ES cell pluripotency by preventing differentiation of cells
into endodermal lineages. Thus our results extend the cur-
rent knowledge of the ES cell transcriptional circuitry be-
yond Oct4, Nanog, and Sox2.
MATERIALS AND METHODS
ES Cell Maintenance
Feeder-free E14 Mouse ES cells were maintained on 0.1% gelatin-coated
dishes in E14 proliferative medium containing DMEM/15% ES FBS (Invitro-
gen, Carlsbad, CA), 0.1 mM MEM nonessential amino acids (Invitrogen), 2
mM l-glutamine (Invitrogen), 0.1 mM -mercaptoethanol (Invitrogen), and
Chinese hamster ovary-Leukaemia Inhibitory Factor (CHO-LIF) (1000 U/ml).
Feeder-free undifferentiated HuES9 human ES cells were maintained on
matrigel-coated dishes in conditioned medium containing knockout DMEM/
10% serum replacement (Invitrogen), 0.1 mM MEM nonessential amino acids
(Invitrogen), 1 mM l-glutamine (Invitrogen), 0.1 mM -mercaptoethanol (In-
vitrogen), 8% plasmanate (National University Hospital Pharmacy, Singapore),
12 ng/ml LIF, and 10 ng/ml human recombinant basic fibroblast growth factor
(bFGF; Invitrogen). Conditioned medium was obtained by culturing mouse
embryonic fibroblast (MEF) cells with HuES9 media. The medium was collected
at 24 h intervals, filter sterilized, and further supplemented with 8 ng/ml bFGF
for HuES9 cell culture.
RNA Interference and Establishment of Clonal
Knockdown Lines
Small Interfering RNA (siRNA) Experiments. RNA interference (RNAi) experi-
ments were performed with Dharmacon siGENOME SMARTpool reagents
(Boulder, CO) against human or mouse Zic3. The Dharmacon siCONTROL
nontargeting siRNA pool was used as a negative control. Mouse ES cells were
transfected according to manufacturer’s instructions in 12-well plates at a
density of 2  105 cells per well. Retransfections were performed on pre-
adherent cells at 48-h intervals, and RNA expression analysis was performed
on samples from day 5. Human ES cells were transfected in 12-well plates
with 2  105 cells, in suspension, per well. Subsequent retransfections were
performed on adherent cells at 24-h intervals and RNA was harvested for
analysis at day 5.
Short Hairpin RNA (shRNA) Experiments. The Oct4 and Nanog RNAi exper-
iments were previously published (Loh et al., 2006). The Zic3 shRNA con-
struct was designed as described (Chew et al., 2005) with a target sequence of
5-GAATTCGAAGGCTGTGACA-3. E14 cells in six-well plates were trans-
fected with 2.0 g pSUPERpuro vector or Zic3-pSUPER.puro (OligoEngine,
Seattle, WA) at a density of 4  105 cells per well. Puromycin selection was
introduced 1 d after transfection at 1.0 g/ml and was maintained for 3 d before
RNA isolation. ES cells were maintained in proliferative medium at all times.
Clonal Zic3 knockdown lines were established by transfection of shRNA
constructs as described above. The Zic3 knockdown and vector control colonies
were picked after 7 d of puromycin selection (1.0 g/ml). Colonies were disso-
ciated into single-cell suspensions by treatment with 0.05% Trypsin (Invitrogen)
and plated on puromycin-resistant mitomycin-inactivated DR4 MEFs (ATCC,
Manassas, VA). In total, 15 Zic3 clonal knockdown and 7 vector control lines
were established and maintained under constant puromycin selection. The lines
analyzed in this article were maintained feeder-free in ES cell proliferative media
on 0.1% gelatin-coated dishes over a period of eight passages.
Secondary ES Colony-replating Assay
ES cells were transfected with Zic3- or empty pSUPER shRNA constructs and
selected 24 h later with puromycin at 1.0 g/ml over 4 d. At the end of 4 d few
cells remained in the untransfected control wells indicating that selection was
effective. The surviving cells were trypsinized and resuspended in E14 medium
without LIF. Ten thousand or 20,000 cells were plated onto mouse feeder layers
in six-well plates for secondary ES cell-colony formation. After 7 d, emerging
colonies were stained with the Wright-Giemsa (Sigma, St. Louis, MO) stain. The
extent of differentiated colonies was defined as the percentage of unstained
colonies out of the total number of colonies in the well.
RNAi Rescue Experiments
The Zic3 open reading frame (ORF; NM_009575) was cloned from reverse-
transcribed cDNA from mouse embryonic stem cells, using the primers
indicated in Supplementary Table 1A. The PCR product was subsequently
cloned into a vector driven by the CAG promoter. The RNAi-immune Zic3
ORF R3M (Supplementary Figure 1) was generated from this template using
site-specific mutagenesis. To perform the rescue experiments, 4  105 mouse
ES cells were seeded per well in six-well plates and transfected according to
the scheme in Supplementary Table 1B. Hygromycin selection (1.0 g/ml)
was introduced 1 d after transfection.
RNA Extraction, cDNA Synthesis, and Quantitative
Real-Time PCR
To minimize genomic DNA contamination, RNA was extracted with TriZol
reagent (Invitrogen) and further purified with the RNeasy minikit (Qiagen,
Chatsworth, CA). cDNA was synthesized with 1.0 g total RNA using the
High Capacity cDNA Archive kit (Applied Biosystems, Foster City, CA). For
each qPCR reaction, cDNA samples diluted 10 times in water were mixed
with 5.0 l TaqMan Universal PCR Master Mix reagent (Applied Biosystems)
and 0.5 l of a single TaqMan probe from the following list: Zic3, Oct4,
Nanog, Sox2, or the lineage markers in Table 1 (20 TaqMan Gene Expression
Figure 1. A profile of Zic3 expression in differentiating E14 cells.
(A) Real-time PCR analysis of differentiation induced by retinoic
acid. Samples were assayed at 2-d intervals (untreated control, and
treated samples day 2, day 4, and day 6). Mean levels  SE are
expressed as percentages relative to undifferentiated E14 cells
(100%). The assays were conducted in duplicate and normalized to
-actin control. (B) Verification of Zic3 protein expression during
the process of RA differentiation. (C) A summary of ChIP mapping
of Oct4, Nanog, and Sox2 binding sites on the Zic3 regulatory
regions in mouse ES cells (Loh et al., 2006; Sox2, Ng, unpublished
data) and human ES cells (Boyer et al., 2005). We examined tran-
scription factor binding sites within 100 kb up- and downstream of
the Zic3 coding region. In human ES cells, Oct4, Nanog, and Sox2
binding sites were located within 3.5 kb upstream of the Zic3
transcription start site, whereas in mouse ES cells, the Nanog bind-
ing site was found within 18.5 kb upstream, and the Oct4 and Sox2
binding sites were within 9.5 kb downstream of the gene, respec-
tively (Loh et al., 2006). Each unit on the scale represents 10 kb.
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Assay reagents; Applied Biosystems) with a final volume of 10 l. Quantita-
tive real-time PCR analysis was conducted in 384-well clear optical reaction
plate (Applied Biosystems) on the ABI Prism 7900 machine (Columbia, MD).
Western Blots and Immunocytochemistry
Zic3 protein detection was performed with goat-anti-Zic3 antibody (1:800
dilution; C-12, Santa Cruz Biotechnology, Santa Cruz, CA) and donkey anti-
goat horseradish peroxidase (HRP; 1:5000; Santa Cruz Biotechnology). Load-
ing consistency was determined with mouse anti--actin (1:3000; Invitrogen)
and goat anti-mouse HRP (1:5000; Santa Cruz Biotechnology). For immuno-
cytochemistry, cells were seeded at a density of 1.0  105 cells per well on
fibronectin-coated chamber slides, fixed in 4% paraformaldehyde, and per-
meabilized with 0.3% Triton X-100. Blocking was performed with 5% fetal
bovine serum and 1% bovine serum albumin in PBS solution for 30 min. Cells
were stained with the following primary antibodies (1:100): goat or mouse
anti-Oct4 (Santa Cruz Biotechnology, N-19 and C-10, respectively), rabbit-
anti-Nanog (Chemicon, Temecula, CA; AB5731), goat anti-FoxA2 (M-20,
Santa Cruz Biotechnology), goat-anti-Gata6 (C-20, Santa Cruz Biotechnology),
or mouse anti-CD140a (PDGFRA; eBioscience, San Diego, CA; 16-1401). This
was followed by the appropriate secondary antibodies detecting mouse or
goat IgG Alexa Fluor 488 (Molecular Probes, Eugene, OR; 1:500) for Oct4
staining, rabbit IgG Alexa Fluor 594 (Molecular Probes; 1:500) for Nanog
staining, or Qdot 655 anti-goat or anti-mouse antibodies (Molecular Probes)
for FoxA2, Gata6, and PDGFRA staining (1:150) according to the manufac-
turer’s protocol. Images were captured with the Zeiss LSM 5 Duo inverted
confocal microscope (Zeiss, Thornwood, NY).
Luciferase Reporter Construct and Assays
The 300-base pair Zic3 enhancer region containing the Nanog-binding site
was cloned from mouse genomic DNA. The primers used were as follows:
forward, 5 ATATAacgcgtTTAGAGGTCAAACCAT-3 and reverse, 5-
TATATagatctTAGTAGTCAAACTGGATT-3 with restriction sites indicated
in lower case letters. The PCR fragment was digested with MluI and BglII and
cloned into the pGL3-Basic vector (Promega, Madison, WI) containing a basal
promoter comprising the 500-bp region immediately upstream of the mouse
Oct4 gene. The following constructs were transfected into cells 2.5  104 cells
in 96-well plates for the luciferase assay: 100 ng firefly luciferase reporter, 1.0
ng of the Renilla luciferase vector, pRL-SV40 plasmid normalization control,
and 250 ng of the respective knock-down construct. Puromycin selection (1.0
g/ml) was introduced 20 h after transfection and cultured for 2 d. Luciferase
activity measured using the Dual Luciferase System (Promega) in a Centro
LB960 96-well luminometer (Berthold Technologies, Natick, MA).
RESULTS
Zic3 Expression Is Associated with ES Cell Pluripotency
Comprehensive expression profiling of mouse and human
ES cells has identified numerous genes that are expressed in
undifferentiated cells and quickly repressed upon differen-
tiation (Brandenberger et al., 2004; Wei et al., 2005). Among
these genes are transcription factors Oct4, Nanog, and Sox2,
which are required to maintain pluripotency of ES cells.
Zic3, a zinc-finger transcription factor, was also found to be
expressed in undifferentiated ES and suppressed in differ-
entiated cells, and thus, may play a role in regulating ES cell
differentiation. We assayed the expression of Zic3 in mouse
ES cells induced to differentiate over 6 d by addition of
retinoic acid (RA; Figure 1A). Similar to the trends observed
for Oct4, Nanog, and Sox2 genes, Zic3 transcript levels de-
creased between 1.5- and 10-fold for each 2-d interval (D2,
D4, and D6), relative to the undifferentiated control. Zic3
Figure 2. Oct4, Sox2, and Nanog regulate Zic3 expres-
sion. (A) Changes in endogenous gene expression levels
of Oct4, Nanog, and Sox2 after gene-specific RNAi and
(B) corresponding changes in endogenous Zic3 gene
levels. cDNAs were prepared from the RNAi knock-
down ES cells and analyzed using real-time PCR. The
levels of the transcripts were normalized against values
derived from control RNAi-transfected ES cells (100%).
(C) Changes in ES cell endogenous Zic3 gene level after
Nanog overexpression with RA induced differentiation.
Nanog overexpression cell line and control cell line
were treated with no RA or 0.3 M RA for 2 d. Tran-
script levels of 0.3 M RA-treated sample were normal-
ized against no RA treatment sample. (D) Diagram of
the construct with putative Zic3 enhancer region fused
upstream of a minimal Pou5f1 promoter and firefly
luciferase gene. (E) The effects of luciferase activity in
deletion of the putative Nanog binding site on Zic3
enhancer were tested by transfecting into ES cells. Ac-
tivity were measured relative to the minimal promoter
only (MP) construct without the Nanog enhancer. (F)
Effects of Nanog RNAi on Zic3 enhancer activity were
tested by cotransfecting the Nanog RNAi with the re-
porter construct into ES cells and luciferase activity
measured. Activity were normalized against the Con-
trol RNAi with mOct4 promoter-only construct. An
RNAi targeting the GFP sequence was used as a non-
specific control.
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RNA levels were also significantly decreased in mouse ES
cells differentiated by treatment with HMBA (hexamethyl-
ene bisacetamide) or dimethyl sulfoxide, and also by aggre-
gation into embryoid bodies (data not shown). The decrease
in Zic3 mRNA correlated with a comparable decrease in
protein expression (Figure 1B). Thus, Zic3 gene expression is
associated with the mouse ES pluripotent state and its ex-
pression decreases as cells differentiate.
Chromatin immunoprecipitation experiments in both
mouse and human ES cells have identified binding sites for
the transcription factors Oct4, Nanog, and Sox2 at the Zic3
gene locus (Figure 1C; Boyer et al., 2005; Loh et al., 2006). The
binding of these transcription factors, which are demon-
strated regulators of pluripotency, suggests that Zic3 is a
direct target for regulation by these TFs and may play a role
in regulating ES cell differentiation.
Regulation of Zic3 by Oct4, Sox2, and Nanog
To further validate that Oct4, Sox2, and Nanog regulate Zic3
expression, we performed gene expression knockdown ex-
periments in mouse ES cells using RNA interference. Mouse
ES cells were thrice transfected with gene-specific siRNAs
against Oct4, Sox2, and Nanog on alternate days to achieve
80–90% reduction in expression of the targeted gene (Figure
2A). Down-regulation of Oct4 and Sox2 reduced the level of
endogenous Zic3 to 25%, whereas Nanog RNAi reduced
the level of Zic3 to 70% (Figure 2B). These data indicate that
Zic3 expression is regulated by Oct4, Sox2, and Nanog.
It has been shown that Nanog-overexpressing ES cells are
resistant to differentiation induced by LIF withdrawal and
RA addition (Chambers and Smith, 2004). As the endoge-
nous levels of Zic3 decreased in the presence of RA-induced
differentiation (Figure 1), we were interested in determining
if Nanog overexpression would sustain Zic3 levels under
RA treatment. ES cells were stably transfected with a con-
struct that expresses Nanog from a constitutively active
promoter. The Nanog-expressing cells and cells transfected
with empty vector were treated for 2 d with 0.3 M RA.
Vector-only control cells showed a decrease in Zic3 RNA
levels typical of RA-induced differentiation. In contrast,
mouse ES cells overexpressing Nanog sustained the level of
Zic3 at greater than 80%, relative to the control ES cell line
(Figure 2C). Thus, overexpression and knockdown of Nanog
in ES cells results in an increase and decrease, respectively,
of Zic3, suggesting that Zic3 expression is regulated by
Nanog, perhaps directly or indirectly.
Our previous study identified a Nanog binding site in the
enhancer region, 16.4 kb upstream of the transcription start
site, of the Zic3 gene (Loh et al., 2006). As this DNA region
was available for further study in our lab, we sought to
determine if Zic3 expression was directly regulated by
Nanog. We fused the 292-base pair portion of the Zic3
enhancer that contains the Nanog-binding site upstream of a
minimal Pou5f1 promoter driving the firefly luciferase gene
(Figure 2D). The minimal promoter was weakly active in ES
cells, whereas activity of the Zic3 enhancer region linked to
the minimal promoter was ninefold up-regulated as quan-
tified by luciferase (Figure 2E). When the sequences of this
putative Nanog binding site were deleted from the Zic3
enhancer the corresponding reporter activity decreased (Fig-
ure 2E). We then transfected Nanog RNAi together with the
wild-type reporter construct and showed that the activity of
the Zic3 enhancer decreased fourfold relative to the controls
(Figure 2F). Collectively, our data show that Zic3 expression
is directly regulated by Nanog and thus, may be a down-
stream effector in controlling ES cell differentiation.
Effect of Zic3 Depletion on ES Cell Differentiation
To investigate the role of Zic3 in ES cells, we used RNAi to
achieve knockdown of gene expression. Both the siRNA and
shRNA methods resulted in a 70% reduction of Zic3 tran-
script levels relative to the nontargeting controls (Figure
3A). Zic3 protein levels reflect this decrease in gene expres-
sion after Zic3 RNAi treatment, whereas protein expression
remained high in vector-only–treated cells (Figure 3B).
Zic3 RNAi transfections resulted in a marked decrease in
pluripotent colonies that stained for alkaline phosphatase
(AP) relative to the mock RNAi control (Figures 3, C and D).
The extent of differentiation was quantified with secondary
replating assays that revealed a three- to fivefold increase in
differentiated colonies in comparison with the nontargeting
control (Figure 3E). To assess the differentiation state of Zic3
Figure 3. Effect of Zic3 RNAi on endogenous Oct4, Nanog, and
Sox2 levels. (A) Zic3 levels were depleted by RNAi using siRNA
and shRNA in mouse E14 cells and siRNA in human HuES9 cells.
RNA was harvested between 4 and 5 d of transfection and transcript
levels assayed by real-time PCR. Shown in this figure are the levels
of Zic3 transcript and the corresponding changes in Oct4, Nanog,
and Sox2 expression. Mean values  SE are plotted as percentages
relative to the nontargeting control (100%). The samples were as-
sayed in duplicate and normalized to endogenous -actin. (B) Cor-
responding decrease in protein levels after Zic3 RNAi treatment.
The Zic3 protein species was depleted in the Zic3 RNAi sample,
whereas -actin protein levels remained high in the control. -actin
protein was used as a loading control. (C and D) Alkaline phospha-
tase staining revealed that the extent of differentiation in Zic3 RNAi-
treated cells was greater than mock-transfected cells. (E) Secondary
replating assays were used to quantitate the extent of differentiation
in Zic3 RNAi cells. A 3- to 5-fold increase in differentiated colonies
were observed with Zic3 RNAi relative to mock-transfected control.
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knockdown cells, we assayed for changes in expression of
key pluripotency genes (Figure 3A). Though the mouse ES
cells showed clear morphological changes (Figure 3, C and
D), surprisingly, there were only modest decreases (15–25%)
in the expression of the key pluripotency genes Oct4 and
Sox2 (Figure 3A), whereas Nanog expression decreased 40%
relative to the nontargeting control. We performed the same
experiment with human ES cells (HuES9). Although there
was 70% decrease in Zic3 transcript levels, Oct4 and Sox2
transcript levels remained unchanged and Nanog levels de-
creased by 25% (Figure 3A). These results indicate that Zic3
plays a role in maintaining ES cell pluripotency and its
action is downstream of the dominant pluripotency factors
Oct4, Sox2, and Nanog.
It is interesting that targeted repression of Zic3 induced
morphological differentiation of ES cells while maintaining
the expression of pluripotency marker genes in the transient
knockdown experiments. We were interested in assessing
the role of Zic3 in the maintenance of pluripotency. To
determine the differentiation status of these cells we assayed
by Q-RT-PCR for expression of markers that represent lin-
eage-specific ES cell differentiation (Table 1). Zic3 knock-
down in mouse and human ES cells resulted in an up-
regulation of a panel of endodermal markers: Sox17 (3.5-fold),
PDGFRA (3.2- to 5.5-fold in mouse ES cells; 2.7-fold in
human ES cells), and Gata6 (2.5- to 3.5-fold; Figure 4). In
addition, two more endodermal lineage genes Gata4 and
Foxa2 were up-regulated in the E14 RNAi cells (2.5-fold).
We also assayed the expression of mesendodermal, meso-
dermal, ectodermal, trophectodermal and Wnt-pathway
markers in Zic3 RNAi cells. These markers remained un-
changed relative to the nontargeting control in both mouse
and human RNAi experiments (Figure 4). These results in-
dicate that Zic3 could play a specific role in maintaining ES
cell pluripotency by suppressing endodermal specification.
Rescue of RNAi-induced Zic3 Phenotype
Our RNAi experiments have established a link between the
expression of Zic3 and suppression of endodermal lineage
specification. We observed consistent results using multiple
siRNAs and shRNAs in both mouse and human ES cells.
However, there is still concern that ES cell differentiation
and marker gene expression were due to off-target effects of
the RNAi. To address this concern we designed a Zic3
expression construct that was immune to RNAi and tested
whether this construct could rescue the knockdown pheno-
types.
The Zic3 RNAi-immune expression construct was engi-
neered with five silent mutations in protein coding domain
sequence (Supplementary Figure 1). As such, this construct
(mutZic3) produces functional Zic3 protein, but with the
added feature that it is resistant to RNAi targeting and
Figure 4. Effect of Zic3 RNAi on lineage marker
gene expression. The panel of genes above was se-
lected for their lineage specificity. Transcript levels
of genes from the endodermal (ENDO), mesend-
odermal (MESENDO), mesdodermal (MESO), ecto-
dermal (ECTO), trophectordermal (TROPH), and
Wnt pathways in mouse and human ES cells were
assayed by real-time PCR after Zic3 depletion by
RNAi. (A) siRNA in mouse E14 cells. (B) shRNA in
mouse E14 cells. (C) siRNA in human HuES9 cells.
Mean levels  SE are expressed as percentages rel-
ative to the nontargeting control (100%). The assays
were read in duplicate and results were normalized
to -actin.
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degradation. Using this mutZic3 construct, we determined
the specificity of the endodermal lineage specification pro-
duced by Zic3 knockdown. First, the expression levels of
endodermal markers Foxa2, Gata4, and Sox17 were induced
in ES cells cotransfected with empty vector and Zic3-RNAi,
compared with cells cotransfeceted with empty vector and
GFP-RNAi (6.5-, 10.1-, and 8.7-fold, for Foxa2, Gata4, and
Sox17, respectively, Figure 5, A–C). However, ES cells that
express the mutZic3 (RNAi immune construct) showed no
induction of endodermal markers by Zic3-RNAi. (Figure 5,
A–C). These experiments indicate that our RNAi results are
not due to off-target effects and further support our conclu-
sions that Zic3 plays a role in maintaining the pluripotency
of ES cells.
Effects of Simultaneous Reduction of Zic2 and Zic3
Expression
Zic2 is another member of the Zic-family of transcription
factors. Zic2 is expressed in ES cells and its expression is
down-regulated upon differentiation (Brandenberger et al.,
2004; Wei et al., 2005). Zic2 may also be regulated by Oct4,
Sox2, and Nanog as binding sites for these TFs have been
mapped to the Zic2 gene by chromatin immunoprecipitation
(ChIP; Supplementary Figure 2). It was interesting that Zic3
RNAi resulted in a twofold increase in Zic2 (Figure 6A), and
this raised the possibility that Zic2 may be compensating for
the reduction in Zic3 levels. Knockdown of Zic2 expression
by siRNA (75% reduction in RNA levels) did not produce
any effect on lineage marker expression (Figure 6B). To
determine if Zic2 compensated for the absence of Zic3, we
performed a double RNAi experiment with Zic2 and Zic3 in
ES cells. The double knockdown prevented Zic2 levels from
increasing in a compensatory manner as observed in the
Zic3 single knockdown (Figure 6C). Interestingly, endoder-
mal specification was markedly enhanced after the Zic2 and
Zic3 double knockdown as demonstrated by increased ex-
pression of Sox17 (4.7-fold), PDGFRA (8.7-fold), and Gata4
(3.1-fold), which is more robust than observed for all three
markers (Sox17, 3.1-fold; PDGFRA, 3.3-fold; Gata4, 1.5-fold)
when Zic3 alone was reduced (Figure 6D). Thus, we dem-
onstrate that in the absence of Zic3, Zic2 is able to compen-
sate at least partially to reduce the extent of endodermal
specification in ES cells.
Zic3 Clonal Knockdown Lines Show Enhanced
Endodermal Specification
To determine if endodermal markers were up-regulated in
the same cells in which Zic3 was depleted, three clonal lines
were generated that stably expressed Zic3 shRNA. As antic-
ipated, Zic3 expression in the clonal lines was down-regu-
lated 60% relative to vector-only control lines (Figure 7A).
This knockdown is slightly less robust than in the transient
Zic3 knockdowns where depletion of Zic3 expression by
70–80% was observed (Figure 3A). The pluripotency genes
Oct4 and Sox2 were reduced between 20 and 30% relative to
controls in all three clonal knockdown lines, whereas Nanog
was reduced by 80% (Figure 7A). The endodermal genes
PDGFRA, Gata4, Gata6, and Sox7 were 30-fold higher than
in the controls, whereas Sox17 was up-regulated between
60- to 80-fold and FoxA2 was increased by 80- to 120-fold in
all three Zic3 knockdown lines (Figure 7B). The induction of
endodermal markers here was substantially greater than
observed in the transient Zic3 knockdowns. Markers of the
mesendoderm, mesoderm, ectoderm, trophectoderm, and
Wnt pathways remained essentially unchanged (2-fold) in
the Zic3 knockdown lines (Figure 7C). Thus the specific
up-regulation of endodermal gene expression in the clonal
lines is consistent, in fact more pronounced, with our obser-
vations in the transient knockdowns (Figure 4).
To ascertain if there were corresponding increases in
endodermal protein levels, immunocytochemistry was per-
formed against FoxA2, Gata6, and PDGFRA in the clonal
lines. The Zic3 knockdown lines consistently demonstrated
robust endodermal marker staining (Figure 8A) that was
absent in the vector control lines (Supplementary Figure 3).
Oct4 staining was also observed in the cells that were pos-
itive for endodermal marker expression (Figure 8A). Inter-
estingly, although the Zic3 clonal knockdown lines ex-
pressed Oct4 and SSEA-1 (Figure 8B), Nanog protein
expression was significantly reduced relative to the vector
control lines (Figure 8C). This agreed with the down-regu-
lation observed in Nanog gene expression levels in the Zic3
knockdown lines (Figure 7A) and raises the possibility that
Nanog gene expression is regulated by Zic3.
DISCUSSION
The work presented here demonstrates that Zic3 plays a key
regulatory role in controlling ES cell differentiation. In this
article, we have demonstrated that the expression pattern of
Zic3 in ES cells corresponds closely with that of known
regulators of pluripotency Oct4, Nanog, Sox2, which have
high levels of expression in the undifferentiated state and
decrease rapidly upon differentiation (Figure 1). Our find-
ings in mouse ES cells are consistent with results from
human ES cells (Brandenberger et al., 2004). The differences
we observed in Zic3 expression levels between pluripotent
and early differentiation phases imply a potentially signifi-
cant role for Zic3 in ES cell pluripotency. In addition, ChIP
mapping by us and others has revealed Oct4, Nanog, and
Figure 5. Zic3-immune construct specifically
reverses changes in lineage marker expression
levels caused by Zic3 RNAi. (A–C) Zic3 rescue
experiments demonstrating the specificity of
Zic3 RNAi and reversibility of lineage marker
expression. E14 cells cotransfected with the Zic3
RNAi-immune overexpression construct and
Zic3 RNAi vector demonstrated notable sup-
pression of endodermal markers Foxa2, Gata4,
and Sox17, relative to Zic3 RNAi cotransfected
with the empty vector control. Zic3 immune
real-time PCR analysis was conducted 3 d after
transfection. -Actin was used as an internal
control for normalization. The measurements
were done in duplicates and the average of the normalized ratio of target gene/-actin was calculated and presented with SD. Relative expressions
calculated with respect to the control experiment (Vector  control RNAi) at 100%. Transfection schemes are represented in Supplementary Table 1b.
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Sox2 co-occupancy on the Zic3 regulatory region, suggesting
that Zic3 may be coordinately regulated by Oct4, Nanog,
and Sox2 in mouse and human ES cells (Boyer et al., 2005;
Loh et al., 2006; Figure 1C). These observations together led
to our hypothesis that Zic3 functions to maintain the pluri-
potent state of ES cells. Here we characterized the relation-
ship of Zic3 with that of the key stem cell regulatory factors
and uncovered a role for Zic3 in the maintenance of ES cell
pluripotency.
Our first objective was to assess the nature of interactions
between Oct4, Nanog, and Sox2 with the Zic3 regulatory
region. In constructing the transcriptional network around
the key pluripotency genes, it is important to establish the
outcome of transcription factor binding on downstream
genes. We addressed this using a combinatorial approach
encompassing the results of ChIP mapping and RNAi, dem-
onstrating that ablation of Oct4, Nanog, and Sox2 in mouse
ES cells resulted in a significant decrease in Zic3 expression
(Figure 3A). Because Zic3 has already been implicated as a
target of Oct4, Nanog, and Sox2 in ChIP experiments (Boyer
et al., 2005; Loh et al., 2006), the concern of nondirect or
secondary effects of RNAi was significantly reduced (Blais
and Dynlacht, 2005). We thus concluded that the interaction
of Oct4, Nanog, and Sox2 with the regulatory region of the
Zic3 gene serves to enhance target gene expression. In other
words, the key pluripotency regulators function as tran-
scriptional activators of Zic3 in ES cells (Figure 9). This point
is underscored by our results with Nanog overexpression
and binding site mutagenesis assays, which demonstrate a
positive association between Nanog binding and Zic3 ex-
pression. We thus demonstrate positive functional interac-
tions between the key pluripotency regulators and the Zic3
gene regulatory region.
Because transcriptional networks are also known to fea-
ture autoregulatory loops (Lee et al., 2002; Blais and
Dynlacht, 2005), we also asked if the inverse relationship
was true, that is, whether Zic3 regulates expression of the
key regulatory genes. We observed that Oct4 and Sox2 levels
remained largely unperturbed by the ablation of Zic3 ex-
pression (Figures 3A and 7A). In the absence of clear
changes despite a robust Zic3 knockdown, our data places
Zic3 downstream of Oct4 and Sox2 in the ES cell transcrip-
tional networks as illustrated in Figure 9. In addition, we
found that Nanog expression decreased significantly in the
Zic3 clonal knockdown lines (Figures 7A and 8C). It remains
to be determined whether Zic3 directly regulates the expres-
sion of Nanog in embryonic stem cells.
ES cells are derived from the inner cell mass of the blas-
tocyst and, as such, are able to undergo unlimited self-
renewal and differentiation into the three germ layers of the
Figure 6. Effect of Zic2 and Zic3 double knockdown.
The genes were assayed by real-time PCR in triplicate
and normalized to a -actin control. Mean levels  SE
are expressed as percentages relative to the nontarget-
ing control. (A) Zic2 gene expression increased twofold
with Zic3 transient knockdown 4 d after transfection. (B)
Zic2 knockdown by siRNA was specific but did not
produce changes in lineage markers assayed. (C) Zic2
and Zic3 coknockdown produced specific knockdown
of Zic3 and at the same time prevented compensatory
increase of Zic2 expression in ES cells. (D) The expres-
sion of endodermal lineage markers Sox17, PDGFRA,
and Gata4 showed a similar pattern of up-regulation as
in the Zic3 single knockdown, but was significantly
enhanced in this Zic2/Zic3 coknockdown.
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embryo: mesoderm, ectoderm, and endoderm (Evans and
Kaufman, 1981; Martin, 1981). In the pluripotent state, ES
cells remain undifferentiated and do not express specific
lineage markers. We were interested in examining the effect
of Zic3 knockdown on the maintenance of ES pluripotency
using specific lineage markers as an assessment of differen-
tiation after Zic3 knockdown (Table 1). Here we show that
ablation of Zic3 expression in both mouse and human ES
cells resulted in a significant increase in markers of endoder-
mal lineage (Figures 4, 7, and 8). These results suggest that
Zic3 may have an important role in preventing endodermal
specification in ES cells.
Many reports support this observation: First, Zic3 knock-
down in ES cells induced expression of Gata4 and Gata6, and
forced expression of Gata4 and Gata 6 in ES cells result in
differentiation toward extraembryonic endoderm (Fujikura et
al., 2002). Further strengthening this association is the fact that
all other endodermal markers assayed (PDGFRA, Sox17, and
FoxA2) are also expressed in extraembryonic endoderm deriv-
atives (Kunath et al., 2005). Second, Zic3 regulates Nodal ex-
pression through direct interaction with its promoter during
gastrulation, and it has been shown that Nodal expression is
essential in proper specification of the embryonic visceral
endoderm (Mesnard et al., 2006). This significance is under-
scored by studies reporting that the earliest abnormalities ob-
served in Zic3 null mice are defects in proper patterning of the
anterior visceral endoderm (Ware et al., 2006b). Finally, Zic3
clonal knockdown lines exhibit a significant decrease in Nanog
gene expression (Figures 7A and 8C), and several groups have
reported that RNAi-mediated depletion of Nanog expression
resulted in an induction of extraembryonic endoderm markers
Gata4 and Gata6 (Mitsui et al., 2003; Hyslop et al., 2005; Hough
et al., 2006).
Here we have shown that Zic3 functions as a gatekeeper
of pluripotency in ES cells by preventing their differentiation
into cells that express endodermal markers. Corroborating
this, we have found that Nanog expression is significantly
reduced in the Zic3 clonal lines. This reduction is notewor-
thy as Nanog is a key regulator of pluripotency in ES cells
(Chambers et al., 2003), and it is well established that dis-
ruption of Nanog expression results in development of ex-
traembryonic endoderm character in ES cells (Mitsui et al.,
2003; Hyslop et al., 2005; Hough et al., 2006). Thus, we
demonstrate here an important role for Zic3 in the mainte-
nance of pluripotency in ES cells through prevention of
endodermal lineage specification, and we suggest that its
action may in part be mediated through the key pluripo-
tency regulator Nanog (Figure 9).
The role of Zic3 in preventing endodermal specification is
further supported by evidence indicating its restricted ex-
pression within the mesoderm and ectoderm lineages dur-
ing gastrulation (Herman and El-Hodiri, 2002). In addition,
Zic3 activity has been specifically implicated in the meso-
dermal and ectodermal molecular pathways in the early
developing embryo (Nakata et al., 1997; Kitaguchi et al., 2002;
Maeda et al., 2002; Kelly et al., 2006). These data in combi-
nation with our results suggest that although Zic3 is instruc-
tive for mesodermal and ectodermal specification in embry-
onic development, it may simultaneously function as a
repressor of ectopic endodermal induction in these tissues.
Figure 7. Zic3 knockdown clonal lines dem-
onstrate endodermal gene marker specifica-
tion. Three Zic3 knockdown clonal lines and
two vector controls were assayed as indicated
in the diagrams. (A) The pluripotency markers
Oct4 and Sox2 were slightly down-regulated
between 20 and 30%, whereas Zic3 and Nanog
decreased significantly between 60 and 80%
relative to the vector controls. (B) All endoder-
mal markers assayed in the knockdown lines
were significantly up-regulated between 20-
and 120-fold relative to the control lines. (C)
Mesendodermal, mesodermal, ectodermal,
trophectodermal, and Wnt pathway genes did
not change significantly in knockdown lines,
demonstrating 2-fold changes relative to the
vector controls. Gene expression levels were
assayed by real-time PCR. The samples were
assayed in triplicate and normalized to endog-
enous -actin. Mean values  SE are plotted
as percentages relative to the vector control.
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The transcription factor Zic3 shares five highly conserved
Zinc finger domains with family members Zic1, Zic2, Zic4,
and Zic5 (Aruga et al., 1994, 1996a,b, 2004). Their partially
overlapping spatial and temporal patterns of expression
during early development suggests potential functional re-
dundancy between the Zic family members (Nagai et al.,
1997; Elms et al., 2004). We observed that Zic2 gene levels
were up-regulated when Zic3 expression was reduced (Fig-
ure 6A). Because Zic2 is also differentially expressed be-
tween pluripotent and differentiation states of ES cells
(Brandenberger et al., 2004; Wei et al., 2005) and binding of
the key pluripotency transcription factor Nanog has been
mapped to the Zic2 regulatory region (Supplementary Fig-
ure 2), we reasoned that Zic2 may participate in the regula-
tion of ES cell pluripotency along with Zic3. To unveil the
possible effects of functional redundancy between Zic2 and
Zic3, a double knockdown was performed in mouse ES cells.
We report that repression of Zic2 and Zic3 expression sig-
nificantly enhanced endoderm specification in ES cells (Fig-
ure 6C). The evidence that Nanog binds to the Zic2 regula-
tory region suggests that it may be involved in similar
pathways as Zic3 in repressing endoderm expression. Thus,
Zic2 and Zic3 may participate in redundant or partially
overlapping networks to silence endoderm specifying gene
expression and contribute to the maintenance of pluripo-
tency in ES cells.
CONCLUSION
In this article, we expand on the significance of Zic3 as a
target of the key stem cell regulatory factors in ES cells. Our
results highlight a role for Zic3 in the maintenance of plu-
ripotency downstream of Oct4 and Sox2, and uncovers its
role as a gatekeeper controlling differentiation of ES cells
into endoderm-specific lineages. In support of this, we
present evidence that a key regulator of pluripotency,
Nanog, which is shown to be important in repressing
endodermal lineage specification, may directly or indirectly
be regulated by Zic3 in ES cells. Having now established that
Zic3 plays an important role in maintenance of pluripotency,
Figure 8. Protein expression in Zic3 knockdown clonal lines. (A)
Oct4 protein expression was high in all three Zic3 knockdown lines,
and the expression of specific endodermal marker proteins Foxa2,
Gata6, and Sox17 was observed in the same cells. (B) The Zic3
knockdown lines expressed stem cell surface protein, SSEA-1, which
is specific to murine ES cells. (C) The Zic3 clonal knockdown lines
demonstrated a significant decrease in Nanog expression.
Figure 9. A model of Zic3 function in embryonic stem cells. Zic3
contributes to the maintenance of pluripotency by operating down-
stream of Oct4, Nanog, and Sox2 to inhibit endoderm lineage spec-
ification as characterized by endodermal markers Sox17, PDGFRA,
Gata4, Gata6, Foxa2, and Sox7. The presence of Zic3 also maintains
the expression of the homeodomain protein Nanog, a key regulator
of pluripotency in embryonic stem cells.
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it will be valuable to search for Zic3-regulated target genes,
which will extend our understanding of the transcriptional
network that governs lineage specification. The elucidation
of molecular signatures of early ES cells in this manner will
contribute to validation and extension of the ES cell tran-
scriptional network beyond Oct4, Nanog, and Sox2. The
critical need to dissect their transcriptional networks is un-
derscored by their potential to yield critical insights into
genetic mechanisms at the earliest stages of embryo devel-
opment and to provide significant inroads into the proper-
ties ES cell unlimited growth and differentiation potential
that will render them therapeutically useful.
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